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The study of the neural crest is fundamental in answering questions that arise in both Stem 
Cell Biology and Developmental Biology. This project focuses on the development of a 
neural crest derivative, the melanocyte. In zebrafish, melanocyte specification depends 
upon the Sry-related High Mobility Group box gene (sox) sox10 and Wnt signalling to 
drive the transcription of mitfa (microphthalmia-associated transcription factor). However, 
the mechanisms involved in stable melanocyte differentiation are not fully understood. In 
vivo data suggested that sox10 formed part of a Feed-Forward Loop repressing melanocyte 
differentiation and is relieved by Mitfa-dependent repression of sox10. Aspects of the 
melanocyte gene regulatory network derived from experimental data and mathematical 
modelling were tested with the aim of improving the understanding of melanocyte biology.  
 Modelling predicted an unknown factor, named Factor Y, was involved as a 
limiting factor for the maintenance of mitfa expression in differentiating melanocytes. Wnt 
signalling was tested as a candidate for this factor by investigating the effects of small 
molecule activators of the pathway during melanocyte differentiation. Resultantly, we 
observed increased cell dendricity, disruption of cell organisation pattern in the head of 
embryos and activation of mitfa expression. However, no other pronounced changes in cell 
differentiation were seen. Therefore, we suggest that maintenance of mitfa and of 
melanocyte differentiation would depend on a complex regulatory ensemble which 
includes factors other than Wnt signalling.  
 sox10 and mitfa expression levels were characterised through time using the Real-
time Quantitative Polymerase Chain Reaction to quantify the genetic variability occurring 
during melanocyte derivation. The previously described decrease of sox10 expression in 
melanocyte lineage was confirmed. Unexpectedly, the decrease of mitfa expression was 
observed suggesting that mitfa is maintained at low levels in melanocytes where stochastic 
effects could be important. This could also suggests the existence of a new unknown factor 
involved downstream of mitfa for melanocyte differentiation.  
 The role of histone deacetylase (Hdac(s)) as a candidate repressor of sox10 
expression during differentiation was investigated in melanocytes. Treating embryos with 
Hdac(s) inhibitor caused the regression of melanocyte differentiation and the persistence of 
sox10 expression in melanocytes. These results suggested a potential role for Hdac in 
Mitfa-dependent downregulation of sox10. 
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Chapter 1. Introduction 
 
1.1 Developmental biology and Gene Regulatory Networks  
 
Developmental biology aims to describe the genetics and the cellular mechanisms involved 
in organism development. Morphogenesis and fate restriction in multipotent cells are key 
processes explored in the field. These processes are organised by Gene Regulatory 
Networks (GRN)s which coordinate the mutual regulation between key factors to allow 
fate choice and specific cell type development. Understanding how different cell types 
emerge from multipotent and pluripotent cell populations, and how GRN regulate the 
developmental process for each cell type remains a challenge.  
 
1.2  Neural crest as a model for stem cell biology and 
developmental biology  
 
The Neural Crest (NC) is a dynamic and transient structure made of multipotent cells 
which delaminate from the neural tube and migrate throughout the embryo, giving rise to 
an extensive range of derivatives (Donoghue et al., 2008, Sauka-Spengler and Bronner-
Fraser, 2008b, Raible et al., 1992, Eisen and Weston, 1993, Weston, 1970, Dupin et al., 
2007). Cells stemming from the NC are of two broad classes, the ectomesenchymal and the 
non-ectomesenchymal tissues. The ectomesenchymal tissue includes all skeletogenic cell 
types such as, chondrocytes, odontoblasts, osteocytes and craniofacial cartilage for 
instance (Cerny et al., 2004, DeLaurier et al., Hall et al., 2006, Hanken and Gross, 2005, 
Schilling et al., 1996, Schneider, 1999, Walker and Trainor, 2006). The non-
ectomesenchymal tissue consists of all neuroglial cell types, including sensory neurons, 
enteric neurons, Schwann cells, but also pigment cell types, such as, black melanocytes 
and in zebrafish, yellow xanthophores and shiny iridophores (Baroffio et al., 1991, Dupin 
et al., 2007, Donoghue et al., 2008, Bronner-Fraser and Fraser, 1991, Kelsh et al., 1996a).  
1.2.1 Neural crest as a model for stem cell biology 
 
NC cells exhibit both multipotency and self-renewal which are the two properties of stem 
cells. Studies in chick, quail and mouse have shown that NC cells could be self-renewing 
(Dupin et al., 2000, Stemple and Anderson, 1992, Real et al., 2006, Le Douarin et al., 
2004, Trentin et al., 2004). In vitro analysis of primary cultures of avian, mouse and 
Xenopus premigratory NC cells showed that cells were multipotent (Stemple and 
Anderson, 1992, Dupin et al., 2003, Bronner-Fraser and Fraser, 1991, Baroffio et al., 1988, 
Bronner-Fraser and Fraser, 1988, Baroffio et al., 1991, Le Douarin and Dupin, 2003). 
Furthermore, in vivo analysis of single NC cell tracing using intracellular injection of 
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rhodamine dextran in zebrafish showed, that while migrating, the multipotent cells of the 
NC were differentiating in the same fates as the ones observed from NC cells in mouse, 
Xenopus and chick (Raible et al., 1992). Two models can be described, the direct and the 
progressive fate restriction model. In the direct restriction model cells become restricted to 
one fate directly from the fully multipotent state and before migrating. In this case, 
migrating cells are committed to a fate. In contrast, the progressive restriction model 
suggests that cells become restricted gradually via a series of several partially restricted 
intermediates and that this process occurs throughout migration. Consequently, in this case, 
migrating cells could be partially restricted precursors. 
 Testing these models by investigating the existence of intermediaries and 
describing their heterogeneity will be of crucial importance in vivo. Studies analysing the 
potentiality of quail NC cells in clonal cultures demonstrated that pools of migrating cells 
consisted of heterogeneous precursors and highly multipotent cells (Dupin et al., 2007). 
However, it remains unclear if all cells of the multipotent pool have the same potentiality 
prior to dispersion. Accordingly, it will be important to direct research towards resolving 
the relationship between individual NC cells and the NC niche in vivo to understand the 
signals responsible for the activation of factors which are involved in inducing transition 
between precursor intermediaries (Raible et al., 1992). Consequently, the study of fate 
restriction and self-renewal in the multipotent pool of NC cells is a relevant model for stem 
cell biology. 
1.2.2 Neural crest development as a model for developmental biology 
 
In vertebrate embryos, NC development is a process of complex aspects and three 
characteristics together are unique to the NC: its origin at the neural plate border; its 
extensive migratory ability; and finally, its multipotency. Consequently, NC appears to be 
an excellent candidate as a model for development biology in general.  
 The NC developmental process is unique and happens early in the development of 
the embryo. It is crucial for the early structure of the embryo and the future fully developed 
organism as NC derived cells are involved in the establishment and development of many 
systems. Therefore, studying NC development is also, more broadly, a model for 
development in general. NC development starts during gastrulation, it is first induced at the 
neural plate border, between the non-neural ectoderm and the neuroectoderm, at the dorsal 
tips of the developing future nervous system, alongside the complex process of the neural 
plate induction (Figure 1.01) (Colas and Schoenwolf, 2001, Dupin et al., 1993, Le 
Douarin, 1999). It continues through, and in parallel with neurulation and lasts until late 
organogenesis (Bronner-Fraser, 2003). The neurulation process is accompanied by 
morphogenetic changes. The paraxial mesoderm changes morphology while the neural 
plate folds to form the neural tube as described in Figure 1.01. In the anterior region of the 
embryo epithelial pleats merge to become the ectoderm epithelium and the neural tube in 
Xenopus, mouse and chick (Mayor et al., 1999, Thiery et al., 1982, Le Douarin, 1980, 
Bronner-Fraser, 2003, Hall, 2008). In zebrafish, as in all teleosts, a ventral increase of the 
ectoderm thickness forms a neural keel (around 10 somites/14 hour post fertilisation (hpf)) 
(Lamers et al., 1981, Raible et al., 1992, Eisen and Weston, 1993). In this case there is no 
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formation of neural folds. By 16 somites (17 hpf) in zebrafish, the neuroepithelium 
develops a central canal internally and can be referred to as a neural tube (Raible et al., 
1992). Subsequently, cells of the NC undergo an epithelial to mesenchymal transition 
(EMT), in part due to cytoskeletal re-organisation (Gammill and Bronner-Fraser, 2003, 
Dupin et al., 1993). After delamination from the neural tube, cells of the NC acquire 
migratory capacities and migrate throughout the embryo in between the ectoderm and the 
somites or between the somites and the neural tube.  
 These events, altogether, are orchestrated by a complex GRNs cascade (Meulemans 
and Bronner-Fraser, 2004, Sauka-Spengler and Bronner-Fraser, 2006, Dupin et al., 2007, 
Le Douarin, 2001). Experiments have proved that resolving the sequence of gene 
expression and factor activities involved in these processes can be conflicting when 
studying different model organisms due to the fact that the timing of events can vary 
throughout species (Sauka-Spengler and Bronner-Fraser, 2008a). Consequently, 
understanding the GRN coordinating the development of each NC cell derivative remains a 
great challenge for developmental biologists. The next step of NC development research is 
to determine the dynamics of the regulatory networks at play in individual cells within the 
NC cell population and the role of NC niche in events occurring through its development 
(Raible et al., 1992). Below, we describe what is currently known about NC induction, NC 
specification, NC cell delamination and NC cells specification and migration. 
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Figure 1.01: The formation of the neural crest is a dynamic process. 
Neural crest cells are first induced at the neural plate border (green) (1), between the non-
neural ectoderm (blue) and the neuroectoderm (purple). During neurulation, the paraxial 
mesoderm changes morphology while the neural plate folds (2) to form the neural tube (3). 
Once the neural tube is closed, cells of the NC undergo an epithelial to mesenchymal 
transition (3-4, not clearly represented) and migrate throughout the embryo, in between the 
ectoderm and the somites or between the somites and the neural tube. (reproduced with the 
kind permission of  Gammill and Bronner-Fraser, (2003)) 
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1.3 Evolutionary development of neural crest 
 
In terms of evolutionary origin, the NC is described as a cell population located between 
the dorsal neural tube and the epidermis and it is considered to be a vertebrate novelty. 
However, it is crucial to understand NC in the context of its evolutionary history and to 
bear in mind that its complexity in vertebrates could have been built upon an ancestral 
genetic simplicity (Donoghue et al., 2008). In the Tunicates, a population of migrating 
cells stemming from an area close to the neural tube was found to be comparable to the 
neural crest (Jeffery et al., 2004). A recent study tested gene expression and derivation of 
the pigment cell lineage in the urochordate Ciona intestinalis and showed that the cephalic 
melanocyte lineage existed in Tunicates (Abitua et al., 2012). Abitua et al., (2012) showed 
that these cells expressed key markers of the neural plate border as well as NC 
specification markers such as Snail, Id or the Forkhead Box factors D (FoxD)s.  In this 
model, induction of a mesenchyme determinant, twist, could reprogram cells of the 
ectoderm into migrating mesenchyme. Thus, the recruitment of certain factors, required for 
mesenchyme determination could have been a crucial event for formation of the NC cells 
from the neuro-ectoderm (Abitua et al., 2012). The study suggested that the GRN 
underlying melanocyte lineage development probably existed before the divergence of 
Chordates and Tunicates (Abitua et al., 2012). 
  
1.4 Neural crest development is disrupted in many human 
diseases 
 
Defects in NC development are called neurocristopathies. They are numerous in humans, 
and include the Waardenburg syndromes (WS) and Hirschprung disease. During the 
development they affect distinct organs and systems stemming from NC (Chen et al., Lee 
et al., 2000, Antonellis et al., 2006, Bondurand et al., 2000, Potterf et al., 2000, Badner et 
al., 1990, Boissy and Nordlund, 1997). Sensorineural hearing as well as myogenesis is 
disrupted in WS and craniofacial structure can also be perturbed. Nerve cells of the large 
intestine are affected in Hirschprung disease causing the aganglionic megacolon disorder. 
Melanocyte development is affected in neurocristopathies and disruption of melanocyte 
development is the cause of several specific diseases. Defects of cell specification are the 
cause of WS, defects of cell proliferation can be the cause of melanoma cancer, defects of 
cell differentiation are responsible for albinism and defects of cell survival can result in 
vitiligo (Lee et al., 2012, Lee et al., 2000, Lucky and Nordlund, 1985, Halaban et al., 
1988). Research which aims to understand the mechanisms involved in the development of 
the NC is fundamental for understanding the genetic basis for these disorders. 
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1.5 Melanocyte related disease in human  
 
There are numerous melanocyte disorders in humans (Hodgkinson et al., 1993, Lucky and 
Nordlund, 1985). Some of the main disorders are described here in order to better outline 
the importance of studying melanocyte development. Two generic terms often used 
interchangeably to denote these disorders are leukoderma and hypopigmentation, whereas 
several terms describe the degree of loss of melanin content. For instance, hypomelanosis 
designates a decrease of melanin within the skin; amelanosis suggests the total absence of 
melanin; and the loss of pre-existing melanin pigmentation is called depigmentation as 
observed in the disease vitiligo (Boissy and Nordlund, 1997, Lucky and Nordlund, 1985). 
Vitiligo is an idiopathic disorder defined by appearance of depigmented patches and has a 
worldwide incidence of less than 1 %  (Lee et al., 2012). Loss of melanocytes in the skin 
can result from several causes, including autoimmune reactions, genetic disruptions and 
oxidative stress (Hedstrand et al., 2001, Lee et al., 2012, Jin et al., 2007, Pietrzak et al., 
2012). One therapy for vitiligo consists of exposing the skin to UVB light from UVB 
lamps (Don et al., 2006). As alternative treatment, shown in a study from Olsson and 
Juhlin, (2002), found that melanocytes could be transplanted for re-pigmentation of the 
white skin patches, however, the longevity of cell survival was limited and variable 
between patients. Vitiligo is also often observed in the hereditary disorder, autoimmune 
polyendocrine syndrome type I (APS I), and it involves immunoreactivity against SOX10 
and SOX9 (Hedstrand et al., 2001). Interestingly, both KIT and FOXD3 expression have 
also been shown to be involved in vitiligo (Goding, 2007). One hypothesis for this 
mechanism suggests it could involve the loss of melanocyte survival genes such as KIT, 
MITF or BCL-2. The model proposed suggested that melanoblasts containing the FOXD3 
variant promoter sequence would show increased FOXD3 expression which would cause 
alterations in melanocyte development (Alkhateeb et al., 2005). However, the complete 
role of FOXD3 and KIT in the progression of vitiligo remains to be clarified (Cooper et al., 
2009). 
 Albinism is a group of related genetic disorders in which patients show not only the 
dilution or absence of melanin in skin but also in eyes and follicles, although melanocytes 
themselves are, at least initially, present (Halaban et al., 1988, Boissy and Nordlund, 
1997). Albinism can be caused by mutations in numerous genes such as tyrosinase 
(Summers, 2009). It is a common genetically inherited disorder with an estimated 
incidence in mixed populations of 1/20,000, however, in some African populations it can 
reach 1/1,500. 
 Naevi are common benign neoplasms which can be present at birth, but can also be 
acquired later in life, and it is a risk factor associated with malignant 
melanomas. Melanoma is caused by the transformation of melanocytes into 
a malignant tumor (Bandarchi et al., 2013). Melanoma is not the most common skin cancer 
but it is the most dangerous as it causes death in the majority of cases. Melanoma is also 
widely observed in domesticated dogs, cows and horses. Cancers are complex diseases 
which can be driven by disruption of one or several genes and/or environmental factors. In 
multifactorial types of cancer, the environment can create the conditions for the 
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development of the disease. Malignant melanoma is a multifactorial cancer which involves 
both an environmental component and genetic predispositions (Bandarchi et al., 2013). 
 The study of normal melanocyte development is fundamental for understanding the 
processes involved in human diseases affecting melanocyte development, but also to 
develop potential treatments against the progression of melanoma (Cronin et al., 2009, 
Lister, 2012, Pathy et al., 1993, Patton et al., 2011, Santoriello et al., 2012, Rebecca et al., 
2012, White and Zon, 2008, Yajima et al., 2011, Yancovitz et al., 2012). It would be 
interesting to test if gene therapy at an early stage could repair genetic disorders involving 
one gene, such as albinism or certain WS. Understanding the GRN involved in the 
melanocyte development would allow us to predict the downstream effects of disrupting 
any melanocyte gene and consequently better inform on the efficacy of therapeutic 
interventions, such as gene therapy and drug treatments. 
1.6 Early neural crest development and regulation first depends 
on complex Gene Regulatory Networks 
 
NC development is regulated by a succession of complex GRNs implementing internal and 
external signalling (Meulemans and Bronner-Fraser, 2004, Le Douarin, 2001, Bronner-
Fraser, 2003, Dorsky et al., 2000a, LaBonne and Bronner-Fraser, 1999). More specifically, 
the genetic regulation of NC development starts when the NC Induction Signals activate 
the Neural Plate Border Specifier genes, which in turn modify effects of the Induction 
Signals and allow formation of bona fide NC which is characterised by elevated expression 
of the NC Specifier genes (Le Douarin, 2008, Marchant et al., 1998, Sauka-Spengler and 
Bronner-Fraser, 2008b, Sauka-Spengler and Bronner-Fraser, 2006, LaBonne and Bronner-
Fraser, 1999, Dupin et al., 2007). In turn, these NC Specifiers initiate specific cell type 
specification and differentiation of GRNs. Figure 1.02 summarises the succession of these 
events.  
1.7 Important signals for neural crest induction 
 
NC induction begins between the prospective neural and non-neural ectoderm, at the 
neural plate border and involves crucial signals. The bone morphogenetic proteins (BMPs), 
as well as Wnt signalling and fibroblast growth factor (FGF) are required for NC induction 
(Figure 1.02) (LaBonne and Bronner-Fraser, 1998, Sauka-Spengler and Bronner-Fraser, 
2008b, Mayor et al., 1995, Garcia-Castro et al., 2002, Le Douarin, 1999, Steventon and 
Mayor, 2012, Tribulo et al., 2003, Villanueva et al., 2002, Schumacher et al., 2011). 
However, the tissues secreting the induction signals in each species are not yet clearly 
defined. In Xenopus and zebrafish, NC induction at the neural plate border has been shown 
to be in part orchestrated by a gradient of BMP signalling (Tribulo et al., 2003). The 
gradient of BMPs creates a gradient of activation of members of the Muscle Segment 
Homeobox family (MSX) which in turn activates specifiers of the NC such as snail 
(Tribulo et al., 2003, Schumacher et al., 2011). 
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  Posteriorising signals, such as Wnt signalling, FGF and retinoic acid have also been 
shown to be required for maintenance of the NC territory (Villanueva et al., 2002, Aybar et 
al., 2003). In Xenopus and zebrafish, experiments of gain-of-function and loss-of-function 
have shown that the canonical Wnt pathway (described later) was necessary and sufficient 
for induction of the NC (Garcia-Castro et al., 2002, Wu et al., 2005, Villanueva et al., 
2002). In avian models, the non-neural-ectoderm could be the source secreting Wnt 
signalling (Garcia-Castro et al., 2002). In contrast, the secretion of the Wnt factor has not 
yet been clearly addressed in mouse (Sauka-Spengler and Bronner-Fraser, 2008b, Lewis et 
al., 2004). In chicks and zebrafish, studies have shown that the Delta-Notch signalling was 
also required for NC formation and limitation of NC to the neural plate border (Meulemans 
and Bronner-Fraser, 2004, Sauka-Spengler and Bronner-Fraser, 2006, Sauka-Spengler and 
Bronner-Fraser, 2008b). Factors involved in NC induction prepare the neural plate border 
for expression of the Neural Plate Border Specifiers (Sauka-Spengler and Bronner-Fraser, 
2008b).  
1.8 The Neural Plate Border Specifiers are required for 
development of bona fide neural crest  
 
The Neural Plate border Specifiers are transcription factors, such as, the Paired Box (PAX) 
factors PAX3, PAX7, the Zinc finger protein ZIC1, the distal-less related homeobox 
factors DLX3 and DLX and also MSX1, MSX2, which are activated by the Induction 
signals as previously described. The genes coding for these factors are expressed together 
in combinations to define NC territory. Their expression also modifies the cellular 
response to BMP, Wnt and FGF signalling which allows the establishment of competence 
of the neural plate border and the activation of a new set of genes, the NC Specifiers 
(Figure 1.02) (Meulemans and Bronner-Fraser, 2004, Sauka-Spengler and Bronner-Fraser, 
2008b, Sauka-Spengler and Bronner-Fraser, 2008a, Monsoro-Burq et al., 2005, Mayor et 
al., 1999). These genes seem to be expressed consistently in gnathostomes and lamprey. 
Furthermore, studies in the urochordate, Ciona intestinalis, have detected expression of 
homologs of neural plate border specifiers pax3/7, zic, and msx in the epidermal cells at the 
lateral tips of the forming neural plate. In Tunicates, functional analysis based on 
morpholino injections showed the conservation of the genetic interactions in the network, 
suggesting ancient roles for these genes, as well as, them being highly evolutionarily 
conserved (Wada and Saiga, 2002, Ma et al., 1996, Imai et al., 2004, Sauka-Spengler and 
Bronner-Fraser, 2008b). 
Chapter 1. Introduction  
   19 
 
1.9 Neural Crest Specifiers are the first factors implementing 
specification of the neural crest to specific derivative cell-types 
 
The combination of Neural Plate border Specifiers and signalling, such as Wnt signalling 
or the BMP signalling, allows the activation of the Neural Crest Specifiers and the NC 
specifiers can regulate each other. Their expression is associated to the initiation of a new 
GRN in the NC (Figure 1.02) (Honore et al., 2003, Sauka-Spengler and Bronner-Fraser, 
2008b, Meulemans and Bronner-Fraser, 2004, LaBonne and Bronner-Fraser, 2000). NC 
Specifiers, such as, FoxD3, the Activator Protein 2 (AP‑2), Twist, Snail1, Snail2, Id3, 
Twist and the Sry-related High Mobility Group box (Sox) factors, Sox8, Sox9, Sox10, are 
responsible for activation of genes involved in the specification of cell types, allowing the 
induction of a large number of factors which drive specification and differentiation of 
specific NC derivatives.  
1.10 Neural crest cell delamination from the neural tube 
involves an epithelio-mesenchymal transition 
 
Before gaining migratory capacity, cells leave the neuroepithelium by delaminating from 
the dorsal neural tube (Figure 1.02). For this, several crucial cell properties like cell 
morphology, cell adhesion, and cell motility, are submissive to reorganisation (Kalcheim, 
2000, Dupin et al., 1993, Burstyn-Cohen and Kalcheim, 2002, Kalcheim and Burstyn-
Cohen, 2005, Klymkowsky et al., 2010). Delamination is a process which allows NC cells 
to detach from the neuroepithelium by undergoing an EMT. The EMT is accompanied by 
major adaptations of the cytoskeleton (Garcia-Castro et al., 2002). Most cells down-
regulate the cell-cell adhesion complexes and modify their apico-basal polarity. The 
reduction of the number of tight junctions and the re-organisation of the extracellular 
matrix, with secretion of matrix metalloproteases implicated in the invasive behaviour can 
be observed. Furthermore, the control of the cell-cycle is specifically adapted for 
delamination (Ikenouchi et al., 2003, Egeblad and Werb, 2002, Burstyn-Cohen and 
Kalcheim, 2002). As a result of activation of the snail family gene members, the 
expression of cadherins is adapted to enable the EMT (Nelson and Nusse, 2004, Nakagawa 
and Takeichi, 1995, Sauka-Spengler and Bronner-Fraser, 2008b). Finally cells show 
protrusive activity (Theveneau and Mayor, 2012). In zebrafish for instance, before the cells 
start dispersing, they enter a process of probing the dorsal surface of the somite by 
extending pseudopodia meanwhile the cells of the dorsal somite show active protrusive 
activity (Raible et al., 1992).  
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Figure 1.02: Cascade of GRNs involved in the formation of the neural crest. 
The cascade of genes in play during the formation of the NC is presented here. First, NC 
induction is controlled by BMP, Wnt, FGF and Notch signalling for activation of Neural 
Plate Border Specifiers (1). The Neural Plate Border Specifiers, in turn, modify the effects 
of BMP, Wnt, FGF and Notch signalling to activate the expression of the NC Specifiers 
(2). The NC Specifiers then activate expression of genes involved in NC derivatives 
specific GRNs (NC effector genes). Importantly, the NC specifiers also control 
modification of cell aspects such as cytoskeleton re-organisation and cell-cycle arrest 
mediating NC. 
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1.11 Cell migration is associated with fate restriction 
1.11.1 Cells migrate via different pathways in embryos 
 
After delamination, NC cells migrate within the embryo and NC cell precursors lose their 
multipotency by becoming progressively more restricted before or during migration 
(Thomas and Erickson, 2008, Le Douarin and Dupin, 2003, Le Douarin et al., 2004, Real 
et al., 2006, Le Douarin, 1980). The order of dispersing, the timing and the pathway 
followed by different cell types for different derivative fates, can vary throughout animal 
models, however, the processes themselves are likely to be largely conserved (Eisen and 
Weston, 1993, Sauka-Spengler and Bronner-Fraser, 2008b, Serbedzija et al., 1990, Raible 
et al., 1992, Le Douarin et al., 2004, Mayor et al., 1995). NC cells migrate as waves 
following two pathways in the embryos; the lateral pathway, between the ectoderm and the 
somites; and the ventral/medial pathway between the somites and the neural tube. Studies 
in chick have suggested that signalling molecules expressed in the dorso-lateral interstice, 
such as, semaphorins, spondins and ephrins, could be responsible for the choice of the 
migratory pathway (Theveneau and Mayor, 2012). In zebrafish, NC cells migrate first via 
the medial pathway (Figure 1.03). Around four hours after the start of the migration, NC 
cells begin migrating in between the somites and the epidermis which corresponds to the 
lateral pathway (Theveneau and Mayor, 2012, Raible et al., 1992). In Xenopus, the 
majority of cells migrate throughout the ventral pathway while a few cells follow the 
lateral pathway (Theveneau and Mayor, 2012). In avian and mammalian models, NC cells 
migrate between the developing somite and the neural tube which consists of the ventral 
pathway. Simultaneously in mouse and within a 24 hours delay in chick, melanocyte 
precursors migrate dorsally between the dorsal ectoderm and the somites (Figure 1.03) 
(Theveneau and Mayor, 2012). Interestingly, in this model the migratory process seemed 
to be orchestrated by autonomous changes, as suggested by experiments grafting NC cells 
and melanocytes ectopically in several parts of the trunk which showed that only 
differentiated melanocytes could migrate on the dorso-lateral pathway (Erickson, 1985). In 
zebrafish and Xenopus, melanocyte precursors can migrate along the two pathways, 
whereas, in mouse and chick, they only migrate laterally (Figure 1.03) (Kelsh et al., 2009). 
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Figure 1.03: Schematic of the Neural Crest cell migration and timing in three 
different models.  
 
After delamination, NC cells in the trunk and tail migrate on one of two major pathways. 
In all species, pathway choice and fates adopted are correlated and in some cases like 
melanocyte in chick, fate specification is required for correct pathway choice. In mouse, 
chick and zebrafish, melanocytes migrate on the dorsolateral pathway. However, in 
zebrafish melanocytes also migrate through the medial pathway. In mouse, melanocyte 
migration starts at the same time as neuronal cell migration through the ventral pathway. In 
chick, neuronal cells migrate first, exclusively via the ventral pathway, whereas later, 
melanocyte precursors migrate using the dorsolateral pathway. In zebrafish, neural cells 
migrate first, using only the medial pathway; then melanocytes and iridophore precursors 
follow the same pathway and only later, melanocyte and xanthophore precursors migrate 
through the dorsolateral pathway. dm: dermamyotome, myo: myotome, nt: notochord. 
(adapted from Kelsh et al., 2009). 
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1.11.2 Complex interactions are involved in fate restriction during cell 
specification 
Fate specification from the NC pool involves complex interactions. However, for each cell 
fate, a rather well conserved genetic network can be defined through models, showing the 
strong conservation of the cell types. The progressive restriction model suggests that key 
factors could permit fate choice in pluripotent or bipotent precursors. This hypothesis 
suggests that cells remain sensitive to internal and external factors until commitment. 
 It is crucial to understand the role of the niche which is involved in the 
specification of some particular cell types such as Schwann cells. Schwann cell precursors 
migrate via the ventral migratory pathway and differentiate along the growing nerves. A 
study from Adameyko et al., (2011) showed that in chick, at least some NC derived 
Schwann cell precursors could be marked by sox10, however, they could also keep the 
potentiality to differentiate into melanocytes. Only when they specify to melanocyte, the 
precursors activate the melanocyte marker microphthalmia associate factor (Mitf). The 
contacts with the nerves, which are associated with Neuregulins and ErbB3 signalling, 
were then critical for specification of Schwann cells in this niche (Adameyko et al., 2009, 
Baynash et al., 1994, Dupin et al., 2007).  
1.11.3 Fate restriction in the case of melanocyte derivation from the 
neural crest 
 
The mechanisms involved in melanocyte derivation from a model to another are not fully 
understood. Figure 1.04 summarises melanocyte derivation from the NC pool (adapted 
from White and Zon, (2008)). Interestingly, studies in mouse and chick suggested that 
melanocytes and glial cells could be derived from a shared progenitor. Within these 
precursors, fate choice would involve foxd3, which could negatively regulate the 
melanocyte fate (Thomas and Erickson, 2009). foxd3 is expressed in early pre-migrating 
NC and is downregulated in melanoblasts, however, molecular mechanisms involved in 
this process remain unknown (Curran et al., 2009, Dupin et al., 2007). Furthermore, it is 
not known if melanoblasts migrating with the first wave on the dorso-lateral pathway could 
also share a bi-potentiality with glial cells. In fish, the existence of a precursor restricted to 
all types of chromatophores has been suggested (Bagnara, 1999). The hypothesis of the 
existence of a chromatoblast is not contradictory to the hypothesis of the existence of a 
melanoglial bipotent precursor (Dupin et al., 2003, Trentin et al., 2004). In zebrafish, data 
suggested the existence, at early stages, of cells of the NC expressing four factors, the two 
melanoblast early markers sox10 and mitfa and the potential iridoblast early markers 
leukocyte receptor tyrosine kinase (ltk) and id2. Expression of these genes could be 
marking chromatoglioblasts in vivo (Lopes et al., (2008); Nikaido M, Rodrigues F, 
unpublished data).  
 A progressive model could be envisaged whereby the chromatoglioblasts would be 
pushed towards a specific fate by expressing certain genes and receiving specific signals at 
a specific time point. Investigating the existence of such precursors in vivo and the limiting 
factors for fate choice, would be crucial. 
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 In mouse, cells known as Melanocyte Stem Cells (MSCs) are found in the hair 
follicle. The factors involved in the maintenance of these cells, as well as the potency of 
these cells in vivo, remains to be tested (Osawa et al., 2005, Lang et al., 2000, Nishimura et 
al., 2002). Expression of Sox10, Pax3 and Mitf seem to be essential for these cells. It has 
been shown that Pax3, with Sox10, could maintain Mitf expression in mouse, however, in 
cell culture Pax3 was a direct repressor of Dct expression which acted as a factor involved 
in the maintenance of multipotency (Lang et al., 2000, Bondurand et al., 2000, Potterf et 
al., 2001). Furthermore, Lang et al., (2000) showed that Wnt signalling via β-catenin could 
prevent Pax3 from repressing Dct on the Dct promoter. MSCs are mostly described in the 
hair follicles in mammals, although, they could also exist in the skin of adult zebrafish. The 
mechanisms involved in the maintenance and the properties of these cells are described in 
Hultman et al., (2009). It is important to consider these cells when studying the renewal 
and the properties of melanocyte fate restriction, however, it is not investigated further in 
this study as it is outside the study of the GRN involved in melanocyte differentiation. 
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Figure 1.04: Melanocyte derivation from neural crest. 
A model of the cell-types generated progressively in melanocyte specification and 
differentiation. At early stages, early NC specification depends upon interactions between 
Wnt and Notch signalling. Transcription of Sox10 is also required for NC specification. 
The pool of NC cell can be marked by the expression of crestin in zebrafish and Sox10. 
Lineage restriction toward the melanoblast fate, through a potential melanoglioblast or 
even chromatoglioblast in zebrafish, is dependent upon mitfa. It can be marked by 
activation of ednrb and c-kit signalling which are not involved in fate specification. In 
these cells the role of Foxd3 as a repressor of melanocytes and the contact with the nerves 
are crucial parameters for determining glial fate at the expense of melanocyte fate. 
Molecular distinction between embryonic melanoblasts and melanocyte stem cell (MSC) 
remains unclear, however, it has been suggested that both express dct. Finally, 
differentiating melanocytes expressed genes responsible for melanin synthesis such as dct, 
tyrosinase or trp1b.  
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1.12 Genetic regulation of  melanocyte specification 
 
Here, we define cell specification as events which allow the expression of factors 
characteristic of a specific fate; note that these cells are likely, at least initially, to remain 
not yet committed and sensitive to environmental factors that may switch their ultimate 
fate. Melanocyte development depends upon the transcription factor SOX10 and Wnt 
signalling to activate expression of the basic-helix-loop-helix leucine zipper transcription 
factor MITF (Dunn et al., 2000a, Hari et al., 2012, Yasumoto et al., 2002, Dorsky et al., 
2000b, Lewis et al., 2004, Takeda et al., 2000a, Saito et al., 2003).  
Sox10 is a High Mobility Group (HMG) transcription factor described as an early 
stage NC cell marker. It is expressed for the first time at gastrula stage around 11 hpf in 
zebrafish (Kelsh, 2006a). Later sox10 expression persists in migrating cells as they are 
specified and begin differentiation and is then gradually lost except in Schwann cells 
satellite cells (Carney et al., 2006, Dutton et al., 2001, Potterf et al., 2001, Le Douarin et 
al., 1991, Lang et al., 2000). In Xenopus, zebrafish, mouse and chick, sox10 has been 
shown to be required for melanocyte specification (Dutton et al., 2001, Aoki et al., 2010, 
Honore et al., 2003, Southard-Smith et al., 1998). In mouse, a spontaneous frameshift 
mutation called Dom, causes a failure to develop glial cells, neurons of the peripheral 
nervous system (PNS) and melanocytes (Southard-Smith et al., 1999). In zebrafish, 
sox10/colourless mutants lack melanocyte pigmentation as cells fail to specify (Dutton et 
al., 2001, Elworthy et al., 2003a, Lister et al., 1999). pax3, a paired-domain and a 
homeodomain containing transcription factor, with sox10, are expressed upstream of mitfa 
and are also necessary for NC cell derivative developments other than melanoblasts 
(Potterf et al., 2000, Lang et al., 2005, Lacosta et al., 2005). 
Regulation of melanocyte development depends upon MITF, the master gene for 
melanocyte development. MITF regulates melanocyte differentiation and lineage survival. 
The first mutation at Mitf locus was first found in mouse by Hertwig, (1942) and this 
bHLH leucine-zipper transcription factor was cloned for the first time by Hodgkinson et 
al., (1993). In mammals, Mitf is expressed in different tissues thanks to alternative first 
exons regulation allowing a specific promoter to drive expression of Mitf in a specific 
tissue (Shibahara et al., 2001). Only Mitf-M is expressed exclusively in melanocytes 
emerging from the NC and is considered in this study. In zebrafish, two duplicates of mitf 
exist, mitfa and mitfb. Both duplicates are homologous to one of the mammalian isoforms 
generated by exon splicing. Both mitfa and mitfb are involved in the retinal pigment 
epithelium development and their functions are redundant in the eyes. mitfb is also 
expressed in the epiphysis and the olfactory bulb, however, only mitfa is involved in NC 
derived melanocytes (Lister et al., 2001). Therefore, pigmented cells of the retinal pigment 
epithelium (RPE), which are the only pigmented cells not arising from the NC are not 
discussed here (Lister et al., 2001). In both mouse and zebrafish, loss of Mitf/mitfa resulted 
in a failure of melanoblast development (Lister et al., 1999, Steingrimsson et al., 2004).  
In zebrafish, the melanocyte specifying factors include sox10 and mitfa. Thus, in 
zebrafish, melanocyte specification can be defined as the series of events leading a NC cell 
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to first express mitfa and a sox10+/mitfa+ precursor to maintain and perhaps enhance mitfa 
expression. mitfa  is activated around 18 hpf by sox10 and Wnt signalling (Figure 1.09) 
(Kelsh, 2006a). Experimentally, activation of β-catenin/Lef1 binding sites in the 
mitfa/nacre promoter of B16 cells as well as analysis of minimal promoter activation in the 
mitfa/nacre mutant zebrafish suggested that mitfa could be a direct target of the Wnt 
signalling in vivo (Dorsky et al., 1998, Dorsky et al., 2000b). In mouse, Wnt1 and Wnt3a 
mutant lose pigmentation (Saint-Jeannet et al., 1997b, Dunn et al., 2000a). Consequently, 
it is well described that Wnt signalling has an important role in melanocyte specification. 
Melanocyte differentiation is less described however, from what is known, it could be 
generally defined as the series of events which are induced by this active mitfa expression 
and which result in the progression of a melanoblast into a differentiated black melanocyte. 
The timing of cell commitment for melanocyte fate is not clearly defined. Expression of 
dopachrome tautomerase (dct), around 19 hpf is considered as a marker for early 
melanoblast stages onwards (Figure 1.09) (Kelsh et al., 2000).  
1.13 Genetic regulation of  melanocyte differentiation 
 
All the NC derivatives initiate GRNs specific to their particular fate. Currently, analysing 
the GRNs of each NC derivative is a major area of research. For instance, sox9 and 
collagen type II α1 (Col2α1) have been shown to be involved in cartilage differentiation 
but more factors and regulatory features are being tested to describe the mechanisms 
involved in this process. Importantly, as suggested in Prasad et al. (2012), the role of 
epigenetic mechanisms in the regulation of chromatin state and the recruitment of 
transcription factors for NC cell specification, remains to be assessed (Prasad et al., 2012, 
Le Douarin et al., 1994). This study focused on the GRN involved in a NC derivative 
differentiation, the melanocyte.   
 In contrast with the mouse system, in zebrafish, the genetic regulation of 
melanocyte differentiation is less described than melanocyte specification. The timing of 
cell commitment is not described yet in melanocytes, however, first signs of pigmentation 
are observed around 27 – 29 hpf. Embryonic melanocytes are only mature by 72 hpf and 
the larval pigment pattern is complete around 4-5 dpf (Figure 1.05). As shown in Lister et 
al, (1999), ectopic expression of mitfa in the mitfa
w2
 zebrafish mutant was sufficient to 
rescue the main aspects of melanocyte differentiation in cells, such as production of 
melanin, cell morphology and location. Mitf expression controls the main aspects of 
melanocyte cell biology, via direct and indirect interactions (Johnson et al., 2010, Cheli et 
al., 2012). Mitfa is responsible for activating genes necessary for melanin synthesis such as 
dct, tyrosinase, and tyrosinase related protein-1 (tyrp1b/trp1b), as well as silva (gene 
encoding a structural protein) for example (Kelsh and Eisen, 2000, Lister et al., 1999). It is 
also essential in regulating melanocyte survival and melanocyte proliferation via activation 
of the anti-apoptotic gene bcl-2 (McGill et al., 2002, Johnson et al., 2010, Cheli et al., 
2012). Melanocyte shape and mobility have also been shown to be influenced by Xn-mitf 
in a study in Xenopus (Kawasaki et al., 2008).  
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 In contrast with mouse, experiments in zebrafish showed that sox10 expression was 
gradually downregulated in melanocytes from around 24 hpf until 50 hpf, when it was not 
detectable anymore in melanocytes by Whole Mount In Situ Hybridisation (WISH) (Hou et 
al., 2006, Greenhill et al., 2011). The mechanisms involved in the decrease of sox10 
expression in zebrafish melanocytes remain unknown. It is also unclear if mitfa expression 
is maintained in cells, and if it is maintained, what factors are responsible for its 
maintenance needs to be identified (Greenhill et al., 2011). Furthermore, the role of Wnt 
signalling in melanocyte differentiation has never been assessed in vivo in fish and in 
mouse (Sommer, 2011). 
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Figure 1.05: Time course of expression of sox10, mitfa and dct and timing of 
melanocyte specification and differentiation in zebrafish. 
At 11 hpf, sox10 is expressed in all NC cells. At 18 hpf, sox10 and Wnt signalling activate 
mitfa expression in a subset of NC cells. However, it is unclear when exactly Wnt 
activation is required to allow this effect. At 19 hpf, Mitfa activates expression of several 
genes coding for the enzymes responsible for melanin synthesis such as dct. From 28 hpf 
to 48 hpf, sox10 expression decreases in melanocytes. Whether or not mitfa remains 
expressed at 72 hpf remains to be clarified. Melanocyte specification starts around 18 hpf 
and probably ends around 30 hpf, however, the timing is not clearly known. Melanocyte 
differentiation is completed by 72 hpf. 
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1.14 The Zebrafish is a suitable model for the study of 
melanocyte  
 
The evolutionary conservation of the melanocyte cell type throughout vertebrate genetic 
models suggests the good conservation of the GRN responsible for melanocyte 
development and even melanin synthesis (Sato et al., 2001, Hallsson et al., 2004). 
Zebrafish melanocytes have been shown to be closely related to human and mouse 
melanocytes as most of the mammalian genes have known functional homologues in the 
zebrafish genome (Johnson et al., 2010, Quigley and Parichy, 2002, Kelsh, 2004). 
Consequently, comparable melanocyte genetic development across vertebrates makes 
zebrafish an excellent model to better understand melanocyte-related diseases in mammals. 
This is important because the understanding of melanocyte genetics in zebrafish and the 
discovery of drugs, or treatments, in zebrafish, could then be used in the future to 
understand, identify and cure melanocyte-development related disorders in humans. 
 Zebrafish is an excellent model for the study of embryonic melanocyte 
development and GRN. Particularly, the transparency of embryos allows the observation of 
melanocytes in living embryos at sub-cellular resolution better than in any other of the 
main genetic models (Kelsh et al., 1996a). In vivo study of melanocytes has a great 
advantage in zebrafish as cell morphology, pigmentation, size, division and migration are 
also very easy to observe (Figure 1.09). The rapid development of melanocytes and 
pigment cells gives easy and fast access to biological material and allows the precise 
analysis of melanocyte phenotypes (Kelsh et al., 1996a). Additionally, the timing and the 
characteristics of embryos changes in early development are well characterized (Kimmel et 
al., 1995). The number of cells in zebrafish NC is smaller than in any other model, 
however, cells are bigger and therefore easier to follow with several tracing techniques and 
microscopy instruments, such as Nomarski microscopy (Raible et al., 1992, Eisen and 
Weston, 1993). Therefore, as suggested in Eisen and Weston, (1993) and in Raible et al., 
(1992), the zebrafish model provides a system for an alternative approach to study NC 
development by investigating individual NC cells through their specification and 
differentiation. 
1.15 Establishment of the pigment pattern in zebrafish 
1.15.1 Embryonic pigment cells migrate and organise in stripes 
 
The melanocyte is the only pigment cell type that exists in mammals, whereas, two other 
additional kinds of pigment cells can be found in zebrafish, xanthophores and iridophores. 
In zebrafish, the pattern of pigmentation is established during early development and is 
conserved and well defined (Kelsh et al., 1996a). Yellow xanthophores are light absorbing 
pigment cells while the iridescent iridophores are light-reflecting chromatophores 
containing guanidine-based reflective platelets (Kelsh, 2004). In zebrafish embryos, 
iridophores migrate on the medial pathway, whereas xanthophores migrate only along the 
lateral pathway and cover the flank of fish. This study is focused on the melanocyte, 
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however, in zebrafish, pigment cell biology encompasses the study of these three pigment 
cell types.  
 In the mouse, as in zebrafish, it seems that melanoblasts are specified prior to 
migration (Hou et al., 2006, Dutton et al., 2001, Lister et al., 1999, Parichy et al., 2000b). 
One mechanism could involve an important receptor, tyrosine kinase kit, which is 
expressed in melanobasts in premigratory NC cells in mouse and which is important for 
cell migration (Hou et al., 2000, Kawa et al., 2005). A transient expression of its ligands, 
KitL/kitla is also detected in cells of the dermamyotome in mouse, and in zebrafish (Wen et 
al., 2010, Hultman et al., 2007). In zebrafish, Kit ortholog, kita, and its ligand, kitla, both 
have been shown to be required for melanoblast survival and migration (Parichy et al., 
1999, Rawls and Johnson, 2003, Cooper et al., 2009). Melanocytes migrate ventrally along 
the medial and the lateral pathway. By 4-5 days post-fertilisation (dpf), embryonic 
melanocytes are organised in four stripes, the dorsal stripe, the lateral stripe, the ventral 
stripe and the yolk sac stripe (Kelsh, 2004, Odenthal et al., 1996, Parichy et al., 2000a, 
Lopes et al., 2008). Figure 1.06 shows an embryo at 3 dpf with all stripes but the yolk-sac 
stripe which form later. 
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Figure 1.06: Embryonic melanocytes are organised in four stripes. 
72 hpf zebrafish embryo showing organisation of embryonic mature melanocytes in four 
stripes, the dorsal stripe, the lateral stripe, the ventral stripe and the yolk-sac stripe which is 
not yet visible on the fish here as it is only formed in 4-5 days-post-fertilisation fish. 
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1.15.2. Melanocytes produce the black pigment melanin 
 
Melanocytes are black pigmented cells containing the pigment, melanin, in granules called 
melanosomes. Mammals synthesise two different types of melanin, eumelanin and 
pheomelanin, whereas there is only one type of melanin in zebrafish, eumelanin (Ito and 
Wakamatsu, 2003). Both pigments are derived from a precursor dopaquinone (ortho-
quinone or 3,4-dihydroxyphenylalanine) and an enzymatic cascade leads to the production 
of the black eumelanin or the reddish/brown pheomelanin (Figure 1.07) (Ito and 
Wakamatsu, 2008). Tyrosinase is an enzyme which catalyses two steps in the reaction to 
convert tyrosine to melanin. Tyrosine is first changed to dopa by Tyrosinase, which then 
catalyses the transformation of dopa to dopaquinone and finally dopaquinone is 
transformed to eumelanin (Figure 1.07) (Hearing and Jimenez, 1987, Ando et al., 2007).  
 Two types of melanocytes can be defined, the NC derived melanocytes and the 
non-NC derived melanocytes. The main roles of melanocytes in organisms seem to be 
photoprotection and thermoregulation (Kawakami and Fisher, 2011). These roles have 
been well described for the NC derived cutaneous melanocytes which are found in hair, 
feather follicles and epidermis. However, the role of some of the NC derived 
extracutaneous melanocytes, such as the ones from the cochlear or the intestine, remain 
unclear. Interestingly, the melanocytes of the retinal pigment epithelium (RPE) in eyes are 
not NC derived. In zebrafish melanocytes, the pigment granules can aggregate or disperse 
in response to neurotransmitters, cell signals and hormones, like the Melanocyte 
Concentrating Hormone (MCH) and the Melanocyte Stimulating Hormone (MSH) 
(Takahashi and Kawauchi, 2006). NC derived melanocytes are found in the dermis, the 
deep layer of the skin. Black melanocytes in zebrafish embryos are shown in Figure 1.08. 
In adult fish, they are present on the dorsal surface where they are associated with the 
dermal scale (Vickaryous and Sire, 2009, Hoerter et al., 2012). 
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Figure 1.07: Enzymatic cascade involved in melanin synthesis. 
Tyrosinase allows the conversion of Tyrosine into DOPA and DOPA into DOPAquinone. 
A molecule of DOPAchrome is then processed by Dct (dopachrome tautomerase) and the 
substrate of this reaction is processed by Tyroinase-related protein 1 (TYRP1) to become 
Eumelanin. Alternatively, the DOPAchrome is processed by Tyrosinase to become 
Eumelanin in a two steps process. DOPAquinone can also be transformed in Pheomelanin 
(reproduced with the kind permission of Ando et al., (2007)). 
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1.15.3 Melanocyte differentiation is observable in zebrafish embryos 
 
Melanocyte differentiation is a process consisting of multiple complex aspects which are 
observable in zebrafish and shown in Figure 1.08. These aspects include: changes in cell 
appearance, such as changes in cell shape, increased cell size, increased cell melanisation 
and divisions increasing cell number; and also, cell movements lead to positioning and 
organisation to form reproducible patterns. It is possible to quantify these changes in 
aspects although at later stages, an increase in cell melanisation can be difficult to measure 
due to the saturation in melanin in cells. Cell shape can be characterised by its roundness 
which varies through cell differentiation. Cells roundness can be measured and calculated 
by a formula determining a parameter called cell dendricity (R), (R = P2 ⁄4pA, where A is 
the cell area and P the cell perimeter). Increased R corresponds to increased cell 
dendricity (circle, R=1) (Kumasaka et al., 2005).  Before 55 hpf and until about 72 hpf, 
cell position and organisation is not clearly established in embryos. However, from 55 hpf 
(Figure 1.09 (A-D)), a pattern with two lines, in a “U” shape, becomes visible. By 72 hpf, 
this pattern is characteristic of WT embryos (Figure 1.09, (A-C)).  
 Melanocyte pigmentation is first observed around 27 hpf when cells show the first 
signs of melanisation, being grey, small and “elongated” (Figure 1.09, (E)). At 48 hpf, cells 
are blacker but are not yet saturated with melanin. At this stage, cells remain dendritic and 
not yet organised as a definitive pattern (Figure 1.09, (F)). Embryonic melanocytes are 
finally fully mature at 4-5 dpf, but by 72 hpf, they already show all characteristics of 
maturation, meaning that cells are fully melanised and have mostly acquired their shape 
and positioning (Figure 1.09, (G)).  
Chapter 1. Introduction  




Figure 1.08: Observable aspects of melanocyte differentiation in zebrafish. 
Cell positioning organisation is visible from around 55 hpf in zebrafish embryos, (A) 
lateral view, (B) dorsal view, (A-B, dotted lines show the section observed for determining 
the disruption of the cell pattern of organisation, from the anterior brain to the posterior 
part of the optic vesicle), (C) head dorsal view (the dotted lines show early “U” shape 
organisation of cells in dorsal head). At 72 hpf, the pattern is fully established ((D) head 
dorsal view, the red dotted line shows the “U” shape organisation). The cells of the yolk 
sac (E,F,G, red arrowheads show melanocytes), at 30 hpf cells are small, grey and 
elongated (E), at 48 hpf, cells are darker, bigger and more dendritic (F), and at 72 hpf cells 
are mostly mature, saturated in melanin and less dendritic (G). e: eye; y: yolk sac; o: otic 
vesicle. Scale bar: 100 µm.  
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1.15.4. Xanthophores are yellow pigmented cells present in zebrafish 
 
Xanthophores are yellow pigmented cells found in the dermis in zebrafish (Figure 1.09). 
The pigments they contain are carotenoids and pteridine. Like melanocytes, xanthophores 
are dendritic cells. Several important markers for xanthophores are known, two of them are 
two enzymes of the pteridine synthesis cascade, the GTP cyclohydrolase (gch) and 
xanthine dehydrogenase/oxidase (xdh/xod) (Ziegler, 2003, Odenthal et al., 1996). In 
zebrafish, the xanthophore precursors, xanthoblasts, appear around 18 hpf and requires 
pax3 (Lister et al., 2006, Minchin and Hughes, 2008). pax3 morpholino knockdown 
triggers severe xanthophore reduction based on the diminution of xdh positive cells, as 
shown by in situ hybridisation analysis investigating xdh expression in injected zebrafish 
embryos (Minchin and Hughes, 2008). In zebrafish, the roles of pax3/pax7 in xanthophores 
and in melanocytes still need to be clarified. Furthermore, secondary pax3-like and pax7-
like genes, pax3b and pax7b respectively, exist in zebrafish and may well act in part 
redundantly on pigment cell development. Another factor, the receptor colony stimulating 
factor 1 receptor (csf1r), is involved in xanthophore development and marks differentiation 
starting around 25 hpf. First signs of yellow pigmentation can only be observed later, 
around 60 hpf (Lacosta et al., 2007, Minchin and Hughes, 2008). 
 There has been suggestion that xanthoblasts and melanoblasts could share the same 
precursor. For instance, the loss of pax3 and the loss of xanthophore pigment has been 
associated with an increase in melanocyte number in zebrafish induced by a developmental 
delay (Minchin and Hughes, 2008). However, the question of whether or not xanthoblasts 
and melanoblasts share the same precursor has not been fully investigated and if pax3 
could act in a cell autonomous manner to mediate xanthophore fate choice from a 
chromatoblast precursor remains to be tested.  
1.15.5. Iridophores are light-reflective cells present in zebrafish 
  
Iridophores are oval shaped shiny reflective cells containing light reflecting platelets of 
guanine which are strictly organised to increase light reflectance and from which depends 
the wavelength of light reflected (Figure 1.09) (Oshima, 2001). There are four types of 
iridophores; two motile types, the blue iridophores found in dark blue stripes, the light blue 
iridophores found in the dorsal skin; and two immotile types, the dark blue iridophores 
found in the dark blue stripes and the white iridophores found in white stripes (Hirata et 
al., 2003). Iridophore specification has been suggested to occur around 20 hpf in zebrafish 
while differentiation is observed later around 42 hpf. The gene ltk has been found to be 
required for iridophore development (Lopes et al., 2008). However, the genes involved in 
iridophore development downstream ltk are not yet completely described. Loss of ltk has 
recently been found to be responsible for shady mutant loss of iridophores (Lopes et al., 
2008). It has been suggested that ltk was expressed in two phases corresponding to 
promoting iridophore development at two different timepoints. ltk expression was observed 
early, and likely in a multipotent progenitor, where it could be required for iridophore fate 
choice and later it exclusively persisted in iridoblasts/iridophores (Lopes et al., 2008).  
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Figure 1.09: The three pigment cell types present in zebrafish and visible at 72 hpf 
In the trunk of embryos, in lateral view (A), black melanocytes and yellow xanthophores 
can be observed (A, white arrowheads point at melanocytes, the red arrowheads point at 
xanthophores in 72 hpf embryo in bright field). A close up on xanthophores in the dorsal 
head (B, the red arrowheads show xanthophores) and in the dorsal trunk (C, the red 
arrowheads show xanthophores) in a 72 hpf embryo treated with PTU to avoid 
melanisation. In the trunk, iridophores can be observed (C, blue arrowhead shows an 
iridophore). Scale bar: 50 µm.  
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1.16 Building the melanocyte GRN model 
1.16.1 Systems Biology as an approach to melanocyte development 
 
Throughout this study, a systems biology approach has been adopted to improve the 
understanding of the GRN underlying melanocyte development. Systems Biology is a field 
which focuses on the integrated study of multiple components of a system simultaneously. 
It also allows integration of quantitative data of a system and utilises modelling to 
understand the system’s dynamics. The use of mathematical and computational modelling 
has allowed the exploration of biological processes to gain insights which might not be 
possible through traditional lab based experimentation due to complex interactions and 
feedback between multiple components within a system. Consequently, systems biology is 
a growing tool for research into genetics and related fields. Significant examples of the use 
of mathematical modelling in biology include the Michaelis-Menten equations describing 
enzyme kinetics, Turing’s studies in morphogenesis, the work of Hodgkins and Huxley, 
(1952) describing membrane potentials in neurophysiology (M.Sriram Iyengar, 2011).  
 
Systems biology proceeds via iterative rounds of biological data collection and 
mathematical modelling as described in Figure 1.10. Where the system changes in time, 
the model is a dynamic one. Its variables are the components which vary with time, its 
parameters are numerical values which encode information about the system which is not 
included in the dynamic state, meaning that these parameters do not vary. The system may 
most simply be encoded by ordinary differential equations (ODE), by which the model 
gives the rates of change of the variables as functions of the state at a given time. In ODE, 
there is only one independent variable with ordinary derivatives. Another type of 
equations, partial differential equations (PDE), contains unknown multivariable functions 
and their derivatives are described as functions of several variables. PDE are often used to 
model multidimensional systems i.e. systems with more than one independent variable. 
Mathematical modelling is limited by the quality and the range of quantitative biological 
data. 
 In zebrafish, Chan et al., (2009) modelled the GRN underlying embryonic 
development and more particularly the signalling responsible for dorsoanterior–
ventroposterior patterning and endoderm formation. They used Pubmed and Zfin 
databases, combined with the Medscan software, to integrate the data available in the 
literature and to investigate the regulatory motifs and feedback loops responsible for 
ventral and dorsal patterning. This study allowed them to describe the intracellular role of 
dharma and tailless 1 (tll1)/chordin in cross-inhibiting GRN motifs for dorso-ventral 
polarity and the role of maternally driven regulatory loops for determination of the dorso-
ventral axis.  
 Further aspects essential in cell development can be integrated by the systems 
biology approach, for example, the determination of cell to cell heterogeneity and the 
stochasticity of gene expression. These two aspects can explain the differences of cells 
emerging from apparently homogeneous cell population in the same environment. As an 
important challenge, linking the systems biology and the developmental biology fields, it 
will be crucial to model cell to cell variability during development to understand 
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parameters which are important for cell specification and differentiation. As explained and 
tested in Mao and Resat, (2004), the role of stochasticity in gene expression and regulatory 
events is at the centre of this challenge and it these aspects will be detailed in the Chapter 
4. 
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Figure 1.10: Simplified representation of an iterative systems biology approach. 
The starting point of this systems biology study was biological data. Data collected were 
then used to build a mathematical model. The model was used with representative 
parameter values to run simulations. The new features of the biological system could be 
predicted from these simulations and, predictions were tested against the existing, or the 
new, experimental observations. This iterative process allowed the confirmation, or re-
adjustment, of the mathematical model. The hypothesis derived from the modelling 
predictions could then be tested, in vivo, and used to improve the system and to better 
mimic the in vivo system. This powerful method allows insight into the biological system 
and better understanding of the key factors and their fluctuations.  
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1.16.2 In vivo study of melanocytic gene expression allowed the definition 
of the first melanocyte GRN 
 
Building the melanocyte network in zebrafish, Greenhill et al, (2011) focused on the 
dynamic regulation of the two well described transcription factors sox10 and mitfa. The 
mathematical model constructed from experimental results, collected in vivo, was the 
starting point of experiments carried out here (Figure 1.11). The study of melanocytic gene 




 mutants allowed, in combination with an 
iterative process of modelling, the assembly of a GRN for melanocyte development. sox10 
and mitfa show a very specific and complex inter-regulatory feedback loop during 
melanocyte development which allows the activation of melanocyte specification. This 
inter-regulation also permits the maintenance of the expression of the genes involved in 
melanocyte differentiation, as well as, the loss of early specification factors such as sox10. 
The GRN of melanocyte development allows the representation of the complex aspects of 
the regulatory mechanisms implicating sox10 and mitfa in melanocytes in zebrafish. 
1.16.3 The modelling predicted the existence of a factor involved in the 
maintenance of mitfa expression in melanocytes  
 
The mathematical modelling made predictions of novel and potentially important 
relationships between genes in the melanocyte GRN (Greenhill et al., 2011). A direct or 
indirect negative feedback loop causes mitfa dependent downregulation of sox10. Clearly, 
if Sox10 is lost, another process has to replace the role of Sox10 in maintaining mitfa 
expression in differentiated melanocytes. This factor was named Factor Y, and was 
predicted to show the following properties: 1) be activated during melanocyte 
differentiation, 2) be a direct or an indirect activator of mitfa, 3) be indirectly or directly 
activated by Mitfa, and 4) be required for maintenance of melanocyte differentiation 
(Figure 1.11). Given that Wnt signalling is a direct activator of mitfa during melanocyte 
specification, it is a plausible candidate regulatory factor for melanocyte differentiation and 
maintenance of mitfa. This hypothesis is the subject of Chapter 3, whereby Wnt signalling 
is tested as a possible candidate for the unknown Factor Y. 
1.16.4 Mitfa can directly regulate sox10 expression 
 
In vivo data showed that sox10 expression and Sox10 proteins were decreasing during 
melanocyte differentiation in zebrafish. Although, it was not tested in zebrafish if mitfa 
expression was maintained in melanocytes until late differentiation phase, it was shown 
that mitfa expression was maintained in melanocytes after sox10 expression decreased. The 
simple melanocyte GRN predicted that the loss of sox10 expression would result, either 
directly or indirectly, from the expression of mitfa. Greenhill et al., (2011) suggested that 
Mitfa could directly repress sox10 expression by binding to one or more of the six M-
boxes (Mitfa-binding sites) identified in the 7.2 kb sox10 promoter region shown to 
reproduce the initial sox10 expression pattern (Dutton et al., 2001).  
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 To assess if Mitfa could be directly repressing sox10 expression, this study focused 
on the Tg(-7.2sox10:GFP) reporter line, in which a 7.2 kb fragment of the promoter 
proximal region of sox10 genomic DNA drives GFP expression. Previous results showed 
that mitfa overexpression caused a clear GFP expression in transgenic fish at both an early 
time point (6 hpf), as well as later (10.5 hpf), consistent with possible direct regulation. In 
contrast, in the same experiment, very few (6 %) embryos injected with sox10 RNA 
showed GFP expression at 6 hpf, whereas essentially all transgenic embryos showed GFP 
by 10.5 hpf (Greenhill et al., 2011). This is consistent with the idea that sox10 did not 
directly regulate this reporter construct itself. The 7.2 kb of sox10 regulatory sequences in 
the Tg(-7.2sox10:GFP) transgene contains six consensus M-boxes, making it plausible that 
Mitfa bound directly to this promoter. This began to narrow the search for the region of the 
sox10 promoter which is likely to mediate this response to Mitfa. Greenhill et al., (2011) 
repeated these experiments in the Tg(- 4.9sox10:EGFP) line in which the 5’ three M-boxes 
were absent (Carney et al., 2006). Interestingly, this transgene showed no response to 
injected mitfa mRNA at 6 hpf. This result suggested that if Mitfa regulated sox10 
expression, it would be via one or more of the 3’ M boxes. Importantly, these experiments, 
which examined the reporter in the context of zebrafish blastomeres, did not necessarily 
reflect the promoter’s response in melanoblasts. Therefore, sox10 expression was 
investigated in mitfa
w2
 mutants in order to better understand mitfa’s role on sox10 
repression in the melanocyte lineage. If Mitfa was necessary for repression of sox10, the 
prediction was that mitfa mutants should show persistent sox10 expression. In mitfa 
mutants, at 72 hpf, a stage when wild-type embryos show no detectable sox10 expression 
in melanocytes, but rather show strong expression in the peripheral nervous system and 
ear, sox10 expression could be detected in the position of the dorsal stripe (Greenhill et al., 
2011). Expression of GFP fluorescent protein, when driven by sox10 promoter, responded 
to ectopic mitfa expression. There are no published reports of MITF (positively or 
negatively) regulating Sox10 expression in mouse, but the correlation observed between an 
ectopic activation of mitfa and a strong transcriptional activation of sox10 in early 
zebrafish embryos allowed Greenhill et al., (2011) to suggest that a co-repressor would 
turn Mitfa into a negative regulator of sox10 in melanocytes in vivo (Greenhill et al., 
2011). Consequently, the hypothesis was suggested that a mitfa-dependent repression of 
sox10 could be the cause for the gradual diminution of sox10 expression, which led to a 
loss of Sox10 protein and mRNA detection by 52 hpf in melanocytes in zebrafish. Mitfa 
and a negative co-repressor, were responsible for sox10 downregulation, and it would be 
interesting to identify this co-repressor.  
 This hypothesis is plausible knowing that it has previously been shown that Mitfa, 
as a transcription factor, could recruit co-regulators, co-activators, or co-repressors, of gene 
expression, to the promoter of specific genes, to modulate their expression specifically in 
melanocytes. The chromatin deacetylase protein (Hdacs) responsible for epigenetic 
downregulation of gene expression, were tested as a candidate as Mitfa co-repressor of 
sox10 in melanocytes as presented in Figure 1.11. Ignatius et al., (2008) studied 
hdac1/colgate mutant zebrafish and described a persistent activation of sox10 expression 
compared to WT, in the dorsal region of zebrafish embryos by 48 hpf. This phenotype 
could be the result of a loss of repression of the gene in absence of Hdac1. A decrease in 
sox10 expression could be Mitfa and Hdac dependent with Hdac being a Mitfa dependent 
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co-repressor of sox10 (Figure 1.11) and this hypothesis was presented and tested in 
Chapter 5. 
1.16.5 Sox10 represses genes downstream of mitfa except tyrp1b 
 
Greenhill et al., (2011) also showed that sox10 had a repressive effect on dct, tyrosinase 
and silva but interestingly not on tyrp1b. This repression was underlined by the observation 
of residual melanisation in sox10 mutants and in sox10/mitfa double mutants as detailed in 
Chapter 5. Furthermore, when embryos were injected at one cell stage with sox10 and 
mitfa sense RNA, tyrp1b expression was readily detected at 6 hpf, whereas dct, silva and 
tyrosinase (tyr) were not. These results suggested that sox10 expression could repress the 
mitfa-mediated expression of most of the melanocyte differentiation genes tested, but that 
tyrp1b expression was not affected by this effect, and that the timing of tyrp1b expression 
was limited by mitfa expression. In Chapter 5, this aspect of mitfa and sox10 regulatory 
interactions was re-evaluated using a different method. The repression of dct expression, 
but not of tyrp1b expression by Sox10, which had been studied in Greenhill et al., (2011) 
by WISH and immunofluorescence techniques, was replicated using the technique of 
qPCR. Consequently, the levels of expression of mitfa, sox10, dct and tyrp1b were 




 mutants in order to quantitatively assess the 
Sox10 dependent repression of some genes downstream Mitfa.  
 Thus, it seems that, in melanocytes in zebrafish, sox10 could have a pivotal role in 
enhancing specification through activation of mitfa, but also in maintaining an 
undifferentiated state by repressing melanocyte differentiation gene expression. It was then 
suggested that, once mitfa expression is activated, it would be maintained in melanocytes, 
turning down sox10 expression and maintaining a differentiated state. Whether or not 
Mitfa could activate mitfa expression was also another hypothesis raised by the modelling. 
The preliminary experiment for testing if Mitfa could activate its own expression in 
zebrafish is described in Chapter 5. 
 Importantly, direct experimental testing demonstrated that sox9b was involved as a 
weak sox10-independent activator of melanocyte differentiation gene expression (Greenhill 
et al., 2011). However, whole-mount in situ hybridisation experiments have shown that 
neither sox9a and sox9b expression replaced sox10 expression in zebrafish embryo 
melanocytes. 
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Figure 1.11: Model of the GRN underlying melanocyte development built from 
experimental data.  
 
sox10 is activated by activators (A) early in NC cells. sox10 activates mitfa expression but 
represses expression of several genes downstream of mitfa including dct, tyrosinase and 
silva, but not trp1b. The model predicted new features for the network and two aspects of 
the model were tested. Firstly, after sox10 loss, the modelling predicted that an unknown 
factor, which was called Factor Y, was required to maintain mitfa expression. Wnt 
signalling was tested as a candidate for Factor Y. mitfa itself could be part of this 
regulation. Secondly, the role of Hdac1 as a Mitfa dependent co-repressor of sox10 was 
investigated. (adapted from Greenhill et al., (2011)). 
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1.17 Describing Wnt signalling 
In Chapter 3, Wnt signalling was tested as a candidate for Factor Y. In order to introduce 
the general regulatory mechanisms of Wnt signalling, the basic pathway is presented here. 
This is further developed, in to the context of my experimental approaches, in Chapter 3.  
 Canonical Wnt signalling is a pathway used repeatedly in embryonic development 
(Barker, 2008). The canonical Wnt/β-catenin pathway is critically involved in the 
processes of patterning, organogenesis, proliferation, regeneration and cell–cell adhesion 
(Takada et al., 1994, van de Wetering et al., 1997, Ungar and Calvey, 2002, Barker, 2008). 
More particularly, it is a key factor for head induction, cardiac development and the 
formation of extremities (Deardorff et al., 2001, Lewis et al., 2004, Wu et al., 2005). The 
canonical Wnt pathway involves the Wnt protein binding to its membrane receptor, 
Frizzled (Fzd) (Figure 1.12). In the absence of the Wnt protein, the glycogen synthase 
kinase-3β (GSK3β) sequestrates β-catenin in a complex in the cytoplasm preventing 
activation of the pathway. The binding of Wnt to its receptor Fzd allows the activation of 
β-catenin via repressing GSK3β, leading to the release of β-catenin from its cytoplasmic 
complex. β-catenin then translocates to the nucleus to activate gene expression with a co-
activator, Lymphoid Enhancer-binding Factor-1 (Lef-1) which also functions as a 
transcription factor (Kofahl and Wolf, 2010). Free β-catenin can also bind to E-cadherin 
and α-catenin to modulate the conformation of the cytoskeleton (Figure 1.12). β-catenin 
degradation is strictly regulated. Indeed, β-catenin protein is constantly produced and the 
mechanisms causing its degradation require sequential phosphorylation via different 
components like casein kinase 1α (CK1α). CK1α phosphorylates β-catenin at Ser45 and 
then β-catenin is phosphorylated at three further N-terminal serine and threonine residues 
(Ser33, Ser37 and Thr41 in humans) by GSK3β. These phosphorylations occur within the 
destruction complex which also contains proteins such as phosphatases and the two 
scaffold proteins adenomatous polyposis coli (APC) and axin-1. β-transducing-repeat-
containing protein (β –TrCP), a subunit of the ubiquitin ligase complex, can then recognize 
and mark the complex with ubiquitin, causing its proteasome-dependent degradation.   
 The non-canonical Wnt pathway is activated by the binding of the Wnt protein 
activators of Frizzled and its co-activators, ROR2, a member of the receptor tyrosine 
kinase-like orphan (ROR) family, and, the protein Related to Tyrosine Kinase (RYK). This 
signal is transduced in the cell via three pathways; the Dishevelled (Dsh)/c-Jun Kinase 
(JNK) dependent pathway, involved in planar cell polarity (PCP); the Dsh/ROCK 
dependent pathway, involved in actin cytoskeleton regulation; and the Ca
2+
/Nuclear Factor 
of activated T cells (NFAT) dependent pathway (Figure 1.13) (Dorsky et al., 1998). 
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Figure 1.12: Description of the Wnt signalling canonical pathway and the roles of free 
β-catenin in cells.  
In the presence of the Wnt signal, Wnt binds to its receptor Frizzled (with co-receptor 
LRP5/6) leading to inhibition of GSK3-β and release from the APC/CK1a complex in the 
cytoplasm. The liberation of β-catenin from the degradation complex which includes APC 
and Axin proteins, results in the translocation of β-catenin to the nucleus. This 
translocation to the nucleus permits the activation of the effectors of the Wnt pathway, β-
catenin and its co-activator, Lef/Tcf, for the transcription of targeted genes. In the absence 
of Wnt signalling, part of the complex, β-catenin (β-cat) is phosphorylated and targeted for 
degradation. The activation of Wnt signalling leads to increase β-catenin in the cytoplasm. 
At the membrane, β-catenin can associate with α-catenin (α-cat) and E-cadherin (E-cad) to 
regulate cell polarity. The black structures represent tight junction proteins regulated by β-
catenin/ α-catenin/ E-cadherin (Adapted from Gilbert, S. Developmental Biology, 9th 
Edition.) 
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Figure 1.13: The role of the non-canonical Wnt signalling in cells. 
Activation of the non-canonical Wnt signalling patway, by the Wnt protein, which binds to 
a receptor Frizzled, and the co-receptor ROR2, allows the activation of the dishevelled 
(Dsh) dependent pathways. This activation leads to regulation of the Planar Cell Polarity 
(PCP) and to the modulation of the actin cytoskeleton by activating the proteins ROCK and 
JNK. ROCK is activated by a cascade which involves the small G- protein Rho, and the 
activation of JNK involves the activation of the small G-protein Rac1. The non-canonical 
Wnt pathway also activates the Ca
2+
 dependent pathway which leads to activation of 
NFAT and which is involved in cell adhesion and cell migration. 
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1.18 Melanocyte development is affected by Wnt signalling  
 
As further described in Chapter 3 and briefly described here, Wnt signalling has been 
shown to be required for melanocyte specification.  Furthermore, it is a known activator of 
mitfa at early stages (Dorsky et al., 1998). In vitro studies showed that Mitf-M promoter 
possesses TCF/LEF1 binding sites. It has been reported that Wnt signalling was capable of 
activating Mitf transcription through those TCF/Lef1 binding sites (Takeda et al., 2000a, 
Dorsky et al., 2000a). This result has suggested a direct activation of Mitf by TCF/LEF1 at 
their binding site. Studies in mouse, Xenopus and zebrafish converged to show the crucial 
role played by Wnt signalling in melanoblast specification (Aoki et al., 2003, Dorsky et 
al., 2000b). Additionally, an inhibitor of the canonical Wnt signalling pathway, Dickkopf-1 
(DKK1), is secreted by fibroblasts in the dermis of human skin and suppresses melanocyte 
differentiation via the suppression of β-catenin and consequently decreases expression of 
MITF (Yamaguchi et al., 2007).  
 The molecular details of the components underlying this process are less clear, 
although in zebrafish, wnt1, wnt3a, as well as, the receptors frizzled 8 and 10, were found 
to be expressed in the dorsal neural tube. This suggests that the pathway might be activated 
in this region (Nikaido et al., 2013, Saint-Jeannet et al., 1997b, Yanfeng et al., 2003). This 
is consistent with the position of activation of mitfa expression. Furthermore, Wnt signals 
are widespread in the embryo and hence it is plausible that Wnt signalling could be an 
important factor in maintenance of mitfa expression at later stages, although its role during 
melanocyte differentiation has never been tested in vivo.  
1.19 Heterogeneity of gene expression is important in 
melanocyte development 
 
As previously explained, cell development consists of two crucial events, cell specification 
and cell differentiation. It is essential to understand the genetic mechanisms regulating 
these events. These mechanisms can be of two types: regulated or stochastic (Elowitz et 
al., 2002, Fournier et al., 2007, Garg et al., 2009, Gillespie, 2009, Gupta et al., 2011, 
McAdams and Arkin, 1997, Raj and van Oudenaarden, 2008). Both of these phenomena 
can cause heterogeneity and cell to cell variability, which can make each individual cell, 
from the same population, different to another one. In melanocytes, cell specification is 
marked by the expression of mitfa, a specification factor. During specification, cells show 
activation of specific factors which can influence cell fate choice. Cell commitment is 
defined by the transition from the phase of specification to a phase where cells are engaged 
in a fate and are no longer sensitive to other specification signals. Cell commitment is not 
clearly defined in melanocyte development, however, expression of dct can be understood 
as a marker for specification and differentiation, the phase when cells will acquire their 
specific phenotype (Kelsh, 2006a, Dutton et al., 2001, Curran et al., 2009). Cell to cell 
heterogeneity is probably a very important parameter for cell specification and cell 
commitment. Cell to cell heterogeneity combined with genetic stochasticity can trigger two 
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cells of the same population, in the same environment, to activate different genetic 
programs. Stochasticity is particularly important when key factors are present at low levels, 
creating probabilistic conditions for gene expression activation. Variations of expression, 
due to intrinsic noise create variability in cell populations from which cell diversity can 
emerge. For example, like that shown in a study by Elowitz et al., (2002) on E.coli. In 
Chapter 4, dct, trp1b, sox10 and mitfa expression levels were tested by reverse 
transcription quantitative real time polymerase chain reaction (RT-qPCR) at five different 
timepoints. The data was collected and analysed in accordance to previous studies by 
Quaranta and Garbett (2010) and Peixoto et al., (2004) for the analysis if genetic 
variability.  
1.20 Aims of the project  
 
In this study, several approaches were combined to improve the modelling of the GRN 
involved in melanocyte development. A gene candidate approach, in vivo, as well as gene 
expression quantification approaches were applied in order to characterise the melanocyte 
population from early to late stages and to better observe mechanisms of gene regulation. 
The general aims of this study were to better understand the regulatory relationship 
between sox10 and mitfa during melanocyte development and to test the role of other 
unknown and poorly described factors. Specifically we wanted to test the following 
hypotheses: 
 Did Wnt signalling fulfil the criteria to contributing to Factor Y?  
The first approach for testing the melanocyte GRN model was to identify a candidate for 
Factor Y (Chapter 3). Wnt pathway was tested as a limiting factor for maintenance of 
stable melanocyte differentiation. Wnt signalling has already been implicated in 
melanoblast specification because it is required for first mitfa expression. It has also been 
shown that the Wnt signalling effectors, Tcf /Lef1 and β-catenin, were able to bind mitfa 
promoter to enhance its expression (Dorsky et al., 2000b). For these reasons, the Wnt 
pathway was a strong candidate for Factor Y and this hypothesis was tested using two 
small molecule activators of the Wnt signalling, BIO and LiCl. These experiments and 
results are described in Chapter 3. 
  Adapt quantitative techniques to analyse gene expression levels and their 
heterogeneity in the NC and melanocyte development during differentiation.  
A second objective was to better understand the development of pigment cells, from the 
multipotent precursors to the differentiated cells. One key issue which remained 
unanswered concerned the precise dynamics of expression for key melanocyte genes 
including mitfa and sox10 in developing melanocytes. Although both were assumed to 
persist in mouse, it was not clearly demonstrated (Hou and Pavan, 2008). The modelling 
depends on the observation that mitfa expression was maintained in differentiated 
melanocyte in zebrafish, whereas sox10 expression was lost. The levels of both mitfa and 
sox10 expressions were tested by qPCR. The technique of RT-qPCR in pools of five cells 
allowed us to investigate gene expression in cell population at a fine resolution (Chapter 
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4). Analysis of the heterogeneity of key gene expressions, combined with analysis of the 
gene expression time-courses, allowed better description of gene expression in 
melanoblasts and melanocytes (Chapter 4).   
 - Quantify the level of melanocytic gene expression in WT and mutants to test 
the GRN model. 
- Does Hdac activity have a role in repressing Sox10 expression? 
- Can Mitfa activate its own expression? 
 
Finally, we analysed expressions of dct, trp1b, sox10 and mitfa in mitfa
w2
 and in sox10
t3
 
mutants in order to test the predictions of the GRN in vivo using quantitative methods 
(Chapter 5). Furthermore, two potential key features of the sox10 and mitfa regulatory 
mechanisms suggested by the modelling were tested (Chapter 5). Firstly, a potential 
feature tested was the role of Hdacs as a co-repressor for the Mitfa-dependent repression 
of sox10 in melanocytes. Secondly, the hypothesis that mitfa could be positively self-
regulating its own expression was investigated (Chapter 5).  
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Chapter 2. Material and 
Methods 
2.1 Fish Husbandry 
 
All zebrafish (Danio rerio) lines, Wild type (AB) zebrafish, transgenic lines Tg(-
7.2sox10:EGFP), (Carney et al., 2006) and Tg(TOP;dGFP) (Dorsky et al., 2002) as well as 
mutant lines mitfa
w2 
(Lister et al., 1999), mitfa
b692 
(Lister et al., 2001), sox10
t3 
(Kelsh et al., 
1996b)
 
zebrafish, were kept at University of Bath and handled as suggested by Home 
Office directives and as described in the referred Zebrafish book, (Westerfield, 2000). All 
the crosses were set up between fish overnight and the embryos were collected in the 
morning. Embryos were raised in embryo medium (EM) (0.5 μM sodium chloride 0.17 μM 
potassium chloride 0.33 μM calcium chloride 0.33 μM magnesium sulphate 0.1 % 
methylene blue in distilled water) at 28.5 °C and staged according to Kimmel et al., 
(1995). Watchmakers’No5 forceps were used for the manipulation of embryos, to remove 
the chorion, between laying and hatching. Embryos older than 15 hpf, which were to be 
manipulated in any way, were anaesthetised with triccaine (Ethyl 3-aminobenzoate 
methanesulphonate, 4 g/L stock, final concentration approximately 0.2 % v/v). Where 
appropriate, melanisation was inhibited, using 1-phenyl-2-thiourea (PTU) (Sigma-Aldrich, 
England), before 24 hpf and at a final concentration of 0.003 % to 0.0015 % in EM. All 
experiments complied with institutional and national animal welfare laws, guidelines and 
policies.  
2.2 Cell dissociation methods  
 
This method has been adapted from The Zebrafish Book, (Westerfield, 2000). 
Dechorionated embryos were rinsed three times in 1X Holtfreter’s solution (0.35 % (w/v) 
NaCl, 0.005 % (w/v) KCl, 0.01 % (w/v) CaCl2, 0.02 % (w/v) NaHCO3 in H2O), transferred 
to an 1.5 mL Eppendorf and disaggregated with a micropestle (Eppendorf, Hamburg, 
Germany) by firmly inserting the micropestle in the tube 5-6 times, being careful not to 
grind the cells. The disaggregate was then centrifuged in a cooled benchtop centrifuge 
(Spectrafuge 24D, Jencons-PLS) at 1100 rotation per minute (rpm) for 5 minutes and the 
supernatant was discarded. The pellet was re-suspended in 1 mL of 0.5 % Trypsin-EDTA 
(Gibco) using a P1000 pipette tip. Cells were incubated for 15 minutes at room 
temperature and pipetted every 5 minutes to help break down the large clumps of cells, to 
enable the small clumps to be broken down into single cells. Cells were then centrifuged 
for 5 minutes at 1100 rpm (Spectrafuge 24D, Jencons-PLS), the supernatant was discarded 
and cells were re-suspended in 1 mL of EM. Suspension was filtered using a 40 µm cell 
strainer into a 50 mL Falcon tube (BD Bioscience, NJ, USA). The cell trainer and the 
falcons were previously rinsed with 10 % FBS (Foetal Bovine Serum) /PBS (Phosphate 
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Buffered Saline, PBS: 2.7 mM KCl, 137 mM NaCl in sterile water) to prevent cells from 
sticking to plastic equipment. After filtering, the Eppendorf was rinsed with 500 µL of 
medium (10 % FBS/PBS) which was re-filtered. The filter was then washed with another 
500 µL of medium (10 % FBS/PBS). The filtering process was performed to ensure that 
only single cells (not clusters) were processed. 
2.3 Plasmid DNA preparation for cloning  
 
All the molecular biology methods described here are referred to the “Molecular Cloning: 
A Laboratory Manual” book from Sambrook and Russell, (2001). 
2.3.1 Transformation and bacterial growth conditions  
 
The transformations of plasmid DNA into E. coli competent cells were performed by heat 
shock. DH-5αF’ (Clontech Laboratories Inc., CA) strain was prepared by Dr Masataka 
Nikaido using chemically induced competency. 30 mL of competent E. coli cells at -80 ºC 
were defrosted on ice for 20 minutes with occasional mixing of the 1.5 mL microfuge tube. 
1 μL of 1 µg.mL
-1
 stock plasmid was added to the cells and the mixture was then kept on 
ice for 20 minutes with the occasional gentle mixing. The tubes were then incubated at 42 
ºC water bath for 42 seconds and immediately placed on ice and left for 5 minutes.  
 
After transformation, cells were incubated in 9 volume Luria Broth medium 
(Sigma-Aldrich, England, LB, (2.5 % (w/v) base in Milli-Q water)) for one hour. 100 µL 
of the cells/LB mixture was then spread on LB-agar plates containing the appropriate 
antibiotic at the appropriate concentration overnight at 37 ˚C. Antibiotics were ampicillin 
(Sigma-Aldrich, England) at 50 µg.mL
-1
 or kanamycin (Sigma-Aldrich, England) at 25 
µg.mL
-1
. Prospective positive colonies on the LB-agar plates were then picked and grown in 
LB-medium with antibiotic. Cells were then incubated overnight at 37 ºC in a shaking 
incubator, the culture volume was chosen according to the specific extraction protocols. 
2.3.2 Minipreperation of plasmids DNA 
 
Colonies were selected from LB-agar plates and were grown overnight in 3 mL LB 
medium with appropriate antibiotic. The plasmid DNA was purified using Promega 
Wizard miniprep or QIAGEN DNA purification kits from which all solutions come from.  
1.5 mL culture was harvested by centrifugation for 5 minutes at 14,000 rpm (Techne 
Genofuge 16M). The supernatant was discarded and the cells re-suspended in 250 μL Cell 
Resuspension Solution (Promega).  250 μl Cell Lysis Solution (Promega) were added and 
mixed, followed by 10 μL pf Alkaline Protease Solution (Promega). The lysate was 
incubated for 5 minutes at room temperature. 350 μL of Neutralisation Solution (Promega) 
were then added and mixed. The lysate was centrifuged for 10 minutes at 14,000 rpm 
(Spectrafuge 24D, Jencons-PLS). A spin column (Promega) was inserted into a collection 
tube and after centrifugation the cleared lysate was applied to the column. This was 
centrifuged for 1 minute at 14,000 rpm (Spectrafuge 24D, Jencons-PLS). The flow-through 
was discarded and the column was washed firstly, with 750 μL and then, with 250 μL, of 
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Wash Solution (Promega), by applying the solution to the column (Promega) and 
centrifuging for 1 minute. The column (Promega) was then centrifuged for a further 2 
minutes (Spectrafuge 24D, Jencons-PLS) to ensure that all the Wash solution (Promega) 
had been cleared from the column (Promega). The DNA was then eluted from the column 
(Promega) by placing the column (Promega) in a clean microcentrifuge tube (Promega), 
applying 100 μL of nuclease-free water to the column (Promega) and centrifuging for 1 
minute at 14,000 rpm (Spectrafuge 24D, Jencons-PLS).  The DNA was checked on a 1 % 
agarose gel (1 % (w/v)) (UltraPure Agarose, Invitrogen) before storage at -20 ˚C. 
2.3.3 DNA digestion 
 
DNA was mixed with 2 μL of 10x buffer appropriate to the enzyme used (Promega or 
Invitrogen), 1 μL of restriction enzyme (Promega or Invitrogen) appropriate for the 
experiment, and 13 μL MilliQ water. The digests were then incubated for 2 hours at 37 ˚C.  
The digests were run on a 1 % agarose gel to look for the presence of the expected bands. 
If the plasmid was not fully digested a further 1-3 μL of enzyme (Promega or Invitrogen) 
were added and the incubation at 37 ˚C was extended for 2 hours, or was processed over-
night at 4 ˚C. The digests were then run on a 1 % agarose gel to check for complete 
digestion. 
2.3.4 Gel extractions 
 
Where it was required to extract a band from a gel (agarose gels 0.8 – 2 % (w/v) (UltraPure 
Agarose, Invitrogen), to send for sequencing, the required band was excised from the gel 
and the DNA purified from this band, using a Qiaquick Gel Extraction Kit (Qiagen). When 
the band had been excised from the gel, the gel slice was weighed. Three volumes of 
Buffer QG (Qiagen were added to the gel slice in a 2 mL microcentrifuge tube (i.e. 300 μL 
Buffer (Qiagen) for every 100 mg of gel). The mixture gel slice/Buffer QG (Qiagen) was 
incubated at 50 ˚C for 10 minutes until the gel slice had dissolved. One gel volume of 
isopropanol was then added to the mixture and mixed. A Qiaquick spin column (Qiagen) 
was placed in a 2 mL microcentrifuge tube and the sample was applied to the column. The 
mixture was centrifuged for 1 minute at 14,000 rpm (Spectrafuge 24D, Jencons-PLS) and 
the flow-through was discarded. Where the volume of the sample exceeded 750 μL the 
column was spun once, and the remainder of the sample was added to the column to be 
spun again. The column was washed by applying 750 µL of Buffer PE (Qiagen) to the 
column and centrifuging for one minute at 14,000 rpm (Spectrafuge 24D, Jencons-PLS the 
flow-though was then discarded. The column was centrifuged again at 14,000 rpm 
(Spectrafuge 24D, Jencons-PLS) for 1 minute to remove all residual Buffer PE (Qiagen). 
The column was then placed in a clean microcentrifuge tube and the DNA was eluted by 
applying 30 μL or 50 μL of MilliQ water to the column. The column was then incubated at 
room temperature for 1 minute and was centrifuged for 1 minute at 14,000 rpm 
(Spectrafuge 24D, Jencons-PLS). The sample was then observed on a 1 % agarose gel 
(UltraPure Agarose, Invitrogen). 
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2.4 In vitro transcription of RNAs  
 
All the molecular biology methods described here are referred to the “Molecular Cloning: 
A Laboratory Manual” book from Sambrook and Russell, (2001). 
2.4.1 RNA preparation using mMessage mMachine (Ambion) 
 
The transcription reaction was set up using mMessage mMachine kit (Ambion) as 
followed. First, the Nuclease free water (Ambion) was added to bring final volume to 20 
μL. Then, 10 μL of 2x NTP/CAP (Ambion), 2 μL of the 10x reaction buffer (Ambion) and 
1 μg of the template DNA, were added to the mixture. Finally, 2 μL of enzyme mix (SP6) 
(Ambion) were added and the reaction mixture was mixed and incubated at 37 ˚C for 2 
hours. After that, 1 μL of the TURBO DNase (Ambion) was added to the sample which 
was mixed and incubated at 37 ˚C for 15 minutes. Finally, the RNA was recovered using a 
MEGAclear kit (Ambion). 
2.4.2 Purification of in vitro transcribed RNA using a MEGAclear kit 
(Ambion) 
 
An RNA transcription reaction was made up to 100 μL with Elution buffer (Ambion).  
First, 350 μL of the Binding solution (Ambion) and 250 μL of 100 % Ethanol were added. 
The mixture was mixed and pipetted to the filter in a collection tube.  This was centrifuged 
for 1 minute at 14,000 rpm (Spectrafuge 24D, Jencons-PLS). The collection tube (Ambion) 
was discarded and the filter washed twice with 500 μL Washing Solution (Ambion).  The 
filter was centrifuged once more, for 1 minute at 14,000 rpm (Spectrafuge 24D, Jencons-
PLS) and the solution was discarded. To elute the RNA, 50 μL Elution Buffer (Ambion) 
was preheated to 95 ˚C and was applied to the filter. In a clean collection tube, the mixture 
was centrifuged for 1 minute at 14,000 rpm. This last step was repeated to increase the 
yield. 
2.4.3 mRNA extraction from zebrafish embryos 
Phenol/Chloroform purification and ethanol precipitation 
In most cases 50 embryos were transferred into 2 mL tubes. 1 mL of TRI REAGENT 
(Sigma-Aldrich, England, T9424) was first added under the hood and the solution was well 
homogenized with syringes (25 mm). TRI reagent (Sigma-Aldrich, England) is a 
commercially available reagent for single step total RNA isolation (Chomczynski and Sacchi, 
1987). The solution was then centrifuged at 12,000 rpm (Spectrafuge 24D, Jencons-PLS) 
for 10 minutes and the supernatant was transferred to new tubes. 0.2 mL of pure 
chloroform (per mL of reagent) was added and the solution was vortexed for 15 seconds 
and was then left standing at room temperature for 10 minutes. Then, the mixture was 
centrifuged 15 minutes at 12,000 rpm (Spectrafuge 24D, Jencons-PLS) at 4 °C and the 
upper aqueous phase was transferred to a fresh tube. 0.5 mL isopropanol per tube per mL 
of TRI reagent (Sigma Aldrich, England) was added and the solution was vortexed for 5-
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10 seconds at room temperature. The solution was centrifuged for 10 minutes at 12,000 
rpm (Spectrafuge 24D, Jencons-PLS) at 4 °C, and the supernatant was removed. The RNA 
pellet was washed in 1 mL 75 % ETOH by inverting the tube gently. The solution was 
finally spun for 5 minutes at 7500 rpm (Spectrafuge 24D, Jencons-PLS). Once the 
supernatant was taken off, the pellet was left to dry and 10 µL of DEPC-treated water was 
added. 1 µL of the solution was run on a 1 % agarose gel (UltraPure Agarose, Invitrogen) to 
attest of the purity and the concentration was measured with the spectrophotometer 
(Biomate 3, Thermo Scientific). If required, solutions were stored at -80 °C and were 
thawed and spun for 5 minutes at 12,000 rpm (Spectrafuge 24D, Jencons-PLS), before re-
use.  
2.5 Reverse Transcription of in vitro synthesised RNA or 
extracted from embryos. 
 
The Invitrogen First strand cDNA synthesis kit with Superscript III (Invitrogen) was used 
for the reverse transcription according to the manufacturer’s protocol. 0.5 µL of random 
primers (250 ng/µL) (Promega), 5 µL of dNTPs (2 mM) (Promega), 7.5 µL of RNA (1 µg 
of total RNA +DEPC-MQ) were first mixed and incubated for 5 minutes at 65 °C and then 
at least 1 minute at 4 °C. Then, 4 µL of 5X first strand Invitrogen buffer, 1 µL of 0.1 DTT, 
1 µL of RNAse out (Invitrogen) and 1 µL of superscript III (Invitrogen) Reverse 
Transcriptase (Invitrogen) (RTase)/µL were added to the previous mix and left 5 minutes 
at 25 °C, 60 minutes at 50 °C, and 15 minutes at 70 °C. Finally, 80 µL of DEPC-treated 
water was added to the mixture, and the concentration was measured using the 
spectrophotometer (Biomate 3, Thermo Scientific). If required, solution could be kept at -20 
°C. 
2.6 Single cell Reverse Transcription 
 
Embryos were first disaggregated by following the method previously described (see 
section 2.2). Cells were then selected using a very thin capillary glass (3 ½ Drummond 
glass capillaries (Drummond Scientific Co., Broomall, PA) set on a microinjector 
(Drummond Scientific Co., Broomall, PA) and by being pulled up by a puller (Sutter 
Instrument Co., Novat,CA) under an Eclipse E800 microscope (Nikon). Single cells were 
then immediately put in a small PCR tube to process to the reverse transcription protocol 
adapted from Bengtsson et al., (2008) (Figure 2.01). The cells were kept in a 10 % 
FBS/PBS solution in a Petri dish (Sterilin). Cells targeted were of a round shape, in the 
bottom of the dish. The capillary was filled with oil and a bubble of air was created using 
the puller in order to separate the cell from the oil and also allowing the visualissation the 
cell and the solution once pulled. Cells picked were black when picking differentiated 
melanocytes or GFP positive when picking sox10-EGFP neural crest cells. Importantly, 
iridophores could be “grey” looking under incident light but here melanocytes could be 
distinguished by their typical brown colour.  
Chapter 2. Material and Methods 
   57 
 
Reverse transcription master mixes were made according to Bengtsson et al., 
(2008), (Figure 2.02). In a first time, cells were immersed in the lysis buffer, Guanidine 
Thiocyonate (GuSCN, Sigma-Aldrich), at a concentration of 0.5 M (diluted in water). 
Bengtsson et al., (2008) showed that, at this concentration, GuSCN (Sigma-Aldrich) was 
one of the most efficient buffer for breaking cell membrane while preserving mRNA from 
the RNAses degradation. This lysis buffer was diluted to the optimal concentration of 40 
mM prior reverse transcription, so that it did not interfere with the enzymatic reactions 
(Bengtsson et al., 2008). Furthermore, in regard to enzyme activity, the ratio Reverse 
transcriptase (RT)/Taq polymerase was controlled to avoid inhibition of PCR reaction by 
RT (Bengtsson et al., 2008). Therefore, the concentration of the Superscript III 
(Invitrogen) was decrease to a ratio < 2 (RT Unity/Taq polymerase Unity) to allow the 
optimal efficiency of the PCR.  
The first Master Mix (MM1) for the reverse transcription was added on top of the 
cell/ 0.5 M lysis buffer solution in the 200 µL PCR tube. The MM1 contained 2.5 µM  
Oligo d(T) (Promega), 2.5 µM Random Primers (Promega), 0.5 µM dNTPs (Invitrogen) 
and 5 mM dTT (Invitrogen). The mix (cell/lysis buffer + MM1) was then incubated for 5 
minutes at 65°C. The second Master Mix (MM2, (1x reaction buffer (Invitrogen), 40 Unity 
RNAse inhibitor (Invitrogen) and 20 Unity of Surperscript III (Invitrogen)) was then 
added, and samples were incubated 5 minutes at 25 °C, 80 minutes at 55 °C, and 15 
minutes at 70 °C (Figure 2.02). Samples were then conserved in freezer at -20 °C.  
Chapter 2. Material and Methods 
   58 
 
 
Figure 2.01: Single cell preparation for reverse transcription and nested or 
quantitative PCR.  
Embryos were disaggregated and cells were isolated in 10 % FBS/PBS solution in 90 mm 
Petri dishes (Sterilin). Cells were then picked one by one and released in a PCR tube in 
about 1 nL 10 % FBS/PBS solution. The adjusted volume of lysis solution Guanidine 
Thiocyonate (GuSCN, Sigma-Aldrich) was then added and, cells were kept on ice until 
proceeding to the rest of the reverse transcription protocol. mRNA extraction and reverse 
transcription were processed in the same tube according to Bengtsson et al., (2008) to 




Figure 2.02: Table showing final concentrations for single cell or five cells reverse 
transcription Master Mix 1 and 2.  
First, the cell is bathed in 4 µL of 0.5 M Guanidine Thiocyanate (GuSCN, Sigma-
Aldrich, England) solution. Secondly, the first Master Mix (MM1) was added and 
samples were incubated at 65 °C for 5 minutes. Thirdly, Master Mix 2 (MM2) was added 
and samples were incubated (5 minutes at 25 °C, 80 minutes at 55 °C, and 15 minutes at 
70 °C). Samples could be stored at -20 °C. The Superscript III (Invitrogen) was used 
from stock preparation concentrated at 200 U per µL.  
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2.7 PCR and Nested PCR 
 
The GoTaq Green Maxter Mix (Promega) was always used for PCR reactions. PCR 
reactions were set according to the Promega’s manufacture’s protocol, in 25 µL final 
volume. A mixture of 0.1 µM of each right and left primers was used for each PCR 
reaction. Using a spectrophotometer (Biomate 3, Thermo Scientific), a volume of 
experimental DNA corresponding to 1 µg of material was added to the mixture, as well as, 
12.5 μL of the GoTaq Green Master mix (Promega) and MilliQ water was added to a total 
volume of 25 μL. The PCR program used was: 2 minutes 95 °C, 35 cycles (1 minute at 95 
°C, 1 minute at 60 °C, 1 minute at 95 °C) and 5 minutes at 72 °C, in PCR thermocycler 
machine (G-Storm, GS00001 or G-Storm, GF00482). Samples were stored at -20 °C when 
needed. Products were run on a 1 % agarose gel ((w/v) (UltraPure Agarose, Invitrogen). 
For nested PCR, the two amplification rounds were processed as described for PCR 
reactions however, two different pair of primers were used, the “external” set in a first time 
for the first round of amplification and the “internal” set in a second time for the second 
round of amplification. For the first round of amplification, cDNA issued from 
embryos/cells was used as template, while for the second round of amplification, DNA 
from first round amplification was used as template (Figure 2.03). 
Primers have been designed using Primer3 Plus software 
(http://www.bioinformatics.nL/cgi-bin/primer3plus/primer3plus.cgi.) software to all span 
an intron. These allowed to control and observe when genomic sequences were amplified 
(Table 2.01).   
 
 




Primer forward Primer reverse 
mitfa 
external 
287 bp AAACCCCCTCGAAGTACCAC AAGTCCTGCATCCATGAACC 

































                                   
Chapter 2. Material and Methods 




Figure 2.03: Primer design for nested PCR.  
An external and an internal set of primers were designed spanning an intron to detect 
amplification of genomic sequence from amplification of cDNA.  
2.8 qPCR 
 
Real time quantitative PCR (RT-qPCR) was performed using SYBR Green I PCR Master 
Mix (Roche) and a Lightcycler II (Roche) machine according to the manufacturer’s 
instructions (Roche). Absolute and relative quantification were performed from samples. 
For relative quantification, gene expression was normalized against zebrafish gapdh 
expression in wild-type embryos and, data were analysed using the (ΔΔCt) (Livak and 
Schmittgen, 2001) method and the Pfaffl method (Pfaffl, 2001).  
2.8.1 The concept of Ct 
 
The threshold cycle (Ct) is the most important measure in fluorescence based reverse 
transcription-PCR (RT-PCR) as it allows reproducible quantification (Higuchi et al., 
1993). The Ct defines the number of cycles required for the fluorescence signal to 
significantly rise above the background. The measure of the fluorescence represents the 
amount of product amplified during the amplification reaction. The more concentrated the 
sample initially was, the least number of cycles it took to reach the Ct. Therefore, the Ct 
value was not affected by the limiting phase of the amplification, the plateau, in which 
reactants become limiting and measurements uncertain. A first step of calibration of 
amplification reaction is always required when using specific primer sets. For this, the 
standardized procedure for building the standard curve was applied. Five reactions 
corresponding to for five diluted concentrations (1/10 dilutions from a prepared pure 
cDNA pool) were processed and Ct(s) could be determined for each reaction, as described 
below. The standard curves and melting curves were then analysed for these reactions in 
order to assess for proportionate amplification (PCR efficiency (E)) and specificity of 
amplification.  
2.8.2 Standard of mRNA calibration for relative and absolute 
quantification 
 
Calibration of qPCR reaction is essential for determining the reliability of qPCR 
amplification (Ct(s) reliable and well proportionate to relative or absolute amount in 
samples) using specific primer sets (Table 2.02). For assessing of qPCR reaction 
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calibration, it is required to build the standard curves for each primer set from high to low 
concentration. Standard curves also allow the association of a Ct to a relative (using a 
reference gene) or an absolute quantification.  
 Calibration is a standardized procedure consisting in measuring Ct(s) in five 









) of a first concentrated yield (sample 1). Standard curves 
allow to determine PCR amplification efficiency (E) which is calculated as described in 
Livak and Schmittgen, (2001) and Liu et al., (2009).  The distance (number of cycles) 
between each Ct value is used to measure the reliability of amplification. Indeed, during 
PCR, the yield was theoretically doubled (E = 2 corresponding to PCR efficiency = 100 
%), therefore, the slope, which corresponds to the theoretical distance between Ct(s) for a 
standard curve should be a value close to -3.32 [(dilution 1 in 10) is E = 10
(-1/slope)
-1 when 
E = 2, slope = -3.32]. For individual standard curves, values of the slope of the different 
test sets ranged from −3.19 to −3.56 reflecting amplification efficiency of 90–110 %. For 
each primer set used in these experiments (tested genes and reference genes), a standard 
curve allowed to determine and to analyse Ct(s) and therefore relative and absolute 
quantification. Importantly, this calibration process is not a control for specific 
experiments. Once the primers were calibrated for qPCR reactions, they could be used for 
any experiments and each specific experiment required a specific control (untreated, WT 
condition prepared in the exact same condition as the treated or mutant to which it is 
compared to). Comparison of mRNA expression was commonly presented by relative fold 
changes for relative quantification.  
Importantly, for preparing the standard curves, single species cDNA solutions were 
diluted in cDNA reverse transcribed from plant extracted mRNA (Arabidopsis sp., kindly 
given by Dr R. Scott lab, University of Bath) in order to replicate the cell/embryo cDNA 
solution background. Therefore, plant cDNA was diluted to low concentration in MiliQ 
water, and used to dilute the single specie cDNA solutions. 
 
The choice of the reference gene as a stable and highly expressed gene was crucial 
for relative expression determination. Here gapdh was used as a reference gene for relative 
quantification. For absolute quantification of gene expression, the mRNA mass was 
converted to a gene copy number using an equation adapted from Staroscik, (2004). This 
calculation was based on the assumption that the average weight of a base pair (bp) is 650 
Daltons. This meant that one mole of a bp weighs 650 grams and that the molecular weight 
of any double stranded DNA template could be estimated by knowing and multiplying the 
product’s length (in  bp) and 650. The number of molecules of template per gram could be 
calculated using the Avogadro's number, 6.022x10
23
 molecules/mole, and finally, the 
number of  molecules or number of copies of template in the sample, could be estimated by 
multiplying by 10
9
 to convert to ng and then multiplying by the amount of template (in ng) 
(Staroscik, 2004) as follows: 
 
Gene copy number = [mRNA(pg) × 6.022 × 10
20
] / [Amplicon(bp) × 1 × 10
9
 × 650] 
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For standard curve reactions built for absolute quantification, all mRNA were 
synthesized from plasmids, in vitro as described below (see section 2.4.1) using SP6 
mMESSAGE mMACHINE® Kit (Ambion) according to manufacture protocol. Each 
mRNA species concentration and purity was measured using a spectrophotometer (Biomate 
3, Thermo Scientific) and was then reverse transcribed as previously described (see section 
2.4). Concentration for cDNA of each species was then assessed and copy numbers were 
calculated formulas in section 2.7.2.  
 
Table 2.02: Primer pairs used for qPCR (5`-3`): 
GENE Primer forward Primer reverse 
gapdh ACCAACTGCCTGGCTCCT TTACTTTGCCTACAGCCTTGG 
β-actin TACCCCATTGAGCACGGTA GTTCCCATCTCCTGCTCAAA 
mitfa CTGGACCATGTGGCAAGTTT TGAGGTTGTGGTTGTCCTTCT 
sox10 TTCTCGCTCTTCACACAACG CGGACATCTGAGACTGCTGA 
dct TCTTCCCACCTGTGACCAAT ACCAACACGATCAACAGCAG 
trp1b CGACAACCTGGGATACACCT AACCAGCACCACTGCAACTA 
 
2.8.3 Data and statistical analysis 
 
In order to follow the fold change in gene expression over time using relative 
quantification, the Ct value was used in samples of the corresponding qRT-PCR 
amplification. Two methods were used to determine relative quantification, the method 
described in Livak et al., (2001), also called the (ΔΔCt ) method, and the method 
developed by Pfaffl et al., (2001).  
 
 In the (ΔΔCt) method, the Ct value of the tested gene (WT or untreated conditions 
and mutant or treated conditions) were corrected for background variations using the Ct 
value of the reference gene in the corresponding sample for the same condition (Ct(tested 
gene)-Ct (reference gene) = ΔCt ). Then, the difference: ΔCt (tested control condition) -  ΔCt (tested gene mutant 
or treated) = ΔΔCt,  was used to determine the fold difference between WT/untreated (control 
or also called calibrator) and mutant/treated samples (gene expression differences). The 
fold difference between the calibrator and the tested condition is determined by 2
-(ΔΔCt) 
(Livak and Schmittgen, 2001). 
 
 In Chapter 4, REST 2009 software (Pfaffl, 2001, Pfaffl, 2009)  and (ΔΔCt) method 
were used to analyse data. Both methods Pfaffl, 2001 and Livak et al., (2001), used the 
comparison to a reference gene and to a calibrator situation. The Pfaffl method differed 
from the (ΔΔCt) method by the fact that it took account of qPCR efficiencies differences in 
determining quantification. The Pfaffl software also allowed randomization of tests which 
permitted to avoid false positive results. Statistic analysis could be realized to determine 
the significance of quantification differences. However, prior to this analysis, it had been 
ensured that qPCR efficiencies were comparable. For absolute quantification, transcript 
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copy numbers were assessed using a standard curve. Ct(s) associated to each sample were 
associated to copy numbers.  
 In Chapter 4, statistical analysis processed in R allowed to assess gene expression 
correlation using a linear regression test as well as significance of gene expression 
variations using Fisher test. Data collected were also used to mathematically describe and 
fit gene expression time-course in R (Crawley, 2007) 
In Chapter 5 Student’s t-test with the Bonferroni correction for multiple 
comparison (Dunn, 1961) were performed using GraphPadPrism 5.0 to test the null 
hypothesis (no significant difference in gene expression levels between mitfa and sox10 
mutants). In all the tests, differences were considered significant if p-value < 0.017. 
 
2.9 Antibody staining 
 
Embryos were fixed in 4 % Paraformaldehyde (PFA) in PBS (Phosphate buffered saline, 
Oxoid) overnight at 4 °C. They were washed three times for 5 minutes in PBSX (PBS with 
0.1 % (v/v) Triton X-100) and three times for 1 hour in MilliQ water. Embryos were 
incubated in blocking solution (1 % DMSO, 5 % Goat/Sheep serum diluted in PBSX) for 
at least 2 hours. They were then incubated at room temperature overnight in polyclonal 
mouse serum primary antibody (Polyclonal IgG Mouse Anti-GFP Primary Antibody) 
diluted 1 in 200 in blocking solution (10 % (w/v) of Blocking Reagent (Roche, Manhein, 
Germany, in 1xMAB (100 mM Maleic Acid 90 mM NaCl In Milli-Q water, adjust pH to 
7.5 and autoclave, this solution could be prepared and kept in the freezer). Embryos were 
washed in PBSx once briefly and three times for 1 hour. They were incubated overnight at 
room temperature in Alexa Fluor 488 fluorescent anti-mouse secondary antibody 
(Polyclonal IgG Alexa Fluor 488 goat anti-mouse) diluted 1 in 500 in blocking solution (1 
% DMSO, 0.5 % Saponin, 1 % BSA 2 % Goat/Sheep serum in PBS). Embryos were then 
washed once briefly and three times for 30 minutes in PBSX. They were placed in 50 % 
glycerol for visualisation and storage.  
2.10 Whole mount in situ hybridisation (WISH) 
 
In situ hybridization was performed using the Kelsh lab protocol adapted from Henrique et al., 
(1995). All amounts of liquid are 1 mL.  
Preparation of zebrafish embryos 
Embryos were fixed overnight in 4 % PFA/PBS at 4 ˚C.  To dehydrate embryos 
they were washed once in PBT (PBS with 0.5 % Tween) for 5 minutes and twice for 10 
minutes in 100 % methanol and then placed in methanol at -20 ˚C at least overnight. 
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Staining Day 1 - Probe hybridisation 
Embryos were rehydrated by washing 5 minutes in 75 % methanol, in 50 % methanol, in 
25 % methanol and finally twice for 5 minutes in PBT. Once rehydrated, embryos were 
fixed for 20 minutes in 4 % PFA/PBS.  Embryos were then subjected to Proteinase K (10 
mg/mL stock, Roche) digestion for varying times depending on age.  24 hpf embryos were 
incubated in a 1/10000 dilution (100 µg.mL
-1
) of Proteinase K for 15 minutes.  Older 
embryos were incubated in a 1/1000 dilution (10 µg.mL
-1
) of Proteinase K for 20-45 
minutes for 27-48 hpf embryos or 45-60 minutes for 50-60 hpf embryos.  Digestion was 
followed by a brief wash in PBT and re-fixing for 20 minutes in 4 % PFA/PBS.  Embryos 
were then washed twice in PBT for 5 minutes each. Embryos were pre-hybridised in 
hybridisation mix (HM: 50 % (v/v) Formamide 5X SSC 50 ng/mL Heparin 500 ng/mL 
tRNA 5) for 1-3 hours in a 68 ˚C water bath. Embryos were hybridised overnight at 68 ˚C 
in 200 μL hybridisation mix with 1/100 dilution of probe. 
Staining Day 2 - Antibody binding 
Hybridisation mix with probe was removed to be kept at -20 ˚C and recycled.  The 
embryos were washed quickly in hybridisation mix at 68 ˚C and then washed as follows 
(2xSSC and 0.2xSSC were diluted in DEPC treated water from a stock solution 20xSSC : 3 
M NaCl 300 mM sodium citrate Adjust the pH to 7.0 with a few drops of 1 M HCl In 
Milli-Q water): 
 10 minutes              75 % HM / 25 % 2xSSC at 68 °C. 
 10 minutes              50 % HM / 50 % 2xSSC at 68 °C. 
 10 minutes              25 % HM / 75 % 2xSSC at 68 °C. 
 10 minutes              2xSSC at 68 °C. 
 2x30 minutes          0.2xSSC / water at 68 °C. 
 5 minutes              75 % 0.2xSSC/25 % PBT at RT (room temperature) 
 5 minutes                50 % 0.2xSSC/50 % PBT at RT 
 5 minutes              25 % 0.2xSSC/75 % PBT at RT 
 5 minutes             MABT at RT (Dilute MAB 5X with Milli-Q water and 0.1 %     
                              (v/v)  Tween20)  
 
Embryos were then incubated for 2-4 hours at room temperature in blocking solution (PBT 
with 5 % sheep serum, 2 mg/mL BSA).  They were incubated overnight at 4 ˚C with anti-
DIG alkaline phosphatase (Roche) diluted 1/2000 with blocking solution. 
Staining Day 3 – Colouration 
The anti-serum was removed.  Embryos were washed once quickly in PBT, then six times 
for 30 minutes in PBT and three times for 5 minutes in NBT/BCIP buffer (Roche).  
Embryos were then incubated in staining solution in the dark at room temperature. For blue 
staining, 200 μL NBT/BCIP solution (Roche) was diluted in 10 mL of NBT/BCIP buffer 
(Roche). Reactions were stopped by washing quickly in PBT and were stored in 4 % 
PFA/PBS at 4 ˚C. Before mounting for examination on a microscope embryos were 
transferred to 50 % glycerol for at least 30 minutes. 
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2.11 Morpholino Injection  
 
Mc1r morpholino (25-bp of Danio mc1r ORF sequence based on the accessioned sequence 
NM_180970 (NCBI) , 5’-AGTGATGGCGCGAAGAGTCGTTCAT- 3`, (Gross et al., 
2009)) was injected in 1-2 cell staged embryos. This morpholino was previously designed 
and reported by Gross et al., (2009). However, neither the efficiency of the morpholino nor 
the knockdown of Mc1r translation were assessed by Gross et al., (2009) in vivo, therefore 
it was not clear whether this morpholino could be validated. Morpholino injections were 
carried out with 1 nL of 0.2 µM (= 12.7 pg) diluted in 1X Danieau solution (58 mM NaCl 
0.7 mM KCl 0.4 mM MgSO4, 0.6 mM Ca(NO3)2 5 mM Hepes pH 7.6 in Milli-Q water).  
2.12 DNA/RNA microinjection 
 
Embryos were injected using a Nanoject II (Drummond Scientific Co., Broomall, PA) 
between 1 to 2 cell stages. Needles were pulled on a Micropipette puller (Sutter Instrument 
Co., Novat,CA) from 3 ½ Drummond glass capillaries (Drummond Scientific Co., 
Broomall, PA).  DNA/RNAs were diluted in MilliQ water with 0.005 % phenol red (0.05 
% (w/v) phenol red In Milli-Q water).  Embryos to be processed for in situ were fixed in 4 
% PFA (4 % (w/v) paraformaldehyde in PBS Autoclaved. PBS is firstly warmed to  60 ºC 
and then PFA is added, it is necessary to adjust pH to improve PFA solubilisation) 
overnight at 4 °C before being dechorionated, re-fixed at room temperature for 




The DNA sequencing was performed commercially by one of two external companies, 
Eurofins MWG Operon, London, UK or Geneservice, UK. Sequence data was analysed 
using the BLAST tool on the NCBI website (www.ncbi.nLm.nih.gov).  
2.14 Microscopy 
-Photography of live and stained embryos 
Live embryos were anesthetized with tricaine (ethyl 3-aminobenzoate methanesulfate salt) 
(MS222 Sigma-Aldrich, England) to approximately 0.003 % mounted in methylcellulose or 
between bridged coverslips and photographed using a Nikon sight DS-U1 camera (Nikon) 
mounted on an Eclipse E800 microscope (Nikon).  
Stained embryos were viewed in whole mount by placing them in a drop of 80 % 
glycerol between stacks of No 1 coverslips on a slide, with a coverslip placed over the top.   
Embryos were then viewed using a Nikon Eclipse E800 using either DIC or 
fluorescence microscopy as appropriate and photographed using a SPOT camera (Image 
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Solutions) or Nikon sight DS-U1 camera (Nikon) together with NIS Elements F software 
or a dual mode cooled CCD camera (Hamamatsu).  For rapid sorting/scoring embryos were 
viewed on an MZ12 dissecting microscope (Leica). 
-Observing single cells 
Melanised or fluorescent cells were observed by wide-field fluorescent microscopy on an 
Eclipse E800 (Nikon) using a DS-U1 camera (Nikon).  
- Confocal microscopy 
 
For confocal imaging, embryos were imaged under a Zeiss Confocal microscope (LSM510 
Meta). Live embryos for confocal microscopy were mounted into 2 % agarose.  
2.15 Image analysis 
 
Pictures were formatted using Adobe Photoshop 7.0, cell dendricity and cell organisation 
were analysed using the free ImageJ software (Abramoff, 2004). For dendricity analysis, 
single cell pictures were isolated in a restricted area around the cell. The cell perimeter was 
next determined using the software function and the roundness parameter could be 
calculated. For analysis of cell organisation, pictures of 72 hpf dorsal head embryos 
showed dark cells on a bright background (zebrafish embryo). Colours were then inverted 
(software function) and edges were found (software function).  
2.16 Small molecule treatments 
 
BIO, (2’Z,3’E)-6-Bromoindirubin-3’-oxime:  gsk3β inhibitor (purchased from 
Calbiochem, 361550-1MG) diluted in DMSO (Dimethyl sulfoxide, Sigma). BIO solution 
diluted at 10 mM was kept in dark at -80 °C and was used within maximum 3 months after 
receiving to avoid destabilisation of the molecule which could affect its activity. In 
treatment experiment, BIO was used at a concentration of 5 µM and controls were exposed 
in DMSO in same concentration as applied in BIO treatment. 
LiCl:  3M Lithium chloride (Sigma-Aldrich, 203637 -powder, ≥99.99 %) was diluted in 
EM and used as 200 mM concentration. The solution was kept at RT and changed each 
month. 
Trichostatin A (TSA): TSA (Sigma, T8552), hdac inhibitor (Vanhaecke et al., 2004) was 
diluted in DMSO and kept at -20 °C. Controls were exposed to DMSO in same 
concentration as applied in TSA treatment (1 µM). 
2.17 Statistics 
All data treatments were processed in Excel or R (Crawley, 2007) and statistical tests in 
GraphPad Prism 5 (http://www.graphpad.com/prism/p5.htm), Analyse-it, XLSTAT (Excel 
associated softwares) or R (Crawley, 2007). 
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Chapter 3. Testing Wnt 
signalling as a candidate for 
Factor Y 
 
3.1 Introducing the hypothesis that Wnt signalling is a good 
candidate factor for Factor Y 
 
3.1.1 The existence of Factor Y is suggested by in vivo data 
 
Features of the GRN responsible for the maintenance of melanocyte differentiation are not 
known. However, it has been suggested that melanocyte differentiation was established by 
maintaining mitfa expression in cells, although the exact mechanism has not been 
described. In this Chapter, the aim was to specifically test for the existence of, and test a 
candidate for, a factor involved in the maintenance of mitfa expression which would 
stabilise the GRN of differentiated embryonic melanocytes.  
 A GRN underlying melanocyte development was previously proposed, based upon 
the experiments presented in Greenhill et al., (2011) introduced in the Introduction 
Chapter. One critical factor for melanocyte survival is Mitfa, the master gene for 
melanocyte development (Lister et al., 1999). In vivo data have shown that mitfa is 
expressed in melanocytes until at least 48 hpf (Greenhill et al., 2011). However, whether or 
not mitfa expression was highly maintained in all cells after 48 hpf remained unclear. 
According to the model, the decrease and the loss of sox10 expression between 28 hpf and 
52 hpf justifies the need for a factor, which we called Factor Y, to maintain mitfa 
expression in melanocytes and allow melanocyte differentiation.  
Due to its role in the GRN, Factor Y would be defined by several characteristics: 1) 
it would be activated during melanocyte differentiation. 2) It would enable the activation of 
mitfa expression, probably from 28- 48 hpf, or to 72 hpf, depending on whether or not 
mitfa expression is maintained in melanocytes until 72 hpf. 3) The model predicted that the 
suppression of Factor Y would cause regression and/or death of melanocytes around 40 hpf 
as a result of the loss of mitfa expression (Johnson et al., 2010), and finally, 4) in contrast, 
elevated Factor Y activity would, in turn, exaggerate melanocyte differentiation and mitfa 
expression in melanocytes.  
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By definition, both Mitfa and Factor Y are required for the persistence of this 
feedback loop activation. Consequently, blocking one of these two factors is predicted to 
cause a loss of this regulatory feature. Importantly, the level of mitfa activation would need 
to reach a certain threshold for the positive feedback loop activated by Factor Y to be 
stably maintained (Greenhill et al., 2011). Without this condition, this regulatory feature 
would be in an unstable state, and melanocyte differentiation would be destabilised.  
In the context of the model, Factor Y would either be one key factor, or an 
ensemble of factors, required for the maintenance of mitfa expression during melanocyte 
differentiation. In this Chapter, we investigated the possibility that Wnt signalling is a 
candidate for Factor Y.  
3.1.2 The role of Wnt signalling in melanocyte differentiation is suggested 
by its role in specification 
 
In zebrafish, the role of the Wnt signalling pathway in melanocyte specification has been 
well described. The two effectors of Wnt signalling, Lef1 and β-catenin, can activate mitfa 
transcription. β-catenin can rescue melanocyte specification in sox10 mutants (Dorsky et 
al., 1998). However, it remains unknown whether the same regulatory interaction could 
also have an ongoing role in melanocyte differentiation, for example, in the maintenance of 
mitfa expression after sox10 expression loss. Here, the canonical Wnt signalling pathway 
was tested as a potential candidate factor involved in the maintenance of mitfa expression 
and of melanocyte differentiation after sox10 loss in melanocytes.  
 Other studies in different biological models have also shown that Wnt signalling, 
via Lef-1 and β-catenin, was required for melanocyte specification. For example, mutant 
mice deficient in Wnt-1 and Wnt-3a lack pigment cells (Ikeya et al., 1997, Novak and 
Dedhar, 1999, Saint-Jeannet et al., 1997a). The overactivation of wnt-1 in zebrafish, as 
well as, overexpression of Wnt-1 or β-catenin in mouse neural tube explants, promoted 
pigment cell formation and led to melanocyte expansion and differentiation (Dorsky et al., 
1998, Dunn et al., 2000b). Furthermore, study of B16-F0 murine melanoma cells in culture 
in vitro and normal human melanocytes (NHM) have shown that β-catenin was not only 
involved in LEF-1 dependent regulation of Mitf, but also interacted with MITF to activate 
MITF-specific target genes (Schepsky et al., 2006, Saito et al., 2002). Consequently, the 
MITF-β-catenin interaction competitively redirected the β-catenin transcriptional activity 
away from the Wnt regulated genes, to the MITF target promoters (Dorsky et al., 1998). 
However, the effective contribution of the canonical Wnt/β-catenin pathway in 
melanogenesis in adult human melanocytes has not been fully studied (Bellei et al., 2010). 
3.1.3 The TOP;dGFP reporter allows detection of Wnt signalling 
activation in zebrafish 
 
To test the activation of Wnt signalling in melanocytes, it was important to define a 
reliable method to detect activation of effectors of the pathways. Dorsky et al., (2002) built 
a useful tool, the TOP;dGFP zebrafish transgenic line, to describe and track the Wnt 
signalling/ β-catenin responsive cells. TOP;dGFP fish express a destabilised GFP variant 
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under the control of a promoter consisting of four consensus Lef1 responsive elements, and 
a minimal promoter (Korinek et al., 1997, Dorsky et al., 1998). Destabilized GFP (dGFP) 
is a variant of GFP with a fused degradation domain (Li et al., 1998). Studies have shown 
that the half-life of the dGFP ranged between one and two hours which allows the 
monitoring of gene induction in living tissues (Li et al., 1998). Consequently, the transient 
dGFP reporter can be detected by fluorescence microscopy in living tissues and it allows 
us to follow the Lef1 responsive cells in embryos throughout development (Dorsky et al., 
2002). 
 Dorsky et al., (2002) described the expression of the TOP;dGFP reporter during  
zebrafish development and described the dynamic changes, from 12 hpf to 72 hpf,  in the 
parts of the embryo where the cells expressed the reporter (see Dorsky et al., (2002) for 
details). The study showed that the reporter could be detected from the gastrulation stage in 
the dorsal organizer, the ventrolateral mesoderm, the tailbud, and in the midbrain-hindbrain 
boundary (tectum), where Wnt signalling was known to be activated and required 
(Heasman et al., 1994, Schneider et al., 1996, Takada et al., 1994, McMahon and Bradley, 
1990). Expression of dGFP was also observed in the NC at 18 hpf by in situ hybridisation 
on sections (Dorsky et al., 2002). However, the activation of the pathway in developing 
melanocytes was not investigated.  
 The expression of the dGFP in the TOP;dGFP was previously investigated  using 
WISH in zebrafish during the phase corresponding to the late differentiation of embryonic 
melanocytes (at 55 hpf, 72 hpf and 96 hpf) (Figure 3.01) (Dr Masataka Nikaido, Dr Robert 
Kelsh Laboratory, University of Bath). At 55 hpf, WISH revealed expression of the GFP in 
the tectum, as well as, in cells of the trunk which correspond (localisation, and 
morphology) to melanocytes of the dorsal stripe (Figure 3.01, B and C). At 72 hpf, the 
expression of GFP in the tectum was still strong, however, the expression in the cells of the 
dorsal stripe in the trunk was faint (Figure 3.01, E and F). At 96 hpf, the signal remained 
detectable in the tectum but no expression was found in the trunk (Figure 3.01 (H)). 
Consequently, these results showed that until 55 hpf, the activation of Wnt signalling could 
still be detected in the melanocytes of the dorsal stripe. It remains possible that the Wnt 
signalling pathway was still activated in melanocytes at 72 hpf at a low level, below the 
threshold for detection by WISH. In this study, the detection of the activation of Wnt 
signalling was tested in single melanocytes during the time window corresponding to the 
cell differentiation phase. 
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Figure 3.01: Detection of GFP in TOP;dGFP transgenic embryos by WISH. 
A non-hydrolysed egfp probe was used to detect GFP in the transgenic TOP;dGFP 
embryos by whole-mount in situ hybridisation at 55 hpf (A-C), 72 hpf (D-F) and 96 hpf 
(G-H). At 55 hpf, the blue/purple signal is observed in the tectum as shown in lateral view 
(A) and in the trunk in the dorsal line of melanocytes as shown in (B) in lateral view and in 
(C) with the dorsal view (in both pictures, arrowheads show cells expressing the signal). At 
72 hpf, the signal could still be observed in the tectum as shown in (D) in lateral view and 
it was also faintly detected in the dorsal line of the trunk (E, lateral view, F dorsal view, 
arrowheads show cells expressing the signal). At 96 hpf, the signal could still be detected 
in the tectum (G, lateral view of the head), but in the trunk (H, lateral view). Key: e: eyes, 
T: tectum, y: yolk sac. (Nikaido M, unpublished data) 
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3.1.4  GSK3β is a negative regulator of the canonical Wnt signalling 
pathway 
 
Glycogen Synthase Kinase 3 beta (GSK3β) is a negative regulator of canonical Wnt 
signalling (see Introduction Chapter). Here, the role of GSK3β is further described in order 
to show that inhibition of this protein can activate the Wnt signalling pathway. In 
zebrafish, mouse, Xenopus and human, two isoforms of the serine/threonin protein kinase 
GSK3 are described, GSK3α and GSK3β. It is unclear if these two isoforms have a similar 
function in vivo. Lee et al., (2007) demonstrated that GSK3α and GSK3β had different and 
non-redundant functions in cardiogenesis in zebrafish. Morpholino knockdown lead to the 
same morphological defect defined as pericardial edema. However, GSK3α was shown to 
be responsible for cardiomyocytes survival, whereas, GSK3β was shown to be implicated 
in valve formation and heart positioning through Wnt/ β-catenin signalling (Lee et al., 
2007). GSK3β is involved in the canonical Wnt signalling via regulating β-catenin 
translocation to the nucleus. In the canonical Wnt signalling pathway, GSK3β maintains 
the phosphorylation of its substrate, β-catenin, in the absence of a signal. The Wnt-induced 
dissociation of β-catenin from the complex allows the stabilization and the activation of the 
free β-catenin. GSK3β recruitment to the membrane is dependent on the activation of 
Frizzled, the Wnt receptor (Figure 3.02). The Wnt co-receptor for the canonical Wnt 
signalling is called the low-density-lipoprotein receptor-related protein 5/6 (LRP 5/6). LRP 
5/6 associates with GSK3β and inhibits its negative regulation of β-catenin (Barker, 2008, 
Chen et al., 2000, Hur and Zhou, 2010, Lee et al., 2004). The Figure 3.02 summarises the 
Wnt signalling pathway and GSK3β activity in Mitf regulation in melanocytes. 
 Besides being crucial for the canonical Wnt pathway, GSK3β is a central regulatory 
node which influences an extensive range of cellular processes regulated by multiple 
signalling factors (Hur and Zhou, 2010, Yost et al., 1996, Sineva and Pospelov, 2010). 
Interestingly, GSK3β is involved at different levels of mitfa regulation. Firstly, GSK3β 
negatively regulates mitfa at a transcriptional level through inhibition of Wnt signalling. 
Secondly, at the protein level, GSK3β has the capacity to phosphorylate MITF protein 
enhancing its capacity to bind the promoter and to activate Tyrosinase expression (Figure 
3.02) (Takeda et al., 2000b). Consequently, GSK3β is a regulator of MITF activity turning 
these two antagonist functions “on” and “off” at different time points and under different 
conditions. However, the dynamics of these effects is still poorly understood and a direct 
role of GSK3β in melanocyte development has never been described.  
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Figure 3.02: The activation of the canonical Wnt signalling pathway activates free β-
catenin and allows the phosphorylation of MITF by GSK3β in melanocytes. 
In the absence of Wnt signalling, GSK3β phosphorylates (P) β-catenin (β-cat) in a complex 
(C+ GSK3β). This phosphorylation prevents β-catenin from translocating to the nucleus 
and causes β-catenin degradation by the ubiquitine/proteasome complex. The canonical 
Wnt signalling pathway is activated when the Wnt protein binds its receptor, Frizzled (F), 
in the membrane and its co-receptor LRP5/6. This activation results in the segregation of 
GSK3β to the plasma membrane and prevents the phosphorylation and the degradation of 
β-catenin (β-cat). In the nucleus, β-catenin can interact with LEF1 for binding gene target 
promoters such as the Mitf promoter. As MITF accumulates it can act together with β-
catenin and LEF-1 to activate melanogenic targets. Furthermore, GSK3β can 
phosphorylate MITF to enhance MITF activity. (Adapted from Saito et al., (2002)). 
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3.1.5 Inhibiting GSK3β can result in boosting Wnt signalling 
 
In zebrafish, experimental blocking of canonical Wnt signalling remains a challenge. No 
small molecules have been developed to repress Wnt or to inhibit activity of its receptor 
and co-receptor, Frizzled/LRP5/6. Experiments to block Frizzled activity using 
morpholinos in zebrafish have not shown clear effects on melanocyte development, 
probably because of the redundancy of the Frizzled receptors (Nikaido et al., 2013). The 
ichabod/ β-catenin zebrafish mutant carries the maternally expressed mutation ichabod 
which inactivates β-catenin. This mutation is homozygous lethal in 99 % of the progeny. 
Thus, only 1 % of embryos, called escapers, can survive. However, these escaper embryos 
show strong disruption of formation of the anterior axis, which does not permit their use 
for the study of the melanocyte GRN (Kelly et al., 2000). Consequently, in these 
experiments we used the chemical inhibition of GSK3β to manipulate Wnt signalling and 
test effects of activation of the pathway in melanocyte differentiation. The effects of the 
treatments with two small molecules, which are known inhibitors of GSK3β, were assessed 
in melanocyte development. These molecules, the 6-bromoindirubin-3’-oxime (BIO) and 
the Lithium Chloride (LiCl), were used to activate the Wnt pathway during different 
phases of melanocyte development. 
 BIO is a well-characterised GSK-3α/β inhibitor. It has been used to investigate Wnt 
signalling in many model systems, including mammalian cardiomyocytes in cell culture, 
melanoma cells (B16-F0) in normal human melanocyte (NHM) cells, in mouse embryonic 
stem cells, and in zebrafish (Tseng et al., 2006, Bellei et al., 2010, Bellei et al., 2008, 
Sineva and Pospelov, 2010, Kim et al., 2008). BIO is a cell permeable indiburin compound 
which acts as a highly potent, selective and reversible adenosine tripohosphate (ATP)-
competitive inhibitor of GSK-3α/β. Its specificity has been tested against various kinases, 
such as, Cdk’s (cyclin-dependent kinase), as well as many other commonly studied kinases 
like MAP kinases, PKA (protein kinase A), PKC isoforms (protein kinase C, involved in 
non-canonical Wnt pathway), PKG (protein kinase G), CK (creatin kinase), and IRTK 
(receptor tyrosine kinase) (Calbiochem, 361550 GSK-3 Inhibitor IX, Merck Chemicals 
Ltd., UK). Importantly, the inhibition of GSK3β using BIO has been shown to activate 
Mitf expression and activity via increased levels of free, stabilised, β-catenin (Bellei et al., 
2008). In human and mouse embryonic stem cells (ESCs), treatment with BIO resulted in 
increased β-catenin activity and promoted self-renewal and pluripotency which both 
contribute to the maintenance of stem cell properties (Sineva and Pospelov, 2010). Studies 
have also shown that BIO could specifically promote proliferation of mammalian 
cardiomyocytes (Tseng et al., 2006). p38-MAPK activity has also been associated with 
increased mammalian cardiomyocyte proliferation, therefore, it has been suggested that 
BIO may interact with, and inhibit, the p38-MAPK pathway (Tseng et al., 2006). 
However, this hypothesis remains to be tested. 
 Lithium Chloride (LiCl) is another small molecule traditionally used to activate 
Wnt signalling. LiCl is a stimulator of β-catenin as well as an inhibitor of GSK3β (Klein 
and Melton, 1996). In Xenopus, experiments using lithium trigger a posteriorisation of the 
embryos, observed by the duplication of the dorsal axis and the loss of ventral tissues (Kao 
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and Elinson, 1988). Incubation of fasted rat hepatocytes with LiCl could activate the 
glycogen synthase and the glycogen phosphorylase, mimicking the effects of insulin 
(Bosch et al., 1986). LiCl is also one of the best treatments for bipolar disorder in humans, 
however, the mechanisms involved in these effects remain poorly understood (Price and 
Heninger, 1994, Avissar et al., 1988). Several hypotheses have been suggested for this 
mechanism. The accepted and previously dominant hypothesis was that LiCl would cause 
inositol depletion (Berridge et al., 1989, Avissar et al., 1988). This was suggested after 
experiments had shown that LiCl could inhibit the inositol monophosphate (IMPase), and 
could decrease the levels of inositol (inositol 1,4,5 trisphosphate, (InsP3)) in cells, by 
blocking the cell Insp3-dependent response to extracellular signals (Berridge et al., 1989, 
Avissar et al., 1988). Furthermore, in Xenopus, injections of inositol could prevent 
teratogenic effects caused by LiCl treatment (Busa and Gimlich, 1989). However, this 
hypothesis did not explain the effect of LiCl on glycogen synthase enzyme. Several studies 
have described and used LiCl for its role as an Inositol Phosphate 3 (IP3) inhibitor (Stachel 
et al., 1993, Jin and Thibaudeau, 1999, Klein and Melton, 1996, Van Lookeren Campagne 
et al., 1988). However, when Klein et al., (1996) used more specific IMPase inhibitors 
when they became available (1000 fold more potent as IMPase inhibitors, than LiCl (Atack 
et al., 1994)), the study intended to reproduce the effects of LiCl in Xenopus. 
Unexpectedly, the phenotype, described as embryo dorsalisation, observed with LiCl could 
not be reproduced with these inhibitors (Klein and Melton, 1996). Because LiCl could 
affect embryo dorsalisation and because it had been suggested to be a glycogen synthase 
inhibitor, its effects on GSK3β inhibition were investigated. The results showed that the 
lithium ion could inhibit 50 % of the GSK3β phosphorylating activity (Klein and Melton, 
1996). It was then shown that LiCl could inhibit GSK3β mediated phosphorylation of 
protein substrates, such as the protein phosphatase inhibitor-2, without affecting the 
activity of other kinases (such as ERK-1/MAP kinase-mediated phosphorylation or CKII 
phosphorylation of casein). This suggested a relatively good specificity of the effects on 
GSK3β (Klein and Melton, 1996). LiCl was suggested to be a specific GSK3β inhibitor 
when the LiCl treatment phenotype was found to be similar to the “dorsalisation” 
phenotype observed in GSK3β dominant negative mutant in Xenopus (Dominguez et al., 
1995, Kao and Elinson, 1988).  
 Consequently, LiCl has been utilised as a Wnt activator and as a GSK3β inhibitor 
in several model systems including Xenopus, zebrafish and mammalian cell culture (Kim 
et al., 2008, Klein and Melton, 1996, Florczyk, 2007). Importantly, effects of LiCl 
observed in gsk3β Xenopus mutant, and in LiCl treated Xenopus embryos, were also 
observed in zebrafish embryos. Stachel et al., (1993), showed that treating zebrafish 
embryos at an early stage with LiCl could disrupt the pattern of formation and the axis of 
specification of embryos. Furthermore, it could cause hyper-dorsalisation of embryos by 
perturbing dorsal signals. Zhang et al., (2003) showed that lithium could directly cause the 
increase of the level of the inhibitory N-terminal phosphorylation of GSK3β and of the 
level of the inhibitory phosphorylation at serine 9 in vitro in cell culture. Consequently, 
LiCl has been considered as a GSK3β inhibitor, however, the molecular effects of LiCl in 
cells remains to be fully defined.  
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 In this study, BIO and LiCl were used as inhibitors of Gsk3β to activate Wnt 
signalling at different time points of melanocyte development in vivo in zebrafish from 7 
hpf to 72 hpf. The results revealed that the levels of specificity and efficiencies as 
inhibitors of Gsk3β, were different for BIO and LiCl. Consequently, the interpretation of 
these experiments was not trivial and will also be discussed in regard to the complex 
activity of Gsk3. 
3.1.6 Approach and aims  
 
Using the systems biology approach we investigated a prediction from the GRN model that 
a factor was needed to maintain melanocyte differentiation and mitfa expression in 
melanocytes. Because of the leading role of Wnt signalling during melanocyte 
specification, we tested the hypothesis that a single candidate factor, Wnt signalling, could 
be limiting for melanocyte differentiation.  
 To test the hypothesis, a transgenic reporter strain was first used to verify that 
Wnt signalling remained detectable in differentiated melanocytes until at least 
72 hpf.  
 The effects of activating Wnt signalling in melanocytes with BIO and LiCl 
were assessed in embryos and in melanocytes. 
 The treatments with inhibitors of GSK3β were utilised to test the role of Wnt 
signalling on melanocyte development in zebrafish embryos and more 
particularly on melanocyte differentiation.  
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3.2 Results 
3.2.1 TOP;dGFP reporter revealed the time-course of  Wnt signalling 
activity in melanocytes 
 
The activation of Wnt signalling was investigated during the melanocyte differentiation 
time-window to validate the pathway as a candidate for the suggested Factor Y. Wnt 
signalling activity was traced in melanocytes from 30 hpf to 72 hpf using fish of the 
transgenic line TOP;dGFP (van de Wetering et al., 1997, Dorsky et al., 2002, Korinek et 
al., 1997). To study the activation of the dGFP reporter in these cells, fish were treated 
with 1-phenyl-2-thiourea (PTU, but only ¾ of the dose required for inhibiting 100 % 
melanin synthesis in order to observe light melanisation and to be able to distinguish 
melanocytes) to avoid the dark cells absorbing the fluorescence. Observing GFP auto-
fluorescence in living tissue could lead to the detection of false positives or false negatives 
samples which was difficult to assess. Therefore, instead of investigating the activation of 
dGFP in living embryos, we used the technique of immunofluorescence which allowed 
staining for GFP in embryos at different stages of cell differentiation.  
  Figure 3.03 shows to the detection of the activation of Wnt signalling in 
TOP;dGFP in control embryos at 40 hpf. This Figure shows the activation of the dGFP in 
the tectum and in melanocytes in TOP;dGFP embryos. In order to determine whether or 
not Wnt signalling remained activated during melanocyte differentiation, melanocytes 
were scored for expression of dGFP during the differentiation phase. The detection of 
dGFP was tested at 30 hpf, 36 hpf, 48 hpf, 51 hpf and 72 hpf in thirty melanocytes in 
fifteen zebrafish individuals (n= (15 x 30) in total, n= 450). The quantification of the 
proportion of GFP positive melanocytes at each timepoint is shown in Figure 3.04. At early 
stages, the majority (78.5 %) of melanocytes had readily detectable GFP expression 
(Figures 3.04, (A)), indicating that most cells at this stage, were responsive to Wnt 
signalling. However, a decrease of GFP positive melanocyte number was observed through 
differentiation (Figure 3.04, (C-D)). At later stages, only a low proportion of cells still 
showed detectable GFP expression (9 %; Figures 3.04 (E)). Importantly, at this stage 
melanisation was more intense than at early stages. This might be partly reflecting the 
difficulties of the detection of weak fluorescence in even partially-melanised melanocytes 
which are very light absorbent. However, it is possible that Wnt signalling was not 
activated in most melanocytes at 72 hpf and that its activation decreased through cell 
differentiation. The fact that Wnt signalling was highly activated in melanocytes from 30 
hpf to 48 hpf led us to consider that Wnt signalling could be a potentially important factor 
in melanocyte differentiation during this period. However, its role at later stages was more 
difficult to assess due to potential decreased activity in cells. 
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Figure 3.03: Control TOP;dGFP embryos express GFP in the tectum and in 
melanocytes at 40 hpf. 
Expression of GFP was investigated by immunofluorescence in TOP;dGFP embryos 
treated with PTU (3/4 dose to observe expression in lightly melanised cells) at 40 hpf and 
documented using a confocal microscope. 60 embryos were investigated and the head of a 
representative embryo is shown in lateral view, with fluorescence and bright field merged 
to observe co-localisation of melanisation and GFP. The red arrowheads point at GFP 
expression in the tectum and the white arrowheads point at melanocytes expressing GFP. 
Key: e: eyes; o: otic vesicle. Bar: 100 µm. 
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Figure 3.04: Detection of the Wnt signalling in melanocytes during differentiation in 
TOP;dGFP transgenic zebrafish.  
Detection of dGFP by immunofluorescence staining in TOP;dGFP transgenic embryos in 
melanocytes from 30 hpf to 72 hpf. Single melanocytes are presented in fluorescence optic 
(A,C,E,G,I) and bright field (B,D,F,H,J) respectively. In the top panels, arrowheads show 
dGFP expression in melanocytes; in bottom panels, arrowheads show the cell 
corresponding to the cell presented on the panel on top. At 30 hpf (A-B), (percentage of 
cells expressing GFP ± s.d. of percentages of cells expressing GFP in each embryo) 78.5 % 
± 12.8 of melanocytes showed GFP activation , at 36 hpf, (C-D), 71.5 % ± 10.5, at 48 hpf 
(E-F), 52 % ± 9.4, at 51 hpf (G-H), 13 % ± 4.2, and at 72 hpf (I-J), 9 % ± 3.8. At each 
stage, 30 melanocytes were assessed for GFP expression in 15 embryos, in the dorsal head, 
and trunk, and lateral trunk, throughout the anterior posterior axis (n = 450). Scale bar: 10 
µm. 
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3.2.2 BIO and LiCl treatments resulted in characteristic Wnt signalling 
defects 
 
Wnt signalling is responsible for the posteriorisation/dorsalisation of the embryos during 
development (Schneider et al., 1996, Klymkowsky et al., 2010, Takada et al., 1994, Saint-
Jeannet et al., 1997a, Kim et al., 2000a, Lee et al., 2007). Experiments of overactivation of 
the Wnt pathway during early embryonic development in zebrafish resulted in the 
posteriorisation of embryos, as observed in zebrafish headless/tcf3 mutants, or in Xenopus 
embryos (Kim et al., 2000a, Roose et al., 1998, Klymkowsky et al., 2010). Here, the 
reproducibility of the phenotype of posteriorisation was tested in embryos after long 
treatments with BIO and LiCl. 
 Embryos were treated from the early stage of 7 hpf to late differentiation stage at 
72 hpf to test whether Gsk3β inhibition, with LiCl and BIO, could reproduce the 
posteriorising/dorsalising effect of the activation of the Wnt signalling (Figure 3.05, (A-I)). 
The results showed that the activation of Wnt signalling resulted in a loss of anterior 
structures, such as, the eyes, the forebrain and part of the midbrain causing a shift in the 
midbrain/forebrain boundary (not shown on picture) (also described in Kim et al., (2000) 
in headless/ tcf3 zebrafish mutant). A reduction in the size of the embryo’s head was also 
observed (Figure 3.05 (D,G)) as well as, a pericardial edema in BIO (5 µM) treated 
embryos, also described in Lee et al., (2007), (Figure 3.05, (G)). In this long-term 
treatment, both BIO and LiCl, induced a significant elevation of the number of 
melanocytes, (mean ± s.d, p-value at unpaired, one-tailed t-test, n= 20, p< 0.001), control, 
(31 ± 3.2), LiCl (55 ± 5.1, p=0.000075), BIO (60 ± 3.5, p=0.00026). This could be 
consistent with the known role of Wnt signalling in activation of melanocyte specification 
(Dorsky et al., 1998).  
 These results showed that both, LiCl and BIO treatments could reproduce the Wnt 
specific overactivation phenotype. However, other hypotheses for explaining the increase 
in cell number were not tested. An abnormal melanocyte shape (not quantified), as well as, 
an enhanced xanthophore pigmentation were also observed (Figure 3.05, (D,E,G,H) 
compared to the control (A,B)).  
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Figure 3.05: Embryos treated with LiCl and BIO from 7 hpf to 72 hpf show over-
posteriorisation/dorsalisation. 
Control DMSO treated embryos (A,B,C), LiCl (200 mM) treated embryos (D,E,F), and 
BIO (5 µM) treated embryos (G,H,I) were documented. LiCl and BIO treated embryos 
show a loss of most anterior structures including eyes (comparing dorsal head pictures, (D, 
G) to (A)). Close-ups on cells of the dorsal head show differences in cell shape and cell 
organisation pattern (B,E,H) (arrowheads show melanocyte in (B), (E) and (H)). A 
pericardial edema (G) can be observed as the pericardiac envelop is swollen. These 
embryos show a clear increase in melanocyte dendricity as shown in cells of the yolk sac 
(arrowheads show the cells in (C), (F) and (I)). In total, 120 embryos were observed for 
each condition and representative embryos are shown here. e: eye; y: yolk sac; o: otic 
vesicle; p: pericardial edema. Scale bar: 100 µm. (J) shows a diagram of window period for 
this treatment, from 7 hpf to 72 hpf. 
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3.2.3 BIO and LiCl activated dGFP expression in TOP;dGFP fish 
 
To verify if LiCl and BIO were suitable reagents to activate the Wnt pathway in 
melanocytes, we tested their capacity to elevate the expression of the dGFP reporter in 
TOP;dGFP fish, in both whole embryos and melanocytes. 
 Embryos were treated from 15 hpf to 40 hpf to cover the specification phase as well 
as the early differentiation phase (Figure 3.06). At this stage, control TOP;dGFP DMSO 
treated fish showed typical and weak GFP expression in the tectum and in the trunk 
(Figure 3.06) (Dorsky et al., 2002). The results show that in the same conditions, both LiCl 
and BIO could elevate the dGFP expression in the tectum of embryos (Figure 3.06). It was 
even more dramatically-increased in the BIO-treated embryos. Figure 3.06 also revealed 
that LiCl treatments caused an increase of GFP expression in cells that were likely to be 
xanthoblasts. These cells could be distinguished by their positioning and their typical 
dendritic shape at this stage. Whether activation of the GFP in xanthophores resulted from 
an off target (non-specific) effect of lithium was unclear. Further study of the basis for this 
xanthophore phenotype, and for its specificity to LiCl, would be of interest, but have not 
been assessed here. 
 We then assessed whether activation of GFP was detectable directly in melanocytes 
of LiCl or BIO-treated TOP;dGFP embryos. Analysis of the GFP activation revealed that 
GFP expression was always colocalised within melanocytes in embryos treated with BIO 
from 15 hpf to 40 hpf (Figure 3.07). Furthermore, in BIO treated embryos, more GFP+ 
melanocytes could be observed compared to the control. This effect is studied further in 
section 3.2.4 where we tested activation of cell specification after BIO treatments. In BIO 
treated embryos, the intensity of the GFP signal seemed to be boosted in melanised cells 
compared to the signal observed in control melanocytes. However, we did not quantify the 
amount of GFP expression within individual melanocytes as the resolution of one cell 
within one image taken was not sufficient for reliably assessing GFP fluorescence within 
each cell. To overcome this limitation, the experiment should be repeated at a higher 
magnification focusing on individual cells. In contrast, activation of the signal in embryos 
treated with LiCl mostly did not co-localise with the melanised cells but instead seemed to 
be boosted in other cells of the skin which could be xanthoblasts. Figure 3.08 presents 
stacks of three pictures corresponding to three focal planes. The stacks are shown as the 
series of the three pictures taken on each focal plane for each condition. The results 
confirmed that on each focal plane, the GFP was fully co-localised with melanised cells in 
control and BIO treated embryos but not in LiCl treated embryos. We speculate that non-
specific effects of LiCl action may help boost Wnt signalling in the development of cells 
like xanthoblasts.  
 Altogether, this data suggested that Wnt signalling could be activated in embryos 
with BIO and LiCl, although, only BIO seemed to be efficiently boosting the signal in 
melanocytes during the differentiation phase. The intensity of the signal could not be 
quantified due to the resolution in melanocytes however, activation of the dGFP was clear 
in the tectum specifically with BIO. Based on this experiment, only BIO was suggested to 
be relevant for further tests on the role of Wnt signalling in melanocyte differentiation.  
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Figure 3.06: BIO and LiCl treatment (15 - 40 hpf) elevates Wnt signalling in the 
transgenic TOP;dGFP zebrafish embryos.  
Lateral view of embryo heads with confocal imaging showing GFP expression after 
immunostaining in fluorescence (top panels, (A-C-E)) and their corresponding bright field 
images (bottom panels (B-D-F). Treatment lasted from 15 hpf to 40 hpf when embryos 
were fixed with 4 % paraformaldehyde for immunostaining. 40 hpf TOP;dGFP DMSO 
treated embryos, (A-B) (arrowheads indicate the tectum),  40 hpf LiCl (200 mM) treated 
embryo (C-D) (both the arrowheads in (C) indicate xanthoblast), 40 hpf BIO (5 µM) 
treated embryo (E-F), (in (E) arrowheads indicate the tectum). Pictures were taken and 
processed using the same parameters in order to compare intensity of fluorescence of the 
GFP. For each condition, 160 fish were assessed through two experimental repeats (fish 
were assessed by fluorescence microscopy and for each condition, 10 fish were chosen for 
confocal imaging). Phenotypes presented here were representative of fish observed for 
each condition. e: eye; y: yolk sac; o: otic vesicle; X: xanthoblast. Scale bar: 100 µm. (G) 
The diagram shows the start (15 hpf), the end (40 hpf) and the length of treatments. 
Chapter 3. Testing Wnt signalling as a candidate for Factor Y 




Figure 3.07: The TOP;dGFP reporter reveals activation of Wnt signalling in 
melanocytes of BIO treated embryos. 
GFP expression was investigated by immunostaining in TOP;dGFP embryos treated from 
15 hpf to 40 hpf and embryos were imaged using a confocal microscope. The fluorescence 
and the bright field images were merged to observe the expression of GFP in cells. Control 
embryos showed expression of GFP in most melanocytes (A,B) (red arrowheads points at 
some melanocytes expressing GFP). BIO treated embryos also showed expression of GFP 
in most melanocytes (C,D) (red arrowheads points at some melanocytes expressing GFP). 
In LiCl treated embryos the results showed that melanocytes did not show activation of 
GFP (E,F) (red arrowheads point at melanocytes, in E, most melanocytes did not show 
activation of GFP and in F, GFP expression could be detected in melanocytes pointed by 
the red arrowheads) but also mainly in other cells (yellow arrowheads point at non-
melanocyte cells/potential xanthoblasts expressing GFP). Key: y: yolk sac. Bar: 100 µm. 
Chapter 3. Testing Wnt signalling as a candidate for Factor Y 
   84 
 
 
Figure 3.08: BIO activates GFP expression in melanocytes. See legend on the next 
page. 
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Figure 3.08: BIO activates GFP expression in melanocytes. See legend on the next 
page. 
GFP expression was investigated by immunofluorescence of TOP;dGFP embryos;  images 
show different focal planes with GFP expression. In each picture, red arrowheads point at 
melanised cells expressing GFP and yellow arrowheads point at non-melanised cells 
expressing GFP. The three focal planes (1,2,3) of the same embryo show GFP expression 
in the control embryo (A,B,C), in the BIO treated embryo (B,C,D) and in the LiCl treated 
embryo (G,H,I). Three images were combined as a stack and are shown as one image for 
the control (J), the BIO treated embryo (K) and the LiCl treated embryos (L). All BIO 
treated embryos expressed GFP with in melanised cells compared to controls and LiCl 
treated embryos only showed a few melanocytes expressing GFP through the focal planes. 
This result suggests that Wnt signalling was activated in melanocytes of BIO treated 
embryos only Key: y: yolk sac. The imaging conditions were the same throughout embryos 
of all conditions.  
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3.2.4 BIO treatment during the melanocyte specification phase resulted 
in increased melanocyte numbers 
 
The Wnt signalling pathway has been shown to be involved in melanocyte specification 
and mitfa regulation at early stages (Hari et al., 2012, Dunn et al., 2000b, Schepsky et al., 
2006). Boosting the Wnt signalling activity during this period was expected to result in an 
increase of the number of melanocytes and a boost in mitfa expression. Here, the effects of 
both molecules were examined to control for the efficacy of the treatments to activate a 
Wnt signalling dependent process such as melanocyte specification. A short treatment 
phase (15-30 hpf) was defined to focus on the time when melanocyte specification occurs. 
The objective was to test whether LiCl and BIO treatments would cause an increase in both 
melanocyte number and mitfa expression, as a result of boosting cell specification (Figure 
3.09).  
 Figure 3.09 shows that an elevation in melanocyte number was observed in heads 
and trunks of BIO treated embryos with BIO, (mean ± s.d, p-value at unpaired, one-tailed 
t-test, n= 20, p< 0.001), (control, 13 ± 2.1), BIO (32 ± 5.3, p=0.00000059), but not with 
LiCl (Figure 3.09). In contrast, melanocyte numbers in LiCl treatment were significantly 
decreased compared to the control (8 ± 2.3, p=0.000006) (Figure 3.09). Other mechanisms, 
or effects, could have caused an increase cell number in BIO treated embryos, such as an 
increased proliferation of cells. However, given the previous data showing a role for Wnt 
signalling in melanocyte specification from NC, the most parsimonious explanation is that 
BIO increases Wnt signalling and increases the number of melanocytes specified. 
 mitfa expression was investigated using the semi-quantitative technique of 
wholemount in situ hybridisation (WISH) to test whether the treatments caused an 
activation of mitfa expression (Figure 3.10). Fish treated with BIO showed a clear increase 
in mitfa expression, as shown by the number of mitfa expressing cells (Figure 3.10, (E-F)). 
In contrast, the experiment in LiCl treated embryos did not phenocopy this result as no 
increase of mitfa expression was observed (Figure 3.10, (C-D)). It could be suggested that 
the increase of mitfa expression in BIO treated embryos could be the cause of the increase 
of melanocyte number at 30 hpf, meaning that the number of cells expressing mitfa 
(corresponding to specified melanocyte number) had been increased by the 15 hpf-30 hpf 
BIO treatments. However, from this experiment it was difficult to assess whether this 
elevation could also be due to increase mitfa expression in cells at this stage. 
 Why LiCl treatments failed to phenocopy this result is not clear, but suggests that 
there are differences in the signalling effects of these molecules. Given our previous results 
(section 3.3.3) showing that LiCl treatments did not activate Wnt signalling in 
melanocytes, we interpret our data as showing consistently that LiCl is unable to activate 
Wnt signalling in the melanocyte lineage. In this context, direct testing of whether or not 
Gsk3β was significantly inhibited in cells after each treatment should also be assessed in 
vivo in melanocytes.  
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Figure 3.09: BIO treatment, but not LiCl treatment, (15-30 hpf) results in increased 
melanocyte number. See legend on the next page. 
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Figure 3.09: BIO treatment, but not LiCl treatment, (15-30 hpf) results in increased 
melanocyte number.  
The trunk of live zebrafish control DMSO treated embryos (A-D), LiCl (200 mM) treated 
embryos (B-E), and BIO (5 µM) treated embryos (C-F), are shown in lateral view. The red 
circles in (A-C) are presented respectively in close up in (D-F). An increase in melanocyte 
number can be observed in treated embryos by comparing treated embryos (C-F) to the 
control (A-C). Scale bar: 100 µm. (G) Graph showing the average of melanocyte number 
counted in the dorsal head, from the anterior brain to the posterior boundary of otic vesicle, 
in 20 embryos for each condition. (***) indicates significant t-test result for cell number 
increase compared to the control (unpaired, one tailed, P<0.001. n=20 in each treatment 
(see text for details)). (H) Diagram of the timing and the length of the time window 
targeted for treating melanocytes during the specification phase (15 hpf to 30 hpf).  
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Figure 3.10: Effects of BIO and LiCl treatments (15-30 hpf) on expression of mitfa at 
30 hpf.  
Lateral views of posterior trunk (A,C,E) and anterior tail (B,D,F) of 30 hpf zebrafish 
embryos, after 15 hpf-30 hpf treatments showing WISH investigating mitfa expression. In 
the DMSO treated embryos (A-B), and in the LiCl treatment embryos (C-D), discontinuous 
mitfa expression can be observed in the dorsal region (arrowheads shows discontinuity of 
the signal), whereas, in the BIO treated embryos (E-F), mitfa expression is continuous in 
the dorsal region (arrowheads shows continuity of the signal), suggesting over-expression 
of mitfa compared to DMSO control. 80 embryos were analysed for each condition and 
pictures shows representative phenotype in each case. Scale bar: 100 µm. (G) Schematic 
shows the timing of treatment, during melanocyte specification time window.  
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3.2.5 BIO, but not LiCl, could be used as an activator of Wnt signalling in 
melanocytes 
 
Taken together, these data show that BIO treatment, but not LiCl treatments, could 
effectively activate Wnt signalling in the melanocyte lineage, elevating melanocyte 
number when used during the melanocyte specification phase, most likely via elevated 
mitfa expression. These results were fully consistent with the expectation that the elevated 
melanocyte number at 30 hpf results from increased fate specification. An alternative 
method could be used to test for an increase of Wnt signalling in melanocytes, such as 
investigating β-catenin translocation to the nucleus. However, due to the lack of specificity 
of the newly release anti-β-catenin anti-body in zebrafish, we could not address this 
ourselves.  
3.2.6 Supernumerary melanocytes survived until 72 hpf 
 
Prior to addressing the main hypothesis relating to the ongoing role of the Wnt signalling 
for melanocyte differentiation, we investigated what happened to the supernumerary 
melanocytes observed at 30 hpf, following the 15-30 hpf BIO treatment. If the BIO 
treatment could activate cell specification and allow extra-specified cells to specify, 
commit, differentiate and survive until three days post fertilisation (dpf), this would 
support the hypothesis that their specification was mitfa dependent. Hence, it was 
investigated here by boosting Wnt signalling from 15-30 hpf and determining the 
melanocyte number at 48 hpf and 72 hpf.  
 The 15-30 hpf BIO treatments and the DMSO control treatments were repeated 
and, at 30 hpf, the embryos of both conditions were divided into two equal batches. One 
batch of BIO treated batch was rinsed and kept in embryo medium/DMSO only 
(“medium”) whereas the other was maintained in BIO treatments (“treatment”) (Figure 
3.11). The DMSO treated embryos were also separated, one was maintained in DMSO, the 
other was rinsed and kept in medium/DMSO. In both batches of the DMSO treated 
embryos (rinsed or not), embryos were exactly similar (WT DMSO fish) and for more 
clarity, we call these controls. All embryo batches were then examined at 48 and 72 hpf 
(Figure 3.11, (A-E)). Melanocytes were then counted in the head/trunk regions of embryos 
to determine whether melanocyte numbers were increased at 48 and 72 hpf in both 
conditions (“medium” and “treatment”) compared with DMSO controls. In both groups 
(“medium” and “treatment”), embryos treated with BIO showed a significant increase in 
melanocyte number (Figure 3.11, (A-B)) (mean ± s.d, p-value in unpaired, one-tailed t-test, 
n=20) (for each condition, 20 of 160 observed embryos were randomly chosen for 
analysis), control 48 hpf (32.6 ± 1.99), 72 hpf (47.5 ± 1.96) “medium” 48 hpf, (44.2 ± 1.8) 
p= 0.00007, “medium” 72 hpf, (57.5 ± 1.29) p= 0.00003, “treated” 48 hpf, (43.8 ± 2.2) p= 
0.00007, “treated” 72 hpf (58.09 ± 1.7) p= 0.000012).
. 
Additionally, the dendricity of these 
melanocytes was investigated at 48 hpf. The dendricity was significantly increased at 48 
hpf after BIO treatments, for both “medium” and “treated” batches, compared to DMSO 
treated embryos (Figure 3.14, (C) (mean ± s.d, p-value) (BIO, “medium”, 3.07 ± 1.02, 
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p=0.00082. and “treatment” 3.3 ± 1.26, p=0.0059), (Control, 2.44 ± 0.43). However, the 
dendricity of cells at 72 hpf was not different from the control (data not shown).  
 These results suggested that Wnt signalling dependent increased specification of 
melanocytes led to an increase of cell commitment, so that neither mechanisms of 
compensation, nor mechanisms of inhibition, were preventing cell development until 3 dpf 
at least. In the dorsal and lateral head and in the dorsal trunk, melanocytes were not 
organised as in WT at 3 dpf, which suggests that either increasing Wnt or mitfa signalling, 
or both, was preventing the cells from adopting the WT patterning (Figure 3.11, head (C,E 
and I,K) and trunk (D,F and J,L)). Another explanation for this mis-organisation phenotype 
could be that the cell number was an important parameter for cells to organise themselves 
into the patterning on the dorsal stripe, as in WT. Furthermore, this organisation 
mechanism was either disturbed or prevented by an increase in cell number. Observing that 
supernumerary cells could survive until 3 dpf suggested that BIO treatments boosted the 
program of melanocyte specification but also commitment to the lineage.  
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Figure 3.11:  Extra melanocytes specified from 15 hpf to 30 hpf survive until at least 
72 hpf. See legend on the next page.
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Figure 3.11:  Extra melanocytes specified from 15 hpf to 30 hpf survive until at least 
72 hpf.  
 
80 live zebrafish embryos were observed at 72 hpf for each condition. Live zebrafish 
embryos (A-I) at 48 hpf (A-F) and 72 hpf (G-I), in dorsolateral view of head (top panels) 
and lateral view of the trunk (bottom panels). Fish were treated from 15-30 hpf and for 
each of the “medium” and “treated” condition, they were observed at 48 hpf (C-D), and at 
72 hpf (E-F). In both treatments, an increase of the melanocyte number could be observed 
compare to the DMSO treated control fish (A-B). In (A-G) no melanocytes could be seen 
around eyes (the red arrowhead shows that no melanocytes are found around eyes) whereas 
in treated fish, (C-E-I-K) cells could be observed close to the eye structure (red arrowheads 
show presence of cells around eyes). In control, (B-H) no melanocytes could be observed 
on the lateral trunk (red arrowhead), whereas, in BIO treated embryos (D-I), melanocytes 
were observed in the lateral trunk, outside of normal patterning (red arrowheads show the 
presence of cells in between lateral and dorsal stripes). e: eye; y: yolk sac; o: otic vesicle. 
Scale bar: 100 µm except (H,J) scale bar: 50 µm. (M) diagram showing the differences 
between “treatment” and “medium” batches. “medium” batch was only treated with BIO 
from 15 to 30 hpf and then rinsed and placed in DMSO/embryo medium and observed at 
48 hpf and 72 hpf, whereas, the “treatment” batch was always maintained in BIO treatment 
until observation. DMSO treated controls were also divided into two batches. One was 
rinsed and placed in new DMSO/medium solution. The other was left in the same 
DMSO/medium solution, however, only one control fish is presented here as no 
differences could be seen between these DMSO controls. 
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Figure 3.12: Melanocyte dendricity is boosted at 48 hpf and cell number is increased 
at 48 hpf and 72 hpf in both conditions (“treatment” and “medium”). See legend on 
the next page. 
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Figure 3.12: Melanocyte dendricity is boosted at 48 hpf and cell number is increased 
at 48 hpf and 72 hpf in both conditions (“treatment” and “medium 
Melanocyte number was significantly increased in zebrafish treated embryos (A-B) at 48 
hpf (A) (p-value<0.001), and 72 hpf (B), (p-value<0.001), in both “treatment” and 
“medium” batches. Melanocytes were counted in the head from the anterior brain to the 
otic vesicle in 20 embryos for each condition, n = 20 (see text for details). The cell 
dendricity R (R = P2 ⁄4pA, where A is the cell area and P the cell perimeter) was 
significantly increased in both “treatment” (p=0.0059) and “medium” (p=0.00082) 
conditions, n= 20 cells on 10 different embryos were analysed for each condition (see text 
for details) at 48 hpf (C). (D) Diagram showing the differences between “treatment” and 
“medium” batches. “medium” batch was only treated with BIO from 15 to 30 hpf and then 
rinsed and placed in DMSO/embryo medium and observed at 48 hpf and 72 hpf, whereas, 
the “treatment” batch was always maintained in BIO treatment until observation. DMSO 
treated controls were also divided into two batches. One was rinsed and placed in new 
DMSO/medium solution. The other was let in same DMSO/medium solution, however, 
only one control fish is presented here as no differences could be seen between these 
DMSO controls. 
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3.2.7 Treating embryos during the melanocyte differentiation phase 
affected two aspects of cell differentiation 
 
Later, cells enter in a phase of differentiation which involves the maturation of the cell 
phenotype. In zebrafish melanocytes, cells start showing the first signs of melanisation 
around 27 hpf and embryonic melanocytes would be mature by 3 dpf when many cells (in 
dorsal embryo at least) are in a postmigratory position, and that the level of melanin is high 
(and not obviously increasing at later stages). To test the role of Wnt signalling on 
melanocyte differentiation, the differentiation phase was divided into three time windows 
as described in Figure 3.13. Firstly, treatment A covered the whole differentiation period, 
from 24-72 hpf. Secondly, embryos were treated during the late differentiation phase 
(treatment B), from 48-72 hpf, when sox10 expression becomes undetectable by WISH as 
demonstrated by Greenhill et al., (2011). Thirdly, in treatment C, embryos were treated 
during early differentiation phase, from 24-48 hpf, when sox10 expression is detectable by 
in situ hybridisation and immunofluorescence techniques, (Greenhill et al., 2011).  By 
dividing the differentiation phase in three time window, we could assess the changing 
effects of activation of Wnt signalling throughout melanocyte differentiation. 
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Figure 3.13: Time windows designed to target the melanocyte differentiation phase 
with BIO treatment. 
Three time windows were targeted during the melanocyte differentiation phase. The 
treatment A covers all of the differentiation phase, from 24-72 hpf. In the treatment B, fish 
were treated from 48-72 hpf, during the late differentiation phase and treatment C covered 
the early differentiation phase, from 24-48 hpf. 
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3.2.7.a Embryos treated from 24 to 72 hpf show disrupted melanocyte pattern 
 
To cover the early and late differentiation phases, embryos were first treated with BIO 
from 24-72 hpf (Figures 3.14-3.15). Cells in the head, and in the trunk, were dispersed and 
seemed to have lost the ability to organise and reproduce the typical pattern “U” of 
melanocytes (Figure 3.16, (G-J), Figure 3.17, (C-D)). The melanocytes in WT DMSO 
treated embryos dorsal head showed a characteristic circular or open U pattern at the 
anterior part of the dorsal stripe (Figure 3.14, (A-F)). In contrast, in the BIO-treated 
embryos these cells were less organised, more scattered, and lacked the clearly “U” shaped 
arrangement of cells was disrupted.  
3.2.7.b Embryos treated from 48 to 72 hpf show disrupted melanocyte pattern  
 
Treatment during the late differentiation phase also resulted in cell disorganisation (Figure 
3.14, (K-N), Figure 3.15, (E-F)). As observed in the previous treatment, cells did not 
reproduce the typical “U” pattern observed in controls at 72 hpf, while cell shape was 
unaffected.  
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Figure 3.14: The BIO treatment (24-72 hpf and 48-72 hpf) affects cell organisation. 
See legend on the next page. 
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Figure 3.14: The BIO treatment (24-72 hpf and 48-72 hpf) affects cell organisation.  
Dorsal view of heads of live embryos at 72 hpf, (A-N). Control DMSO treated embryo, (A-
F) (lower panels always show close ups of the top panels), BIO treated embryo (G-N) 
show the loss of cell arrangement compared to the repeated conserved pattern observed at 
72 hpf in control fish. 24-72 hpf BIO treated fish (G-J), 48-72 hpf BIO treated fish (K-N). 
160 live zebrafish embryos were observed at 72 hpf for each condition and here we show 
two representative individuals for each treatment. e: eye; o: otic vesicle. Scale bar: 100 µm. 
(O) Diagram of BIO treatment period. 
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Figure 3.15: Melanocyte organisation is disrupted at 72 hpf, after 24-72 hpf and 48-72 
hpf BIO treatments. See legend on the next page. 
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Figure 3.15: Melanocyte organisation is disrupted at 72 hpf, after 24-72 hpf and 48-72 
hpf BIO treatments 
Embryo heads in dorsal view at 72 hpf (A-C-E). DMSO control (A), BIO treated embryo 
from 24 -72 hpf, (C), 48-72 hpf BIO treated embryo (E). Images were processed in ImageJ 
(B-D-E) to find cell edges and to invert tones. Each point represents a cell and dispersion 
of cells could be observed but was not measured in treated embryos (D and F) compared to 
control (B). 160 live zebrafish embryos were observed for each condition. The phenotype 
shown here was consistently observed through treated embryos. Key: o: otic vesicle. Scale 
bar: 100 µm. (G) Diagram of BIO treatment period. 
Chapter 3. Testing Wnt signalling as a candidate for Factor Y 
   103 
 
3.2.7.c Treating embryos from 24 hpf to 48 hpf leads to changes in melanocyte shape 
 
Embryos were treated during the early differentiation phase, 24 - 48 hpf. Treatment with 
BIO during this phase resulted in changes in cell shape and more precisely, in an increase 
in cell dendricity (Figure 3.16). The roundness parameter, dendricity, was calculated as R 
= P2 ⁄ 4pA, where A is the cell area, and P, the cell perimeter. A and P were measured 
using ImageJ software. A significant increase in the cell dendricity was found with BIO 
treatments (Figure 3.16, (G-M), Figure 3.17, (B)) (mean ± s.d, p-value at t-test, unpaired, 
one-tailed test) (control, 2.44 ± 0.43) (BIO, 4.25 ± 1.68, p = 0.004). This result suggested 
that cell shape was an aspect of cell differentiation which was sensitive to BIO only from 
24 - 48 hpf.  In contrast to the results observed after the 15-30 hpf treatment, no increase in 
melanocyte number was observed after the 24-48 hpf treatment (mean+ s.d, p-value) 
(control, 23.9 ± 2.01, BIO, 23.1 ± 4.03, p=0.443). A probable explanation for this is that 
Wnt signalling was not limiting anymore for melanocyte specification at this stage or, 
more likely, that fate specification in the head region at least was complete.  
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Figure 3.16: BIO treatment (24-48 hpf) increases melanocyte dendricity. See legend 
on the next page. 
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Figure 3.16: BIO treatment (24-48 hpf) increases melanocyte dendricity.  
Live embryos at 48 hpf, (A-N). The heads of embryos are shown in a dorsolateral view for 
each condition, control DMSO treated embryos (A,C,E), BIO treated embryos (G,I,K,M) 
(arrowhead in (B) points at a dendrite). Representative single cells are also presented for 
each condition, control DMSO treated, (B,D,F), and BIO treated, (H,J,L,N, arrowheads 
points at dendrites). Scale bar: 100 µm except single cell panels, scale bar: 30 µm). 160 
zebrafish embryos were observed for each condition, the phenotype shown here was 
consistently observed through treated embryos. e: eye; y: yolk sac; o: otic vesicle (O) 




Figure 3.17: BIO treatment from 24-48 hpf caused an increase in melanocyte 
dendricity but did not increase cell number at 48 hpf. 
The average melanocyte number was not changed in treated embryos compared to the 
number of melanocytes in the controls (160 embryos were observed for each condition and 
cells were counted from the anterior brain to the otic vesicle, in 20 embryos for each 
condition (n=20), control (mean ± s.d, p-value) 23.9 ± 2.01 and BIO, 23.1 ± 4.03, p=0.443, 
p-value>0.1 (A). Embryos treated with BIO showed a significant increase R (R = P2 ⁄4pA, 
where A is the cell area and P the cell perimeter) which corresponds to increased cell 
dendricity (for circle, R=1). 20 cells were investigated (n=20) in 10 different embryos for 
each condition. Control, R=2.44 ± 0.43, BIO R= 4.25 ± 1.68, p = 0.004, t-test result, p-
value<0.01 (**) (B). 
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3.2.8 Treating embryos with BIO during melanocyte differentiation led to 
increased mitfa expression 
 
In the context of our main hypothesis, boosting Factor Y activity should cause an increase 
in mitfa transcription. To test this, mitfa expression level was measured after BIO 
treatments using quantitative RT-PCR (Figure 3.18). The t-test was performed (mean 
relative expression level ± s.d, p-value), and showed that after 24-48 hpf BIO treatments, 
mitfa expression level was significantly increased from 100 to 535 ± 7.1, (p = 0.00087). 
The BIO treatment lasting from 48-72 hpf, and from 24-72 hpf, also caused a significant 
increase of the mitfa expression, 496 ± 9.8, p= 0.0085 and 872 ± 32.1, p = 0.000092, 
respectively. Consequently, mitfa expression was found to be increased by around five fold 
in embryos treated from both 24-48 hpf and 48-72 hpf, whereas, a nine fold increase was 
observed in embryos treated from 24-72 hpf. 
 The results of the RT-qPCR experiments showed a significant increase in mitfa 
expression in BIO treated embryos. At 48 and 72 hpf, mitfa expression was strictly 
restricted to melanocytes (Kelsh et al., 2000). This showed that boosting Wnt signalling 
during melanocyte differentiation triggered an increase in mitfa expression. Interestingly, a 
correlation could be noted between the increase of mitfa and the time of exposure to the 
small molecule. Treatments lasting 24 hours (24-48 hpf, 48-72 hpf) seemed to increase 
mitfa expression about five fold while treatments lasting 48 hours (24-72 hpf) seemed to 
increase expression of mitfa about eight fold. This could suggest a positive feedback loop 
of Mitfa on mitfa expression itself explaining the greater increase observed in long term 
treatment.  
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Figure 3.18: BIO treatments result in a significant increase in mitfa expression in 
zebrafish embryos. 
Experiments of RT-qPCR comparing mitfa expression levels in WT and BIO treated 
embryos (WT mitfa level = 100 % transcripts (red line on graph)) (A). Gene expression 
was investigated in 10 samples of 50 pooled embryos for each condition, in triplicate.  
Expression levels were normalised to the stable expression of a reference gene, gapdh. All 
treatments caused significant increase of mitfa expression (t-test, two- tailed, 24-48 hpf, p= 
0.00087, 48 72 hpf, p= 0.0085, 24-72 hpf, p = 0.000092). Key: p-value<0.001 on graph 
denoted as: (***). (B) Diagram showing time period of the three treatments (Treatment A, 
24-72 hpf), (Treatment B, 48-72 hpf), (Treatment C, 24-48 hpf). 
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Wnt signalling has previously been shown to be required during cell specification as an 
activator of mitfa, independently of mitfa. Therefore, activating Wnt signalling with BIO 
treatments during melanocyte specification, in mitfa
w2
 mutant embryos, would result in 
activating mitfa expression. In contrast, during cell differentiation, the modelling suggested 
that activation of mitfa expression by Factor Y would be mitfa dependent, due to the 
feedback-loop. Consequently, in the context of this hypothesis, in the absence of mitfa 
expression (as in mitfa
w2
 mutant), activation of Factor Y would not be expected to lead to 
activation of mitfa expression. This hypothesis that boosting Wnt signalling would activate 
mitfa expression in the mitfa
w2 
mutant only when targeting the specification phase and not 
the differentiation phase, was tested here and the results are shown in Figure 3.20, (A-B)).  
 mitfa expression was investigated by WISH and the results showed that expression 
of mitfa was neither boosted nor changed when embryos were treated during melanocyte 
differentiation phase (Figure 3.20, (C-L). At 48 hpf, mitfa was detected in the dorsal and 
the lateral region of the trunk. At 72 hpf, mitfa was detected in cells of the dorsal stripe and 
the lateral stripe. This suggested that, in the absence of mitfa, Wnt signalling could not 
activate mitfa expression after 24 hpf. In contrast, mitfa expression was boosted in mitfa
w2 
mutant embryos treated from 15-30 hpf as shown by the increase of the signal detected in 
the trunk (Figure 3.20, (A-B)). Using a quantitative technique such as RT-qPCR could be 
interesting to quantitatively assess the changes of mitfa expression level with treatments. 
  According to these results, Wnt signalling dependent activation of mitfa during 
melanocyte differentiation is likely to be mitfa dependent. This feedback regulation is 
consistent with the hypothesis of Factor Y predicted by the modelling. However, one 
aspect of this loop which was not tested is the activation of Factor Y by Mitfa. For 
investigating this aspect of Factor Y, we would need to analyse activating factors binding 
mitfa regulatory sequences by ChIP for instance. 
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Figure 3.19: mitfa expression is not changed in mitfa
w2
 mutant embryos treated with 
BIO treated during melanocyte differentiation. See legend on the next page.  
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Figure 3.19: mitfa expression is not changed in BIO treated mitfa
w2
 mutant embryos 
during melanocyte differentiation. 
WISH testing mitfa expression in mitfa
w2
 mutant fish showing. Lateral views of the trunk 
for the representative phenotype, for each condition (A-L), at 30 hpf (A,B), 72 hpf (C-H) 
and 48 hpf (I-L). 15-30 hpf mitfa
w2
 mutant BIO treated embryo (B) showed an increased 
mitfa expression compared to mitfa
w2
 mutant DMSO treated embryo (A). 24-72 hpf (E,F) 
and 48-72 hpf (G,H) mitfa
w2
 mutant BIO treated embryo did not show difference of mitfa 
expression compared to control mitfa
w2
 mutant DMSO treated embryos (C,D). 24-48 hpf 
mitfa
w2
 mutant BIO treated embryo (K, L) did not show difference with mitfa
w2
 mutant 
control DMSO treated embryo (I,J). 40 zebrafish embryos were investigated for each 
condition. y: yolk sac. Scale bar: 100 µm. (M) Diagram showing the time period for each 
treatment.  
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3.2.10 BIO treatments could activate mitfa expression in WT embryos 
but did not influence sox10 expression 
  
In the modelling, the hypothesis of the activation of mitfa expression by Factor Y, was 
mathematically defined as a sox10 independent process. Consequently, the activation of 
Factor Y should not cause activation of sox10 expression. This is important to verify that 
the activation of mitfa expression, observed when treating embryos with BIO, was not an 
indirect effect of increased sox10 expression. Therefore, the next experiment aimed at 
investigating whether BIO treatment caused increased sox10 expression. 
 sox10 expression was investigated by WISH in both control and BIO treated 
embryos after treatments A,B and C (Figure 3.20), to test the effects of Wnt signalling on 
activating sox10 expression (Figure 3.20). The results showed that sox10 expression was 
not affected by BIO treatments as no differences were observed between the treated and 
the control embryos. At 30 hpf, sox10 was expressed in the otic vesicle, in the cranial 
ganglia (Figure 3.20, A,D) and dorsally and laterally in NC pre-migratory cells of the trunk 
(Figure 3.20, B,E,C.F). At 48 hpf and at 72 hpf, sox10 expression was observed in the otic 
vesicle and dorsally and laterally in Dorsal Root Ganglia (DRG)s and glial cells (Figure 
3.20). No differences were observed for the expression of sox10 between the control and 
the treated conditions. This suggested that the Wnt signalling dependent increase of mitfa 
expression was independent of Sox10 and therefore, could play a role in in vivo 
melanocyte differentiation.  
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Figure 3.20: BIO treatments have no effects on sox10 expression. See legend on the 
next page. 
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Figure 3.20: BIO treatments have no effect on sox10 expression. 
sox10 expression was investigated by WISH after treatments with BIO. The results showed 
no difference in the sox10 expression between the control DMSO treated embryos and the 
BIO treated embryos. sox10 expression is shown in the head of the embryos, 
(A,D,G,J,M,P,S,V) in dorsal view, but also in the trunk of embryos, (B,E,H,K,N,Q,T,W) in 
lateral view (lat), as well as, in the anterior trunk (C,F,I,L,O,R,U,V). The DMSO treated 
embryos treated for different periods are shown as following: 15-30 hpf (A-B) , 24-72 hpf 
(G-I), 48-72 hpf (M-O), 24-48 hpf (S-U), and BIO (5 µM) treated embryos are shown as 
following: 15-30 hpf treatment (D-F), 24-72 hpf treatment (J-L), 48-72 hpf treatment (P-
R), 24-48 hpf treatment (V-X). e: eye; y: yolk sac; o: otic vesicle; g:cranial ganglia. 40 
zebrafish embryos were investigated for each condition, a representative phenotype for 
each batch is presented here. Scale bar: 100 µm. (Y) treatment corresponding to 24-72 hpf 
(treatment A), 48-72 hpf (treatment B), treatment 24-48 hpf (treatment C). 
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3.2.11 Treating embryos with LiCl during melanocyte differentiation had 
contrasting effects 
 
When testing LiCl treatment effects during melanocyte specification, we found that in 
contrast to the effects observed with the BIO treatments, LiCl treatments did not affect 
melanocyte development. Specifically, the treatments did not boost Wnt signalling nor 
mitfa expression (at 30 hpf) in melanocytes and there was no increase of the melanocyte 
number during melanocyte specification. Instead, GFP expression in the TOP;dGFP 
reporter was boosted in other cell types which could be xanthoblasts. Xanthophore 
pigmentation was also increased. Here we present the contrasting effects of LiCl in 
melanocyte differentiation. 
 Treating embryos from 48-72 hpf and 24-72 hpf triggered a disruption of cell 
organisation (Figure 3.21). The causes of disruption to cell organisation with LiCl were not 
directly investigated and it was not tested if it could be related to the loss of organisation 
observed with BIO treatments. Melanocyte number was increased when treating embryos 
from 24 to 48 hpf (Figure 3.22, (B-C)), (control, 21.5 ± 2.01, LiCl 28.5 ± 5.09, p = 
0.0014), however, the cell dendricity at 48 hpf was not changed (data not shown).  
 mitfa expression was investigated using RT-qPCR in embryos treated with LiCl 
during melanocyte specification (Figure 3.23). The t-test was used to test for a difference 
in the mean relative expression levels of each condition (mean relative expression level ± 
s.d). After the 24-72 hpf LiCl treatment, mitfa expression increased to 260 ± 65.4, (p= 
0.0076), whereas the 48-72 hpf LiCl treatment did not cause a significant change in mitfa 
expression level, 157 ± 80.7, (p=0.162). Finally after the 24-72 hpf treatments, mitfa 
expression was increased to 987 ± 308, (p=0.00035). This experiment showed a two and a 
half times increase of mitfa expression from 24 hpf to 48 hpf, and approximately a nine 
times increase from 24 hpf to 72 hpf treatments. However, treatment from 48 hpf to 72 hpf 
did not result in a significant increase of mitfa expression (Figure 3.23). In general, the 
effects with LiCl and BIO were difficult to compare and therefore must be interpreted with 
caution and in the context of understanding the activity of molecules within cells, as 
discussed later.  
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Figure 3.21: LiCl treatments (24-72 hpf) (48-72 hpf) disrupt cell organisation pattern. 
See legend on the next page. 
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Figure 3.21: LiCl treatments (24-72 hpf) (48-72 hpf) disrupt cell organisation pattern 
The head of a representative live embryo is shown in dorsolateral view (A-C). Melanocyte 
numbers were counted from the anterior brain to the optic vesicle in 20 embryos for each 
condition, and the t-test showed that no significant changes could be observed after the 
treatments. Compared to the DMSO control embryo (A), embryos treated with LiCl from 
24-72 hpf, or from 48-72 hpf, show no significant increase in the melanocyte number 
(p=0.08) (B), (C) (p=0.41) in (D). In (B) and (C) cell organisation was disrupted. 160 
zebrafish embryos were observed for each condition at 72 hpf. (E) Diagram of treatment 
periods. Scale bar: 100 µm. e: eye; y: yolk sac; o: otic vesicle. 
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Figure 3.22: LiCl treatment (24-48 hpf) causes increased melanocyte number. See 
legend on the next page 
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Figure 3.22: LiCl treatment (24-48 hpf) causes increased melanocyte number 
 
Embryos are shown in a dorsolateral view (A-B). DMSO treated control embryos (A), 
embryo treated with LiCl from 24-48 hpf (B) show significant increase in melanocyte 
number (p=0.0014) (t-test, 20 embryos were analysed for each condition, n=20), 160 live 
zebrafish embryos were observed at 48 hpf for each condition and 20 embryos were 
randomly chosen for counts. e: eye; y: yolk sac; o: otic vesicle. (C). Scale bar: 100 µm. (D) 





Figure 3.23: LiCl (200 mM) treatments (24-48 hpf and 24-72 hpf) result in a 
significant increase in mitfa expression in zebrafish embryos. 
Experiments of RT-qPCR testing mitfa expression level in WT and LiCl treated embryos 
(WT mitfa level = 100 % transcripts (red line on graph)). mitfa expression was investigated 
in 10 samples of 50 pooled embryos for each condition, in triplicates. Expression levels 
were normalised to gapdh expression. A t-test was performed: after 24-72 hpf LiCl 
treatment, mitfa expression was significantly increased p= 0.0076, whereas 48-72 hpf LiCl 
treatment did not cause significant change in mitfa expression level, p=0.162. Finally after 
24-72 hpf treatments, mitfa expression was significantly increased p=0.00035. p-value 
<0.01 (**) and p-value <0.001 (***).  
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3.2.12 Xanthophore pigmentation is increased in embryos treated with 
LiCl 
 
While having contrasting effects in melanocytes compared to BIO, LiCl treatments showed 
consistent activation of xanthophore pigmentation. Furthermore, increased GFP expression 
was observed in xanthoblasts in TOP;dGFP embryos treated with LiCl from 15 to 40 hpf 
(see Figure 3.08, (C)). Here, we show that yellow pigmentation at 48 hpf and 72 hpf was 
dramatically boosted after LiCl treatments (Figure 3.24). Figure 3.24 shows embryos 
treated with PTU and LiCl from 24-48 hpf. The increased yellow pigmentation is clearly 
observable in the dorsal head and the lateral and dorsal trunk when compared to control 
embryos.  
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Figure 3.24: LiCl treatment (24-48 hpf) leads to increased xanthophore pigmentation.  
48 hpf control DMSO treated zebrafish (A-C), and 48 hpf BIO treated zebrafish fish (D-F), 
after 24-48 hpf treament. All embryos were treated with PTU to block melanin synthesis. 
In (D-F), the red arrowheads show the increased xanthophore pigmentation. (A-D) show 
embryo heads in dorsal view (dorsal), (B-E) show embryo trunks in lateral view (lat) and 
(C-F) show a close up on embryo trunks in dorsal view (dark cells are iridophores). 160 
embryos were observed for each condition and the representative embryos are shown here. 
e: eye; y: yolk sac; o: otic vesicle. Scale bar: 100 µm. (G) Diagram showing the time 
period for the treatment. 
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3.2.13 LiCl treatments might trigger increased xanthophore 
differentiation 
 
The embryos were treated with LiCl during two time periods to determine whether the 
boost of xanthophore pigmentation resulted from either increased cell specification or 
increased cell differentiation. From15-30 hpf, the treatment covered the specification phase 
as xanthophore specification was suggested to occur between 18-25 hpf, and from 24-48 
hpf it covered cell differentiation phase (Figures 3.25-3.26) (Parichy et al., 2000b). After 
treatments, embryos were examined for the expression of an early xanthoblast/xanthophore 
marker, xdh. The 15-30 hpf treatment did not trigger an unequivocal increase of xdh 
expression (Figure 3.25). Comparing xdh expression in the lateral trunk, it seemed that cell 
migration could be affected by the treatments (Figure 3.25, B-E). Only the 24-48 hpf 
treated fish showed a clear increase in xdh expression in the tail (Figure 3.26). However, as 
it was not investigated whether the expression level was activated in each cell in the tail 
compared to control, or if the number of developing cells in the tail was increased, we 
could not distinguish between differentiation or specification defect.  
 This experiment was repeated with BIO in order to test whether BIO could activate 
xanthophore specification and differentiation. The results of the WISH showed no 
differences between DMSO treated embryos and BIO treated embryos for xdh expression 
after treatments (data not shown). 
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Figure 3.25: LiCl treatment (15-30 hpf) did not boost xdh expression.   
80 zebrafish embryos were investigated by WISH and observed for expression of xdh. 
Representative embryos are shown, DMSO control embryo at 30 hpf (A-C) and embryo 
treated with LiCl, from 15 to 30 hpf, which covered the xanthophore specification phase 
(18-25 hpf) (D-F). (A,D) lateral view of head, (B,E) lateral view (lat) of trunk, (C,F) dorsal 
view (dorsal) of head. e: eye; y: yolk sac. Scale bar: 100 µm. (G) Diagram showing the 
time period for the treatment. 
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Figure 3.26: LiCl treatment (24-48 hpf) lead to increase xdh expression in tail. See 
legend on the next page. 
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Figure 3.26: LiCl treatment (24-48 hpf) lead to increase xdh expression in tail.  
80 zebrafish embryos were investigated by WISH and observed for expression of xdh for 
each condition. Representative embryos are shown here. Control DMSO treated fish (A,-
D), LiCl treated embryo (E-H). Lateral trunks are shown in (B, C, F, G, red arrows show 
blue signal). Lateral view of the tails are shown in (D-H, red arrowhead in (H) shows 
continuity of expression in tail compare to (D) where red arrowhead shows faint 
expression in tail). Heads in dorsolateral view are shown in (A-E). Scale bar: 100 µm. (I) 
Diagram showing the time period for the treatment. 
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3.2.14 Xanthophore development is affected by LiCl at late stages 
 
To determine whether LiCl treatments covering the xanthophore specification phase from 
15-30 hpf could cause an increase in xanthophore pigmentation at 48 hpf and 72 hpf, the 
same experimental set up (“medium” and “treatment” batches) was used as described for 
the BIO treatments in section 3.2.5 (see diagram in Figure 3.27,(P)). In short, TOP;dGFP 
embryos were treated from 15-30 hpf and were divided into “medium” and “treatment” 
batches at 30 hpf. In the “medium” batch, embryos were rinsed, whereas, in the 
“treatment” batch, embryos were maintained in LiCl treatment until 48 hpf and 72 hpf. 
Embryos were then incubated at 27 °C until 48 hpf and 72 hpf, the results are presented in 
Figure 3.27. 
  The boost of pigmentation in xanthophores was not observed at 48 hpf nor at 72 
hpf in the “medium” batches (Figure 3.27). In contrast, a clear increase of yellow 
xanthophore pigmentation as well as an increase of dGFP was observed in these cells both 
after 15-48 hpf and 15-72 hpf in the “treatment” batches (Figure 3.27). This phenotype 
corresponded to the phenotype observed previously when treating embryos from 24-48 hpf 
(section 3.2.13). This suggested that LiCl treatment throughout a minimal period between 
24-30 hpf was crucial for elevated xanthophore pigmentation (Figure 3.27).  
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Figure 3.27: LiCl treatment in TOP;dGFP fish. See legend on the next page. 
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Figure 3.27: LiCl treatment in TOP;dGFP fish. 
Embryos were treated from 15-30 hpf, half were rinsed (“medium”) (C,D,J,K) and then 
observed at 48 hpf (C,D) and 72 hpf (J,K). The rest were maintained in LiCl treatment 
“treatment”) (E,F,L,M,G,O) and observed at 48 hpf (E,F,G) and 72 hpf (L,M,O). Heads are 
shown in a dorsolateral view in (A,C,E,H,J,L) and trunks are shown in lateral view in 
(B,D,F,G,I,K,M,O). Both at 48 hpf and 72 hpf, the “medium” batches did not show 
changes of xanthophore pigmentation compared to control at 48 hpf (A,B), and 72 hpf 
(H,I) respectively. However, both “treatment” batches showed increased xanthophore 
pigmentation compare to control embryos. Arrowheads in (F-M) point at increased 
xanthophores, as do arrowheads shown in the trunk, where these cells also showed 
increased dGFP (arrows in (G-O) respectively). 80 TOP;dGFP transgenic zebrafish 
embryos were  observed for each condition and the phenotype was consistenly observed in 
treated embryos. e: eye; y: yolk sac; o: otic vesicle. Scale bar: 100um. (P) Diagram 
showing the differences between “treatment” and “medium” batches.  The “medium” batch 
was only treated with BIO from 15 to 30 hpf and then rinsed and placed in DMSO/embryo 
medium and observed at 48 hpf and 72 hpf, whereas, the “treatment” batch was always 
maintained in BIO treatment until observation. DMSO treated controls were also divided 
into two batches. One was rinsed and placed in new DMSO/medium solution. The other 
was left in the same DMSO/medium solution, however, only one control fish is presented 
here as no differences could be seen between these DMSO controls. 
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3.2.15 Summarising the effects of LiCl and BIO treatments on 
melanocytes and xanthophore development 
 
Figure 3.28 and Table 3.01 summarise the effects of BIO and LiCl in embryos. BIO 
treatment during the times of melanocyte differentiation led to increased mitfa expression 
in embryos. mitfa was strictly expressed in melanocytes after 30 hpf, therefore, this result 
suggested that mitfa was increased in melanocytes. Knowing that BIO treatment could 
activate Wnt signalling in melanocytes, this result was consistent with the model 





suggesting that activation of mitfa by BIO was mitfa dependent. The BIO treatment did not 
cause elevation of sox10 expression, therefore, inhibition of Gsk3β seemed to activate 
mitfa expression in a sox10-independent manner, as predicted for Factor Y. It remains to be 
tested if the activation of Wnt signalling, or another effect depending on Gsk3β inhibition, 
was the cause of this phenotype. 
 To summarise the effects of LiCl on melanocyte differentiation, elevated cell 
numbers were observed in the 24-48 hpf treatments. Interestingly, this could be correlated 
with melanocyte number increase after the 24-48 hpf treatment. This result is unlikely to 
be the consequence of increased melanocyte specification as the experiments testing the 
activation of Wnt signalling in melanocyte with LiCl showed that the molecule failed to 
activate the pathway. However, it was possible that due to the differences of molecule 
activities, LiCl could be boosting cell proliferation from 24-30 hpf.  
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Figure 3.28: Scheme summarising the effects of BIO and LiCl treatments on 
melanocytes and xanthophores. 
Treating zebrafish embryos from 15-30 hpf leads to increased melanocyte specification. 
Treatment from 24-48 hpf affects melanocyte shape and treatments from 24-72 hpf and 48-
72 hpf lead to disorganisation of cells in head. LiCl specifically boosts xanthophore 
pigmentation from 24/30-48 hpf and increase pigmentation was also observed after 24-72 
hpf treatment. 
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Table 3.01: Summarising the effects of LiCl on melanocyte and xanthophore, and the 
effects of BIO on melanocytes. 
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3.3 Discussion 
Our results showed that with BIO, but not LiCl, we could: 1) dramatically activate Wnt 
signalling in the tectum of embryos; 2) observe colocalisation of Wnt signalling activation 
in melanocytes; 3) measure increase number of melanocytes at early stages. In contrast, 
treatment with LiCl showed: 1) light activation of Wnt signalling in the tectum; 2) 
activation of Wnt signalling in cells that are likely to be xanthoblast (shape, position), 3) 
increase xanthophore pigmentation. Furthermore, activation of mitfa expression was 
consistently oobserved with BIO treatments using WISH and qPCR whereas, it could only 
be observed once with LiCl treatments. BIO is a well described inhibitor a GSK3β. Even if 
we could not measure Wnt signalling activation in single melanocytes after BIO 
treatments, our data suggest that we could activate Wnt signalling in the tectum and that 
Wnt signalling was activated in melanocytes, suggesting or bringing a new arguments for 
suggesting that Wnt signalling was activated in melanocytes after BIO treatments. 
However, activation of the Wnt pathway in BIO treated melanocytes should be quantified. 
Our results suggest that boosting β-catenin in melanocytes caused changes in cell shape. It 
still needs to be determined whether this was due to the role of β-catenin in cell adhesion 
or indirectly to its transcriptional role which has allowed activation of mitfa which in turn 
can regulate cell shape. The cell organisation disruption could also be related to the role of 
β-catenin in cell adhesion. Our results suggest that the increase xanthophore pigmentation 
observed with LiCl treatments is unlikely to be Wnt signalling dependent as it was not 
observed with BIO. Consequently, an off target effect of LiCl, which remains to be 
determined, could be responsible for this phenotype. 
3.3.1 Discussing the efficacy of the experimental set up to improve the 
targeting of the canonical Wnt signalling pathway in the future 
 
It is important to ask to what extent Wnt signalling was crucial in vivo in melanocytes and 
to what extent ours results support or reject the hypothesis of the existence of Factor Y. To 
confirm that the effects of cell organisational and shape changes were dependent on Wnt 
signalling, it would be necessary to address four potential limitations of the experimental 
methods. These four fundamental points could be investigated to clarify the effects of the 
small molecule treatments and the role of Wnt signalling in melanocyte development. 
These points are summarised here and in the Figure 3.29. The following should be 
investigated: 
1- The inactivation of GSK3β caused by BIO and perhaps LiCl in cells in 
zebrafish.  
2- Activation of the p38-MAPK pathway by the treatment.  
3- The increase of free β-catenin in the cytoplasm as a result of the treatments 
and its consequences on the cell adhesion complex. 
4- The increase translocation of β-catenin to the nucleus in melanocytes. 
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Figure 3.29: Four points need to be investigated to validate the method used in these 
experiments to activate Wnt signalling in melanocytes in zebrafish. 
Controlling the validity of these experiments will first require the assessment of whether or 
not the small molecules (BIO and LiCl) were significantly inhibiting GSK3β activity (1). 
Secondly, we should test whether the p38-MAPK pathway was also activated by the 
treatments (2). Thirdly, whether the level of free β-catenin was significantly increased after 
treatments (3) and finally whether this also triggered increased translocation of β-catenin to 
the nucleus (4).  
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3.3.2 The efficacy of GSK3β inhibition triggered by BIO and LiCl was 
not assessed in cells.  
 
In these experiments we investigated the activation of the TOP;dGFP reporter in 
melanocytes of embryos treated with the small molecules. The intensity of the GFP in 
single melanocytes seemed increased but this could not be quantified at our resolution. 
This would have to be further quantified in single cells by investigating dGFP expression, 
in cells or in fish, with more resolution than here. However, the boost of GFP in the tectum 
of BIO treated fish was clearly observable. Consequently, both the colocalisation of the 
Wnt signalling and the boost of the signal in fish after BIO treatments suggested that, in 
contrast with LiCl, BIO could efficiently inactivate GSK3β in cells. BIO stabilized all 
forms of β-catenin (phosphorylated or not) and indirectly increased the level of the Ser 
675- β-catenin form causing the activation of both the canonical Wnt pathway and the β-
catenin/Cadherin pathway involved in cell-cell adhesion (Sineva and Pospelov, 2010, 
Tseng et al., 2006). The increase of free β-catenin levels in cells has been observed in 
studies using BIO suggesting that BIO treatments could activate Wnt signalling, consistent 
with our results (Sineva and Pospelov, 2010, Sato et al., 2001, Tseng et al., 2006).  
 LiCl is described as a direct and an indirect inhibitor, of GSK3α/β. In direct 
inhibition, lithium impedes enzymatic activation of GSK3β by competing with another ion, 
Mg
2+
, which is required at the cation binding site of the GSK3β enzyme. The indirect 
inhibition of GSK3β by LiCl could be due to the activation of the protein kinase B 
(AKT/PKB) which would allow the phosphorylation of the single serine residues (serine-
21 for GSK3α; serine-9 for GSK3β) of the regulatory aminoterminal domain. However, 
LiCl is also described as an inhibitor of other pathways. Interestingly, Jin and Thibaudeau 
(1999) used LiCl in zebrafish as an inhibitor of the IP-signalling pathway. Jin and 
Thibaudeau (1999) treated zebrafish embryos from 24 hpf to 6 dpf at a concentration of 50 
mM LiCl and they did not note any increase in melanocyte number. However, a weak 
increase in melanin production could be measured after the 5 days treatment. In our study, 
we did not observe increased melanisation, however, we treated embryos for shorter 
periods which might not have been sufficient to trigger this change. The embryos shown in 
Jin and Thibaudeau (1999) after treatments seemed to show a melanocyte organisation 
defect as observed in our experiments, however, they did not discuss the significance of it. 
No xanthophore phenotype was discussed nor described. In their study, the five days long 
LiCl treatments led to accumulation of IP3 (inositol triphosphate). This inositol phosphate 
accumulation then caused stimulation of pigmentation in zebrafish embryos through the 
synthesis and the deposition of melanin within the melanocytes. Increased melanisation 
could be due to several changes, such as, stimulation of cell proliferation, stimulation of 
cell differentiation or dispersion of melanosomes throughout the cell, as well as, an 
activation of the synthesis and the deposition of melanin into melanosomes. The Jin and 
Thibaudeau (1999) study suggested that various signalling pathways were potentially 
affected directly or indirectly by lithium, including the IP3 pathway and/or GSK3s. An 
increase of melanin content and of Tyrosinase activity in LiCl treated embryos was also 
observed when embryos were treated in combination with a protein-kinase A (PKA) and C 
(PKC) inhibitor (forskolin). This suggested that the PKA/PKC pathway, the GSK3 
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pathway, and/or the IP3 pathway, could all work together for the regulation of melanin 
production. The Jin and Thibaudeau (1999) study showed that LiCl can interact with other 
pathways than the GSK3 pathway. Together with our results, it suggests that the LiCl 
dependent effects observed in our study were probably caused by the stimulation of a 
different factor/pathway other than the Wnt signalling pathway. 
 It would be interesting to assess the inhibition of GSK3β in cells. An in vitro 
GSK3β kinase assay could allow the quantification of the level of GSK3β activity (Zhang 
et al., 2003). Testing the levels of substrate phosphorylation by Gsk3β would allow 
quantifying the ratio of activated /unactivated protein with or without treatment. Lastly, 
testing GSK3β phosporylation at the N-terminal, and at the serine 9, could also allow 
measuring GSK3β inhibition. 
3.3.3 The role of the cAMP pathway activation as a side effect of GSK3β 
inhibition  
 
GSK3β is a serine/threonine kinase which can target different factors of different pathways 
such as, Adenosine-Monophosphate (AMP) Response Element-Binding protein (CREB), 
the nuclear factor of activated T cells (Nfat) family in neurons, Mothers against 
decapentaplegic homolog 1 (SMAD1), and c-Jun13 and β-catenin, in different cell types 
(Sineva and Pospelov, 2010, Hur and Zhou, 2010). Previous studies have described the 
effects of inhibiting GSK3β with BIO in cardiomyocyte development. Because inhibition 
of p38-MAPK activity has been shown to promote mammalian cardiomyocyte 
proliferation, it was suggested that BIO could interact with it to regulate cardiomyocyte 
proliferation in culture (Tseng et al., 2006). However, no direct inactivation of the p38-
MAPK was detected after BIO treatments in cardiomyoctes in the study and the role of 
p38-MAPK is not clear. 
 Bellei et al., (2010) described the effects of inhibition of the GSK3β by the cAMP 
pathway. Bellei et al., (2010) used BIO (up to 24 hrs treatment, 1µM) and transient 
transfection to activate β-catenin activity in B-16 melanoma cells. They observed 
activation of most Wnt targets following inhibition of GSK3β activity, including Mitf. 
They also show that cAMP pathway dependent inhibition of GSK3β allowed free β-catenin 
to activate gene expression in the nucleus. They conclude that the cAMP pathway and β-
catenin could work together to activate targets such as melanocytic genes. Whether or not 
the experiments presented in our study mimicked the effects of GSK3β inhibition by 
cAMP and/or activation of β-catenin by Wnt signalling has not been investigated. It will be 
important to test which of these pathways dominated the regulation of β-catenin for 
melanocyte development and if they could interact and compensate their effects. If the 
effects observed in our study were cAMP dependent or more widely GSK3β inhibition 
dependent, the mechanism and the hypothesis would have to be redefined to suggest that 
the cAMP pathway, or GSK3β, can influence certain aspects of melanocyte development. 
It will be important to determine if the canonical Wnt signalling pathway or the cAMP 
pathway (or both) were responsible for the phenotypes observed. If inhibition of Gsk3 had 
impacted on the cAMP pathway leading to either increased cell dendricity, loss of cell 
organisation or to activation of mitfa during melanocyte differentiation, then this study 
Chapter 3. Testing Wnt signalling as a candidate for Factor Y 
   135 
 
would have to be re-interpreted as the investigation of the role of cAMP activation on 
melanocyte differentiation. Alternatively, if both the Wnt pathway and the cAMP pathway 
were activated, then this study would also need re-interpretation as the role of Gsk3 in 
regulating melanocyte differentiation.  
3.3.4 Increase in free β-catenin in the cytoplasm could be responsible for 
the cell shape and the cell organisation phenotype 
β-catenin is a major protein for the maintenance of the architectural structure of the cell. It 
regulates the activity of Cadherins by binding and linking Cadherins to the actin 
cytoskeleton through α-catenin (Figure 3.31) (Nelson and Nusse, 2004). The mis-
regulation of the β-catenin/ Cadherins regulatory control could lead to impaired cell 
adhesion and migration resulting in changes in cell shape/cell organisation. The study of 
normal human epidermal melanocytes in vitro reported that active β-catenin could regulate 
both the increase and the decrease of the melanocyte dendricity by adjusting the levels of 
two downstream modulators, PKCf and PKCd (Kim et al., 2010). Kim et al., (2010) 
showed that overexpression of PKCf resulted in the decrease of the levels of the proteins 
Rac1 and Cdc42, known for their potential role in organising the actin cytoskeleton. 
Consequently, this led to a reduction of dendrite formation in melanocytes. In contrast, 
overexpression of PKCd led to an increase of Rac1 and Cdc42 levels and to an increase of 
melanocyte dendrite numbers. Whether this mechanism was activated by the BIO 
treatments was not tested here. 
 Increased Mitfa could appear as an alternative mechanism for the changes observed 
in cell shape and organisation. Studies in Xenopus reported that increased X-mitfα 
expression could result in increased melanocyte dendricity and cell dispersal (Kumasaka et 
al., 2005, Kawasaki et al., 2008). Kumasaka et al., (2005) used Xenopus laevi to test the 
effects of constitutive activation of mitfα (Xlmitfα -M) as well as the effects of dominant 
negative mitf (dnmitfα) expression in melanocytes. The study showed that overactivation of 
Xlmitfα led to increased melanocyte number, increased cell dendricity and increased dct 
expression. In contrast, dnmitfα expression caused decreased melanocyte number, 
decreased cell dendricity and decreased dct expression. Kawasaki et al., (2008) used the 
same system to better investigate the effects of mitfα on dendricity and on melanosome 
dispersion. The results suggested that mitf could control the melanocyte morphology 
aspects such as dendricity, maybe via the protease Rab27 (Carreira et al., 2005, Carreira et 
al., 2006, Tachibana et al., 1996) 
            It would be important to assess whether the changes in cell shape, and cell 
organisation, observed with the BIO treatments were caused by either the activation of the 
β-catenin/E-cadherins complex (Figure 3.30); by the β-catenin dependent regulation of 
PKCf and PKCd; or finally by a β-catenin dependent activation of mitfa which could have 
resulted in changes in the regulation of a protease involved in cell dendricity, such as 
Rab27a.   
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3.3.5 The role of β-catenin as an effector of Factor Y 
 
In these experiments we observed an apparent decrease of dGFP expression in melanocyte 
after 48 hpf. This observation could be an artefact of the detection technique in which 
increasing melanin levels in differentiating melanocytes may interfere with GFP detection. 
However, the GFP could be detected in melanocytes suggesting that in normal situation, 
the cells were certainly responsive to the Wnt signalling and did experience some level of 
Wnt signalling. An alternative approach to test whether or not Wnt signalling was 
maintained in melanocytes after 48 hpf would be to test the levels of nuclear β-catenin in 
melanocytes in embryos throughout their differentiation. This same approach used on 
treated embryos could also confirm the efficiency of BIO treatments and could assess 
whether LiCl could cause activation of β-catenin. If both molecules can cause this effect, 
then the differences in the phenotype could be explained by the different efficacies of the 
molecules, or perhaps, the side effects they cause. For this, the double marking of 
melanocytes using GFP reporter in mitfa-GFP transgenic line, and another antibody 
staining for β-catenin, could allow the observation of co-localised signals in cells in PTU 
treated embryos.  
Chapter 3. Testing Wnt signalling as a candidate for Factor Y 




Figure 3.30: GSK3β inhibition increases free β-catenin levels in cells  
Increased free β-catenin (β-cat) causes a boost of the canonical Wnt pathway (red arrow). 
The levels of free β-catenin are increased, consequently, the translocation of β-catenin to 
the nucleus is increased. This can lead to the activation of mitfa expression, and it could 
cause the potential increase of expression of the GTProtease Rab27a, which could in turn, 
be the cause of changes in cell shape. The free β-catenin (β-cat) can also accumulate at the 
membrane, to associate with E-cadherins (E-cad) in a complex to regulate the cytoskeleton 
(black arrow). The cAMP pathway, via MC1R signalling, is also a negative regulator of 
GSK3β. Therefore if the cAMP pathway was boosted in by the treatments, it could have 
enhanced the inhibition of GSK3β. 
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3.3.6 The results suggest that Wnt signalling can affect melanocyte 
differentiation but it is not a limiting factor in the process  
 
In these experiments, the hypothesis of the role of Wnt signalling as a single limiting factor 
for melanocyte differentiation was tested. In the light of the results described here, it seems 
that Wnt signalling is not limiting for melanocyte differentiation. The definition of Factor 
Y was re-assessed as an ensemble of factors which contribute to the maintenance of the 
differentiated state in melanocytes.  
 In regard to the data, the changes observed in melanocytes, such as cell shape and 
organisation, were suggested to be indirect effects of elevated mitfa expression which is 
supported by the study of X-mitfα effects in melanocyte dendricity in Kawasaki et al., 
(2008) in Xenopus. Melanisation is also an important but not a major aspect of melanocyte 
differentiation. In our experiments the melanin content was investigated looking at the 
absorbance at 490 nm, as used in the study of melanisation in zebrafish by Jin and 
Thibaudeau (1999). It was found never to be increased however, our treatments were 
significantly shorter compared to Jin and Thibaudeau (1999). Consequently, the weak 
increased melanisation observed in Jin and Thibaudeau (1999) might have been due to the 
cumulative effect of continuous treatment over a longer period of time compared to ours. 
To assess if Wnt signalling was essential for the melanocyte differentiation process, and 
more particularly, for mitfa expression activation at this stage, it would be fundamental to 
test the inhibition of Wnt signalling. According to the model, loss of Factor Y should cause 
melanocyte dedifferentiation after 36 hpf via a decrease, or a total loss, of mitfa expression. 
Therefore, if the inhibition of Wnt signalling in melanocytes resulted in a sudden decrease 
of mitfa after about 36 hpf, then it would be plausible that Wnt signalling could be directly 
required for mitfa maintenance.   
 In 2010, a screening study aimed to investigate small molecules targeting to inhibit 
Wnt signalling’s activity in colon cancer (Chen et al., 2010). However, this was 
unsuccessful and more work is needed to indentify an inhibitor. In zebrafish, no small 
molecules have been successfully developed or tested for this purpose. Consequently, other 
methods should be developed in order to test Wnt inhibition in melanocyte development. 
 Lowering β-catenin activity specifically in melanocytes will be crucial, and thus, a 
new mutant or transgenic tool could be created to reach this objective in vivo. Dorsky et 
al., (2002) used injection of Lef1 morpholino at one cell stage to assess the gene 
expression changes ectopically. The experiments resulted in a loss of posterior tail 
structures however, the 36 hpf injected embryos did not seem to show a decrease in 
melanocyte pigmentation compared to the control embryos (Dorsky et al., 2002). In the 
study, Dorsky et al., (2002) tested the efficacy of the morpholino in blocking the 
translation of injected targeted plasmids in reticulocyte lysates. However, it is surprising 
that no failure of cell melanocyte specification was caused by the injections. In a previous 
study, Dorsky et al., (1998) had used injection of the mRNA of the truncated versions of 
the negative regulator, Tcf-3, and of a dominant negative version of Wnt-1 in premigratory 
NC in Xenopus and in zebrafish (Dorsky et al., 1998). The conclusion was that β-catenin 
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injection could rescue the Tcf-3 phenotype. In contrast, the β-catenin injection did not 
rescue the phenotype when blocking Wnt1, the mechanism of these interactions still needs 
to be investigated.  
Two different experiments could be performed to test the effects of inhibition of Wnt 
signalling on melanocyte differentiation:  
 Creating a new conditional, temperature dependent, β-catenin mutant using 
mitfa heat-shock promoter (mitfa
fh53
 from Johnson et al., (2010)), could allow 
the inactivation of Wnt signalling in melanocytes at specific timepoints. 
Therefore, using temperature induction (25°C) of a dominant negative 
mutated, or truncated, version of β-catenin, fused to GFP (IRES), in 
melanocytes would allow the testing of the role of β-catenin at different 
timepoints. This method would also permit the control of the activation of the 
construct with the GFP reporter. Inactivation of β-catenin, from 15-30 hpf, 
should lead to decreased melanocyte specification and should trigger a 
reduction of the number of melanised cells at 30 hpf. Inactivation of β-
catenin, from 24-48 hpf, and from 48-72 hpf, could cause severe changes in 
melanocytes, such as, a regression of the cell differentiation or a decrease of 
cell dendricity and even a decrease of melanisation. Finally, loss of Wnt 
signalling in melanocytes would trigger a decrease or even a loss of mitfa 
expression. However for these experiments, a new temperature sensitive β-
catenin allele would need to be identified. 
 In Hari et al., (2002), a Cre/LoxP system was used with tamoxifen to induce a 
constitutive version of β-catenin (Ctnnb1
Δex3
) in sox10 expressing 
melanoblasts (sox10-Cre) in mouse. In zebrafish, the Cre/LoxP system was 
not thought to be efficient, however, a recent study published from Hans et al, 
(2009) showed that the Cre/LoxP system was perfectly suitable in this model. 
Rodrigues et al., (2012) developed a new transgenic tool in zebrafish, a sox10-
Cre line Tg(-4725sox10:Cre)(ba74) which marked all NC derived pigment 
cells. This tool could be used, in combination with a LoxP tamoxifen 
inducible truncated version of β-catenin, to test for the effects of impaired 
Wnt signalling activity in melanocytes between 36 and 48 hpf. 
3.3.7 Complex aspects of Factor Y 
 
The activation of Wnt signalling during melanocyte differentiation caused increased mitfa 
transcription. Interestingly, the Mitf regulatory network in melanocytes contains numerous 
connections with the signalling pathways and genes involved in the full range of different 
functions for the maintenance of the melanocyte. mitfa has also been described as an 
oncogenic factor and its roles in the survival of melanocytes, the cell cycle and the 
proliferation of cells, have been described in several studies (Bertolotto and Ballotti, 2009, 
Bondurand et al., 2000, Carreira et al., 2005, Carreira et al., 2006, Cheli et al., 2012, 
Cronin et al., 2009, Garraway et al., 2005, Goding, 2000, Hou et al., 2000, Johnson et al., 
2010, Kido et al., 2009, McGill et al., 2002, Mellgren and Johnson, 2004, Phung et al., 
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2011). Consequently, it could be suggested that the activation of a direct or an indirect 
activator of mitfa, such as Factor Y in the context of the modelling, might be expected to 
cause dramatic effects in differentiated melanocytes.  
 Firstly, Factor Y is likely to correspond to multiple components. As in a 
progression process, or in a process of several steps, misregulation of melanocyte 
differentiation, via mitfa increase or decrease could require the disruption of several key 
factors which remain to be defined.  
 Secondly, if mitfa expression was not key after 48 hpf, then activating mitfa after 
48 hpf would have no effect, or an indirect effect, on melanocyte differentiation. However, 
we show in Chapter 4, that mitfa expression is maintained at low levels until at least 72 hpf 
in melanocytes, consequently it is plausible to suggest that it could be a key factor to 
maintain for melanocyte differentiation. 
 Thirdly, epigenetic mechanisms should be taken into account for investigating 
Factor Y. It is plausible that epigenetic regulation would be responsible for the changes of 
mitfa expression level, from melanocyte specification to melanocyte late differentiation 
phase. Consequently, if epigenetic mechanisms were responsible for maintaining mitfa 
expression silent or low during melanocyte differentiation, then a misregulation of these 
mechanisms could cause important misregulation of melanocyte differentiation.  
3.3.8 Identifying other candidates for Factor Y 
 
Given the limited effects of overactivation of Wnt signalling, we propose that Factor Y 
may consist of an ensemble of factors which together maintain mitfa expression. Factor Y, 
if it exists, was redefined as an ensemble of factors, which could maintain the equilibrium 
in melanocyte state when differentiated. Therefore, other candidate factors could be at play 
in this role such as Mitfa itself, Tyro3, cAMP via p38 and the Mc1r pathways (Phung et 
al., 2011, Maresca et al., 2010, Zhu et al., 2009, Gross et al., 2009). 
3.3.8.a Mitfa itself as a potential candidate for Factor Y 
It has been shown in vitro that MITF could be an auto-regulator of its expression (Saito et 
al., 2002). However, it remains unclear in vivo, if, and when, Mitfa could be responsible 
for its own activation. In Chapter 5, the response of activation of mitfa expression to 
ectopic mitfa induction was tested in zebrafish to explore the possibility of Mitfa as a 
candidate for regulation of mitfa. Interestingly, there is currently no evidence in 
melanocytes for a factor which would antagonise mitfa effects and prevent melanocytes 
from expending or overexpressing mitfa after 24 hpf. This could suggest that the network 
did not need such a factor to maintain a balanced mitfa level in melanocyte but rather 
another mechanism, perhaps involving dynamic transcription or epigenetic regulation, 
could regulate its level.  
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3.3.8.b tyro3 as a candidate for Factor Y 
The receptor tyrosine kinase 3 (Tyro3) could positively regulate Mitf expression in 
melanoma cells in culture (Zhu et al., 2009). Furthermore, Tyro3 knockdown triggered the 
reduction of the tumourous potential of aggressive melanoma cells in vivo in xenograft in 
nude mice (Zhu et al., 2009). It would be interesting to test the role of Tyro3 in normal 
melanocytes and particularly in mitfa regulation during cell differentiation.  
3.3.8.c The cAMP pathway as a candidate for Factor Y 
Other candidate factors for Factor Y are the cyclic AMP (cAMP) and the MAPK 
pathways. cAMP is an intracellular signalling pathway which is modulated by extracellular 
signals such as α-msh/MC1R, p38, MEK and PKA (Mansky et al., 2002, Price et al., 1998, 
Phung et al., 2011, Saha et al., 2006). Interestingly, Liang et al., 2011 showed a link 
between the regulation of CtBP2, the cAMP/PKA pathway and activation of Mitf in 
melanocyte differentiation in NC culture. CtBP2 is a co-repressor of Wnt signalling. The 
study showed that the degradation of CtBP2 caused the activation of Mitf expression and 
triggered melanocyte differentiation via the activation of the cAMP/PKA pathway (Liang 
et al., 2011). In zebrafish, the PKA/cAMP pathway has also been shown to induce mitfa 
expression by activating the degradation of the antagonist factor, CtBP2 (Liang et al., 
2011). CtBP2 has also been shown to be physically interacting with β-catenin to inhibit β-
catenin in absence of cAMP pathway activation (Figure 3.31) (Liang et al., 2011). GSK3β 
can also be inactivated by the p38-MAPK pathway to activate both β-catenin 
transcriptional and non-transcriptional functions in cells (Bellei et al., 2008). If the cAMP 
and Wnt signalling pathways both regulate mitfa via β-catenin would have to be 
determined in further experiments. Bertolotto et al., (1998) have demonstrated that 
forskolin treatment stimulating the cAMP pathway led to increased tyrosine-related 
proteins 1 and 2 (Trp1 and Trp2/Dct) expression in B16 melanoma cells (Bertolotto et al., 
1998). The study described the effect of cAMP stimulation on increased binding of MITF 
on M-box of Trp1 and Trp2/Dct promoters (Bertolotto et al., 1998). The results showed the 
plausible role of cAMP in cell melanisation, via MITF. Therefore, it would be interesting 
to study the role of cAMP by blocking its activation specifically in melanocyte at a certain 
stage. Interestingly, (Ishizaki et al., 2010) showed that two specific inhibitor of the MEK 
signalling had no effects in pigmentation in zebrafish. Whether another component of the 
pathway could be responsible for activation of melanocytic genes could be tested. 
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Figure 3.31: Activation of the cAMP pathway in melanocytes. 
In melanocytes, Mc1r and Wnt signalling could both activate the cAMP/PKA signalling by 
boosting β-catenin (β-cat) activity, and by inhibiting an inhibitor of β-catenin, CtBP2. This 
would lead to increased β-catenin in the nucleus and cause mitfa activation. The 
mechanism by which PKA co-regulates the β-catenin activity is not well understood so far. 
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3.3.8.d Mc1r pathway as a candidate for Factor Y 
Mc1r is a transmembrane receptor and member of the GPCR (G protein couple receptor) 
superfamily of genes. It is comprised of an N-terminal domain, seven hydrophobic 
transmembrane domains, and a carboxy terminal domain (Vassilatis et al., 2003). Mc1r is 
activated by the binding of its ligand, α-Msh, which triggers the activation of the cAMP 
signalling and results in an intracellular increase in the cAMP levels (Li et al., 2010, 
Maresca et al., 2010). The activation of Mc1r can lead to the activation of downstream 
effectors in the pigmentation pathway, including the target gene Mitf, which transcription 
was up-regulated by cAMP signalling in melanocytes (Figure 3.32) (Widlund and Fisher, 
2003). cAMP signalling, via the PKA and the CREB pathways, can trigger expression of 
MITF in melanocyte in mammals (Kabbarah and Chin, 2006). Consequently, Mc1r is a 
good candidate for Factor Y (Appendix 2).  
3.3.8.e Disc1 as a candidate for Factor Y 
Recent findings suggested that Disrupted in schizophrenia 1 (DISC1) could prevent 
GSK3β from phosphorylating β-catenin via physical interaction (Hur and Zhou, 2010). 
DiscI could then positively affect β-catenin transcriptional activity by preventing GSK3β 
inhibition. Mitf is a target of β-catenin, therefore, Disc1 could be an indirect activator of 
Mitf, by the activation of Wnt signalling. No melanocyte phenotype has been described in 
disc1 zebrafish mutant. However, Drerup et al., (2009) showed an abnormal increase of 
sox10 expression in these mutants. The role of Disc1 could then be important for mitfa 
expression by activating β-catenin and inhibiting sox10 in melanocytes, although, this 
remains to be tested.   
3.3.9 Xanthophore pigmentation was boosted after LiCl treatments 
 
Using LiCl for analysis of GSK3β inhibition in melanocytes showed inconsistent effects 
compared to BIO. The lack of reliability with the use of the molecule throughout the 
different tests has resulted in the need for careful interpretation of the results obtained for 
the melanocyte development. In contrast, activation of xanthophore development was very 
consistent with LiCl.  
 dGFP expression was observed in LiCl treated embryos, localised to cells that 
could be identified as xanthoblasts by their position and morphology. This correlated 
strikingly with the elevated xanthophore pigmentation seen in LiCl-treated embryos. In 
contrast, we were not able to detect an increase in xanthophore pigmentation in BIO-
treated embryos; if there was an increase, it was never as strong as when treating with 
LiCl. One hypothesis could be that in these cells, a pathway targeted by LiCl might limit 
pigmentation. It remains unclear if the xanthophore pigmentation boost was triggered by 
the LiCl dependent activation of Wnt signalling or by the stimulation of another pathway 
as a side effect of LiCl treatment. The lack of effect from the more specific inhibitor, BIO, 
argues for the off-target mechanism being key. 
 After the 24 hpf to 48 hpf treatment, the increase in xanthophore pigmentation 
correlated with a boost of xdh expression in the tail. However, it is not clear whether this 
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expression activation could be the cause of increased pigmentation. Other factors could 
probably be affected by the treatment. Consequently, these experiments did not show a 
dramatic increase of xdh expression and another marker should be tested to understand the 
cause of increased yellow pigmentation at 48 hpf. It seemed that expression of xdh was not 
activated after treatment during cell specification (15-30 hpf), therefore, it could be 
suggested that cell differentiation aspects, such as cell pigmentation, were increased by the 
treatments. Increased cell number could result in cell pigmentation increase however we 
did not investigated it. Only embryos treated during the 30 hpf to 48 hpf period showed 
increased xanthophore pigmentation at 48 hpf and 72 hpf. Altogether, these experiments 
showed that LiCl treatment, from 30 hpf to 48 hpf, could activate a limiting factor in 
xanthophore pigmentation development and cause an increase of the xdh expression. 
Furthermore, because xdh expression was not boosted after the 15-30 hpf treatments, it can 
be suggested that cell specification was not activated. 
  Another family of factors crucial for xanthophore specification and development is 
the pax3/7 family (Minchin and Hughes, 2008). pax3 is expressed in pigment precursor 
early in NC development, before 30 hpf. In zebrafish, the morpholino knockdown of pax3 
triggered the reduction of sox10 expression at 25 hpf. pax7a and pax7b, are expressed only 
in xanthophore after their specification (Lacosta et al., 2007, Lacosta et al., 2005, Minchin 
and Hughes, 2008). It is unlikely that pax7a and pax7b could be the targets of LiCl in 
treated embryos as they are. LiCl could also be boosting any enzymatic reaction 
responsible for pteridin synthesis like that described in Ziegler, (2003).  
 These results are difficult to interpret and further experiments are needed to fully 
understand the activities of LiCl in cells. It is plausible that LiCl stimulated signalling 
pathways other than the Wnt signalling pathway. The LiCl induced effects on xanthophore 
pigmentation could be the consequence of the activation of another target of LiCl, resulting 
in the activation of Wnt signalling. An explanation for this could be that Wnt signalling 
activation in xanthoblasts was the result of a factor that was activated by LiCl, but not by 
BIO.  
 Knowing the lack of effect of BIO in xanthophores, it is unlikely that xanthophore 
response to LiCl would be Wnt signalling dependent. However, to study xanthophore 
development and specifically to investigate this possibility from 24 to 48 hpf, a new 
transgenic fish could be created. This fish line could, for instance, carry a truncated version 
of β-catenin-fused GFP protein under the control of pax7 or xdh promoter. This would 
allow us to observe of the effects of a lack of Wnt signalling in xanthophore and to assess a 
potential lack of yellow pigment.  
3.3.10 Conclusion 
 
To conclude, we showed that Wnt signalling remained activated during melanocyte 
differentiation, however, we did not find that it was a limiting factor in the melanocyte 
GRN differentiation. Therefore, it is acceptable to reject its role as a single factor for 
Factor Y. Thus, pointing to the possibility that Factor Y could be an ensemble of factors 
which remain to be identified. 
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Chapter 4. Characterisation 
of Genetic Heterogeneity in 
Melanocytes 
 
4.1 Introducing the concept of heterogeneity as an essential 
aspect of cell derivation from a multipotent pool 
4.1.1 Genetic heterogeneity is a crucial aspect of both Neural Crest and 
melanocyte development 
 
Variations of gene expression levels in individual cells within the same cell population 
may drive two apparently similar cells towards different fates (Baroffio et al., 1991, 
Bronner-Fraser and Fraser, 1988, Quaranta and Garbett, 2010, Levsky and Singer, 2003). 
Bulk population studies determine the average gene expression level in cell populations, 
but fail to evaluate gene expression variations in individual cells (Peixoto et al., 2004, 
Quaranta and Garbett, 2010, Kamme and Erlander, 2003, Klein et al., 2003, Levsky and 
Singer, 2003). These variations in expression at an individual cell level are not only likely 
to be of importance for cell fate, but also evolutionarily important. Consequently, it is key 
to measure and understand the extent of the influence of these variations at the individual 
cell level. 
 
The aim of this Chapter is to develop a specific approach to better understand 
individual cell activity and to better characterise the melanocyte population. Melanocytes 
are derived from the multipotent NC cell pool via the process of specification and 
differentiation. Previous genetic analyses have identified two crucial transcription factors 
for melanocyte development, Sox10 and Mitf (Johnson et al., 2010, Sommer, 2011, Kelsh, 
2004, Kelsh and Eisen, 2000, Dutton et al., 2001, Lister et al., 1999). The understanding of 
the fine scale regulation and the activity of these factors in melanocyte populations through 
development is at the centre of this study. To reach this aim, we developed a method to 
detect and measure gene expressions in five cell pools. This technique could now be used 
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4.1.2 Heterogeneity within cell populations is the result of genetic 
variability and stochasticity   
 
Gene expression heterogeneity can be a determining parameter for fate choice. Measuring 
the heterogeneity of gene expression of a cell population can also inform on the genetic 
state of the population. Cell heterogeneity could then be modelled through time and could 
inform on the genetic stability of a cell population. The genetic heterogeneity of cell 
population is associated with the gene expression variability in individual cells of this 
population. Genetic variability can be caused by both pre-programmed and/or stochastic 
variations from one cell to another (Stahlberg and Bengtsson, 2010, Elowitz et al., 2002, 
Garg et al., 2009, Gillespie, 2009, Janes et al., 2010, Kaern et al., 2005, Lipniacki et al., 
2006, Lei, 2009, Roberts et al., 2011, Stolovicki and Braun, 2011). Consequently, the 
variability of gene expression is linked to regulated cell-to-cell heterogeneities as well as to 
stochasticity of gene expression. 
 Pre-programmed regulation can cause variability when certain factors are activated 
in a subset of cells due to the different characteristics of their regulatory network and to the 
conditions. Stochastic variability is caused by random transcriptional events. Stochastic 
activation of gene expression is observed when transcription factors are present in low 
numbers which are the condition for a probabilistic system. The stochasticity of gene 
expression can have no functional consequences but it can also provide the flexibility 
needed by cells to adapt to fluctuating environments, or to respond to sudden stresses. It is 
also a mechanism by which population heterogeneity can be established during cellular 
differentiation and development (Raj and van Oudenaarden, 2008, Janes et al., 2010). 
Because of the difficultly of separating meaningful variations from irrelevant background 
variation of gene expression at a multi-cell level in all types of cells, it is necessary to 
investigate gene expression as close as possible to the single cell level.  
4.1.3 Understanding genetic variability in melanoblast/melanocyte 
populations 
 
In this Chapter, one objective was to measure the genetic variability of the melanoblasts 
and the melanocyte population. Comparing heterogeneity of cells in these cell populations 
through time could provide information on the genetic state of cells and consequently on 
the stability of the GRN driving their development at each time point. Previous genetic 
analyses of melanocyte derivation have suggested the existence of several potential 
precursors and here we present a preliminary view on the deciphering of the heterogeneity 
of gene expression in cells of the melanocyte lineage.  
 The variability of melanocytic gene expression in the melanoblast population has 
been suggested but has never been explicitly studied as an aspect of the development of the 
cell population. Figure 4.01 summarises melanocyte derivation from the NC pool and 
shows the potential precursors (melanoglioblasts, chromatoblasts, chromatoglioblasts, 
glioblasts, melanoblasts) which may well be present, albeit in unknown proportions, at 
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each stage. The presence of such precursors in the NC cell population would be expected 
to result in a certain cell to cell heterogeneity of gene expression in this population.  
 According to previous analyses, some variability could be expected in the 
expression of melanocytic genes within in the NC cell population (Curran et al., 2010, 
Dutton et al., 2001). Analysis of the regulatory interactions at play in melanocytes 
permitted us to build a mathematical model which indicated that dct expression was 
activated by Mitfa and repressed by Sox10, while tyrp1b expression was not repressed by 
Sox10 (Greenhill et al., 2011). From 11 hpf to 18 hpf, sox10 was expressed in all NC cell 
precursors. At 18 hpf, mitfa expression was activated and marked a large proportion of 
sox10 (+) cells which consists of a poorly-defined mixture of multiple precursors including 
neuroglioblasts, chromatoglioblasts and melanoblasts. This was deduced by the study of a 
mitfa:GFP transgenic fish line which showed that mitfa expression was initially detected in 
a broad population of sox10 positive (+) cells from 18 hpf to 26 hpf knowing that at 24 hpf, 
GFP expression in this fish accurately reflected mitfa expression (Curran et al., 2009). 
However, no single cell expression studies have been carried out to investigate the exact 
proportion of sox10 (+) cells activating mitfa transcription at early stages. Around 20 hpf, 
the genes coding for enzymes responsible for melanin synthesis, dct, tyrosinase related 
protein 1 (tyrp1b/trp1b), tyrosinase (tyr), and silver (si), were activated by Mitfa in an 
unknown proportion of mitfa (+) cells. Interestingly, Curran et al., (2009) showed that at 
24 hpf, only 55 % of the mitfa:GFP cells were dct positive. From 23 hpf to 36 hpf, mitfa 
was broadly expressed in NC cells and neither the type nor the proportion of precursors in 
the pool of cells were determined (Curran et al., 2009). The first sign of pigmentation can 
be observed around 27-29 hpf, but it is not clear yet when or how mitfa expression 
becomes restricted to the melanocyte lineage (Kelsh et al., 1996b). After 30 hpf, dct and 
tyrp1b expression were strictly restricted to melanocytes as shown by experiments 
investigating colocalisation of melanin and dct expression by WISH (Kelsh et al., 2000, 
Kelsh and Eisen, 2000, Thisse and Thisse, 2008).  
 After 36 hpf, expression of mitfa is restricted to melanoblasts/melanocytes until at 
least 48 hpf and melanisation increases until at least 72 hpf in melanocytes. In contrast, 
sox10 expression is decreased in these cells. Investigating gene expression in the 
population of melanocytes (after 36 hpf), will reveal the variability of gene expression in 
these cells during the process of cell differentiation. It is would be interesting to assess 
whether melanocytic genes are expressed homogeneously in this cell population or 
whether their expression shows strong variation, and, if it ever reaches homogeneity in the 
fully differentiated cells at 72 hpf. 
  In this study, we began to investigate melanocyte-related gene expression in both 
the NC cell population and the melanocyte population in order to test the genetic 
variability of their expression in these different cell populations through time. As described 
in Figure 4.02, two timepoints were analysed during the specification phase (23 hpf and 30 
hpf) in isolated GFP+ NC cells (of mixed fate) from sox10:GFP(+) transgenic embryos and 
three timepoints were investigated throughout early to late differentiation (36 hpf, 48 hpf 
and 72 hpf) in melanised cells. 
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Figure 4.01: Time course of the derivation of melanocytes from a heterogeneous 
population of precursors. 
 
From 11 hpf to 18 hpf, sox10 is expressed in most NC cells (red cells). At 18 hpf, Sox10 
activates mitfa expression in a majority of cells including cartilage and peripheral ganglia 
precursors. An unknown proportion of these cells could then be bipotent melanoglioblasts, 
or chromatoglioblasts, in zebrafish (mixture light blue/red/light red). Around 19 hpf, Mitfa 
targets such as dct, are activated in about 50 % of cells according to Curran et al., (2006). 
Cells expressing dct could be defined as melanoblasts (blue). sox10 expression decreases 
in melanoblasts and in differentiating melanocytes as cells are committing to the 
melanocyte fate. At 30 hpf, it is unclear whether some cells remain bipotent. At 48 hpf, 
sox10 expression is difficult to detect, melanocyte specification phase is terminated and 
committed melanocytes undergo continuing differentiation (light blue and dark blue). 
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Figure 4.02: Time course for the stochastic profiling study of gene expression. 
The five time points studied for the analysis of gene expression during melanocyte 
development are presented here. sox10-GFP cells were selected at 23 hpf and 30 hpf 
during cell specification (green cells) and melanised cells (black cells) were selected at 36 
hpf, 48 hpf and 72 hpf during cell differentiation. 
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4.1.4 Melanocyte heterogeneity can be described by using quantitative 
methods within the approach of stochastic profiling  
 
In this study, we used a stochastic profiling approach to quantitatively measure 
heterogeneity of gene expression in melanocyte populations. Stochastic profiling is a 
method which consists of measuring gene expression levels in multiple small pools of cells 
which have been randomly sampled from a population (Figure 4.03). The key elements for 
this method stem from repeated random sampling and comparison to a reference gene 
which is homogeneously expressed in the cell population.  
 This method was successfully used in several studies to quantify the variability of 
gene expression, such as in Janes et al., (2010) and in Quaranta et al., (2010). Low 
variability of gene expression is associated with homogeneity of gene expression in the 
population, while high variability of expression is associated with heterogeneity of gene 
expression in the cell population studied (Janes et al., 2010, Quaranta and Garbett, 2010, 
Peixoto et al., 2004). Figure 4.03 describes the stochastic profiling method. In brief, simply 
using a mean to describe expression does not inform us of the variation that occurs 
between cells, and similarly, sampling single cells is unreliable because of poor detection 
resolution. Instead, empirical studies show that repeat random samples of five cell pools 
are more informative about the degree of variation of gene expression within the 
population. As the number of samples of five cell pools increases, we can see the 
frequency of occurrence of different expression levels. When plotted as a histogram of the 
expression level, populations with low variation will have a narrow distribution with a well 
defined peak (left histogram), whereas, a population with high variation will have a wider 
and flatter histogram (middle graph).  
 In this study we characterised the cell to cell variability of expression of mitfa, 
sox10, dct and tyrp1b in two different cell populations; the early NC cell mixture of 
precursors; and differentiating melanocytes. Gene expression was measured by quantitative 
RT-qPCR in ten repeated pools of five cells for each gene. Gene expression heterogeneity 
was estimated by calculating the variances for each gene at each time point and was 
statistically compared to the house-keeping reference gene series using the Fisher test 
(analysed in Program R).  
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Figure 4.03: Method of stochastic profiling allows identification of heterogeneity in a 
cell population. See legend on the next page. 
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Figure 4.03: Method of stochastic profiling allows identification of heterogeneity in a 
cell population. 
In the top panel, gene expression was measured in the whole cell population as an average; 
by definition, it is assumed that all the cells of the population expressed the gene of 
interest, “black”. In this case, the background was not a problem (white background), but 
the heterogeneity could not be determined. In the middle panel, gene expression was 
measured in individual cells of a population. Gene expression heterogeneity could be 
observed (not all cells expressed the gene “black”) however, with a very low amount of 
starting material, the measurements were subjected to important intrinsic background noise 
(grey background). This caused errors which could mislead the interpretation of the results. 
In the lower panel, gene expression was measured in repeated samples of five cells from 
the population, i.e. by stochastic profiling. Under these conditions, heterogeneity between 
cells can still be observed, and measuring gene expression level in each sample (the lower 
graphs show the “proportion” of cells expression gene “black” in each sample (one cell 
=1)) allowed the description of this heterogeneity. The intrinsic background variation is 
also greatly reduced compared to single cell experiment (white background). Whether the 
peak of the curve representing the frequency of samples at each level will be narrow or 
broad will indicate whether there was homogeneity or heterogeneity of ‘black’ expression 
in the cells. (adapted from Quaranta and Garbett (2010)).  
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4.1.5 Setting gene expression quantification using RT-qPCR  
 
qPCR reactions have several advantages, one of which is that it has been shown to be 
significantly less variable than any conventional RT-PCR procedure (Wittwer et al., 1997). 
Several studies measured the coefficient of variation for data from qPCR and RT-PCR and 
showed it to be very low with qPCR, 0·4 % (Lightcycler) which was significantly better 
than the 14 % reported in the same experiment for conventional RT-PCR (Zhang and 
Byrne, 1997, Wittwer et al., 1997). The RT-qPCR method is very robust, however, data 
are less reproducible when working with very low copy numbers because of stochastic 
effects (also called “the Monte Carlo effect”) (Peccoud and Jacob, 1996). Statistics of 
particle distribution predict that it should require a much greater number of replicates to 
differentiate 5 from 10 copies of RNA than for the differentiation of 5,000 from 10,000 
copies (Dixon et al., 2000, Klein et al., 2003, Nygaard et al., 2005, Taniguchi et al., 2009, 
Yuan et al., 2006). Importantly, the sequence and the structure of the target sequence, as 
well as the reverse transcription efficiency, allow only a proportion of the RNA to be 
reversed transcribed. In conjunction with small quantities of target molecules, several other 
variables, such as the efficiency of reverse transcription and qPCR, as well as, the 
exponential nature of PCR amplification, can cause many minor variations which can 
greatly influence the final yield of the amplified product (Wu et al., 1991). Therefore, 
controlling each step, including the reverse transcription (RT) efficiency, is crucial. For 
these experiments, the RNA yields before RT, and the cDNA yield after RT, were 
controlled using agarose gels, and spectophotometric quantification when possible.  
 The analysis of the qPCR results is complex and has been discussed by several 
authors (Rutledge and Cote, 2003, Nygaard et al., 2005, Yuan et al., 2006). Particularly, 
there has been much debate regarding the assumption that all reactions would have the 
same efficiency rate resulting in a perfect doubling of the material at each cycle. Thus, in 
the field of “qPCR analysis”, there has been a focus on better understanding and improving 
the methodology for analysis of qPCR data (Bar et al., 2011, Larionov et al., 2005, Livak 
and Schmittgen, 2001, Pfaffl, 2001). The major focus of the research in qPCR, are to 
optimise the detection of expression through a reliable method, and to improve the 
knowledge of the important parameters involved in amplification. 
 The validity of qPCR relies on the design and the optimisation of the primer pairs 
which allow the amplification of a specific DNA sequence with a good PCR efficiency. 
Quantification of gene expression by qPCR can be of two types: relative and absolute. In 
relative quantification analysis, the use of a reference gene is essential to subtract the 
background fluctuation of gene expression such as variations related to the cell cycle state. 
Therefore, the reference gene is often a housekeeping gene whose expression is unvarying 
in the system. In contrast, no corrections are applied in the absolute gene expression 
quantification method. In this case, the gene expression can be compared to the absolute 
expression quantification of a reference gene, shown to be homogeneous in the cell 
population. In both absolute and relative quantitative analysis, expression level is first 
determined by the raw (Ct). The Ct corresponds to the number of cycles necessary for the 
signal to exponentially rise above the background level when running the qPCR (Wong 
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and Medrano, 2005). However, for a reliable analysis of the Ct, it is crucial to first follow a 
strictly defined process of calibration. This calibration process allows the detection and the 
measurement of the fluorescence related to the concentration of the specific gene sequence 
target.  
 Both analysis methods require that the genes under investigation are calibrated for 
qPCR reaction by building a standard curve (Figure 4.04). The standard curve is not a 
control for a specific experiment, and once calibrated, the standard curve for a gene can be 
used to determine expression level for this gene in different experiments. However, it is 
important to derive a standard curve which covers the range of concentrations to be 
encountered experimentally, and to produce specific controls for each experiment.   
4.1.5.a. Description of the method for the analysis of qPCR data used for relative 
quantification expression 
 
Relative quantification is an accurate method to evaluate the changes in expression of a 
gene between experimental conditions but also through time when several timepoints are 
studied. It consists of utilising a reference gene (housekeeping gene) to normalise, and 
compare, raw expression levels of genes of interest. Therefore, it is of utmost importance 
to control and test for several reference genes in order to ensure that their expression level 
is stable within the system studied (Figure 4.04) (Ling and Salvaterra, 2011, Pei et al., 
2007) 
Normalised expression can then be compared using different methods. A 
widespread method is the delta-Ct (∆Ct) method (Livak and Schmittgen, 2001, Bustin, 
2000). This method consists of determining firstly, the difference in the Ct of the targeted 
gene and the reference gene [∆Ct = Ct target – Ct reference gene]. And secondly, the 
difference between the ∆Ct of the calibrator (Wild Type (WT), or control/untreated 
condition) and the ∆Ct of the sample (treated/mutant condition), [∆(∆Ct) = ∆Ct calibrator – 
∆Ct treated/mutant]. The processes of RNA extraction, and of reverse transcription of the 
cDNA, for the calibrator, need to have been performed in the exact same conditions as the 
mutant and the treated samples. The fold difference in gene expression level, between the 
calibrator, and the tested sample, is then determined by (2
-∆(∆Ct)
). This value can be used to 
compare expression levels in samples. Figures 4.04, 4.05, and Table 1, detail and 
summarise this method.   
This method has to be utilised with caution as it is based on a simplification which 
assumes that qPCR efficiencies for the genes compared are comparable. It is possible to 
compare expression level of several target genes by using relative qPCR analysis, if the 
slopes, and the PCR efficiencies (E), are less than 10 % different. This can be verified by 
determining the gradient of the slope of the line found when plotting the difference in Ct 
for the two genes, against the logarithm of the concentration. If the slope of this line is less 
than 0.1 (10 %), then efficiencies are deemed comparable. If it is not the case, another 
method which corrects for differences of qPCR efficiencies can be used for relative 
quantification, such as the Pfaffl method (Pfaffl, 2001). Because it takes efficiency 
parameters into account, the Pfaffl method has been thought to be more robust than the 
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∆(∆Ct) method. It is key to determine efficiencies of qPCR amplification to use the 
appropriate method of analysis. In our study, the qPCR efficiencies were comparable, 
therefore, the ∆(∆Ct) method, as described in Figures 4.04 and 4.05, was chosen to analyse 
the data. 
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Figure 4.04: Construction of the standard curve to assess qPCR efficiency (E) for 
each primer set. 
The standardised procedure for building the standard curve for each experimental and 











]). To span a large range of concentrations, sample [1], the most 
concentrated sample consists of a pool of a highly concentrated cDNA extracted from 
pooled embryos. The qPCR reaction is observed by plotting the fluorescence against the 
cycle number (top panel). It is defined by two phases, a phase of exponential amplification 
and a plateau which corresponds to the end of the reaction when reagents are limiting (as 
indicated on top panel). This reaction allows the determination of (Ct) for each 
concentration, from high to low, in each sample (in duplicate or triplicate, not shown here 
for clarity). The (Ct) corresponds to the cycle number required for the signal to rise above 
the background level which is set by the “Threshold”. The (Ct) and the Logarithm of the 
concentration (Log[concentration]) for each sample are used to build the standard curve 
(lower panel). The gradient (slope) and the PCR efficiency (E) are then determined for 
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Figure 4.05: Schematic for the experimental set up and analysis for absolute and 
relative quantification of gene expression using the delta-delta Ct method. 
 
For analysis of relative quantification of gene expression, four types of samples were run 
for both reference and tested genes. A sample of known concentration ([10
-3
]) was run and 
used by the software to recall the standard curve and to associate Ct(s) to concentrations. 
The “calibrator/cal” sample which corresponds to the “control” or “untreated” condition 
was run. This sample represents the control for the experiment, it was processed exactly as 
the experimental samples corresponding to treated or mutant conditions called “unknown 
sample 1 and 2”. Finally a negative control, “blank” which contains no cDNA was always 
run. The determination of quantification takes two steps. 1) Ct (tested gene sample) - Ct (reference 
gene sample) = Δ(Ct), 2) Δ(Ct)calibrator - Δ(Ct)unknown sample = ΔΔ(Ct).  The ΔΔ(Ct) is then 
converted into fold change 2
- ΔΔ(Ct)
. For absolute quantification analysis, the concentration, 
or the copy number, was associated to the (Ct) by the software thanks to the previously 
built standard curve.  
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Table 4.1: Determination of relative expression using the ΔΔCt method 
The determination of relative expression using the ΔΔCt method is a two step process. 
Firstly, the ΔCt(s) are determined by comparing the Ct of the reference gene to the Ct of 
the tested genes in both the calibrator sample (control) and the tested/unknown sample 
(mutant or treated). For this, the difference between the Ct tested gene and the Ct reference gene 
(ΔCt calibrator) is calculated for the reference gene as well as, the difference of the Ct tested 
gene and the Ct reference gene, (ΔCt unknown sample), for the tested gene. Secondly, the difference 
between the ΔCt (calibrator) and the ΔCt (unknown sample) determines the ΔΔCt (unknown sample). 
This value is then used to define the fold changes in expression level between the unknown 
sample and the calibrator control condition (2








Unknown sample  
(treated/mutant) 
 
Tested gene Ct Ct   
Reference 
gene 
Ct Ct  
Subtraction 
Ct 
ΔCt (calibrator)  -   ΔCt (unknown sample ) = ΔΔCt (unknown sample ) 
 
Chapter 4. Characterisation of Genetic Heterogeneity in Melanocytes 
   159 
 
4.1.5.b Determination of a reference gene in the study system  
 
One of the fundamental parameters to select for qPCR analysis is a correct reference gene. 
The reference gene needs to be expressed homogeneously in the system studied. Numerous 
reports showed that the choice of a reference gene depends on the model studied (Ling and 
Salvaterra, 2011). In theory, housekeeping genes are expressed in most types of cells as 
they are required to maintain the basic metabolic activities of cells. However, studies have 
shown that many so-called ‘housekeeping genes’ are expressed in a tissue-specific manner 
and that in some cases their level of expression within a cell population can vary 
significantly (Larionov et al., 2005, Ling and Salvaterra, 2011). Several reference genes 
are commonly used, including principally glyceraldehyde- 3-phosphate-dehydrogenase 
(gapdh), β-actin and ribosomal RNAs (rRNA). Other mRNAs are also utilised 
occasionally, for example histone H3 and cyclophilin. β-actin was one of the first RNAs to 
be used as an internal standard, and it is still advocated as a quantitative reference for RT-
qPCR assays. The analysis of β-actin mRNA in Drosophila melanogaster showed that this 
housekeeping gene was expressed at moderately abundant levels in most cell types and 
encodes a ubiquitous cytoskeleton protein (Ling and Salvaterra, 2011). The RNA encoding 
GAPDH is ubiquitously expressed and moderately abundant in zebrafish. It is frequently 
used as an endogenous control for quantitative RT-PCR analysis because, in certain 
experimental systems, its expression seemed constant through time (Pei et al., 2007, Winer 
et al., 1999). 
  For my experiments, two genes, β-actin and gapdh, were tested for consistency 
through time to be validated as reference genes (section 4.2.2). In agreement with the 
findings of Pei et al., (2007), good consistency was found with gapdh but not with β-actin 
for detection in qPCR in zebrafish.  
4.1.6 Further investigating gene expression in single cells  
 
To study the cell to cell variability in melanocyte population, a method to investigate gene 
expression in single cells was tested. For this study, the objective was to characterise the 
cell to cell variability of expression of four melanocytic genes, mitfa, sox10, dct and 
tyrp1b. At a single cell level the low quantity of starting material is always a major 
difficulty, therefore, the first technique developed was the single cell nested PCR which 
allowed us to use two rounds of amplification. Expression of both mitfa, a melanocyte 
marker, and ltk, an iridophore marker, was investigated at two time points, an early 
timepoint, 23 hpf (melanoblasts cells), and a late timepoint, 72 hpf (melanocyte cells). The 
efficacy of reverse transcription was investigated by using newly made cDNA from single 
cells and gene expression was amplified successfully. In this Chapter, the results of 
studying forty single cells, at 23 hpf and 72 hpf, by RT-nested PCR are described. The 
objective of this experiment was simply to ask whether gene expression was detectable or 
not and coexpressed, or not, in cells at these timepoints. Unfortunately, it was not possible 
to extend these experiments to single cell RT-qPCR. After performing qPCR on cDNA 
isolated from single cells as previously experimented for nested PCR, the gene expression 
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amplification failed. The single cell qPCR technique was not validated. In this Chapter, we 
detail the intent of testing single cell RT-qPCR investigating dct at 48 hpf. 
4.1.7 Aims and approach 
 
In this Chapter, data have been collected and analysed to pave the way to future 
quantitative modelling of the melanocyte GRN. The objective was to collect quantitative 
data to improve the understanding of the genetic variability of melanocytic genes via 
establishing a method of quantifying gene expression in five cell pools ex-vivo. The 
relationship between sox10 and mitfa expression during melanocyte development was 
always a key focus of interest.  
Firstly, quantitative data were investigated by analysing mean expression level of 
mitfa, dct and tyrp1b in the bulk melanocyte population. cDNA from pooled embryos were 
collected at 23 hpf, 30 hpf, 36 hpf, 48 hpf and 72 hpf and were analysed. Secondly, the 
heterogeneity of mitfa, dct, tyrp1b and sox10 expression was statistically assessed at these 
time points. Thirdly, both the relative and the absolute expression levels of mitfa, dct, 
tyrp1b, and sox10, were presented and analysed in ten samples of five cells by qRT-PCR. 
Fourthly, the existence of a potential chromatoblast precursor was tested by investigating 
the expression profile of mitfa and ltk in forty single cells at 23 hpf and 72 hpf, by nested 
RT-PCR. These results could hint at the potential existence of pluripotent, or bipotent, 
precursor marked by mitfa expression at early stages. By developing a technique of 
quantification of gene expression in small pools of cells, we could define an approach 
which allowed us to go further in the characterisation of the melanocytic gene expression 
through time.  
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4.2 Results 
4.2.1 Calibrating the parameters for gene expression detection 
 
In our experiments, we used the SYBR Green I kit (Wittwer et al., 1997). The reliability of 
the qPCR rests upon the quality of the standard curve and the analysis of the melting curve. 
Both of these processes are standardised procedures which describe the reliability and the 
efficacy of the primer sets to target and amplify the wanted cDNA sequence. This section’s 
objective is to document the standardised calibration of the primer sets which was 
undertaken to specifically target each of the DNA sequences with optimal qPCR efficiency 
(E). The melting curve analysis is also described here. 
 
Each mRNA sequence was synthesised and reverse transcribed in vitro to produce a 
highly concentrated pure sample of each cDNA sequence. The protocol used for reverse 
transcription was the same protocol as described for reverse transcribing similarly 
concentrated mRNA samples extracted from whole embryos. The cDNA pool was then 
diluted five times on a logarithmic scale. Importantly, each single species cDNA solution 
was diluted in cDNA reverse transcribed from plant extracted RNA (Arabidopsis sp., 
kindly given by Dr R. Scott lab, University of Bath) to replicate the cell/embryo cDNA 
solution biological diversity in proportion for each cDNA concentration. The plant cDNA 
was diluted to low concentration in MiliQ water, and used to dilute the single species 
cDNA solutions.  
 
The standard curve is a standard measure of efficiency of detection with specific 
primers. Consequently, it was not a control for a certain experiment, it was a standardised 
procedure to assess the efficiency (E) of the qPCR reaction (not of the reverse 
transcription), meaning to assess the reproducibility of the proportionate relationship 
between amplifications and concentrations in diluted samples. All the reactions preceding 
the amplification, such as the RT, had to be homogeneous to preserve the proportionality 
of concentration in the five samples. This is why it was not possible to first dilute the 
mRNA pool (logarithmic dilution) nor subsequently the use of different RT protocol (RT 
for whole embryo for highly concentrated samples and single cell/five cell pool RT 
protocol for lowly concentrated samples) for building the standard curves. A control for 
each specific experimental test was then required to assess expression levels using the 
specific experimental conditions.  
 
 SYBR Green I did not allow specific amplification of a sequence (which is the 
reason why it is very difficult to realise multiplex analysis with this kit). The specificity of 
the cDNA sequences amplified was assessed by the melting curves issued from standard 
amplifications. The melting curve of each amplified sequence was specific to the sequence 
as it depends on nucleotide content to determine the specific melting temperature (Tm). For 
each transcript targeted, the melting curve, showing the specific Tm, was presented to 
assess the specificity of the yield.  
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4.2.1.a Standard curve analysis 
 
The efficiencies of the amplification reactions are a crucial parameter to assess for 
quantifying gene expression by qPCR. A variation of more than 10 % in PCR efficiencies 
for the target gene would not allow accurate quantification.  
With a 100 % PCR efficiency (E), a logarithmic dilution (10x dilution) should give 
a difference between Ct(s) of 3.32 (every 3.32 cycles the amount of DNA amplified is 10 
fold higher). qPCR efficiency (E) is related to the slope of the reaction by the following 
equation: [E = 10 
 (-1/slope)
 – 1]. If the slope of the standard curve is -3.32 then PCR 
efficiency is 100 %. PCR efficiency (E) between 90 - 110 % was acceptable 
(corresponding to a slope between   -3.58 and -3.1) (Wong and Medrano, 2005). PCR 
efficiency (E) can be affected mainly by primer design, annealing temperature and Mg
2+
 
concentration which can be optimised for maximising activity of the Taq polymerase.  
Figures 4.06 to 4.11 show both the qPCR amplification of the five logarithmic 
dilutions and the standard curve built from the result of this amplification, gapdh (Fig. 
4.06), β-actin (Fig. 4.07), mitfa (Fig. 4.08), sox10 (Fig. 4.09), dct (Fig. 4.10), and tyrp1b 
(Fig. 4.11). For each figure, the amplification reactions showed an exponential 
amplification phase and reached a plateau. (Ct)s for amplification reactions were 
proportionate to sample concentration. The standard curve describes the PCR efficiency 
(E) and slope for each calibration. Slopes were comprised of between -3.56 and -3.18 
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Figure 4.06: Standard amplification and standard curve for gapdh. 
 
On the top panel, standard amplification; samples (duplicates are shown for each 
concentration) of five dilutions (1/10) of known concentration have been amplified in 
duplicates in order to build the standard curve shown on the lower panel. The qPCR 
efficiency was then calculated as well as the slope. slope = -3.257, E= 102.8 % 
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Figure 4.07: Standard amplification and standard curve for β-actin. 
 
On the top panel, standard amplification; samples (duplicates are shown for each 
concentration) of five dilutions (1/10) of known concentration have been amplified in 
duplicates in order to build the standard curve shown on the lower panel.                                                
The qPCR efficiency was then calculated as well as the slope. slope = -3.185, E= 106.5 %  
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Figure 4.08: Standard amplification and standard curve for mitfa.  
 
On the top panel, standard amplification; samples (duplicates are shown for each 
concentration) of five dilutions (1/10) of known concentration have been amplified in 
duplicates in order to build the standard curve shown on the lower panel.                                                
The qPCR efficiency was then calculated as well as the slope. slope = -3.553, E= 91.184 % 
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Figure 4.09: Standard amplification and standard curve for sox10.  
 
On the top panel, standard amplification; samples (duplicates are shown for each 
concentration) of five dilutions (1/10) of known concentration have been amplified in 
duplicates in order to build the standard curve shown on the lower panel.                                                
The qPCR efficiency was then calculated as well as the slope. slope = -3.18, E= 106.3 % 
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Figure 4.10: Standard amplification and standard curve for dct.  
 
On the top panel, standard amplification; samples (duplicates are shown for each 
concentration) of five dilutions (1/10) of known concentration have been amplified in 
duplicates in order to build the standard curve shown on the lower panel.                                                
The qPCR efficiency was then calculated as well as the slope. slope = -3.438, E= 95.3 % 
Chapter 4. Characterisation of Genetic Heterogeneity in Melanocytes 









           
 
Figure 4.11: Standard amplification and standard curve for trp1b.  
 
On the top panel, standard amplification; samples (duplicates are shown for each 
concentration) of five dilutions (1/10) of known concentration have been amplified in 
duplicates in order to build the standard curve shown on the lower panel.                                                
The qPCR efficiency was then calculated as well as the slope. slope = -3.192, E= 105.7 % 
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4.2.1.b Melting curve analysis 
 
The melting curves were built by slowly increasing the temperature above the melting 
temperature (Tm) of the amplicon and measuring the fluorescence. The Tm is defined by 
the temperature at which half of the DNA strands of the sequence are denatured (Breslauer 
et al., 1986, von Ahsen et al., 2001). The Tm of the amplicon depends markedly on its 
nucleotide composition, thus, it is specific to each sequence and it allowed us to identify 
the specific signal obtained from the correct product. A characteristic melting peak at the 
melting temperature (Tm) of the amplicon distinguished it from amplification of artifacts 
which would be expected melt at lower temperatures in broader peaks (Breslauer et al., 
1986). Comparing the melting temperature peak of each standard amplification reaction to 
the expected calculated peak for the sequence allowed detection of contamination, 
mispairing or any artifacts. 
 The specific melting curve temperature was calculated using the online Promega 
tool (http://www.promega.com/techserv/tools/biomath/calc11.htm#stacking). Estimation of 
the calculated value was adjusted to the Mg
2+
 (2 mM) and to the salt concentrations to 
prevent underestimation of this value in the context of these measurements in the reaction 
solution (von Ahsen et al., 2001). Values for the Tm are presented in Table 4.2. Melting 
curves are presented in Figures 4.12-4.17 for all the primers used in the experiments 
(Fig.4.12, gapdh), (Fig.4.13, β-actin), (Fig.4.14, mitfa), (Fig.4.15, sox10), (Fig.4.16, dct), 
(Fig.4.17, trp1b). This showed that the qPCR reaction specifically amplified the targeted 
sequences. 
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Table 4.2: Amplicon length and calculated melting temperature for each amplified 
sequence.  
 
Gene Amplicon  
length 
Melting Temperature 
(Tm) in °C 
gapdh 202 bp 89 
β-actin 251 bp 89 
mitfa 90 bp 84 
sox10 428 bp 89 
dct  166 bp 86 
trp1b 98 bp 83 
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Figure 4.12: gapdh melting curve.  
 
cDNA amplified with gapdh primers show a peak at 89 °C as predicted, showing the 






Figure 4.13: β-actin melting curve.  
 
cDNA amplified with β-actin primers show a peak at 89 °C as predicted, showing the 
specificity of qPCR 
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Figure 4.14: mitfa melting curve.  
 
cDNA amplified with mitfa primers show a peak at 84 °C as predicted, showing the 





Figure 4.15: sox10 melting curve.  
 
cDNA amplified with sox10 primers show a peak at 89 °C as predicted, showing the 
specificity of qPCR. 
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Figure 4.16: dct melting curve.  
 
cDNA amplified with dct primers show a peak at 86 °C as predicted, showing the 





Figure 4.17: trp1b melting curve.  
 
cDNA amplified with trp1b primers show a peak at 83 °C as predicted, showing the 
specificity of qPCR. 
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4.2.2 Establishing gapdh as a reference gene 
4.2.2. a. Testing gapdh and β-actin as reference genes 
 
Relative quantification analysis is based on the use of a reference gene to compare gene 
expression. Expression of the reference gene is characterized by the fact that it does not 
significantly vary between systems. For this experiment, two reference genes were tested, 
gapdh and β-actin. The variability of gapdh and β-actin expression level was determined 
through time, both in whole embryos and in random sampling of melanoblasts and 
melanocytes. The variance of expression levels was statistically tested through repeated 
samples using one-way ANOVA, two-tailed test. 
 β-actin and gapdh were tested in fifty pooled embryos at different timepoints, in 
triplicate samples. β-actin expression was tested at 30 hpf, 36 hpf, 48 hpf and 72 hpf, and 
was found to be significantly variable (p = 0.0001) (Figure 4.18). In contrast, gapdh 
expression was tested at 23 hpf, 30, hpf, 36 hpf, 48 hpf and 72 hpf, and its variance was not 
significantly changing (p = 0.11) (Figure 4.19). Therefore, gapdh, but not β-actin, was 
found to be homogeneously expressed in the system. Furthermore, gapdh expression 
variability was tested in ten repeated samples of five cells at five different time points and 
no significant variation was found between samples (in sox10-GFP (+) cells at 23 hpf, Fig 
4.20, p = 0.5212, at 30 hpf, Fig 4.21, p = 0.3934, in melanised cells at 36 hpf, Fig 4.22, p = 
0.189, at 48 hpf, Fig 4.23, p = 0.8825,  at 72 hpf, Fig 4.24, p = 0.883). 
These tests showed that gapdh expression was homogeneous in NC cells, 
melanoblasts and melanocytes through time in zebrafish. Thus, it was suitable for use as an 
external reference gene for qPCR experiments. In contrast, β-actin showed significantly 
variation in the system 
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Figure 4.18: β-actin expression level in pooled embryos varied significantly through 
time.  
Bars represent standard deviation of triplicates; one way ANOVA test, two-tailed, p = 




Figure 4.19: gapdh expression level did not significantly vary through time, in pooled 
embryos. 
Bars represent standard deviation of triplicates, one way ANOVA test, two-tailed, p = 0.11.  
p>0.01. 
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Figure 4.20: gapdh expression level was homogeneous though ten repeated 5 cell 
samples at 23 hpf (sox10-GFP cells). 
Bars represent standard deviation of triplicates, one way ANOVA test, two tailed, p 





Figure 4.21: gapdh expression level was homogeneous though ten repeated 5 cells 
samples at 30 hpf (sox10-GFP cells).  
Bars represent standard deviation of triplicates, one way ANOVA test, two tailed, p 
=0.3934, p>0.005, there is no significant difference values through samples. 
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Figure 4.22: gapdh expression level was homogeneous though ten repeated 5 cell 
samples at 36 hpf (melanised cells).  
Bars represent standard deviation of triplicates, one way ANOVA test, two tailed, p 




Figure 4.23: gapdh expression level is homogeneous though ten repeated 5 cell 
samples at 48 hpf (melanised cells).  
Bars represent standard deviation of triplicates, one way ANOVA test, two tailed, p 
=0.8825, p>0.005, there is no significant difference values through samples. 
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Figure 4.24: gapdh expression level is homogeneous though ten repeated 5 cell 
samples at 72 hpf (melansied cells).  
Bars represent standard deviation of triplicates, one way ANOVA test, two tailed, p 
=0.8830, p>0.005, there is no significant difference values through samples. 
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4.2.3 Relative quantification of melanocyte specific gene expressions in 
pooled embryos 
 
Having validated primer sets, protocols and a control reference gene, we next investigated 
the quantitation of gene expression in the embryo. First, gene expression was analysed in 
whole embryos, to obtain an average measure of transcript abundance at each stage. In this 
experiment, expression levels of mitfa, and of the two melanocytic genes dct and tyrp1b, 
were investigated in fifty pooled embryos (minus head which were omitted to exclude 
expression of genes such as dct in the RPE). sox10 expression was not investigated here as 
its expression at 23 hpf stage marks all NC cells (Dutton et al., 2001, Carney et al., 2006). 
Gene expression was investigated at 23 hpf, 30 hpf, 36 hpf, 48 hpf and 72 hpf to observe 
changes in the developing melanocyte lineage at a population level. 
  In order to compare expression through time, the 23 hpf time point was established 
as the “calibrator” sample. All expression levels were expressed compared to the 23 hpf 
expression level for each specific gene (23 hpf = 100). The Livack method (delta-Ct) was 
applied to the data and statistics were calculated using the REST 2009 software which 
takes qPCR efficiencies into account. This allows randomisation which increases the 
robustness of the test. Data are presented in Figures 4.25 and the statistical results are 
shown in Table 4.3.  
The Livack analysis method showed that mitfa expression level was lower at 30 hpf 
compared to 23 hpf. After 36 hpf, mitfa expression seemed to decrease in embryos and it 
was found to be significantly decreased at 72 hpf compared to the expression at 23 hpf. 
However, an increase is observed at 48 hpf. These results could suggest that mitfa was 
expressed more broadly at 23 hpf than at 30 hpf in NC cells. Consequently, if we relate 
these measurements to WISH investigating melanocytic genes in embryos at 72 hpf and 
showing exclusive expression in melanocytes, this mitfa expression decrease could be 
related to the restriction of mitfa expression to the melanocyte lineage through time. In 
contrast, dct expression significantly increased at 36 hpf, and then decreased until 72 hpf. 
tyrp1b expression seemed to increase and to be stabilised after 36 hpf when analysed with 
the Livack method. The increase of dct and tyrp1b expressions after 23 hpf suggests that 
these genes could have been expressed exclusively in melanoblasts since 23 hpf, and that 
their expression had increased while cells had gone through the differentiation process. 
The decrease of dct expression could be related to the reaching of a stable level of 
expression around 72 hpf. These speculative interpretations of the results are limited by the 
fact that many cells were pooled together and that expression level was averaged. 
Measuring gene expression in five cell pools could give more insight to the description of 
gene expression in the two cell populations.  
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Figure 4.25: Graphs summarising the changes of average expression levels for mitfa, 
dct and tyrp1b in fifty pooled embryos using the Livack analysis methods. 
 
Average expression level at 30 hpf, 36 hpf, 48 hpf and 72 hpf for each gene, after 
correction for the reference gene gapdh and using the 23 hpf expression level as a baseline 
(the red dotted line represent expression level at 23 hpf which was the baseline for 





Table 4.3: p-values associated to the statistical test (REST 2009) comparing gene 
expression to the level of expression of the gene at the“calibrator” timepoint, 23 hpf. 
 p-value at 30 hpf p-value at 36 hpf p-value at 48 hpf p-value at 72 hpf 
mitfa 0.003 0.031 0.067 0.033 
dct   0.080 0.030 0.020 0.048 
trp1b            0.049 0.044 0.025 0.016 
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4.2.4 Investigating whether gene expression level in pools of five cells is 
correlated with the variance in gene expression  
 
In the next experiments, we investigated gene expression in five cell pools to describe 
expression on a finer scale and to evaluate expression variability in the two cell 
populations. For the first step, to assess the reliability of the technical replicates at low 
levels of detection, we tested the correlation between gene expression level and gene 
expression variability. More precisely, we tested whether the variability observed in the 
measurements of gene expression could be attributed to the technical unreliability and 
difficulty of measuring low expression levels. It was crucial to assess whether the 
variability of low gene expression was correlated to the fact that expression was low. A 
linear regression was used to test statistically whether or not technical difficulties in 
measuring low expression levels were responsible for the variability or not.  
The objective of this test was to determine whether low expression level was 
significantly associated with high variances. Gene expression was measured in each of the 
ten samples of five cells at each of five timepoints and absolute and relative expression 
levels were determined in each case. The series of Ct(s) collected for both relative and 
absolute quantification experiments were plotted against their variances. Figure 4.26 shows 
the results of the linear regression tests for each gene at each timepoint. The results are 
presented in the graphs (each point shown on the graph corresponds to the test applying the 
average gene expression level in the ten samples collected for both relative and absolute 
quantification analyses (shown as the average Ct) against the variance of this series of 
values); the p-values which allow assessing for the significance of the test; and the R
2
 
values which indicate how much of the variation in expression level was explained by the 
expression level. The graphs show the line corresponding to the linear model. Further to 
the results of the linear regression, it is important to take account of the distribution of the 
data points on, and between, the graphs as the distribution of the data gives a sense of the 
relative sizes of variance and expression compared between the genes. 
When data were taken altogether, no significant correlations between the variances 
and expression levels were found (p = 0.1319, R
2 
= 5.66 %) (data not shown). When 
plotted individually, the test showed no significant correlation between the variances and 
expression levels for the low expression genes; sox10 (p = 0.6352, R
2 





= 32.99 %); trp1b (trp1b p = 0.7291, R
2 
= 10.72 %). Interestingly for gapdh (p = 
0.003 R
2 
= 65.43 %) and dct (p = 0.006 R
2 
= 58.53 %) the test showed a significant 
correlation between gene expression level and variance of gene expression. These genes 
were expressed at “high” levels (Ct(s) are grouped in the lowest part of graph for gapdh, 
under 40 in samples of five cells, and under 52 for dct) meaning that this correlation did 
not relate to the fact that high variances were associated to low expression levels. The plot 
corresponding to gapdh test in Figure 4.26 shows that all points were grouped together 
suggesting that the variances and the levels of expression (the series of Ct(s)) at each 
timepoint varied within a very tight spectrum (this confirmed previous analysis of the 
variability of gapdh in section 4.2.2). The information shown in the graph explains the 
significant p-value found here by suggesting that the Ct(s) and the variances of the series 
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were both very low. This result did not suggest that there was technical difficulty for the 
reproducibility of measurements for gapdh. The results for dct showed that three series of 
values seemed to show high variance, however, the expression level were not particularly 
low (Ct(s) all under 52 in five cell samples). Consequently, this correlation was not an 
indicator of the loss of reproducibility when measuring gene expression at lower levels but 
rather it is likely the result of a low number of data points. However, it remains possible 
that the variability of dct expression had been partly related to detection therefore, in the 
analyses of dct expression level measurements and dct variability, this point will be 
discussed. Altogether, these data suggest that technical detection of low expression level 
was not a major factor affecting the measurement of biological variability in these genes’ 
expression. 
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Figure 4.26: Test of correlation between expression levels and variances for each 
gene. 
 
The series of gene expression levels (Ct(s)) measured in ten samples for both absolute and 
relative quantification experiments, at each timepoint (23 hpf, 30 hpf, 36 hpf, 48 hpf and 
72 hpf) were used to determine averages and variances of each series                                              
[2 (series of ten samples) * 5 (timepoints) = 10 (series in total for each gene))]. The variance of each series was 
then plotted against the average of each series and linear regression was used for each 
gene. The lines correspond to a projection of the best model fit from the linear regression. 
Top left panel sox10 (p = 0.5842, R
2 
= 8.10 %), top right panel, mitfa (p = 0.05, R
2 
= 32.99 
%), second panel left, dct (p = 0.0161 (*), R
2 
= 47.76 %), second right panel, tyrp1b (p = 
0.7207, R
2 
=10.6 %), lower panel, gapdh (p = 0.003, R
2 
= 65.43 %). 
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4.2.5 Determining the heterogeneity of melanocytic gene expression in the 
NC cell population and in the melanocyte population 
4.2.5.a. Investigating variability of gene expression through time 
 
The variability of gene expression was statistically tested using the method of stochastic 
profiling as described in Quaranta et al., (2010). A random selection of sox10-GFP NC 
positive cells (presumably including melanoblasts, glioblast and other precursors), were 
selected at 23 hpf and 30 hpf from transgenic fish , whereas at 36 hpf, 48 hpf and 72 hpf 
we specifically selected melanocytes (i.e. melanin+ cells) at (Dutton et al., 2001)). At early 
stages (23 hpf, 30 hpf) the cell population was expected to be highly heterogeneous for 
melanocytic genes. In contrast, the variability of the genes in melanocytes, at later stages, 
36 hpf, 48 hpf and 72 hpf was expected to be decreased. 
To establish the variability of gene expression, we used both the cycle data Ct 
collected from the relative quantification experiment and from absolute quantification 
experiment. The differences of variances of the series of data were tested against the 
variance of gapdh at each time point for each gene. Differences in variances were 
statistically tested using Fisher test (one-tailed in R (Crawley, 2007). Variances were 
significantly different (i.e. displaying heterogeneity of expression) when the ratio of the 
(gapdh variance) / (gene tested variance) was greater than 3.7, which was the critical value 
defined by the test from the data (with DF=9, α=0.05, critical value: 3.7 from Fisher’s F 
probability distribution tables). Figure 4.27 shows both graphs for analysis of relative and 
absolute quantification expression. The graphs allow us to visualise the significance by the 
three lines which correspond to different levels of significance of p-values (p = 0.05, p = 
0.01 and p = 0.001). All the values plotted above these lines indicate a significant result i.e. 
that gene’s expression is more variable in the 5 cell pools than the housekeeping control 
gene, and thus that the cells are likely heterogeneous for expression of that gene (Figure 
4.27). 
 
 Both analyses using the Ct(s) collected for absolute and the relative quantification 
showed similar results when testing the significance of the test. At 23 hpf, only sox10 
expression was stable in samples. dct and trp1b expression variances were significantly 
varying compared to gapdh and mitfa expression was also significantly different. This 
result suggested that at this stage, mitfa, dct and tr1pb were heterogeneous in the sox10-
GFP cell population. At 30 hpf, only dct and trp1b were significantly varying compared to 
gapdh. Whether this result could suggest that both mitfa and sox10 expressions were 
restricted to the same precursor cells could be discussed. However it seems that dct and 
trp1b expressions remained significantly variable in the sox10-GPF (+) cell population 
suggesting that at this stage, more than one precursor type could exist in this population. 
 At 36 hpf, in the melanocyte population, the variances of sox10 expression, dct 
expression and trp1b expression were significantly different from gapdh’s variance to a 
lesser extent. This result suggested that dct and trp1b expressions remained 
heterogeneously expressed in the melanised cells. In contrast, mitfa was not varying 
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significantly (p>0.05) when using the Ct(s) collected from absolute expression 
quantification, whereas, it was borderline when using Ct(s) of relative quantification 
experiment. These results showed that in melanised cells at 36 hpf, expression of mitfa was 
rather homogeneous while sox10 expression was significantly heterogeneous. This result 
suggests that the melanised cell population could potentially be in a transition phase 
characterised by the stabilisation of mitfa and destabilisation of sox10 expression. The low 
level of variability of dct and trp1b expressions suggests that the melanocyte population 
was not yet genetically settled at this stage. At 48 hpf, sox10, mitfa and trp1b were just 
above the first significance line (p<0.05) which corresponds to low, but significant level of 
heterogeneity compared to gapdh. The most variable gene was dct (p<0.001). sox10 was 
expressed at low levels which suggested that its expression was decreased in the whole 
melanised cell population at this stage. mitfa expression was also decreased at this stage. 
This destabilisation of expression could suggest that an unknown regulatory event 
(epigenetic or presence of a new factor) was modifying the steady-state level of mitfa 
expression, to a new lower value. Analysing relative quantification data collected at 72 hpf 
showed that all genes seemed to be homogeneously expressed in the melanised cell 
population except sox10 (p<0.001) (with dct borderline, just above threshold 0.05). 
Analysing the variances of Ct(s) collected for absolute quantification, trp1b and dct 
variances were weakly significantly (p<0.05) different from gapdh variance. These results 
could suggest that at 72 hpf, melanocytes had reached a relative stable state with relatively 
stable and high expression of dct and trp1b, and with stable and low expression of mitfa 
and unstable and low sox10 expression. 
 In both experiments, these tests showed that the variances of melanocytic gene 
expression were reduced during melanocyte development implicating a decrease of 
heterogeneity of gene expression during lineage restriction. In contrast, sox10 expression 
heterogeneity was increased in melanocytes.  
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Figure 4.27: Testing sox10 and melanocytic gene expressions heterogeneity during 
melanocyte lineage restriction. 
The plots show the variances of gene expression data series (Ct(s)) at each timepoint. 
Analysis of the absolute quantification experiment is presented in the top panel and 
analysis of the relative quantification experiment is shown in the lower panel. The Fisher 
test shows the results of comparing the variances of each series (mitfa, dct, trp1b and sox10 
at each timepoint for both experiments) to the variance of gapdh at each timepoint. The 
dotted lines represent different levels of significance for the Fisher test (p = 0.05, p = 0.01 
and p = 0.001). When the data points are above the line, variances were significantly 
different from those of gapdh at that level.  
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4.2.6 Quantifying gene expression level in five cell samples in both the NC 
cell population and the melanocyte populations 
 
Quantification of gene expression during specification and differentiation in the small cell 
pools is presented here. In this experiment, qRT-PCR measurements were used to 
determine gene expression levels in repeated samples of five cells. Expression levels of 
mitfa, sox10, dct and tyrp1b were measured in ten independent 5-cell samples at 23 hpf, 30 
hpf, 36 hpf, 48 hpf and 72 hpf. As before, sox10-GFP(+) NC cells were analysed at early 
stages (23 hpf and 30 hpf) and melanised cells were analysed at later stages (36 hpf, 48 hpf 
and 72 hpf). Data are shown in five graphs (Figures, 4.28. (23 hpf), 4.29. (30 hpf), 4.30 (36 
hpf), 4.31 (48 hpf), 4.32 (72 hpf)). These graphs show the relative expression levels for 
each gene in each of the ten samples (1-10), and using gapdh as a reference gene. Each 
sample was run in duplicate and both values are presented in the graphs.  
 In most samples, the expression level measured in duplicates were highly 
consistent, suggesting good technical reproducibility. However, in ten cases (over the 200 
duplicates presented, meaning in 5 % of the samples), the values for the duplicates were 
less consistent: at 23 hpf, for sox10, in sample 1, and trp1b in sample 6; at 30 hpf, for trp1b 
in sample 2 and 4 and mitfa in sample 1; at 36 hpf, for trp1b in sample 2 and 4; at 48 hpf 
for trp1b in sample 1 and 10, as well as dct in sample 7.   
4.2.6.a Relative quantification of gene expression at 23 hpf in neural crest cells 
 
sox10-GFP (+) cells were selected at 23 hpf and expression levels were measured in ten 
pools of five cells by qRT-PCR. Figure 4.28 shows relative expression levels in the ten 
samples. At this stage, sox10 marks the NC cell population which probably contains 
several precursors, such as neuroglioblasts and melanoblasts in the specification phase. 
Consistent with this, there was considerable variation in the expression levels observed 
between samples. trp1b expression level was high in sample 1 (mean fold change ± s.e) 
(2300 ± 659)- sample 5 (1010 ± 20)- sample 6 (1750 ± 469) – and sample 8 (1000 ± 173), 
whereas dct expression was only highly expressed in sample 9 (1250 ± 264). sox10 
expression was particularly highly expressed in sample 1 (1550 ± 482). mitfa expression 
levels (from 100 ± 28 to 500 ± 132) seemed to be always close to dct expression level 
except in sample 9.   
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Figure 4.28: Relative quantification of mitfa, dct, tyrp1b and sox10 by qRT-PCR in ten 
samples of five sox10-GPF+ cells, at 23 hpf. 
Samples are numbered 1-10, and relative expression levels are shown (fold change), 
calculated as 1/Δ(1/Ct) (y = 1/Δ(1/Ct)), where Δ(1/Ct) = 1/Ct gene of interest – 1/Ct 
reference gene (gapdh). Samples were run in duplicates. The expression levels determined 
for each gene in each replicate are shown.  
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4.2.6.b Relative quantification of gene expression at 30 hpf in Neural Cest cells 
 
At 30 hpf, sox10-GFP positive cells were selected and then expression levels were 
measured in ten pools of five cells by qRT-PCR. Figure 4.29 shows relative expression 
levels in the ten samples. At this stage, sox10 remained expressed in glial and other 
precursors such as melanoblasts which had probably started differentiating. In sample 2 
(mean fold change ± s.e), (900 ± 633) – sample 4 (550 ± 400) and sample 7 (700 ± 102), 
trp1b expression level was high whereas dct expression was only highly expressed in 
sample 6 (818 ± 38). In contrast with the results from 23 hpf, here sox10 expression 
seemed to be weakly expressed (from 100 ± 5 to 270 ± 17) and mitfa expression levels 
were high (from 300 ± 68 to 1200 ± 356) particularly in samples 1-2-6-7.   
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Figure 4.29: Relative quantification of mitfa, dct, tyrp1b and sox10 by qRT-PCR in ten 
samples of five sox10-GPF+ cells, at 30 hpf. 
Samples are numbered 1-10, and relative expression levels are shown (fold change), 
calculated as 1/Δ(1/Ct) (y = 1/Δ(1/Ct)), where Δ(1/Ct) = 1/Ct gene of interest – 1/Ct 
reference gene (gapdh). Samples were run in duplicates. The expression levels determined 
for each gene in each replicate are shown. 
Chapter 4. Characterisation of Genetic Heterogeneity in Melanocytes 
   191 
 
4.2.6.c. Relative quantification of gene expression at 36 hpf in melancoytes 
 
Melanised cells were selectively analysed at 36 hpf and expression levels were measured 
in ten pools of five cells by qRT-PCR. Figure 4.30 shows relative expression levels in the 
ten samples. At this stage cells selected were differentiating melanocytes. In sample 4 
(mean fold change ± s.e), (850 ± 519)- sample 5 (630 ± 17)- and sample 6 (1100 ± 356), 
trp1b expression level was high whereas dct expression was only highly expressed in 
sample 5 (680 ± 120). sox10 expression was weakly expressed (from 70 ± 0.6 to 100 ± 7.3) 
in all samples and mitfa, as well as, dct (except in sample 5) was expressed at a consistent 
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Figure 4.30: Relative quantification of mitfa, dct, tyrp1b and sox10 by qRT-PCR in ten 
samples of five melanised cells, at 36 hpf. 
Samples are numbered 1-10, and relative expression levels are shown (fold change), 
calculated as 1/Δ(1/Ct) (y = 1/Δ(1/Ct)), where Δ(1/Ct) = 1/Ct gene of interest – 1/Ct 
reference gene (gapdh). Samples were run in duplicates. The expression levels determined 
for each gene in each replicate are shown. 
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4.2.6.d Relative quantification of gene expression at 48 hpf in melanocytes 
 
At 48 hpf, melanised cells were analysed and expression level were measured in ten pools 
of five cells by qRT-PCR. Figure 4.31 shows relative expression levels in the ten samples. 
At this stage, melanocytes are still differentiating, increasing melanin content, for instance. 
In sample 1 (mean fold change ± s.e = 2010 ± 816), sample 5 (1400 ± 117)- and sample 8 
(1200 ± 299), trp1b expression level was high whereas dct expression was expressed in a 
consistent manner (from 150 ± 10 to 490 ± 186) except in sample 7 (980 ± 546) in which it 
was expressed at higher level. sox10 expression remained low in each sample (around 100 
± 17). mitfa expression seemed consistently expressed (from 200 ± 0.2 to 400 ± 241) at 
levels comparable to dct but slightly lower.  
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Figure 4.31: Relative quantification of mitfa, dct, tyrp1b and sox10 by qRT-PCR in ten 
samples of five melanised cells, at 48 hpf. 
Samples are numbered 1-10, and relative expression levels are shown (fold change), 
calculated as 1/Δ(1/Ct) (y = 1/Δ(1/Ct)), where Δ(1/Ct) = 1/Ct gene of interest – 1/Ct 
reference gene (gapdh). Samples were run in duplicates. The expression levels determined 
for each gene in each replicate are shown. 
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4.2.6.e Relative quantification of gene expression at 72 hpf in melanocytes 
 
Melanised cells were selected at 72 hpf and expression levels were measured in ten pools 
of five cells by qRT-PCR. Figure 4.32 shows relative expression levels in the ten samples. 
At this stage, embryonic melanocytes are considered to be fully differentiated. In sample 7, 
(mean fold change ± s.e) (1210 ± 29) – sample 9 (1580 ± 255) – and sample 10 (1300 ± 
255), trp1b expression level was high. Expression of dct remained consistent (from 100 ± 
1.2 to 500 ± 30), whereas, expression of mitfa was decreased compared to expression at 48 
hpf (around 250 ± 46). sox10 expression remained low in each sample as at 48 hpf (around 
100 ± 30). 
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Figure 4.32: Relative quantification of mitfa, dct, tyrp1b and sox10 by qRT-PCR in ten 
samples of five melanised cells, at 72 hpf. 
Samples are numbered 1-10, and relative expression levels are shown, calculated as 
1/Δ(1/Ct) (y = 1/Δ(1/Ct)), where Δ(1/Ct) = 1/Ct gene of interest – 1/Ct reference gene 
(gapdh). Samples were run in duplicates. The expression levels determined for each gene 
in each replicate are shown. 
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4.2.6.f Summarising relative expression level measured in five cell pools 
 
The data collected here are summarised to better understand the changes in expression 
levels at each timepoint through the cell population (Figure 4.33). Gene expression levels 
measured for each gene were averaged at each timepoint for the ten samples, the standard 
deviation (bars) is shown for each series in the graph. To interpret these data, it is crucial to 
keep in mind that measurements were undertaken in NC cells at 23 hpf and 30 hpf and in 
melanocytes after 36 hpf.  
  At 23 hpf we observed that trp1b seemed highly expressed but with a high level of 
variability. At 30 hpf trp1b expression had decreased in NC cells. sox10 expression 
decreased slightly from 23 hpf to 30 hpf. In contrast mitfa expression seemed to be slightly 
elevated. dct expression was relatively stable from 23 hpf to 30 hpf when averaging the 
data. To summarise these results, in NC cells we saw that trp1b expression seemed to be 
variable in the cell population (high and low levels), as was previously determined (section 
4.2.5.). We observed that sox10 expression seemed to be lowered in the cells. The boost of 
mitfa expression at 30 hpf compared to 23 hpf was not found in the study of mitfa 
expression in whole embryos. Therefore, whether this result could correspond to a fine 
boost of mitfa which was not detected in the whole embryo would have to be verified. dct 
expression seemed to be expressed at the same level, at 23 hpf and 30 hpf, which could 
suggest that dct was expressed in melanoblasts since 23 hpf.  
 As previously observed in whole embryo, sox10 expression was low in 
melanocytes, after 36 hpf and mitfa expression was decreased. As expected, trp1b and dct 
expression levels were increased in melanocytes compared to when investigating NC cells. 
Their expression level increase was also observed in whole embryo as well as their 
stabilisation for trp1b and a light decrease for dct. Therefore these results are consistent 
with the previous observation in whole embryos. 
Chapter 4. Characterisation of Genetic Heterogeneity in Melanocytes 




Figure 4.33: Graphs summarising mitfa, dct, tyrp1b and sox10 relative expression 
levels in 10 samples at five time points during melanoblasts/melanocyte development. 
 
These graphs show a decrease of sox10 expression over time but also a decrease of mitfa 
expression at 72 hpf. trp1b expression increase from 30 hpf and remained stable and high 
by 48 hpf. dct expression seemed to be increased at 36 hpf and stabilised by 72 hpf. Bars 
show the standard deviation. The green cells remind that at 23 hpf and 30 hpf cells 
analysed were sox10-GFP(+) cells, whereas, at 36 hpf, 48 hpf, 72 hpf, cells selected were 
melanocytes (black cells). The red line on the lower graph also reminds the change in cell 
population type. 
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4.2.7 Determining mitfa, tyrp1b, dct and sox10 mRNA copy number in 
five cell samples 
  
In previous experiments, the relative gene expression levels were determined in five cell 
pools. Here, the objective was to determine the absolute copy number of mitfa, sox10, dct 
and tyrp1b cDNA in ten different pools of five cells after RT-qPCR. As for relative 
quantification cells were analysed through specification and differentiation phases at 23 
hpf, 30 hpf, 36 hpf, 48 hpf, and 72 hpf.  
 The data collected here present an estimation of gene expression, at a certain 
timepoint, under the conditions of the experiments. The data obtained at 23 hpf and 30 hpf 
will have to be analysed in the context of the NC cell population. The data collected from 
melanocytes should reflect gene expression in a cell population gaining in stability and 
homogeneity as suggested by the analysis of its variability previously presented (fully 
homogeneous population was assessed at 72 hpf in the previous experiment).  
 Figure 4.34 shows the results for mitfa, dct, tyrp1b, sox10 and gapdh (for 
comparison) at 23 hpf, 30 hpf, 36 hpf, 48 hpf, and 72 hpf, respectively. At each timepoint, 
a graph for each gene is presented summarising expression level for each gene in each 
sample (each sample was run in triplicates). The stability of gapdh expression has been 
previously studied (section 2.2). From 23 hpf to 72 hpf, gapdh expression was comprised 
of between (mean copy number in samples ± s.d = 4500 ± 56 and 8100 ± 72 transcript 
copies in samples.  
Results shown in Figure 4.35 summarise this experiment and present the mean of 
transcript copy number found for each gene at each time point. In the sox10-GFP(+), sox10 
expression was always detected, as in relative quantification experiments. mitfa expression 
seemed to be slightly increased from 23 hpf to 30 hpf which could suggest, as in the 
relative quantification analysis, that a higher proportion of sox10-GFP cells could be 
melanoblasts at 30 hpf compared to 23 hpf. This result was not observed when looking at 
mitfa in whole embryos which could suggest that even if mitfa expression was more 
restricted to the melanocyte lineage by 30 hpf, a higher proportion of mitfa (+) cells 
colocalised with sox10-GFP cells at 30 hpf than at 23 hpf. This hypothesis will be further 
developed in the cross-validation section of this Chapter (section 4.2.9). In contrast with 
the results obtained with relative quantification expression, trp1b expression was low at 23 
hpf and slightly increased by 30 hpf. The variations in the level of trp1b expression from 
an experiment to another might be related to the fact that the expression of trp1b is variable 
at this stage in the NC cell population as suggested by our test of variability presented in 
section 4.2.5. dct expression, as in relative quantification analysis, seemed to be 
maintained at the same level of expression (maybe expressed in the same proportion of 
cells) at 23 hpf and 30 hpf.  
In melanocytes, mitfa expression was at its highest at 36 hpf and then decreased 
until at least 72 hpf. This result is consistent with the relative quantification analysis of 
mitfa expression. Further consistency with the relative quantification analysis, is the 
decrease of sox10 expression we observed here. At 36 hpf, tyrp1b and dct expression levels 
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were expressed at a high level compared to what observed in NC cells which is consistent 
with the fact that we are selectively analysing melanocytes. However, in contrast with the 
relative quantification experiment in pools of cells and in whole embryos, their expression 
kept increasing after 36 hpf and until 72 hpf. Whether the stabilisation of dct and trp1b 
expression was not observed here because of the lack of expression correction by a 
reference gene (reflect irrelevant changes in transcription) or whether this increase was 
crucial in the biology and the differentiation of melanocytes will have to be further 
explored. 
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Figure 4.34: Absolute quantification (copy number) of mitfa, sox10, dct and tyrp1b at 
23 hpf, 30 hpf, 36 hpf, 48 hpf, 72 hpf in ten samples (1-10) of 5 cells by qRT-PCR. See 
legend on page 212. 
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Figure 4.34: Absolute quantification (copy number) of mitfa, sox10, dct and tyrp1b at 
23 hpf, 30 hpf, 36 hpf, 48 hpf, 72 hpf in ten samples (1-10) of 5 cells by qRT-PCR. See 
legend on page 212.  
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Figure 4.34: Absolute quantification (copy number) of mitfa, sox10, dct and tyrp1b at 
23 hpf, 30 hpf, 36 hpf, 48 hpf, 72 hpf in ten samples (1-10) of 5 cells by qRT-PCR. See 
legend on page 212. 
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Figure 4.34: Absolute quantification (copy number) of mitfa, sox10, dct and tyrp1b at 
23 hpf, 30 hpf, 36 hpf, 48 hpf, 72 hpf in ten samples (1-10) of 5 cells by qRT-PCR. See 
legend on page 2012 
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Figure 4.34: Absolute quantification (copy number) of mitfa, sox10, dct and tyrp1b at 
23 hpf, 30 hpf, 36 hpf, 48 hpf, 72 hpf in ten samples (1-10) of 5 cells by qRT-PCR. See 
legend on the next page.  
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Figure 4.34: Absolute quantification (copy number) of mitfa, sox10, dct and tyrp1b at 
23 hpf, 30 hpf, 36 hpf, 48 hpf, 72 hpf in ten samples (1-10) of 5 cells by qRT-PCR. 






Figure 4.35: Average gene copy number for 10 samples of five cells at five time points. 
Graph showing mean of gene copy number determined by absolute quantification after RT-
qPCR in ten 5-cell pools at 23 hpf, 30 hpf (both sox10-GFP (+) cells as reminded by the 
green cells on x axis), 36 hpf , 48 hpf and 72 hpf (melanised cells as reminded by the black 
cells on x axis). The transition between the two different cell populations is shown by the 
dotted res line on the graph. The bars represent standard deviation for each mean. An 
increase in mitfa expression can be observed from 23 hpf to 36 hpf with a peak at 36 hpf. 
An increase in tyrp1b and dct copy number could also be observed. However, tyrp1b and 
dct expression kept increasing until at least 72 hpf while mitfa expression decreased from 
36 hpf and until at least 72 hpf. sox10 expression remained low until 36 hpf and decreased 
until 72 hpf at least . 
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4.2.8 Single cell analysis of melanocyte gene expression 
4.2.8 a Using single cell analysis to test for existence of a chromatoblast expressing 
mitfa at 23 hpf 
 
The hypothesis of the existence of a chromatoblast has already been suggested but was 
never tested in vivo (Bagnara et al., 1979, Lacosta et al., 2007, Minchin and Hughes, 2008, 
Lopes et al., 2008). Recent work proposed that, in an early phase (around 23 hpf), ltk 
expression might mark a chromatoblast-like cell-type (Lopes et al., 2008). Given the 
extensive expression of mitfa in the NC at this stage, we hypothesise that ltk and mitfa 
expression would overlap in a substantial proportion of cells which could be 
chromatoblasts (Curran et al., 2009). However, later, such as at 72 hpf, the genes would 
not be co-expressed since ltk would only be detected in differentiated iridophores and mitfa 
only in differentiated melanocytes. From as early as 36 hpf, expression of ltk and 
expression of melanocyte markers do not overlap (Nikaido et al., in preparation). In this 
experiment, the objective was to test this hypothesis in zebrafish at 23 hpf. 
 To test the co-expression of mitfa and ltk in NC cells at early stages, the expression 
of ltk and mitfa was investigated by nested RT- PCR technique at 23 hpf in 40 individual 
GFP+ NC cells from sox10:GFP(+). To investigate the likelihood of false positive 
detection at 23 hpf, the experiment was repeated at 72 hpf when mitfa was restricted to the 
melanocyte lineage and ltk to the iridophore lineage.  
 Single cell reverse transcription and PCR were processed according to the protocol 
described in Bengtsson et al., (2008). Nested PCR consisted of two rounds of 
amplification. This method allowed the amplification of expression from single cell cDNA. 
sox10-GFP (+) cells were selected at 23 hpf, and melanised cells were selected at 72 hpf. 
We attempted to use β-actin as a positive control for detection at both timepoints. 
Unfortunately, β-actin expression could only be detected in 80 % of samples. This could be 
due to variations of β-actin expression in some samples or to failure of detection. As 
shown in subsequent experiments, β-actin expression was variable in melanocyte 
populations which probably explains these results. In retrospect, a more appropriate control 
gene, such as gapdh, would have been a better choice, as demonstrated in section 4.2.2. 
However, at 72 hpf, mitfa, which is exclusively expressed in melanocyte at this stage, 
could replace β-actin as a positive control for detection. In contrast, as ltk would not be 
expressed in differentiated melanocytes, it could be used as a control for false positive. 
 Figure 4.37 shows the results at 72 hpf.  Although β-actin expression was detected 
in 35/40 (88 %) of cells analysed at this stage, in practice essentially all isolated 
melanocytes (39/40; 98 %) could be shown to express mitfa, whereas, only 2.5 % (1/40) 
showed a band corresponding to the iridophore marker ltk. This false positive band could 
correspond to random weak activation of ltk, or to an error in the selection of the cell 
which could be an iridophore (actin(+)/mitfa(-)ltk(+)) as under incident light iridophores 
can be difficult to distinguish from melanocytes. Several faint bands were also observed in 
the ltk agarose gel. The presence of these light bands was not investigated as they were not 
the expected size for the amplified fragment. Taken together, these results showed that ltk 
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was not significantly expressed in mitfa (+) melanised melanocytes at 72 hpf and that gene 
expression detection by single cell RT-nested PCR protocol could be used to investigate 
expression of ltk and mitfa at 23 hpf. Interestingly, this result also shows that mitfa remains 
expressed in most melanocytes by 72 hpf, even if its expression level is low and difficult to 
detect by other methods. This result will be later discussed in the context of the cross-
validation of results (section 4.2.9). 
Figure 4.38 presents the RT- nested -PCR on forty single cells investigating ltk, 
mitfa and β-actin at 23 hpf. The housekeeping gene, β-actin, was detected in 73 % (31/40 
cells) of cells analysed. This result suggested that β-actin was not expressed 
homogeneously in these cells and/or that its detection was not reliable. This experiment 
would have to be repeated using another control gene such as gapdh. Furthermore, wells 6, 
7, 10, 11, 13, 15, 19, 30, showed a higher band which corresponded to the genomic DNA 
β-actin (confirmed by band size and by direct sequencing, data not shown). At 23 hpf, 90 
% (36/40 cells) of the sox10-GFP(+) cells expressed mitfa and half (20/40 cells) of the 
sox10-GFP(+) cells expressed the iridoblast marker, ltk. Furthermore, 100 % of cells 
expressing ltk, expressed mitfa, and additionally, 64.5 % (20/31 cells) of mitfa expressing 
cells expressed lkt.  
These results showed that mitfa was broadly expressed in sox10-GFP(+) cell 
population at 23 hpf and that more than half of these mitfa expressing cells also expressed 
ltk. The results also suggest that two different populations of mitfa (+) cells could co-exist 
at 23 hpf, a sox10(+)/mitfa(+)/ltk(+) population and a sox10(+)/mitfa(+)/ltk(-) population 
which is  consistent with descriptions in the literature (Lopes et al., 2008). 
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Figure 4.37: Single cell nested RT-PCR for β-actin, mitfa and ltk mRNA in 40 
melanised cells at 72 hpf.  
Each well (1-40) corresponds to a single cell tested. Two negative controls were run, the 
negative control without cDNA template (0) and the negative control corresponding to a 
non-melanised cell (x). Two positive controls are shown, the positive control with total 23 
hpf embryo cDNA (one round amplification) (c), and the nested PCR positive control (two 
rounds amplification) (cc). The 100 bp DNA marker (Promega) is shown in (M). 
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Figure 4.38: Single cell nested RT-PCR for β-actin, mitfa and ltk mRNA in 40 
sox10:GFP positive cells from 23 hpf. 
Each well (1-40) corresponds to a single cell tested. Two negative controls were run, the 
negative control without cDNA template (0), and the negative control corresponding to a 
non-melanised cell (x). Two positive controls are shown, the positive control with total 23 
hpf embryo cDNA (one round amplification) (c), and the nested PCR positive control (two 
rounds amplification) (cc). The 100 bp DNA marker (Promega) is shown in (M). 
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4.2.8 b Developing single cell qRT-PCR 
 
In the previous experiment, gene expression was assessed in single cells using the method 
of RT-nested-PCR. The previous experiment did not allow us to investigate the difference 
in gene expression level for mitfa in the mitfa+/ltk+ cells and in the mitfa+/ltk- cells at 23 
hpf. In this experiment, the objective was to go further in the quantification of gene 
expression by attempting to use the RT-qPCR technique at the single cell level.  
 The method of RT was used in combination with qPCR analysis (Bengtsson et al., 
2008). As a first control for acceptable amplification of the signal, it was key to observe 
the exponential linear amplification phase. Secondly, it was important to verify that the 
melting curve showed a peak at a temperature specific to the targeted sequence. In order to 
optimise the detection of gene expression, the final cDNA volume obtained after RT was 
reduced and the totality of this volume was used to test for expression of only one gene, in 
duplicate (instead of five genes as in the qRT-PCR of whole embryos). Consequently, the 
concentration of cDNA was maximised and used to run the qPCR with an increased 
probability of detecting low concentration of the target cDNA sequences.  
 As a test case, the absolute expression levels of a highly expressed gene, dct, was 
tested at 48 hpf in ten melanocytes. The results showed that the exponential linear 
amplification was observed in only three samples (cells 2, 7 and 10 see Appendix 2). This 
result suggested that gene amplification occurred correctly in only three samples. 
Exponential amplification, as well as melting curve analysis, both confirmed that only 
these three samples revealed amplification of the targeted dct sequence. The level of 
expression was measured in an absolute way using the absolute standard curve and copy 
numbers were determined for these samples (see Appendix 2). This method requires 
further optimisation to be used in the future.   
4.2.8.c Gene expression estimation in single cells 
 
In previous experiments, gene expression levels were determined in pools of five cells. In 
this section, the objective was to use these data to determine gene expression level in single 
cells. For this, we used the data previously collected by Yang and Johnson (2006) which 
describes the number of dct (+) cells at each timepoint in zebrafish (dct (+) cells at 36 hpf: 
190 ± 10, at 48 hpf: 250 ± 13, at 72 hpf: 300 ± 15). This data, in combination with our data 
in melanoblasts/melanocytes, could be used to estimate the number of transcripts for each 
gene in single cells. This estimation could then be used to evaluate the mean expression 
levels for mitfa, tyrp1b, and dct in single cells from the relative and absolute quantification 
experiments. Curran et al., (2009) showed that around 26 hpf, 50 % of the mitfa (+) cells 
express dct however, because it remains unclear what type of cells express mitfa at early 
stages and whether the proportion of dct (+) could increase within the mitfa (+) cells, this 
analysis was only valuable at later stages, after 36 hpf in melanocytes.  
 Table 4.4 shows estimations of transcript copy number in single cells from the 
absolute quantification experiment, and Table 4.5 presents relative estimation of 
expression level in single cells from the total embryo relative quantification experiment. 
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The disparities observed within these two tables could be related to the differences of 
analysis between absolute and relative quantification and the differences in measuring 
expression in pools of cells or in whole embryos. Further investigation is required to 
establish whether these results are contradictory or not. A value of 100 copies of mRNA in 
a cell is often considered to be the threshold underneath which stochatsic and probabilistic 
effects may become important. Our data suggest that from 48 hpf, stochastic effects be 
could part of mitfa activation as we found that less than 100 mRNA copies were probably 
present in single cells. This result suggests that it could be interesting to investigate the 
stochastic aspect of mitfa transcriptional activition in melanocytes at late stages. sox10 
expression was also found to be very low, less than 10 copies in single cells after 48 hpf. 
However, whether this decrease reflects a loss of expression or whether sox10 expression 
is maintained at a very low level by a probabilistic effect is also unknown. 
 
Chapter 4. Characterisation of Genetic Heterogeneity in Melanocytes 
   213 
 
Table 4.4: Estimation of transcript number for each gene, at each timepoint in single 
melancoytes. 
This estimation was calculated using data collected in absolute quantification experiments. 
The mean of values (mean ± s.d) in the 10 samples of five cells was used to calculate the 
mean copy number in single cells, at each timepoint. 
 
 
mitfa sox10 dct tyrp1b 
36 hpf 452 ± 117 21 ± 15 137.6 ± 120 314.6 ± 114 
48 hpf   72.6 ± 27 4 ± 1.6 117 ± 76 482.4 ± 131 




Table 4.5: Estimation of relative quantification (calibrated to gapdh expression) in 
single melanocytes.  
This estimation was calculated using dct (+) cells number at each time point, found in 
Yang and Johnson, (2006), and relative expression for each gene in whole embryo.  
  
 
mitfa dct tyrp1b 
36 hpf 0.09615 2.07692 1.23077 
48 hpf 0.18182 1.27273 1.09091 
72 hpf 0.01667 0.76667 1.01667 
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4.2.9 Combined analysis of expression results  
 
In the previous sections, quantitative and qualitative data were collected. Expressions of 
melanocytic genes were studied in whole embryos (section 4.2.3) and in small pools of 
cells (section 4.2.6 and section 4.2.7). We used both the relative quantification (section 
4.2.6) and absolute quantification (section 4.2.7) methods to analyse expression levels in 
pools of cells. The variability of gene expression was determined in these pools (section 
4.2.5), and additionally, we tested whether technical difficulties of detection could have 
been responsible for the variations observed at low levels and found that it was not the case 
(4.2.2). Furthermore, we investigated gene expression in individual cells at 23 hpf in 
sox10-GFP cells and at 72 hpf in melanocytes (section 4.2.8). The data collected in the 
sox10-GFP (+) cells and in the melanocyte populations have to be analysed in two different 
contexts. First, they were analysed in the context of a precursor mixture cell population, 
and second, in the context of a specific cell population differentiating. The cross-analysis 
of this study is complex because different techniques were used, such as nested RT-qPCR, 
whole embryo RT-qPCR and five cell pools RT-qPCR, but also because two reference cell 
populations and different scales of analysis were studied (the whole embryos, small pools 
of cells, the sox10-GFP cells or the melanocytes).  
  At 23 hpf, it has been suggested that NC- sox10-GFP cells could consist of 
different unknown types of precursors (chromatoblasts, glioblasts, neuroglioblasts). The 
study of melanocytic gene expression variability (section 4.2.5) suggested that dct, trp1b, 
and mitfa were highly variable in this cell population at this stage. The high standard 
deviation observed when analysing trp1b expression in small pools of cells with the 
relative quantification method could be related to the variability at this stage (section 
4.2.6). Combined with the results obtained by RT-nested-PCR in individual cells (showing 
that 65 % of the cells expressing mitfa also expressed the iridoblast marker, ltk, at this 
stage) these data support the hypothesis of the existence of various precursors at 23 hpf. 
One in particular could be a chromatoblast, as shown here (65 %: sox10(+)/mitfa(+)/ltk(+)) 
and trp1b would be expressed in a subset of cells that are already beginning melanocyte 
differentiation. 
 Throughout the development of NC, precursors enter specification and 
commitment. Consequently, the population present at 30 hpf in the sox10-GFP cell 
population was more likely to contain a mixture of precursors at different stage of 
differentation compared to 23 hpf. These precursors might include melanoblasts, glioblasts 
or neuroblasts. By 30 hpf, in the sox10-GFP cell population, dct and trp1b remained 
variable (section 4.2.5), whereas, the variability of mitfa was decreased compared to the 
one at 23 hpf. Knowing that in whole embryo analysis, mitfa expression was decreased at 
30 hpf compared to 23 hpf, and conversely, it was increased in small pools of cells, it 
seemed that comparing whole embryos (4.2.3) to small pools of cells showed apparently 
contradictory results. However, this apparent contradiction can be explained by taking into 
consideration the difference between investigating gene expression in a growing whole 
embryo (increased number of cells in total) and in a specific cell population (becoming 
more restricted) (Figure 4.39). The sox10-GFP cell population becomes more restricted 
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from 23 hpf to 30 hpf (expressed in less cell types at 30 hpf than at 23 hpf), in contrast, in 
the same time period the whole embryo increases in cell number. Therefore, considering 
that the number of melanoblasts present at 23 hpf could be close to the number of 
melanoblasts present at 30 hpf and that the rest of the mitfa (+) precursors present at 23 hpf 
will switch off mitfa expression, we find that mitfa expression appears decreased when 
testing it in whole embryos. In contrast, it seemed increased when measuring it in the 
specific sox10-GFP cell population (Figure 4.39). Consequently, these results were not 
contradictory, but rather, the context in which we were testing gene expression was 
different.  
 Melanocyte differentiation is a continuing process from 36 hpf to 72 hpf. The 
experiment investigating genetic variability suggested that the melanocyte population was 
only genetically homogeneous by 72 hpf. The fact that in all experiments, dct and trp1b 
expressions were higher at each of the three timepoints measured during cell differentiation 
(36 hpf, 48 hpf and 72 hpf), compared to 23 hpf and 30 hpf, is coherent with the fact that 
melanocytes were selectively chosen at later stages and indicates increasing expression per 
cell. However, in all experiments we observed that mitfa expression remained quite low, 
and specially decreased at 72 hpf. This could suggest that mitfa is expressed at low level in 
fully differentiated cells. Therefore, this data suggest that mitfa, consistent with its role as a 
transcription factor, is never highly expressed in cells. However, the results of single cell 
RT-nested-PCR showed that all melanocytes expressed mitfa at 72 hpf, suggesting that 
mitfa did not disappear in cells, consistent with evidence for the ongoing role of Mitfa 
(Johnson et al., 2010).  
 sox10 expression had been suggested to be lost in melanocytes. All experiments 
described here suggest the decrease of sox10 expression which confirmed the data found in 
the previous study in Greenhill et al., (2011), although as is perhaps to be expected, using 
the more sensitive technique of qRT-PCR sox10 expression remains detectable, albeit at 
very low levels.  
 Expression levels of dct and trp1b in melanocytes were mostly consistent through 
the study. However, the whole embryo analysis as well as the relative quantification 
experiment in small pools of cells showed that dct and trp1b are perhaps reaching a plateau 
by 72 hpf (and a slight decrease was observed in small pools of cells) whereas, in absolute 
quantification analysis, dct and trp1b expressions seemed to always increase until 72 hpf. 
It remains to be tested whether the expression level reached for dct and trp1b at 72 hpf in 
absolute quantification experiment is due to parameters which were irrelevant to the 
melanocyte biology during cell differentiation, such as cell growth in embryo, and which 
were not corrected by this technique.  
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Figure 4.39: Observing mitfa expression in whole embryo shows a decrease while it 
seems to be increased when measuring expression in sox10 (+) cells. 
mitfa is expressed in an unknown but large proportion of NC cells at 23 hpf (on both top 
and bottom left panels, mitfa expression is represented by the blue line) whereas it is 
restricted to melanoblasts at 30 hpf (hypothesis of a slight decrease of mitfa expression 
from 23 hpf to 30 hpf as melanoblasts division also occurs). The number of NC cells 
(sox10 (+) cells at 23 hpf and 30 hpf, black line on the bottom left panel) decreases (most 
precursors differentiate, sox10 expression is maintained in melanoblasts and glioblasts only 
and expression levels drop in some early differentiating cells) whereas the number of cells 
in the whole embryo increases as the embryo grows (black line, top left panel, number of 
cells increases through time). Consequently, when measuring the proportion of mitfa 
expression level in the whole embryo (red line, top right panel), we observe a decrease of 
mitfa expression. When looking at gene expression in the sox10 (+) cell population, we 
observe a slight increase of expression (red line, bottom right panel). Thus the apparent 
disparities observed in the result of our experiment (23 hpf to 30 hpf) are in fact related to 
the reference point of the experiments which vary from an experiment to another (see text).  
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The results presented in this Chapter consist of a preliminary study for developing a new 
approach to the melanocyte GRN. It has been well described that cell-to-cell variations and 
gene expression level variations in apparently isogenic populations, were essential 
parameters to evaluate for understanding cell specification from a multipotent pool 
(Elowitz et al., 2002, Peccoud and Jacob, 1996, Quaranta and Garbett, 2010, Fournier et 
al., 2007, Raser and O'Shea, 2005, Janes et al., 2010). We showed it is possible to design a 
method to investigate gene expression in five cells and to use it to investigate gene 
expression level and gene expression heterogeneity. We used this method to measure the 
genetic variability of melanocytic genes in the NC cell population and in the melanocyte 
lineage. These results are intended to contribute to both developing refined techniques for 
quantification of melanocyte gene expression in vivo and better understanding of the 
heterogeneity of expression of melanocytic genes.  
4.3.1 The advantages of the stochastic profiling method 
 
In these experiments, we used the stochastic profiling method. In contrast with measuring 
gene expression in a single sample from the whole embryo, investigating gene expression 
in small pools of cells allowed us to observe biological variation in gene expression within 
the cell population (ten random samples containing five melancoytes randomly selected). 
The stochastic profiling method, combined with statistical analyses of the gene expression 
variances allowed us to analyse the heterogeneity of melanocytic genes through time. 
Previous experiments such as the ones presented in Greenhill et al., (2011) investigated 
gene expression at different timepoints. The study presented here took this investigation 
further by assessing the characteristics of gene expression variations within the cell 
population at certain times and through time.  
Altogether, the results showed that: 
 Around 23 hpf, melanocytic genes were heterogeneously expressed in NC 
cells suggesting the existence of a population of precursors.  
 One such precursor at this stage co-expresses mitfa and ltk, as well as 
sox10, and is likely to be a chromatoblast.  
 tyrp1b and dct expression levels stabilise relatively late in melanocyte 
differentiation. 
 mitfa expression decreases as melanocytes differentiate, but remains 
detectable.  
 The decrease of sox10 expression observed in whole embryos in 
Greenhill et al., (2011), was confirmed quantitatively. 
In Janes et al., (2005), as in Quaranta et al., (2008), the stochastic profiling method, 
associated with the Monte Carlo simulation in MATLAB software, was used to model their 
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data to understand cell heterogeneity. However, other methods could be used to investigate 
gene expression heterogeneity in cells. Tang et al, (2006) used microarray analysis to 
understand the variability of gene expression in cell populations. Hernandez et al., (2012) 
investigated, via microarray analysis, the heterogeneity of expression of factors increasing 
invasiveness in ductal carcinomas and in breast cancer cells. Other studies used the 
correlation of gene expression to show the heterogeneity of gene expression in cells and to 
observe cell variability. For instance, Schulz et al., (2007) studied the variability of the 
channel proteins expressed in neuronal cells by testing pairwise expression correlation of 
channel protein genes using the Pearson correlation. They showed a qualitative and a 
quantitative specificity of channel genes expressed in each cell as well as a high variability 
of gene expression levels in the neuronal cell population.  
4.3.2 Measuring gene expression in small pools of cells 
 
Thanks to the protocol of cDNA production adapted to low material amounts (published by 
Bengtsson et al., (2008)) and to a rigorous qPCR standardisation process, we have here 
developed a technique to measure gene expression in pools of five cells freshly ex vivo. For 
the first time we could investigate the levels of melanocytic gene expression in pools of 
five cells. This technique is now available for further investigations, such as, quantifying 
the heterogeneity of dct and trp1b in the mitfa-GFP cell population around 23 hpf to 
determine whether mitfa only marked melanoblasts at this stage. Furthermore, it could be 
used to examine the existence of precursors such as chromatoblasts by investigating the co-
expression of key genes such as id2, ltk (iridoblasts markers) mitfa, dct (melanoblast 
markers), and pax7 (xanthoblasts marker) in sox10-GFP(+) cells.  
 One limitation of this technique was that mRNA transcription was considered but 
protein translation was not. This is a substantial limitation, since not all mRNA molecules 
might be translated to protein and the translation process is also susceptible to bursting, 
meaning that many proteins are produced from one mRNA copy, before translation is 
silenced (McAdams and Arkin, 1997, Li and Xie, 2011). Consequently, mRNA expression 
is likely to not reflect protein levels perfectly. Furthermore, transcript stability might be 
fluctuating which could result in translation kinetics bias. Besides, transcripts have 
different “life times” in cytoplasm, allowing the translation for variable time periods. In 
contrast with bacterial systems, in mammalian and zebrafish, mRNA and protein lifetimes 
are comparable (Golding et al., 2005, Li and Xie, 2011). However, measuring protein 
levels would not be feasible at this stage because antibodies were not available in 
zebrafish. Hence, despite its limitations, mRNA quantification was a feasible approach to 
begin to understand cel-to-cell variability in the NC. 
 In future, these preliminary data could be used to investigate gene expression 
correlation by testing some of the known features of the GRN described in the modelling. 
For instance, whether the variations of mitfa expression could explain the variations of dct 
and trp1b could be tested.  
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4.3.3 Understanding the decrease of mitfa expression in melanocytes 
 
The single cell analysis at 72 hpf suggested that mitfa expression remained detectable at 72 
hpf in melanocytes. However, the decrease of mitfa expression was measured in all 
experiments presented. Consequently, it could be suggested that the transcription factor, 
mitfa, is expressed at low levels in differentiated melanocytes. This could simply reflect 
the change from a differentiating state, where transcription of melanocyte-specific products 
is highly active, to a maintenance state where homeostasis is the main demand. 
Alternatively, this result might suggest a different role for mitfa during late melanocyte 
differentiation. In one case, mitfa could remain the main gene responsible for maintenance 
of melanocytes; perhaps the mechanism involving Factor Y (described in the Chapter 3) is 
set to allow maintenance of mitfa expression but only at a decreased level.  
 Alternatively, the decrease of mitfa expression could suggest that mitfa was no 
longer directly the gene responsible for maintenance of the differentiated melanocyte 
phenotype and might suggest the existence of a new factor in the network. Such an idea 
was  first described in Model A (Figure 4.40): a factor called Factor X could be activated 
to relay mitfa’s role in melanocyte differentiation (Greenhill et al., 2011). This factor 
would ensure melanocyte development after the decrease of mitfa. Factor X would then be 
described as a mitfa-dependent factor, induced in melanocytes around 36 hpf in zebrafish 
and which would have the property to maintain melanocyte differentiation. Factor X could 
activate dct expression as well as other melanocytic genes such as tyrosinase. If Factor X 
exists, once turned on, it would replace mitfa and its expression would be maintained either 
via another activation loop either by low levels of mitfa. This hypothesis suggests that after 
a certain timepoint, maintaining Factor X would be sufficient to maintain melanocyte 
development, in the absence of mitfa.  
 It would be interesting to test the hypothesis of the existence of Factor X, however, 
no candidate factors are known yet and there is no other evidence for its existence other 
than the observation of mitfa expression decrease in embryos and cell pools after 48 hpf. 
Factor X would be a transcription factor carrying at least an M-box in its regulatory 
sequence. If it exists, whether Factor X could be activated early in melanoblasts or only 
during cell differentiation cannot be determined from the hypothesis here. Interestingly, in 
mitfa
w2 
mutants, melanocyte maintenance fails if mitfa is inactivated in late differentiation 
even after 72 hpf, suggesting that Mitfa itself continues to be required, and rather negating 
the value of the hypothetical factor X (Johnson et al., 2010). Postulating the existence of 
Factor X, would not rescue the original model A from Greenhill et al., (2011). A new 
version of the model, even taking into account this unexpected decrease of mitfa 
expression, would still require the presence of a factor to maintain mitfa expression at a 
later stage, during differentiation. In the future, improving characterisation of mitfa and 
sox10 expression dynamics would allow better evaluation of the network.  
 Combining two approaches could allow testing for the existence of Factor X by: 1) 
running a genome sequence analysis looking at genes responsive to Mitfa and carrying M-
boxes in their promoter would allow the creation of an initial candidate gene list. 2) ChIP 
experiments could permit the identification of transcription factor genes activated by Mitfa 
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during melanocyte differentiation. A list of candidate transcription factors combining 
results found by these analyses could then be tested in several ways. A microarray 
screening study based on MITF targets described by Hoek et al., (2008) could also be 
referred to. To reduce candidate factors, it could be interesting to investigate dct or 
tyrosinase promoters for specific binding sites. As a last step, in vivo tests could then be 
run by designing probes for WISH to test if a candidate gene could be expressed during 
melanocyte differentiation, as around 36 hpf in partly PTU treated embryos. Finally, a 
functional test activating or repressing the gene candidate’s expression could show the 
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Figure 4.40: Model A described Factor X as an important factor for melanocyte 
differentiation downstream Mitfa 
The model A shows that after activation of mitfa, by Sox10 (which was first activated by 
factor called A), Mitfa can both repress sox10 expression and activated Factor X (A). In 
the model, Sox10 could also downregulated Factor X before activation of mitfa (A). The 
prediction for the timecourses of expression of sox10, Factor A, mitfa and Factor X, when 
this model was envisaged, are presented in (B). The model suggested then that a Factor X 
would be highly expressed compared to mitfa (B). A new model including Factor should 
now also include other tested parameters as the decrease of sox10 and mitfa expressions. 





4.3.3 Better definition of the precursor population at early stages 
 
In our experiments the NC pool was studied at 23 hpf and 30 hpf. In this cell population, 
several precursors were present. Single RT-nested PCR experiments showed that about 65 
% of sox10-GFP(+)/mitfa(+) cell were also ltk (+) at 23 hpf. The result showed that mitfa 
expressing cells were heterogeneous at this stage. Whether ltk and mitfa were 100 % co-
expressed earlier than 23 hpf in NC cells remains to be tested. Furthermore, whether the 
variability of mitfa expression observed at 23 hpf could reflect a functional difference 
between two cells with low or high levels of mitfa remains to be addressed. Then high 
mitfa could mark a certain type of precursor (melanoblasts for instance) while low mitfa 
could mark another kind of precursor (melanoglioblast for instance). Alternatively, it could 
also be suggested that this phase of variability was inevitably following mitfa first 
activation. Whether some sox10 (+) cells were mitfa (-) was not tested here.  
At 30 hpf, cells selected were sox10-GFP positive cells which would be expected to 
include glial precursors (Dutton et al., 2001). This could suggest that mitfa was also turned 
on in these cells at this stage before being inhibited by a sox10 dependent repressor such as 
the forkhead box D3 (foxd3) (Carney et al., 2006, Dutton et al., 2001). foxd3 is activated 
by sox10 in glioblast/melanoblast and it has been described as a repressor of mitfa and of 
melanocyte fate (Ignatius et al., 2008). Mechanisms involved in foxd3 dependent inhibition 
of mitfa remain unclear. In these experiments, no glioblast markers other than sox10 were 
tested. It would be interesting to determine and to compare the heterogeneity of foxd3 
expression in cells to that of mitfa at 30 hpf in the sox10-GFP(+) cell population. Also, it 
would be interesting to know whether foxd3 and mitfa are co-expressed at this timepoint in 
sox10-GFP (+) cells and to determine whether changes in these expression levels could be 
correlated with fate acquisition.  
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More experiments could be performed to test the hypothesis of the existence of a 
chromatoblast, in zebrafish, by investigating expression of several markers in early 
sox10(+) (glioblast marker, as described in Carney et al., (2006)), and in mitfa (+) cells 
(Lister et al., 1999)). Investigating expression of pax7 to test for xanthoblast marker, and 
ltk to test for an iridoblast marker could show the existence of a precursor at early stages 
(15 hpf to 30 hpf) (Lopes et al., 2008, Lacosta et al., 2007, Minchin and Hughes, 2008). 
Lastly, the analysis of cell tracing using mitfa-GFP transgenic fish could be interesting in 
order to track cells from 23 hpf to 36 hpf when a potential precursor could be described.  
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4.3.4 Further testing of gene expression correlations in the GRN  
 
Further statistical analysis and experiments in vivo would have to be carried out to better 
understand the results presented here. For instance, we could observe that expression level 
of mitfa, dct and trp1b could be varying similarly in some samples (section 4.2.7, Figure 
4.34, for instance at 23 hpf, samples 2-3-4). Analysis of correlation could help determine 
whether these data could reflect the proximity of regulatory relationship in the GRN. 
Furthermore, testing direct activation and repression of these genes using ChIP 
experiments looking for binding of mitfa and sox10 on dct, trp1b, sox10 and mitfa, at each 
timepoint would be fundamental. Furthermore, testing the role of epigenetic markers, such 
as, acetylation, methylation and chromatin state, for each gene in individual cells at each 
timepoint, could also allow to better understanding of variations in gene expression. These 
results, combined with accurate measurements of gene expression in cells at each 
timepoint, could permit further understanding of the GRN dynamics and mechanisms.  
4.3.5 Further evaluation of noise and gene expression stochasticity 
involved in melanocyte development 
 
Systems biology and computational approaches are used to capture biological variations in 
complex biological systems to achieve more realistic representations of the system. Many 
studies have statistically analysed and modelled gene expression in cellular systems, but 
using different methods (Guo et al., 2003, Fournier et al., 2007, Elowitz et al., 2002, 
Nygaard et al., 2005, Mao and Resat, 2004, M.Sriram Iyengar, 2011, Hubbell et al., 2002). 
Gene expression fluctuations can be explained by many biological phenomena such as 
stochasticity of gene transcription, deterministic gene expression and biological noise 
(Paulsson, 2004, Elowitz et al., 2002, Raser and O'Shea, 2004). Stochasticity allows the 
activation, the repression and the plasticity of gene expression whereas the deterministic 
approach does not. Recently, there has been an increasing evidence to support stochastic 
(probabilistic) mechanisms of gene regulation. In a review, Li and Xie, (2011) showed the 
crucial role of stochasticity in gene expression and activation. It would be important to 
better define the part of stochasticity in melanocyte gene expression (Li and Xie, 2011). 
This aspect of melanocyte development is poorly documented and it could be important to 
investigate to help understand the instability of other systems such as melanoma (Goding, 
2000, Uong and Zon, 2009, Mao and Resat, 2004). Our data suggest that around 48 hpf 
and later, stochastic effects could play an important role in activation or maintenance of 
low mitfa expression levels. 
In the future, three key parameters would have to be investigated to better define 
the stochasticity of the system; the rates of transcription; chromatin state for target genes; 
and the distance between promoters. Then, it would be possible to determine whether 
stochasticity could have been responsible for genetic variability in the multipotent cell 
pool. Several regulatory events could be involved in causing gene expression variability in 
melanoblasts. The transition from a precursor state to a differentiated melanocyte steady 
state involved important changes in the GRN which could cause variability in cells. 
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Testing the fine tuning of mitfa and sox10 in cells and assessing the role of background 
noise in melanocyte precursors will be crucial in the future.   
4.3.6 Absolute quantification and the limitation of measurements 
 
Absolute quantification consists of measuring the absolute gene expression concentration 
in each sample without normalising it. Optimisation of the method is of importance to 
minimise experimental variations such as tube variability due to experimental set up, as 
well as background amplification noise. In our experiments, relative quantification of gene 
expression was assessed using both the ΔΔCt method with the associated statistics and by 
the REST 2009 software developed by Pfaffl et al., (2002). Absolute quantification was 
determined as transcript copy numbers in five cell pools. According to the manufacturer 
and to studies, gene detection with SYBR Green I is sensitive enough to detect gene 
expression down to 10 copies (Colborn et al., 2008, Steuerwald et al., 1999, Budhia et al., 
2006). However, when gene expression was lower than 10 copies per sample, it was 
considered to be too low to be confidently assessed.  
 Thanks to several quantitative techniques, many studies have investigated gene 
copy number in cells (Kelso et al., 1999, Diercks et al., 2009). mRNA represent 2 % of 
total RNA in a cell corresponding to 0.5 to 1 pg of material (Brady, 2000). According to 
Taniguchi et al., (2009), this would correspond to about 106 transcripts per cell. In another 
study, Nygaard et al., (2005) measured absolute gene expression in samples of carcinoma 
Hela cells and reported that 8116 genes per cell were expressed in a range from 0.3 to 
40,000 per cell with over 90 % of these genes being represented in low copy number, from 
1 to 15 copies (Nygaard et al., 2005, Brady, 2000). These experiments showed that only 
about 20 genes were expressed at high to very high levels in single cells, meaning up to 
40,000 copies per cell. These observations are interesting as they give a sense of 
transcriptional activity in a cell. However, it seemed that gene copy numbers could vary a 
lot depending on different cell types, genes and cell developmental stage and state. The 
data we collected in this experiment (section 4.2.7) fitted the ranges presented here, with 
low expression for those encoding transcription factors and higher expression level for 
enzymes. However, it will be key to further study the biological significance of this 
absolute numbers to define their relevance. In our study, the lack of resolution under 10 
copies per sample was a limitation to measure very low copy numbers. To overcome this 
limitation, single cell mRNA analysis could be performed using mRNA sequencing 
analysis with has a better resolution. 
 Peccoud et al., (1996) used “monte carlo” simulation to estimate confidence 
intervals for detecting targets by including the initial number of molecules present to 
detect. They showed that relative uncertainty of detection ranged from 10 % to 25 % when 
initial copy number was 100. This correlation (measured by the slope in calibration 
experiments) has been shown to be lost depending on the ratio between the level of gene 
expression in the sample and the sample size (Nygaard et al., 2005). Nygaard et al., (2005) 
applied an ANOVA approach to examine the effects of variation with reduced amount of 
total RNA in first round of amplified RNA production. Nygaard et al., (2005) showed that 
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a critical level of expression was observed where stochastic fluctuations became significant 
and prevented reliable measurements. They also showed that this level was sample size 
dependent meaning that there was a correlation between the threshold and sample size. In 
Karanth et al., (2009) data were analysed using the Pfaffl method. Karanth et al., (2009) 
could determine the relative steady-state of fatty-acid binding protein (fabp) gene, in 
zebrafish, depending on different diets. For this, Karanth et al., (2009) first calculated gene 
copy number according to Bustin et al., (2005) and used copy number ratio of fabp and 
reference gene to determine steady-sates. In another study, Wacker et al., (2008) used the 
ΔCt method associated with a student t-test to analyse single cells, muscle fibers gene 
expression. The variety of methods used for establishing a qPCR technique and analyzing 
the qPCR is related to the variety of models study. It is essential to chose and apply the 
appropriate method with strong statistical analysis for each specific experiments as we did 
in this Chapter for each different measurements.  
4.3.7 Investigating gene expression in single cells 
 
In this chapter single-cell expression could be assessed by RT-nested PCR but not by RT-
qPCR. The technique of single cell RT-nested PCR has been used in several studies 
(Phillips and Lipski, 2000, Dixon et al., 2000, Kelso et al., 1999). Phillips and Lipski, 
(2000) showed the robustness of the technique using multiplex amplification in a first 
round and specific amplification in a second round, to study heterogeneity of cells of the 
autonomic regions of the nervous system. Several protocols described the methods to 
process to small material amount RNA extraction and reverse transcription avoiding 
contamination, loss and RNAse degradation in samples (Kurimoto et al., 2006, Hartshorn 
et al., 2005, Bengtsson et al., 2008). Hartshorn et al., (2005) described a method to detect 
gene expression in big single cells such as blastomeres. For this study, the protocol 
described in Bengston et al., (2008) was used as it was best suited protocol for this 
experiment. This protocol allowed us to extract RNA from single cells and convert RNA to 
cDNA for amplifying gene expression by PCR, qPCR or nested PCR. 
 The nested qPCR results allowed us to better characterise mitfa (+) cells at 23 hpf. 
However, the reference gene used, β-actin, could not be detected in all samples suggesting 
that the experiment should be repeated using gapdh as a reference gene. It has been shown 
to be expressed in homogeneous manner in the melanocyte population (Pei et al., 2007). 
mRNA amplification has become a widely used approach (Kelso et al., 1999, Taniguchi et 
al., 2009, Phillips and Lipski, 2000). We tested the single cell RT-qPCR in ex-vivo in 
zebrafish melanocytes. The technique did not work due to lack of detection with the set up 
and with the kit used. Optimisation using a more appropriate set up and machine could 
allow detection of gene expression in single cells. As previously explained, an important 
concern in qPCR experiments is the reliability of results obtained in reflecting 
concentration or level of expression of starting material (Cookson et al., 2005, Colborn et 
al., 2008). This problem is amplified when working with very low quantities of input 
RNA, where stochastic effects and background amplification due to template dilution may 
also have created bias in gene expression detection. However, in the future, it would be 
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interesting to develop a single cell assay with accurate quantification of expression in order 
to validate and push further the analysis of single cell heterogeneity.  
 Experiments of live imaging, following multiple messengers and using time-lapse 
for example, could allow observation of the variability in gene expression through time and 
space in single cells. However, it remains difficult to combine this sort of approach with 
quantitative techniques. Single cell expression could also be quantified using serial 
analysis of gene expression (SAGE) method or RNA seq also called "Whole 
Transcriptome Shotgun Sequencing" or single cell microarray (Kurimoto et al., 2006).  
4.3.9 Conclusion 
 
This preliminary study allowed us to investigate key points of the GRN: the 
characterisation of the melanoblast and melanocyte population showed the heterogeneity of 
early mitfa(+) cell populations; as well as the decrease of mitfa expression in melanocytes 
at 72 hpf. Furthermore, our results suggest the existence of a chromatoblast at early stages. 
The combination of biological data and statistical analyses permitted the observation of the 
GRN within a different and new approach, stochastic profiling and will contribute to 
deciphering the quantitative features of the GRN. In conclusion, the stochastic profiling 
approach seemed appropriate to achieving quantification of variation in gene expression, 
even if the accuracy of techniques for reading gene expression in small pools of cells is 
difficult to achieve. This can be overcome by increasing sample size, and in the future, 
using more accurate techniques for gene expression measurements in single cells. 
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Chapter 5. Insights into 
sox10 and mitfa regulation 
  
5.1 Introducing the complex regulation between the two 
transcription factors Sox10 and Mitfa in melanocytes. 
 
Two transcription factors, Sox10 and Mitf, have been found to be crucial for melanocyte 
development in several species such as mouse, human, Xenopus and zebrafish (Lister et 
al., 1999, Elworthy et al., 2003b, Jiao et al., 2004, Kumasaka et al., 2005, Hou et al., 
2006). However, several aspects of the interactions between these factors remain unclear, 
for example, the role of Sox10 in differentiation of melanocytes in zebrafish compared to 
mouse, and the role of Mitfa as a repressor of sox10 in zebrafish during cell differentiation. 
In this Chapter, aspects of sox10 and mitfa inter-dependent regulation were tested in vivo in 
order to investigate caveats of the melanocyte GRN. 
5.1.1 The role and the regulation of sox10 during melanocyte 
development 
 
The role of sox10 in early melanocyte development does not appear consistent from one 
species to another. For example, in zebrafish, in vivo data suggested that there was no 
requirement for an ongoing role of sox10 in melanocyte for differentiation. In contrast, in 
vitro data in mouse suggested that Sox10 might contribute to the expression of melanocyte 
differentiation genes, Dct and Tyr (Murisier et al., 2007, Hou et al., 2006). In Sox10-
mutant mice primary NC cultures, Mitf expression was neither sufficient to rescue 
pigmentation nor to induce Tyrosinase expression in cell culture in the absence of the 
factor SOX10, suggesting that SOX10 was required to act alongside MITF to activate 
Tyrosinase expression (Hou et al., 2006). In zebrafish, sox10 over-expression induced 
ectopic mitfa expression and thanks to mitfa induction, pigmentation was fully rescued. In 
contrast, loss of sox10 expression in zebrafish embryos resulted in the loss of mitfa 
expression and pigment cell types (Dutton et al., 2001, Elworthy et al., 2003b). 
Consequently, in zebrafish the essential function of sox10 in the melanocyte lineage is 
mediated by the transcriptional regulation of mitfa (Elworthy et al., 2003b). Furthermore, a 
previous study based on immunohistochemistry and WISH, showed that sox10 expression 
was lost upon early melanocyte differentiation in zebrafish in vivo (Greenhill et al., 2011). 
Therefore, in contrast to what observed in zebrafish, SOX10 was maintained in the 
melanocytic lineage of mammalian species and might control melanocyte differentiation in 
addition to fate specification in the mouse (Dutton et al., 2001, Hou et al., 2006).  
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 Together, the data indicated a crucial role for sox10 in melanocyte specification 
although its precise role during differentiation remains controversial throughout species 
(Hou et al., 2006, Aoki et al., 2003, Carney et al., 2006, Elworthy et al., 2003b, Kelsh, 
2006b, Dutton et al., 2001, Potterf et al., 2001). A GRN was constructed from previous 
experimental data in order to better understand the influence of different factors in the 





mutants, has been crucial for the collection of data and the testing of key 
hypotheses. In the mutant sox10
t3
, the sox10 allele contains a 1397 bp insertion which 
interrupts the sox10-coding sequence upstream of the HMG domain and adds eight novel 
amino acids before prematurely truncating the protein. The mitfa
w2
 mutant allele contains a 
single base substitution which creates a premature stop codon and results in a truncated 
protein (Lister et al., 1999). Testing the expression of sox10, mitfa, tyrp1b, dct and silva in 
these mutants has allowed the evaluation of the repressive effects of Sox10 on some genes 
downstream Mitfa in zebrafish. In our experiments, one objective was to quantitatively 
assess the role of Sox10 in the regulation of genes downstream of Mitfa in zebrafish and to 
understand the mechanisms involved in the loss of sox10 during melanocyte 
differentiation. 
5.1.2 Sox10 can repress the expression of genes downstream of Mitfa 
 
Melanocyte specification in zebrafish is based upon activation of mitfa by Sox10. In turn, 
Mitfa activates the expression of the genes responsible for melanin synthesis. Importantly, 
previous experiments have shown a clear distinction between the effects of sox10 and mitfa 
over-expression in zebrafish. Improved understanding of these differences would allow 
better definition of the regulatory role of both transcription factors in melanocyte 
development in zebrafish. 
 Testing gene expression induction ectopically can demonstrate potential activatory 
and repressive regulatory interactions between factors. For this, the ectopic activation of 
gene expression had to be tested before the endogenous gene expression was activated in 
embryos. In zebrafish embryos, sox10 expression is activated at 11 hpf in NC and mitfa is 
activated around 18 hpf in a potential precursor cell population in NC (Dutton et al., 2001). 
Consequently, induction of gene expression, such as mitfa or sox10, could be tested 
ectopically by injecting mRNA at the one cell stage and by testing probable direct gene 
expression activation before activation of endogenous expression (at 6 hpf). Detectable 
responses from direct activation are considered to result from protein synthesis and gene 
expression activation. Indirect activation would appear later. It would be caused by protein 
translation and transcriptional activation of another factor which in turn would be 
translated and would then activate gene expression.  
 Ectopic expression of mitfa or sox10 gene expression in zebrafish embryo has been 
tested previously. When ectopically over-expressed in one cell stage embryos, the wild-
type mitfa mRNA caused a strong expression of all melanocyte differentiation genes tested 
by 6 hpf. This suggested direct activation of their expression by Mitfa. In contrast, by 6 
hpf, wild-type sox10 mRNA induced mitfa expression however no expression of 
melanocyte differentiation genes could be detected. Interestingly, by 10.5 hpf, tyrp1b was 
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activated while dct, tyr and silva were not. This suggested an indirect activation of tyrp1b 
via activation of mitfa by Sox10 (Greenhill et al., 2011). This interpretation is confirmed 
by the failure to activate tyrp1b expression by injecting sox10 mRNA in mitfa
w2
 mutant. 
This result suggested that tyrp1b expression was strictly mitfa-dependent in zebrafish and 
that in the presence of high sox10 expression, low mitfa expression could not activate all 
melanocytic genes (Greenhill et al., 2011). It was then suggested that Sox10 could have 
repressive effects on expression of some melanocytic genes, except tyrp1b. Importantly, 
these results were consistent with the previous observation of residual melanin in sox10 
mutant fish (Figure 5.01). The de-repression of expression of the genes responsible for 
melanin synthesis led to the production of residual melanin in the dorsal part of embryos 
up to 40 hpf even in the absence of mitfa (Figure 5.01) (Greenhill et al., 2011). This 
residual melanin appeared later than in WT embryos (presumably due to the lack of mitfa 
and the low levels of melanocytic gene expression). From 40 hpf, and up to 56 hpf, it was 
possible to quantify the increase in the number of melanised cells, and additionally in some 
cases, it was possible to assess the changes of aspect of residual melanin from fainted and 
spread, at 41 hpf, to dense and round, at 43 hpf (Figure 5.01).  
 Sox10 is a factor involved in NC specification and in maintenance of pluripotency 
(Kim et al., 2003, Kelsh, 2006b). Therefore, there is a potential this repressive effect could 
be enhanced in non-melanoblast cells and be reinforced by the absence of mitfa. 
Consequently, it would be difficult to observe the weak repressive effect directly in WT 
condition in melanoblasts. However, WISH experiments investigating the expression of 













 mutant, showed detectable sox10 dependent 
downstream repression of dct and silva and tyrosinase at 24 hpf and 36 hpf (Figure 5.02, 
Table 5.01) (Greenhill et al., 2011). Table 5.01 shows the de-repression of dct, silva and 
tyrosinase in most sox10
t3
 mutant embryos from 24 hpf to 42 hpf whereas fewer embryos 
showed residual gene expression in mitfa
w2 
mutants (Greenhill et al., 2011). The 
quantitative aspect of de-repression of genes downstream Mitfa was not assessed in these 
experiments. 
In this Chapter, complementary analyses were carried out to investigate 




mutants in order to 
assess the level of de-repression of genes downstream of Mitfa in the absence of Sox10. 





different time points, 30 hpf, 36 hpf and 72 hpf by quantitative RT-PCR. We tested 
whether the de-repression of dct could be observed in the sox10
t3 
mutants compared to dct 
expression in mitfa
w2
 mutant particularly around 30 hpf. Whether tyrp1b expression, which 





mutants was also investigated. These experiments allowed the quantification of 
gene expression in mutant lines, and additionally, evaluation of the changes in expression 
level that were predicted by the model during cell differentiation in zebrafish. 
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Residual melanised cells appeared in zebrafish sox10
t3
 mutants around 40 hpf and increase 
until 56 hpf. The dorsal trunk of a single embryo shows the dynamic changes in residual 
melanised cells from 45 hpf to 56 hpf (A, arrowheads show residual melanised cells). Note 
how initially many cells show diffuse melanin (arrowheads at 45 hpf) and how new 
melanised cells appear with time (arrowheads at 48 hpf) and until 56 hpf. A single 
melanised cell at 41 hpf and 43 hpf shows the change from diffuse melanin (41 hpf) to a 
tiny, dense spot (43 hpf) (B). The graphical plot shows the increase of the mean (±s.e.) 
number of segments containing residual melanised cells from a typical series of embryos 
(n=19), from 35 hpf to 57 hpf (C), (reproduced with the kind permission of Greenhill et al., 
2011). 
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 zebrafish mutants 
 









 mutants are presented at 24 and 36 hpf as 
indicated (A-AB). Insets in each panel show enlargement of area of dorsal posterior trunk. 
Note the pronounced de-repression of silva and dct, mild de-repression of tyr, and minimal 
residual expression of tyrp1. Note that all WISH were over-developed in order to detect 
low level expression, (reproduced with the kind permission of Greenhill et al., 2011). 
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Table 5.01: Quantification of zebrafish mutant embryos showing residual marker 
gene expression. 





mutants from 24 hpf to 60 hpf. Colour coding reflects percentage with residual 
expression: 90-100%; 20-89%; 0-19%, n.d: not determined. (Reproduced with the kind 
permission of Greenhill et al., 2011). 
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5.1.3 The GRN predicts that the decrease of sox10 expression during 
melanocyte development is Mitfa dependent 
 
5.1.3.a The transcription factor Mitfa activates sox10 expression ectopically 
In zebrafish, in contrast with observations in the mouse model, sox10 expression seems to 
be decreased during melanocyte differentiation (Hou et al., 2006, Harris et al., 2010, 
Greenhill et al., 2011). Interestingly, ectopic injections of mitfa mRNA in transgenic Tg(-
7.2sox10:GFP) embryos showed strong activation of GFP in embryos at both 6 hpf and 
10.5 hpf suggesting direct activation of expression (Table 5.02). As a positive control, 
sox10 mRNA was injected. As a negative controls two constructs were injected; the 
version of the sox10 allele containing a non-conservative substitution (L142Q) of a fully-
conserved residue in the HMG domain, sox10 (L142Q), and mitfa
w2
 mRNA. This resulted 
in no activation of GFP (Figure 5.03). 
  The results showed that mitfa mRNA injection could ectopically activate sox10 
expression in zebrafish. Consequently, ectopic mitfa expression could activate sox10 
expression suggesting that Mitfa could directly or indirectly activate sox10 promoter 
(Figure 5.03, Table 5.02) (Greenhill et al., 2011). To narrow the region of the sox10 
promoter which could be bound by Mitfa, the experiment was repeated in Tg(-
4.9sox10:GFP) line in which the farthest 5’ region, including three M-boxes, was absent. 
No activation of GFP could be seen at 6 hpf in embryos injected with mitfa mRNA 
(Greenhill et al., 2011). These results suggested that Mitfa might activate sox10 expression 
by binding one or more of the 3’ M-boxes in the promoter of sox10. From these 
observations, the hypothesis was suggested that sox10 decrease would be Mitfa dependent 
in zebrafish in vivo. The recruitment or the presence of a negative co-regulator of Mitfa, in 
vivo in NC, would cause this to become a repressive interaction (Greenhill et al., 2011). 
The hypothesis was suggested that Hdac1 could be this co-repressor. 
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Figure 5.03: Ectopic injection of mitfa mRNA in one-cell stage embryos can activate 
GFP in Tg(-7.2sox10:GFP) by 6 hpf. 
 
Embryos are shown in lateral view in bright field, or fluorescence, as indicated. Tg(-
7.2sox10:GFP) embryos were injected with RNA encoding wild-type (A, left panel) or 
mitfa
w2
 mutant mitfa (A, right panel) or sox10 wild-type mRNA (B, left panel) or 
sox10(L142Q) mutant (B, right panel). Representative embryos are shown at 10.5 hpf, with 
GFP expression detectable in those injected with wild-type, but not mutant forms, 
(reproduced with the kind permission of Greenhill et al., 2011). 
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Table 5.02: Proportion of embryos from Tg(-7.2sox10:GFP) outcross showing 
expression of GFP at 6 hpf and 10 .5 hpf after injection of with indicated mRNA.  
(NB: Only 50 % of embryos from this cross would be transgenic, thus maximum 
percentage GFP+ embryos expected is 50 %. At 6 hpf and 10.5 hpf, both series of embryos 
injected with WT mRNA showed expression of GFP whereas negative controls tests 
injecting mutant mRNA version of the genes showed no GFP expression (reproduced with 
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5.1.3.b Mitfa and Hdac1 could be responsible for the repression of sox10 expression in 
melanocytes  
It has been suggested that a co-repressor present in vivo in NC cells could be recruited by 
Mitfa to repress sox10 and allow the differentiation of melanocytes (Greenhill et al., 2011). 
In this study, we tested the hypothesis that Hdac is a co-repressor for Mitfa to 
downregulate sox10 expression in melanocytes. 
Hdac1 is a protein of the histone deacetylase family which are proteins involved in 
chromatin deacetylation which is a key mechanism of epigenetic gene silencing (Harrison 
et al., 2011, Cunliffe, 2004). hdac1 expression is ubiquitous in zebrafish during 
development until 19 hpf. After this timepoint, hdac1 expression is not spatially restricted 
but it is strongly maintained in head and more weakly expressed in dorsal and ventral 
stripe at 36 hpf (Thisse, 2004). In zebrafish, histone deactylase 1 (hdac1) function has been 
shown to be involved in the process of development of the central nervous system. 
Particularly, it has been shown to be necessary for the specification and patterning of 
neurones and myelinating glial cells, via regulating the transcription of key genes for early 
neurogenesis such as achaete-scute complex-like 1b (ascl1b) (Harrison et al., 2011).  
In the context of the hdac1/colgate mutant analysis, a small molecule inhibitor of 
Hdacs, Trichostatin A (TSA), was used to test the our hypothesis. TSA treatments were 
used at different time periods focusing on sox10 expression and development of 
melanocytes, especially during melanocyte differentiation. The study of the colgate/hdac1 
zebrafish mutant showed two interesting features. Firstly, melanocytes exhibited 
developmental retardation during differentiation with reduced melanised cells suggesting 
defective melanocyte development from 27 hpf until at least 72 hpf (Figure 5.04). 
Secondly, a persistent sox10 expression was observed in the dorsal part of embryos at 52 
hpf (Figure 5.05) (Ignatius et al., 2008). Interestingly, sox10 expression was not changed at 
24 hpf in mutant (Figure 5.05). Furthermore mitfa expression was firstly reduced in 
colgate/hdac1 mutant at 25 hpf, but then recovered and was increased at 48 hpf compared 
to its expression in WT (Figure 5.06). dct and c-kit expressions remained greatly reduced 
in mutant embryos from 25 hpf to 48 hpf at least, whereas foxd3 expression was boosted at 
24 hpf in premigratory NC cells and in the somites (Ignatius et al., 2008). To explain these 
results, Ignatius et al., (2008), suggested that Hdac1 could be a repressor of foxd3.  
In our experiments, we explored the phenotype of loss of melanocyte 
differentiation in the colgate/hdac1 zebrafish mutant and the persistence of sox10 
expression at 48 hpf. According to our hypothesis, the phenotype of elevation of mitfa at 
52 hpf in the colgate/hdac1 mutant could be explained by the persistence of sox10 in 
colgate/hdac1 mutants. Also, this persistence of expression could cause a repression, or a 
delay of dct expression (due to the previously described repressive effects of Sox10 on 
dct).  
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Figure 5.04 Melanocyte differentiation is disrupted in the colgate/hdac1 zebrafish 
mutant by 27 hpf 
27 hpf WT (A) and hdac1/colgate mutant (B) embryos in lateral view. In WT embryos, 
melanocytes can be observed posterior to the eye and otic vesicle while some are migrating 
over the flank of the embryo (A). In contrast, in mutant embryos fewer melanocytes can be 
observed and cells seemed to accumulate posterior to the otic vesicle (arrowheads in B 
points at melanocytes posterior to the otic vesicle), very few migrating melanocytes can be 
seen (B), (reproduced with the kind permission of Ignatius et al., 2008). 
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Figure 5.05: sox10 expression is reduced at 24 hpf but persistent at 52 hpf in 
colgate/hdac1 zebrafish embryos 
 
WISH investigating sox10 expression in WT (A,C) and colgate/hdac1 mutant (B,D) 
embryos.  24 hpf embryos (A-B) and 52 hpf embryos (C-D) are presented in lateral view. 
At 24 hpf, no differences could be observed in the expression of sox10 in number of 
cranial and trunk NC cells ((A-B) arrowheads). At 52 hpf sox10 expression was persistent 
and robust in the dorsal stripe of colgate/hdac1 mutants, while expression in wild-type is 
absent to faint ((C-D) arrowheads), (reproduced with the kind permission of Ignatius et al., 
2008).  
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Figure 5.06: mitfa expression is reduced at 25 hpf and activated by 48 hpf in 
melanocytes in colgate/hdac1 zebrafish mutants.  
 
WISH investigating mitfa expression in WT (A,C) and colgate/hdac1 mutant (B,D) 
embryos at 25 hpf  (A-B) and 48 hpf (C-D). Embryos are presented in lateral view. At 25 
hpf, fewer mitfa-positive melanoblasts were specified in colgate/hdac1 mutants as 
compared to WT. At 48 hpf mitfa expression is decreased in differentiating melanoblasts in 
wild-type however it is robustly expressed in melanoblasts in colgate/hdac1 in dorsal 
region (C and D arrowheads), (reproduced with the kind permission of Ignatius et al., 
2008). 
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5.1.4 The role and the regulation of mitfa in melanocyte development 
 
One aspect of the Mitfa regulatory network which remains unclear is its auto-regulation. It 
has been shown in vitro that MITF might activate its own expression (Saito et al., 2002). 
However, this hypothesis has not been assessed using in vivo data and it remains unclear if 
and when Mitf could be responsible for its own activation. In this Chapter, to clarify 
whether or not it is plausible that Mitfa could activate its own expression, we tested mitfa 
transcription response to ectopic mitfa mRNA induction in zebrafish at one cell stage.   
5.1.5 Aims and approach 
 
The objective of these experiments was to better understand the dynamic interactions 
between sox10 and mitfa, focusing especially on the melanocyte differentiation phase.  
 We investigated expression levels of mitfa, sox10, dct and tyrp1b by RT-




mutants to quantify the degree 
of de-repression of dct in sox10 mutants (Greenhill et al., 2011).  
 Hdac-mediated repression of sox10 expression was tested by investigating the 
effects of Hdac inhibition on sox10 expression. This experiment was critical 
to test the hypothesis that Mitfa and Hdac could be co-repressing sox10 
expression during melanocyte differentiation.  
 Mitfa dependent activation of mitfa was tested ectopically in vivo to assess 
whether Mitfa could activate its own expression,  
Altogether these experiments should help to clarify the regulatory interactions which 
associate Sox10 and Mitfa during melanocyte differentiation and contribute to the testing 
of the GRN. 
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5.2 Results 







Previous WISH experiments have described the decrease of sox10, mitfa, dct and tyrp1b 
expressions in zebrafish sox10
t3 
mutant and the decrease of dct, mitfa and tyrp1b in mitfa
w2 
mutant (Greenhill et al., 2011). The results showed the de-repression of dct expression, but 
not of tyrp1b expression in the sox10
t3 
mutant. However, these experiments did not 





In the experiments presented here, we used the quantitative technique of RT-qPCR to 




mutants at 30 hpf, 36 hpf 





were analysed. Heads were removed using forceps to 
avoid detection of dct expression from eyes or sox10 expression from otic vesicle. RNA 
was extracted using tri-reagent (Sigma) and RT-qPCR were run (Livak and Schmittgen, 
2001). The results were normalised to the expression level of the reference gene gapdh, 




 were compared statistically. Data were 
analysed using the ΔΔCt method (Livak and Schmittgen, 2001).  
 The results of gene expression quantification by RT-qPCR in mutants are presented 
in Figure 5.07 - expression levels are reported as a proportion of the expression levels 
found in WT at each timepoint. The results of the statistical analysis (p-values) are 
presented in Table 5.03. The results showed that gene expression for all genes examined 




mutants compared to 





 mutants as the non-functional mRNA could be produced in mitfa
w2
 
mutants whereas no mitfa mRNA was produced in sox10
t3
 mutants. Importantly, the level 
of mitfa expression in mitfa
w2
 mutants was less than in WT, which indicates that the sox10-
dependent activation of mitfa is not sufficient to explain fully the level of mitfa in the WT. 
In other words, there is some sort of Mitfa-dependent activation of mitfa at these stages. A 
significantly higher level of tyrp1b in sox10
t3
 mutant compared to mitfa
w2 
mutant was also 
observed, however, in both mutants the levels of expression remained very low. 
Investigating the level of expression of dct at the early time-point, 30 hpf, showed that dct 
expression was significantly higher (about five times) in the sox10
t3
 mutant compared to 
expression in the mitfa
w2
 mutant, whereas this was not the case for tyrp1b. This data are 
consistent with the de-repression of dct expression in sox10
t3
 mutant suggested by the 
model. Consequently, this experiment suggested that previous results showing the sox10 
de-repression of dct, but not of tyrp1b expression, could be confirmed and quantified. 
Together the data support the suggestion that sox10 is a weak repressor of some but not all 
genes downstream to Mitfa in zebrafish melanocytes. 
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Figure 5.07: RT-quantitative PCR of mitfa, dct and tyrp1b expression in zebrafish 
wild-type (WT), mitfa
w2




Values shown are means (bars show standard deviation), at 30 hpf, 36 hpf and 72 hpf. 
Expression levels in WT controls were normalised to gapdh expression for each sample 
and expression is shown as a percentage of WT transcript expression levels normalised to 
gapdh expression. The differences in gene expression levels in sox10 mutants compared 
with mitfa mutants were tested and significant results are indicated on the graph (one-tailed 
t-test with Bonferroni correction for multiple comparisons,**). (reproduced with the kind 
permission of Greenhill et al., 2011).  
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Table 5.03: Result of the statistical analysis (p-values) of the comparison of gene 
expression in mitfa
w2
 mutant and sox10
t3
 mutant.  
Student t-test with Boniferroni correction for multiple comparison was used to determine 
p-values and after correction. The results were significant when p-value < 0.017. For each 
condition, gene expression was determined in five samples of fifty pooled embryos. 
 
 
gene mitfa dct trp1b 
30 hpf 0.0116 0.0117 
 
0.0071 
36 hpf    0.0026 
 
0.0348 0.0248 
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5.2.2 Testing Hdac as a Mitfa dependent co-repressor of sox10 
 
We investigated a mechanism for sox10 downregulation in melanocyte during the 
differentiation phase. In regards to the analysis of the colgate/hdac1 mutant (maintenance 
of sox10 in melanocytes at 48 hpf and melanocyte development retardation), the 
hypothesis was that Hdac1 could be a Mitfa dependent inhibitor of sox10 during 
melanocyte differentiation. This co-regulation could be happening via a complex 
Mitfa/Hdac1 or alternatively, via the recruitment of Hadc1, by Mitfa, to the regulatory 
sequences on sox10 promoter.   
The objective of these experiments was to phenocopy the effects of melanocyte 
differentiation loss and sox10 expression persistence at 48 hpf, observed in colgate/hdac1 
mutant with the TSA treatments (Ignatius et al., 2008). Consequently, the focus of the 
experiments was to observe effects of inhibiting Hdac(s) on sox10 expression persistence 
in the dorsal part of embryos and on disruption of melanocyte differentiation at about 48 
hpf zebrafish embryos. If Hdac(s) are involved in inhibiting sox10 expression in a Mitfa 
dependent manner, we would expect to observe a persistence of sox10 expression in 
melanocytes in TSA treated embryos and in mitfa
w2
 mutant. If Mitfa and Hdac(s) work 
together as co-repressors, we would expect no effects of TSA treatments on mitfa 
expression levels and no effects of the TSA treatments in absence of Mitfa. Embryos were 
treated from 12 hpf, 24 hpf, 30 hpf and 36 hpf to 48 hpf covering both the specification and 
differentiation phases of melanocyte development. 
5.2.2.a Hdac inhibitor treatments caused melanocyte development disruption 
 
The phenotype of the colgate/hdac1 zebrafish mutant has been described by Ignatius et al., 
(2008). Compared to 27 hpf wild-type (WT) embryos, where the melanocytes were 
posterior to the eye and otic vesicle and migrating over the flank of the embryo, the 
colgate/hdac1 mutant had fewer melanocytes with most located posterior to the otic vesicle 
and there was no observation of migrating melanocytes. Importantly, Ignatius et al., (2008) 
showed that NC induction and migration of non-melanogenic cells were unaffected in the 
mutant. Furthermore, in WT, by 72 hpf, melanocytes were present in four stripes whereas, 
in colgate/hdac1 mutants, melanocyte numbers remained low (Ignatius et al., 2008). 
Ignatius et al., (2008) suggested that melanocytes present in colgate/hdac1 mutant failed to 
migrate and were mainly localized to the dorsal stripe and to a patch of melanocytes 
posterior to the otic vesicle (Ignatius et al., 2008). Cells which did migrate ventrally in 
colgate/hdac1 mutants were present in the anterior ventral stripe over the yolk extension. 
In the experiments described in this Chapter, we saw no evidence for impairment of cell 
migration and therefore it was not investigated.  
 Embryos were treated with TSA during four time periods and the changes on 
melanocyte differentiation were assessed. The results of TSA treatments on melanocyte 
differentiation are presented in Figures 5.08 and 5.09. We observed that all TSA treatments 
from 12-48 hpf, 24-48 hpf, 30-48 hpf and 36-48 hpf, clearly resulted in developmental 
retardation in fish (Figure 5.08). Zebrafish development and morphological changes are 
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very well described at these stages, therefore, assessment of embryonic retardation can be 
readily achieved (Kimmel et al., 1995). Zhu et al., (2011) also described this type of 
developmental retardation phenotype when treating fish with TSA. This suggests that these 
effects could be the result of inhibition of Hdac proteins involved in early development, by 
TSA, as it was not observed in colgate/hdac1 embryos. Consequently, to compensate for 
this developmental retardation, treated embryos were staged on general morphology and 
the melanocyte phenotypes (e.g. melanisation, cell shape or number of cells) were 
observed and compared to the phenotype of melanocytes in a stage-matched embryo.  
 We found that TSA treatments led to disruption/inhibition of melanocyte 
differentiation. TSA treatment from 12 hpf to 48 hpf caused reduced pigmentation 
(reduced melanised cell number) and strong developmental retardation as seen by the 
reduced development of head structures such as eyes, and by a reduction of body size 
(Figure 5.08). Embryos treated from 30-48 hpf and 36-48 hpf showed developmental 
retardation, although, the number of melanised cells did not seem to be affected compared 
to the phenotype in the 24-48 hpf treated fish (Figures 5.08). We found that after treatment 
48 hpf embryos could be morphologically staged as equivalent to 36 hpf embryos. 
Therefore, to compare the melanisation and melanocyte development between treated and 
untreated fish, the 36 hpf staged embryos were used as a control (Figure 5.09). The results 
showed that treating embryos from 24 - 48 hpf led to an important decrease of melanised 
cells compared to the 36 hpf stage control (Figure 5.09). This reduction of melanised cells 
could be due to the reduction or loss of cell melanisation (Figure 5.09). This observation 
suggested that the developmental retardation and the pigment phenotype were two 
independent phenomena. It also suggested that Hdac was important in the time period of 
24 to 30 hpf for melanisation and melanocyte development. However, it remains to be 
investigated whether Hdac could be involved in sox10 regulation at early stages. 
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Figure 5.08: Hdac inhibitory treatments lead to developmental retardation of the 
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Figure 5.08: Hdac inhibitory treatments lead to developmental retardation of the 
zebrafish embryo and to disruption of melanocyte differentiation. 
Embryos were treated with Trichostatin A (TSA) (1 µM concentration) for four different 
time windows, 12-48 hpf, 24-48 hpf, 30-48 hpf and 36-48 hpf. Embryos treated from 12-48 
hpf (D-F), show drastic decrease melanocyte number (not quantified, only observed), lack 
of eye structure (in B arrowheads points eyes whereas in E, arrowheads points the lack of 
eye), short body size and developmental retardation. Embryos treated from 24, 30 and 36 
to 48 hpf (G-P) show developmental retardation compare to 48 hpf DMSO treated control 
(A-C). Embryos treated from 24-48 hpf also seem to show decrease melanocyte number 
(not quantified, only observed)). Treated embryos (G-P) were staged as morphologically 
equivalent to 36 hpf (Kimmel et al., 1995) (in C,F,I,L,P, arrowheads points at melanocytes. 
Embryos are shown in lateral view. e: eyes; y: yolk sac, Scale bar: 100 µm. For each 
condition, 160 fish were tested and observed and representative phenotypes are shown 
here. (Q) The scheme summarises the effects and the timing of the different TSA 
treatments in embryos and melanocyte development. 
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Figure 5.09: Treating zebrafish embryos with TSA from 24 to 48 hpf causes 
disruption of melanocyte differentiation and reduced melanised cell number. 
Embryos were treated with Trichostatin A (TSA) (1 µM concentration), from 24 to 48 hpf 
and shown in lateral view (D-F). Embryos were staged as 36 hpf and melanocyte number 
as well as shape or size of melanocytes was reduced as shown in (D-F) compare to stage-
matched control (A-C). (A,D) show embryos in lateral view, (B,E) show heads and 
anterior trunk in lateral view and (C,F) show yolk sac in lateral view (arrowheads point at 
melanocytes). For each condition, 160 fish were tested and observed and representative 
phenotypes are shown here. e: eyes ; y: yolk sac. Scale bar: 100 µm. 
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5.2.2.b Hdac inhibitor treatments caused persistence of sox10 expression in 
melanocytes  
 
For the next step in investigating Hdac as an Mitfa-dependent repressor of sox10 
expression during melanocyte differentiation, we assessed the effects of TSA treatments on 
sox10 expression. Dutton et al., (2001) described the time course of sox10 expression in 
zebrafish from the five-somite stage to 60 hpf. Until about 23 hpf sox10 expression is a NC 
cell marker. Later it is downregulated in most derivatives, until its expression becomes 
strictly restricted to glial cells (Potterf et al., 2001, Carney et al., 2006, Drerup et al., 2009, 
Kelsh, 2006b, Dutton et al., 2001). From five-somite stage to fourteen-somite stage, sox10 
is expressed in most cranial and trunk premigratory NC cells. From eighteen-somite stage, 
sox10 is strongly expressed in the premigratory and migrating NC cells and in the otic 
vesicle. By 24 hpf, sox10 expression is associated with cranial ganglia and posterior lateral 
line nerve, but also with the otic vesicle and migrating NC cells throughout the trunk and 
in premigratory crest. Then, cells expressing sox10 extend along the posterior lateral line 
nerve, and in some migrating cells of the rostral trunk. At 36 hpf weak sox10 expression 
was reported in some melanocytes in some cells of the dorsal stripe. At 40 hpf, sox10 was 
detected in cells adjacent to the notochord in segmentally arranged lines which were 
presumed to be glial cells. By 60 hpf sox10 was expressed in the enteric nervous system of 
embryos.  
  colgate/hdac1 mutant embryos showed persistence of sox10 expression in the 
dorsal region of embryos at 48 hpf (staged as 36 hpf) in NC derived cells. These cells are 
likely to be glioblasts and melanoblasts according to positioning and staining with sox10 
(Ignatius et al., 2008). In the experiment described here, TSA-treated embryos were staged 
at 36 hpf and sox10 expression was investigated by WISH after TSA treatments. 
The results shown in Figure 5.10 demonstrate that embryos treated with TSA from 
24-48 hpf had elevated sox10 expression in dorsal position, the position of premigratory 
NC cells. However, to test whether sox10 expression was boosted in melanocytes, the 
experiment was repeated reducing the dose of PTU treatment to avoid total inhibition of 
melanin synthesis in cells. Cells of the dorsal stripe were then observed carefully to test for 
co-localisation of the WISH signal and melanin (Figure 5.11). Our results clearly showed 
that sox10 expression was boosted in brown melanised cells in embryos treated from 24 - 
48 hpf compared to staged control embryos. The blue signal was weaker and even 
sometimes absent from melanised brown cells in controls, whereas it was co-localised in 
melanocytes of treated embryos. 
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Figure 5.10: sox10 expression is boosted in premigratory NC derived cells in 24-48 
hpf TSA treated zebrafish embryos. 
Embryos were treated with PTU and Trichostatin A (1 µM concentration) from 24-48 hpf 
(D-F). WISH with sox10 probe shows an elevated sox10 expression in premigratory (the 
arrowhead in E shows the cells marked by the signal in the dorsal part of the embryo’s 
trunk) and migrating NC derived cells (probably melanoglioblasts according to the stage) 
of treated embryos (E-F, the arrowhead shows the cells marked by the signal) compared to 
staged DMSO treated control (H-I). (A,D,G) show dorsolateral view of heads, (B,E,H) 
show lateral view of trunk and (C,F,I) show dorsal view of trunk. 80 embryos were 
observed and analysed for each condition and representative embryos were shown here. e: 
eyes ; y: yolk sac ; o: otic vesicle. Scale bar: 100 µm. 
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Figure 5.11: sox10 expression is boosted in melanocytes after 24-48 hpf hdac 
inhibition by TSA treatment in zebrafish embryos. 
Embryos were treated with low dose PTU (70 %) allowing only light production of 
melanin. WISH investigating sox10 expression shows that Trichostatin A (1 µM) treated 
embryos (C,D) from 24 hpf to 48 hpf present increased sox10 expression in melanocytes  
(B,D red arrows showing co-localisation of brown cells and blue signal) compare to 36 hpf 
staged control (A,B, the blue arrowheads show blue signal (sox10 expression) outside of 
melanised cells (the black arrowheads show melanocytes that lack detectable blue signal) - 
note that co-localisation of blue signal and melanin is less frequent in controls than in 
treated embryos). Fifteen embryos of each condition were observed in close up and 
representative phenotypes were documented here, however, no quantification were 
realised. All pictures were taken in dorsal view in dorsal trunk in dorsal stripe. Scale bar: 
100 µm. 
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5.2.2.c The persistence of sox10 expression is observed in mitfa
w2
 mutant  
 
The Mitfa and Hdac1 co-repressor of sox10 hypothesis suggested that the lack of one of 
the two factors would result in disruption of the inhibitory mechanism. Consequently, 
mitfa
w2
 mutant lacking mitfa expression should phenocopy the persistence of sox10 
expression observed both, in dorsal region of colgate/hdac1 mutant around 48 hpf, and in 
TSA treated embryos stages at 36 hpf. Furthermore, mitfa
w2 
mutant did not produce the 
functional Mitfa protein, therefore, TSA treatment should not trigger any changes in sox10 
expression compared to expression observed in untreated mitfa
w2 
mutant embryos. We 
tested these predictions, and the results are presented in Figure 5.12.  
 WT TSA treated embryos and DMSO treated mitfa
w2
 mutant embryos both showed 
the persistence of sox10 expression in the dorsal region of the trunk. In addition, TSA 
treated mitfa
w2
 mutant embryos presented the same phenotype as staged DMSO mitfa
w2 
mutant embryos. This suggested that the TSA treatment did not cause any changes on 
sox10 expression in the absence of mitfa. Furthermore, loss of mitfa in mitfa
w2
 mutant 
could also phenocopy the phenotype of persistence of sox10 expression observed in 
colgate/hdac1 mutant. This result could suggest that TSA dependent increase of sox10 
required the factor Mitfa. This suggested that both the lack of Mitfa and the inhibition of 
Hdac in WT embryos, led to activation of sox10 expression in melanocyte. 
5.2.2.d Summarising the effects of TSA on melanocyte differentiation and sox10 
expression during melanocyte development. 
 
Altogether, these results suggested that inhibition of Hdacs repressed melanocyte 
differentiation while also boosting sox10 expression in melanised cells. In the context of 
the study described in Ignatius et al., (2008), these results also suggested that Mitfa and 
Hdacs proteins could work together as a repressor of sox10. An alternative hypothesis 
could be that Mitfa was required to activate Hdac trancription which in turn would have a 
repressive effect on sox10. However, in situ hybridisation experiments investigating hdac1 
expression showed that it was ubiquitously expressed from an early developmental stage in 
zebrafish. In contrast, mitfa is expressed only in melanocytes at 48 hpf, therefore, mitfa 
expression is the spatial limiting factor and does not seem to activate hdac1 transcriptional 
expression. Whether Mitfa could activate another Hdacs protein has not been reported. 
Previous data have suggested the possibility that Mitfa might directly bind the sox10 
promoter; it is plausible, therefore, that Mitfa might help target Hdac activity to the sox10 
promoter, thus resulting in repression of sox10. 
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In situ hybridisation investigating sox10 expression in WT and mitfa
w2
 mutant embryos 
treated with DMSO (control) (A-B) or Hdac inhibitor (TSA, 1 µM concentration) (C-D) 
from 24 hpf to 48 hpf. Embryos are shown in lateral view and a dorsal view of head is 
presented for each case showing elevation of the typical sox10 expression in cranial 
ganglia (c) and in otic vesicle (o) in untreated mutant (B) and treated embryos both WT (C) 
and mutant (D) compared to the control (A). Elevated sox10 expression in premigratory 
cells (black arrowheads in external dorsal part of trunk show these cells in B,C,D) and 
migrating NC cells (red arrowheads in middle trunk in B,C,D) can be observed in DMSO 
treated and TSA treated mitfa
w2
 mutant fish as well as in WT TSA treated embryos 
compare to WT untreated condition for which staining of migrating cells is particularly 
faint (no red arrow in A). For each condition 80 embryos were analysed and representative 
phenotypes are represented here. e: eyes ; y: yolk sac; c: cranial ganglia. Scale bar: 100 
µm.  
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5.2.3 Mitfa-dependent maintenance of mitfa expression 
 
In vitro experiments reported in Saito et al. (2002) have shown that Mitf might regulate its 
own expression in a process involving the Wnt signalling effector, LEF-1, as a non-binding 
cofactor. However, no in vivo experiments have yet demonstrated this mechanism. The 
GRN model for melanocyte development in zebrafish was described previously. It did not 
rule out the hypothesis that Mitfa could activate its own expression in a feedback loop and 
actually predicted this feature as a direct or indirect self-activation. As a preliminary 
investigation of this hypothesis, we tested the capacity of mitfa to activate its own 
expression. 
  To test whether Mitfa could drive mitfa expression, the mitfa mRNA was 
ectopically injected in embryos at the one cell stage. Both mitfa and dct expression were 
investigated by WISH at 6 hpf and 10.5 hpf after injections. dct being a direct target of 
Mitfa, activation of dct was used as a positive control for activity of the mitfa mRNA 
injected construct and efficiency of Mitfa activity after injections. For detection of induced 
mitfa expression, we had to avoid detecting the injected construct. Consequently, the probe 
used for WISH was designed to the 3’UTR region of the endogenous gene, outside of the 
sequence used to synthesise the injected construct. The mitfa
b692 
mutant was used as a 
negative control (Lister et al., 2001). In the mitfa
b692
 mutant, a single base change creates 
an amino acid substitution replacing the conserved isoleucine at position 215 in the first 
helix of the helix–loop–helix dimerization domain for serine, as described in Lister et al., 
(2001). This allele causes the inability of Mitfa to activate the transcription through its 
cognate binding site and to rescue melanophore development when expressed in the mitfa 
mutant embryos (Lister et al., 2001). Expression of mitfa was first investigated by WISH in 
fish from an incross of heterozygous mitfa
b692
 mutants. The expected c 25% of the progeny 
showed decreased mitfa expression compare to WT as shown at 30 hpf, and were assumed 
to be homozygous mitfa
b692
 mutants (Figure 5.13). As a negative control, endogenous mitfa 
(3’UTR) expression and dct expression were tested at 6 hpf and 10.5 hpf after injecting the 
mitfa
b692 
mutated RNA form. In these embryos we expected neither induction of dct nor 
mitfa after injection of the mitfa
b692
 mutated RNA form.   
 Embryos were photographed in animal pole view or lateral view (description of 
orientation on Figure 5.14) at 6 hpf which corresponded to the gastrula phase also called 
the shield stage (corresponding to 50-75 % epiboly) (Figure 5.14). 10.5 hpf, corresponds to 
the end of gastrulation and very early segmentation (Figure 5.14). After injection of the 
mitfa mRNA at one cell stage, expression induced at 6 hpf was likely to show direct 
activation of gene expression whereas expression at 10.5 hpf could more likely relate to 
indirect activation. 
 Figure 5.15 presents the results of the WISH investigating dct and mitfa (3’UTR 
probe) expression in embryos at 6 hpf and 10.5 hpf after injection of WT mitfa mRNA and 
mitfa
b692 
mutated RNA form at one cell stage. Embryos injected at one cell stage with 
synthesised WT mitfa mRNA showed strong ectopic expression of mitfa and dct at 6 hpf 
(Figure 5.15 A-B, animal pole view, dotted blue/dark purple signal in cells of the 
blastomere) and at 10.5 hpf (Figure 5.15, E-F, lateral view, dotted blue/purple signal in the 
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margin blastomeres/yolk cells). Interestingly, at 10.5 hpf, the signal corresponding to dct 
and mitfa (3’UTR) was not as widespread in the embryo as observed in embryos at 6 hpf. 
However, the expression observed at 10.5 hpf was weaker than observed at 6 hpf. It could 
be suggested that this low activation at 10.5 hpf showed that only some of the cells 
activating the endogenous Mitfa factor at 6 hpf were able to perpetuate activation of the 
gene later. Consistently with this, expression of dct was also reduced at 10.5 hpf compared 
to 6 hpf. It could be tested whether a feedback loop was only activated in a certain 
proportion of cells causing maintenance of mitfa, and in turn, of dct expression, in these 
cells. Alternatively, it is possible that in vivo in melanocytes a cofactor of Mitfa normally 
drives efficient feedback activation of mitfa by Mitfa. Figure 5.15 showed that embryos 
injected with mitfa
b692 
mutant mRNA did not activate expression of dct nor mitfa at either 6 
hpf or 10.5 hpf in blastomeres. Neither did these embryos show expression in yolk cells in 
the lateral view nor in animal pole view (lateral views of embryos in the Figure) as the 
blue/purple signal was not detected.  
 Altogether, these experiments showed that mitfa could drive its own expression 
when ectopically activated in zebrafish embryos. It remains to be tested whether mitfa 
activates its own expression in melanocytes during development.  
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Figure 5.13: mitfa expression is reduced in mitfa
b692 
mutant. 
WISH investigating mitfa expression in WT (A) and mitfa
b692
 mutant (B). Embryos from 
incross of mitfa heterozygotes were treated with PTU and processed for in situ 
hybridization with mitfa probes at 30 hpf stage. A majority (53/69; 73 %) showed normal 
strong mitfa expression and were presumed wild-type siblings (A, WT), whereas 33/124 
(27 %) had weakened expression and were presumed mitfa mutants (B). (Reproduced with 
the kind permission of Greenhill et al., 2011).  
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Figure 5.14: Zebrafish embryo orientation and stage description at 6 hpf and 10.5 
hpf.  
At early stages of development, embryos can be orientated as in (A) the blastomeres is 
developing in the animal pole (AP: animal pole) while the yolk cells are beneath the 
blastomeres margin in the vegetal pole, (VP: vegetal pole) then the ventral and dorsal sides 
can be defined. The 6 hpf shield stage is represented in (B) in lateral view and animal pole 
view while the bud stage (C, 10 hpf) and the 5 somites stage (D,11 hpf ) are only 
represented in lateral view. Adapted from Kimmel et al., (1995). 
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Figure 5.15: Injection of mRNA encoding WT mitfa drives ectopic expression of dct 
and mitfa at both 6 hpf and 10.5 hpf in zebrafish embryos. 
Injection of WT mitfa mRNA drives ectopic expression of dct (A,E, arrowhead) and mitfa 
(B,F, widespread blue signal (dots as shown by arrowheads)) at 6 hpf (A,B, animal pole 
view, blue signal shown by arrowheads) and 10.5 hpf (lateral view). In contrast no 
expression could be detected in embryos injected with RNA encoding the mitfa
b692
 mutant 
form (C,G,D,H, embryos are shown in lateral view). Expression of the endogenous mitfa 
gene is detected using an anti-sense probe corresponding to the 3’UTR of the gene, a 
sequence absent from the injected RNA. 200 embryos were analysed for each condition 
and embryos presented here show the representative phenotype. A volume of 1 nL of 0.25 
ng.µL
-1
 concentrated mRNA was injected. (Reproduced with the kind permission of 
Greenhill et al., 2011).  
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In this Chapter, several aspects of the GRN were investigated and we showed that: 
 Hdac could be involved, with Mitfa, as a co-repressor of sox10 in 
melanocytes. More particularly, Hdac1 remains the best candidate for this 
feature. 
 We could quantify the de-repression effect of sox10 on dct expression as 
well as confirm expression of melanocytic genes, in mitfa and sox10 
mutants, according to the melanocyte GRN in zebrafish. 
 Mitfa could be a potential activator of its own expression in vivo. 
5.3.1 Hdac1 might be an important factor for melanocyte development 
 
The mathematical modelling predicted that sox10 downregulation in melanocytes would be 
mitfa dependent (Greenhill et al., 2011). Consistent with this prediction, hdac1 mutants 
showed both persistent sox10 expressions in NC cells and poor melanocyte differentiation, 
although, the connection between these phenotypes was not addressed. The data collected 
here allowed further characterisation of the melanocyte differentiation disruption 
associated with the persistent sox10 expression. Chemical inhibition of the histone 
deacetylase function at the time of early melanocyte differentiation allowed us to show that 
blocking Hdac activity in melanocytes led to poor melanocyte differentiation and 
correlated with persistence of sox10 expression.  
 Hdac1 seems to be an important factor for melanocyte development, however, it is 
still unclear what mechanisms are in play and what its role is in vivo. One limitation in this 
experiment was that the small molecule used, Trichostatin A (TSA), is a Hdac inhibitor, 
therefore, it was not specific to Hdac1. This molecule has already been utilised in zebrafish 
to test the role of hdac4 in development at 36 hpf and 6 dpf (Zhu et al., 2011). However, 
only Hdac1 has been shown to have a role in melanoblast development in zebrafish. In 
order to test specific inactivation of Hdac1, it would be essential to investigate this 
hypothesis in colgate/hdac1 mutants, however, it would not be possible to control for 
temporal changes in roles of Sox10, Mitfa and Hadc1. Alternatively, a new conditional 
transgenic line could be created which would express a truncated or dominant negative, 
version of Hdac1 to test conditional blocking of the protein in melanocytes during 
differentiation. It would be interesting to use qPCR analyses in purified NC cells or 
melanoblasts to assess and compare elevation and persistence of sox10 expression in the 
following; WT TSA treated embryos; in mitfa
w2
 embryos; and in mitfa
w2
 TSA treated 
embryos. Furthermore, ChIP experiments looking for Mitfa/Hdac1 complexes on sox10 
promoter would allow verification of the presence of both proteins during melanocyte 
differentiation as direct regulators of sox10. Analysis of sox10 epigenetic markers and 
particularly the acetylation during cell differentiation would also be informative.  
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 The model presented in Figure 5.16 summarises the hypothesis proposed here. 
Hdac1 and Mitfa together would form a complex to allow dowregulation of sox10 
expression in melanocytes and perhaps of foxd3 expression, as suggested in Ignatius et al., 
(2008). In this model, losing Hdac1 or Mitfa would cause maintenance of sox10 and of 
foxd3 in melanocytes and would explain the colgate/hdac1 phenotype described in Ignatius 
et al., (2008) as well as the results described here. As described in the Figure 5.26, the 
maintenance of foxd3 would firstly cause mitfa expression to be decreased as described in 
colgate/hdac1 mutant. Reduced mitfa expression would thus explain reduced activation of 
dct expression in a first instance as observed in colgate/hdac1 mutant. However, the mitfa 
dependent kit signalling would allow the survival of melanocytes and later, the persistence 
of sox10 would permit boosting mitfa expression, as observed in colgate/hdac1 mutants. In 
this model, blocking foxd3 with a morpholino would rescue mitfa expression at early stages 
and therefore would allow recovery of dct expression in melanocytes at early stages, as 
described in the colgate/hdac1 mutant.  
5.3.2 The role of Hdac1 as a repressor of foxd3 in melanocytes 
 
foxd3 is known as a direct repressor of mitfa expression in NC and it has been suggested to 
be involved in glial/melanoblast fate choice by turning off mitfa expression in cells (Lister 
et al., 2006, Curran et al., 2009, Ignatius et al., 2008). The mechanism involved in foxd3 
dependent repression of mitfa is not understood yet. Cooper et al., (2009) suggested that 
foxd3 could be downregulated by the kit signalling in melanocytes. A loss of activation of 
kit signalling would then cause the maintenance of foxd3 which would result in the 
repression of mitfa (Cooper et al., 2009). In WT, foxd3 expression might be kept low in 
melanocytes so that foxd3 and mitfa were never observed to be co-expressed (Thomas and 
Erickson, 2009, Dottori et al., 2001, Curran et al., 2009). Interestingly, the study of foxd3 
mutants showed that defects of melanocyte pigmentation caused by the loss of Foxd3 (such 
as mitfa expression delay at 24 hpf or increase melanocyte number) could be compensated 
after cell differentiation (Stewart et al., 2006). Stewart et al. (2006) studied the sym1 
mutation, a nucleotide deletion which disrupted the forkhead DNA-binding domain of the 
foxd3 gene, introducing a premature stop codon and therefore deactivating foxd3 (Stewart 
et al., 2006, Yuan et al., 2006). This study showed that loss of foxd3 resulted in migration 
delays in NC derivatives migrating on the medial pathway (e.g. neuronal, glial or 
melanocyte precursors) in zebrafish (Stewart et al., 2006). Furthermore, in the study, the 
loss of foxd3 resulted in a delay of mitfa and dct expression as well as a delay in 
melanocyte differentiation. Interestingly, all these phenomena were later compensated and 
no abnormal phenotype was observed in melanocyte number at 3 dpf suggesting there was 
no crucial role for foxd3 in melanocyte development.  
 In colgate/hdac1 mutants, foxd3 expression was increased in somites. Furthermore, 
an increase in the number of cranial satellite glia in the pre-otic and post-otic placodes 
could be observed in this mutant as well as a reduced melanocyte number compared to 
WT. The melanocyte phenotype did not recover until at least 3.5 dpf (Ignatius et al., 2008). 
Interestingly, Ignatius et al. (2008) showed that blocking foxd3 by morpholino injection 
could rescue the melanocyte phenotype in colgate/hdac1 mutant. Looking at WISH 
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investigating foxd3 expression in colgate/hdac1 mutant, it seemed that in the absence of 
Hdac1, foxd3 was expressed in melanocytes. Consequently, extended expression of foxd3 
was suggested as an explanation for reduced melanocytes in colgate/hdac1 mutant. 
However, extended expression of foxd3 did not explain persistence expression of sox10 in 
melanocytes. It seems that the persistence of sox10 expression was a defect of the 
melanocyte GRN itself, due to the lack of Hdac1. Together, these experimental data in 
sym1 and colgate/hdac1 mutants showed that loss of foxd3 does not seem to affect 
melanocyte development in a critical manner. Although, its prolonged expression could 
prevent normal melanocyte development and differentiation, it did not explain sox10 
persistence at 48 hpf in colgate/hdac1 mutants.  
 The role of foxd3 was not investigated in our study. However, the boost of foxd3 at 
24 hpf could explain the reduction of mitfa in mutant embryos at 25 hpf, whereas, sox10 
expression persistence in colgate/hdac1 mutant at 48 hpf could explain the elevated mitfa 
expression in the dorsal region. It is then plausible that Hdac1 repression of foxd3 would be 
mitfa dependent. It would be important to clarify the timing for foxd3 downregulation in 
melanocytes or mitfa (+) cells and the role of a potential Mitfa/Hdac1 complex in this 
process. Ignatius et al., (2008) suggested that Hdac1 was a repressor of foxd3.  
Consequently, in a future experiment, it would be interesting to test this hypothesis by 
comparing the epigenetic state of foxd3 DNA in foxd3 expressing and non-expressing cells 
(silencing by acetylation) and by testing the presence of Hdac1 on the regulatory sequences 
of foxd3 in melanocytes. foxd3 expression could also be investigated in mitfa
w2
 mutants 
during melanocyte differentiation (24 hpf to 48 hpf) to test for increased /prolonged foxd3 
at these stages. 
 Interestingly, one mechanism suggested for Foxd3 dependent repression of mitfa is 
through a co-repressor, CtBP2 (Liang et al., 2011). In zebrafish, Liang et al. (2011) 
showed that morpholino knockdown of CtBP2a and CtBPP2b led to increased melanocyte 
number at 3 dpf as well as increased mitfa expression at 24 hpf in mitfa-GFP transgenic 
fish which was confirmed by qPCR analysis (Liang et al., 2011). Whether or not CtBP2 
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Figure 5.16: Hdac1 and Mitfa together can repress sox10 and foxd3 in melanocytes. 
In WT and un-treated cases (left panel), Hdac1 and Mitfa form a complex (red) which 
represses sox10 and foxd3 expression in melanocytes. Therefore, sox10 and foxd3 
expression are lost in melanocytes as observed in vivo (the black dotted lines represent the 
interaction which only take place before Hdac1/Mitfa repression effect.). The kit signalling 
(mitfa dependent as indicated by blue arrow) could allow melanocyte survival against the 
foxd3 repressive effect in the left panel. However, when one of the two components of the 
complex is missing (mitfa mutant, Hdac-inhibitor treated embryos, colgate/hdac1 mutant 
embryos, shown the right panel), sox10 expression is persistent in melanocytes (as 
observed in vivo in colgate/hdac1 mutant, in Hdac-inhibitor treated embryos and in mitfa
w2
 
mutant embryos) and foxd3 expression is boosted (as observed in vivo in colgate/hdac1 
mutant). In these cases, the kit signalling also allows survival of melanocytes however, cell 
differentiation is impaired by maintenance of foxd3 and persistence of sox10 expression in 
cells. 
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5.3.3 A strategy to better understand mitfa and sox10 regulation in 
melanocyte development. 
 
In order to quantitatively test the GRN model, we quantified expressions of sox10, dct, 
tyrp1b and mitfa in embryos at 30 hpf, 36 hpf and 72 hpf in sox10 and mitfa mutants. 
These experiments confirmed Sox10’s negative effect on some genes downstream of 
Mitfa, such as dct, but not tyrp1b. The results of mitfa expression quantification in sox10 
and mitfa mutants, showed that sox10 activation was not sufficient to generate normal 
levels of mitfa expression in WT. This result could suggest that another factor of regulatory 
mechanism, absent in mitfa mutant, could be important for mitfa activation. Wnt signalling 
has been shown to be required with Sox10 for mitfa activation; interestingly, Chen et al., 
(2000) have described a LEF-1 and Mitf dependent mechanism of co-activation of Mitf. 
Thus, our data are consistent with Mitfa associated with a co-activator such as Lef-1.  
 In the future, RNA sequencing or microarray studies should allow investigation of 
other factors in play during the regulation of sox10 and mitfa. These analyses could allow 
deciphering new factors downstream of Mitfa and/or Sox10. Consequently, it would be 
possible to identify candidate factors for better establishing the regulatory network 
responsible for interactions and expression timecourse of these crucial factors in 
melanocytes in zebrafish. Whether or not more differences between mouse and zebrafish 
could be in play in vivo would have to be investigated further. It would also be interesting 
to quantify expression levels of mitfa, sox10, dct and tyrp1b in melanocyte in mouse 






Chapter 5. Insights into sox10 and mitfa regulation 
   264 
 
5.3.4 Investigating the role of Mitfa in mitfa expression 
 
The model predicted that factors other than sox10 could be involved in mitfa regulation. 
The role of mitfa as a self-regulator has never been addressed in vivo. Here, mitfa 
expression was investigated by ectopically injecting embryos with mitfa mRNA in order to 
preliminarily test the possibility that Mitfa could activate its own expression.  
 
 The observation of low mitfa activation in mitfa
w2
 mutant, combined with 
predictions of the GRN model, suggested that Mitfa could activate mitfa expression. The 
results of the experiment we presented suggested that Mitfa would potentially directly or 
indirectly activate the expression of mitfa. Our experiments focused on ectopic expression, 
and not in melanocytes. However, these data support the hypothesis that Mitfa alone or 
with a cofactor (possibly Lef-1, (Saito et al., 2003)) could be involved in a positive 
feedback loop to maintain its expression. It would be interesting to investigate whether 
Lef-1 could have been recruited in embryos at 6 hpf, which could suggest that Mitfa also 
recruits Lef-1 in melanocytes.  
  
 Mechanisms of negative and positive feedback loops have often been described as 
features of GRNs in eukaryotes. These feedback loops can allow a very simple network of 
just two genes to exhibit non-trivial behaviours like changes in cell fates (Schlitt and 
Brazma, 2007, Becskei et al., 2001). Mitf promoter did not seem to carry M-boxes which 
are Mitf DNA binding sites (Saito et al., 2002). To assess this question further in zebrafish, 
the Zebrafish DNA mitfa genome sequence (gi|76666366|emb|BX927362.10|) (from clone 
CH211-170N20 in linkage group 6, complete sequence) was investigated looking for M-
box sites (AGTCATGTGCT) using BLAST
R
 software and found no matches. This 
suggests that neither the promoter, nor the first intron of mitfa genome sequence, carry a 
Mitfa binding site. Consequently, the regulation of its own expression could be indirect or 
allowed by recruiting a cofactor which could bind Mitf’s promoter or alternatively it could 
be due to activation via a remote enhancer. Further experiments would be required to test 
in vivo whether Mitfa could drive mitfa expression. One suggestion would be to generate a 
new zebrafish line: a sox10 mutant line expressing mitfa under a heat-shock promoter. In 
these fish, inducing a first temperature dependent activation of mitfa at about 30 hpf should 
be sufficient to engage a feedback loop which would trigger constant expression of mitfa. 
Expression of mitfa could then be tested later, at several timepoint, 32, 36, 40, 48 hpf, by 
WISH or qPCR and compared to a no heat-shock control. Furthermore, ChIP experiments 
testing for the recruitment of both Lef-1/Mitfa or Mitfa alone in melanocyte during 
differentiation would allow us to assess the role of Mitfa in its own expression in 




Altogether these experiments permitted us to go further with our understanding of the fine 
regulation of the GRN. For example, quantifying gene expression in both sox10 and mitfa 
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mutants added further support to the interpretation of previous experiments. Specifically 
we confirmed the hypothesis of sox10’s role in melanocyte differentiation in zebrafish and 
their differences from the described data in mouse. Our experiments also suggest focusing 
future experiments on testing two potential co-regulating complexes involving Mitfa. 
Firstly, the Hdac1/Mitfa complex could be involved in sox10 repression with Mitfa as a 
binding factor, and secondly, the Lef-1/Mitfa complex could be an activator of Mitfa with 
Lef-1 as a binding factor. It would be crucial to determine the epigenetic status of both 
mitfa and sox10 during cell differentiation as well as investigating factors binding 
promoters by ChIP experiments to test these hypotheses.  
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Chapter 6. Discussion 
6.1 Overview  
In this thesis, I have presented and contributed knowledge on the genetics of melanocyte 
development. Some of the key findings are as follows: 
 mitfa expression was maintained in melanocytes in an Mitfa-dependent 
fashion (Chapter 4 and 5) suggesting the existence of a positive feedback 
loop on Mitfa involving a Factor Y. 
 Wnt signalling remained activated in melanocytes after cell specification. It 
was not limiting for melanisation, although it may play a role in other 
aspects of melanocyte differentiation, including cell adhesion/patterning. 
Thus, whilst Wnt signalling may contribute to Factor Y, it is likely only one 
of several factors that act here (Chapter 3).  
 We showed that melanocytic gene expression could be quantified in whole 
embryos, and in pools of five cells in the NC cell population and in 
melanocytes using stochastic profiling (Chapter 4). This method allowed us 
to observe an unexpected decrease of mitfa expression in melanocytes at late 
stages (Chapter 4). 
 Single cell PCR showed the co-expression of mitfa and ltk in a substantial 
proportion of sox10+ NC cells, consistent with the proposed partially-
restricted pigment cell progenitor (chromatoblast) discussed in Lopes et al 
(2008). 
 Inhibiting Hdac in zebrafish embryos suggested that Hdac could be a Mitfa-
dependent co-repressor of sox10 (Chapter 5). This could explain the 
decrease of sox10 expression in melanocytes, which was confirmed by 
stochastic profiling of sox10 expression in melanocytes (Chapter 4). 
This research used NC in zebrafish to investigate melanocyte development and has broad 
implications as melanocytes are found widely in vertebrates, including human. This also 
contributes, in a wider sense, to knowledge in the fields of zebrafish development, NC 
development, stem cell biology, developing techniques for the study of expression 
variation, cell heterogeneity and fate restriction and melanocytic diseases. 
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6.2  Defining mitfa expressing cells at early stages 
For the melanocyte lineage, the known determining factors are mitfa and sox10 but the 
results of our study suggested that in zebrafish, not all mitfa/sox10 positive cells at 23 hpf 
would become melanocytes (Dutton et al., 2001). Observing the co-expression of an 
iridoblast marker such as ltk in sox10(+)mitfa(+) cells at 23 hpf suggested that the 
existence of a chromatoblast should be further tested in zebrafish before 30 hpf. Lineage 
restriction study could allow the following of cells from early to late stages to determine 
the potentiality of mitfa (+) cells at 23 hpf. From 23 hpf to 30 hpf, the NC cell pool is 
heterogeneous and both characterising the precursor types present and identifying the 
mechanisms causing genetic heterogeneity would allow us to better define fate restriction 
in NC. Developing a zebrafish NC cell culture from single cells could help understand the 
potentiality of cells at each time point.  
6.3 MITF as a co-factor for many potential factors 
Our results suggested that Mitfa could recruit a co-inhibitor, Hdac, for downregulation of 
sox10 expression and perhaps also a co-activator (e.g. Lef-1), for its auto-activation. 
Interestingly, MITF has been shown to bind other protein factors in mammals, including 
SOX10, LEF1, PAX3, CREB, GLI2, OC-2, CtBP2 and MITF (Kim et al., 2000b, Liang et 
al., 2011, Saito et al., 2003, Bondurand et al., 2000). Other factors could bind MITF such 
as Rab27a, a member of the RAS oncogene family involved in melanosome transport in 
mouse (Sestakova et al., 2010, Kawasaki et al., 2008). These analyses show that Mitfa is at 
the centre of a protein interaction network, allowing complex regulation of gene 
expression.  
 One example of a co-regulation mechanism involving Mitfa has been tested here as 
a feature of the network: the role of Hdac as a Mitfa-dependent co-repressor of sox10 
expression. The study of colgate/hdac1 mutant combined with our study of effects of Hdac 
inhibition suggested that, in this case, sox10 downregulation could be explained by the 
activity of Hdac, and particularly Hdac1, as a co-repressor for Mitfa in melanocytes 
(Ignatius et al., 2008). Several crucial aspects of this mechanism remains to be tested: 
whether Mitfa and Hdac1 both directly interact; whether this complex could also recruit 
other factors; whether this complex remains attached to the sox10 promoter after 
differentiation. As described in Turner, (2000), Hdacs have the ability to trigger long-term 
epigenetic changes. Thus, interaction between Hdac1 and Mitfa at mitfa DNA binding site 
on sox10 promoter might cause long term/permanent downregulation of sox10 expression 
in melanocytes. It would be interesting to perform ChIP analysis looking for Mitfa/Hdac1 
interacting on sox10 promoter. This could be complemented by measurements of 
chromatin acetylation levels at the sox10 gene before and after 48 hpf. We predict 
acetylation levels would be higher before Hdac was active in melanocytes, before 48 hpf, 
and would then decrease. 
 Our analysis also raises the hypothesis that foxd3 could be inhibited by Hdac1 in a 
Mitfa dependent manner in colgate/hdac1 mutant. foxd3 is required for NC cell 
development and several studies in zebrafish, Xenopus and mouse, suggested that foxd3 
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had an important role in regulating melanocyte specification (Curran et al., 2010, Wang et 
al., 2011, Kos et al., 2001, Honore et al., 2003). Ignatius et al., (2008) observed an 
increase of foxd3 expression in colgate/hdac1 zebrafish mutant and thus suggested that 
Hdac1 could be a negative regulator of foxd3 in melanocytes. Knowing that foxd3 
expression is inhibited in melanocytes and that Mitfa can probably recruit co-factors such 
as Hdac1, it is plausible that foxd3 expression could be inhibited by Hdac1 in a Mitfa 
dependent manner in colgate/hdac1 mutant. Investigating whether or not and in which 
cells the expression of foxd3 is boosted in mitfa
w2 
mutant and if mitfa expression is 
activated in foxd3 mutant, could help understanding the regulation between these two 
factors. 
6.4 mitfa is lowly expressed in melanocyte differentiation in 
zebrafish 
 
Together, the data collected and analysed in Chapters 3-5 have allowed us to observe and 
suggest improvements to the core melanocyte GRN published in Greenhill et al., (2012) 
and more particularly for the role of mitfa in this process. Melanocyte differentiation relies 
on mitfa expression, but our experiments suggest that it is maintained only at a low level in 
melanocytes. Weakly maintaining mitfa expression (weak role of Factor Y) could directly 
or indirectly allow the system to firstly activate another factor which was previously 
described as Factor X, which remains to be determined. Here we discuss the mechanisms 
involved in the decrease of mitfa expression and the potential existence of Factor X. 
6.4.1 Mitfa expression is decreased but maintained in melanocytes 
 
Our data quantifying mitfa expression in single cells showed that mitfa remained expressed 
in melanocytes at 72 hpf (Chapter 4). However, the decrease of absolute and relative 
expression of mitfa in melanocytes by 72 hpf suggested that the genetic or epigenetic 
mechanisms involved in its maintenance are also involved or play a part in this decrease 
(Chapter 4). Consequently, in this hypothesis, Factor Y would be an ensemble of factors 
which allow the maintenance of mitfa but at a low level of expression.   
 The hypothesis raised by the model suggests that Mitfa itself could be a regulator of 
mitfa expression is supported by the result of activation of mitfa by Mitfa in an ectopic 
context in vivo (Chapter 5). However, this prediction of the model also raises another key 
question, whether Mitfa acts alone or via another factor. We have not directly addressed 
this question is this study but it will be important to investigate it in the future. It would 
first be important to test if this feedback interaction existed in vivo in melanocytes, and if it 
did, would it be sufficient to maintain mitfa expression during melanocyte differentiation. 
Mitfa can recruit co-factors, to re-direct or to cause activation or inhibition of gene 
expression. Here, Mitfa could perhaps activate its own expression using a co-factor such 
as, Lef-1, as suggested by Saito et al., (2003). In this hypothesis, Mitfa/Lef1 would work 
together to maintain a low level of mitfa expression and melanocyte differentiation. This is 
supported by the data we collected showing that Wnt signalling remained lowly activated 
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in melanocytes after cell specification (Chapter 3). However, boosting Wnt signalling did 
not cause dramatic effects on melanocyte differentiation even if mitfa expression was 
boosted. This data suggest that Wnt signalling was not limiting for cell differentiation. In 
this hypothesis, both the co-activation of mitfa by Mitfa/co-activator of mitfa (Lef-1?), and 
other unknown factors or mechanisms, would be responsible for the maintenance of low 
levels of mitfa expression. Furthermore, in this hypothesis, this low level of mitfa 
expression would be key for maintenance of melanocyte differentiation. Interestingly, this 
has been verified in Johnson et al., (2010) where a conditional loss of mitfa in melanocytes 
after 48 hpf, in zebrafish caused loss of cell differentiation with loss of melanisation, loss 
of cell dendricity, reduced melanised cell number. 
6.4.2 Mitfa and Factor X could be important for melanocyte 
differentiation GRN 
 
Alternatively, the decrease of mitfa observed in melanocytes could suggest that Mitfa 
could be activating another key factor in the process of melanocyte differentiation. This 
other factor could be a factor previously suggested, Factor X, and its first activation could 
be Mitfa dependent. In this hypothesis, Factor Y could actively maintain low levels of 
mitfa expression in cells as in the previous hypothesis, however, here, after activation of 
Factor X, Mitfa would only be key for activating Factor X. The existence of Factor X had 
already been suggested by Greenhill et al., (2011) (called model A), however, the 
observation of mitfa expression decrease in cells is the first potential biological evidence 
for its existence. As discussed in Chapter 4, these observations would not rescue the 
original model A which was too simplistic and also had other flaws such as, it could not 
explain the sox10-independent maintenance of mitfa expression we observe in vivo, nor the 
mitfa-dependent decrease of sox10 expression suggested by in vivo data (Greenhill et al., 
2011, Elworthy et al., 2003b). A new version of the model, taking into account this 
unexpected decrease of mitfa expression, would include the presence of a factor to relay 
mitfa expression at a later stage, during differentiation, together with other parameters 
described in model C and here (Greenhill et al., 2011). Testing if Wnt signalling was 
Factor Y caused a boost of mitfa expression during melanocyte differentiation, however, 
this did not dramatically affect melanocyte differentiation. This result could also suggest 
that Mitfa is the only not key factor after 48 hpf in melanocytes. The Figure 6.03 
summarises the new proposal for the melanocyte GRN at both specification and 
differentiation states, including the Factor X hypothesis. It would be interesting to test the 
hypothesis of the existence of Factor X, however, no candidate factors are currently known 
from zebrafish. Investigating transcription factors responding to Mitfa could help finding 
appropriate candidates.  
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Figure 6.03: Factor Y as a factor to maintain low levels of mitfa expression and 
Factor X as a key factor for melanocyte differentiation first activated by Mitfa. 
The blue dashed arrows and the blue cadre show the GRN in place during melanocyte 
specification (Greenhill et al., 2011). The green arrows (feedback Factor Y/Mitfa), the 
green cadres (co-inhibition of sox10 by Mitfa/Hdac1) and the green circles (Factor Y= Wnt 
signalling with cAMP pathway and/or Mitfa itself and existence of Factor X as a Mitfa 
dependent factor activator of melanocytic genes) show the potential new features of the 
GRN for melanocyte differentiation in regards of the results presented in this study.  
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6.5 New factors interacting with mitfa for melanocyte 
differentiation 
 
In this study, we found that Wnt signalling was not limiting for melanocyte differentiation, 
consequently, new candidate factors should be investigated. Furthermore, going further 
with the GRN involved in melanocyte development means finding new factors involved in 
the GRN, or, identifying new mechanisms involved in maintaining the differentiated state. 
As described in Levy et al., (2011), Dicer could be a potential factor involved in 
melanocyte development. Levy et al., (2011) showed that protein and mRNA levels of 
microRNA and DICER were upregulated in melanocytes during development in human 
primary melanocytes and suggested that Mitf could be responsible for this increase. MITF 
could then activate Dicer expression via two E-boxes on Dicer promoter. Importantly, in 
their experiment, Dicer knockdown caused a loss of hair follicle melanocytes. In zebrafish, 
the orthologue dicer1 is active on processing miRNA, however, its role in mitfa regulation 
or in melanocytes has not been investigated yet. To test Dicer1 involvement in mitfa 
regulation, it would be interesting to use morpholinos against dicer1, as in Cifuentes et al., 
(2010) and look at melanocyte development at 30 hpf and mitfa WISH around 20 hpf. 
  Another study has shown the role of Transcription factor AP-2, Tfap2a and Tfap2e 
in melanocyte differentiation in zebrafish via regulation of mitfa activity (Van Otterloo et 
al., 2012). The study showed that knockdown of both tfap2a and tfap2e in zebrafish 
triggered downregulation of dct, tyrosinase and tyrp1b expression as well as cell 
autonomous changes such as a reduction of melanocyte melanin content and reduced cell 
number at 36 and 48 hpf (Van Otterloo et al., 2012). Their study suggested that the role of 
Tfap2 could be to modulate Mitfa transcriptional activation of target genes via direct 
phosphorylation of Mitfa, or via phosphorylation of a factor which in turn would regulate 
Mitfa activity (Van Otterloo et al., 2012). It would be important to better test the timing of 
activity of Tfap2a and Tfap2e for melanocyte development to understand whether it is 
required for melanocyte specification and later for differentiation and finally if it affects 
genes other than mitfa. For this, it would be possible to utilise a conditional approach using 
a dominant null allele of tfap2a, under a heat-shock promoter, inducible at a specific 
temperature. Then, conditional knockdown of the gene at different time of melanocyte 
differentiation would allow for the testing of the effects of decreased tfap2a on melanocyte 
development. 
6.6 The study of Mitfa and Sox10 expression in zebrafish has 
important implications for melanoma research  
 
The role, the regulation and the expression level variations of mitfa and sox10 we described 
in our study in zebrafish are relevant to the better understanding of melanoma. The 
oncogenic role of the gene MITF has been described as well as its pro-proliferation effect 
depending on its level of expression (Kido et al., 2009). This justifies the study of the 
regulatory mechanisms activating or inhibiting MITF. In this study we showed that mitfa 
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expression was decreased in melanocytes during cell differentiation however, its expression 
remained maintained. Mitf has been found to be involved in melanoma progression in 
several studies implicating different pathways such as the MAPK/MERK pathway as 
shown in B16 melanoma cells in vitro in Englaro et al., (1998). A study in melanoma cell 
lines has shown that BRAF is involved in enhancing melanoma response to MITF and 
therefore, suggested that Mitf and BRAF could both be the targets for melanoma treatments 
(Kido et al., 2009). It would be interesting to investigate whether the activation of the 
MAPK/MERK pathway in melanocytes could be indirectly Mitfa dependent and is 
therefore decreased during normal cell differentiation. 
 In our experiments in normal melanocyte development, we observed a decrease of 
sox10 expression in melanocytes. Interestingly, in melanoma cells in culture, it has been 
suggested that the factor Tyro3 could play a role in activating Mitf, via Sox10. Indeed, it 
has been suggested that Tyro3 could activate Mitf expression in a Sox10 dependent manner 
and by bypassing BRAF in melanocyte and melanoma backgrounds (Zhu et al., 2009, 
Easty et al., 2011). Ectopic expression of Tyro3 could activate, or downregulate (Tyro3 
shRNA infection) Mitf expression by redirecting SOX10 to the nucleus. Therefore, in cell 
culture Tyro3 knockdown led to reduced melanoma and in contrast, Tyro3 overactivation 
led to increased melanoma and the levels of Tyro3 measured by RT-PCR in melanoma 
cells were found to be increased by 3 folds in 50 % of samples studied compared to normal 
skin tissue (Zhu et al., 2009, Easty et al., 2011). A clear mechanism for this interaction 
remains to be described in vivo and the role of Tyro3 in normal melanocyte development 
remains to be described in zebrafish. It would be interesting to test whether B-raf or Tyro3 
could activate sox10 during melanocyte development in zebrafish.  
 Altogether, these studies suggested that over-activation of Sox10 could be key in 
the increase of Mitf observed in melanoma cells. They suggested that the Sox10 expression 
increase could be related to the MAPK pathway via several routes such as P38 kinase or 
BRAF but also that the epigenetic state of Sox10 and Mitf could be crucial in this 
misregulation. Factors and pathways such as p38, Braf, Mc1r, PKA, cAMP, Gsk3β, Nfat, 
Disc1, CtBP2, Sox2, Dicer or Tyro3 have been suggested to be important actors in the 
network and they also will have to be investigated in fish to improve our understanding of 
the GRN of both normal melanocyte and melanoma (Kido et al., 2009, McGill et al., 2002, 
Gross et al., 2009, Drerup et al., 2009, Saha et al., 2006, Zhu et al., 2009, Liang et al., 
2011, Adameyko et al., 2011, Levy et al., 2011).  
6.7 Measuring transcriptional variation may help to better 
characterise melanocyte development and perhaps melanoma 
development 
 
In this study we developed a technique to measure cell heterogeneity in a population. 
Heterogeneity can be biologically critical for the emergence and/or the survival of different 
cell types during cell specification and differentiation but also for the survival of cancer 
cells in a population. Going further in the development of techniques to measure cell to cell 
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heterogeneity would help understand the role of different cell clones in melanoma tumor 
formation.  
 Our experiments now show that it is possible to investigate gene expression in 
melanocytes in pools of five zebrafish cells. In the future, further development of the 
technique could allow us to investigate gene expression at the single cell level, ex vivo. 
Single cells analysis could also allow us to measure expression levels of key genes in 
melanoma cells compared to normal cells at different timepoint of the melanoma tumor 
progression. The technical difficulty of measuring gene expression in a low amount of 
material remains a major obstacle for this research. Various techniques have been 
described and several machines and kits have been developed to permit a better approach 
to this problem. New methods such as the one developed by the Xie Group of the 
University of Harvard allow probing of single molecules in cells (Friedman et al., 2006). 
Another technological approach was used in Narsinh et al., (2011) for studying the role of 
cell heterogeneity in pluripotency. This technology developed by Fluidigm DELTAgene 
Assays, consists of high-quality, rapid, and robust single cell qPCR. Such approaches 
could be tested with the objective to design an assay for detection of very low material 
amount in zebrafish cells.  
 The heterogeneity within cells seems to play an important role in the maintenance, 
the survival and the progression of melanoma cells. In vivo, melanoma cells have also been 
shown to be heterogeneous (Sieber-Blum and Hu, 2008). Also they have been shown to be 
characterised by the heterogeneity of signalling pathways and factors also involved in 
melanocyte development (Croteau et al., 2012, Busca et al., 2000, La Porta and Zapperi, 
2012, Schatton and Frank, 2008). This heterogeneity is not well defined from one tumor to 
another and it is a crucial parameter to better understand cancers in vivo. Croteau et al., 
(2012) described striking intra-tumor heterogeneity by measuring gene expression in two 
clonal tumors which were distinguished after isolation from a same parental tumor. The 
study showed high heterogeneity of metalloproteinase-1 (MMP-1) in melanoma cells 
which was involved in aggressiveness, and interestingly, the heterogeneity of Braf was also 
observed. The two clonal populations rapidly showed different characteristics of growth, 
survival and invasiveness (Croteau et al., 2012). Studies in melanoma cells reported that 
Mitf expression level could be either increased or decreased relating heterogeneity of its 
expression (Easty et al., 2011, Rebecca et al., 2012, Yancovitz et al., 2012). 
 Other studies have described stochasticity in cancer cell population with a 
stochastic Markov model (Gupta et al., 2011). This model assumed that the changes in cell 
states, called the interconversion rates, only depend on the cell’s current state and remains 
constant under fixed environmental conditions. In this study, Gupta et al., (2011) showed 
the role of stochasticity in single cell behaviour promoting phenotypic equilibrium in the 
cancer cell population. In cancer cell populations, this equilibrium allowed the 
maintenance of some specific cell-surface markers profiles across many divisions in cell 
culture (Gupta et al., 2011).  
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6.8 Zebrafish is a new tool for developing drugs against 
melanocyte-related disease in human 
 
In this study we used zebrafish as a model to study melanocyte development and the 
results we collected for normal development of the cell can be used for understanding 
abnormal development such as in neurocristopathies and melanoma. Furthermore this 
knowledge can be extrapolated in human and used for engineering new therapeutic 
strategies.  
 Melanoma is associated with mis-regulation and an increase of β-catenin, B-
RAF/B-RAS and the cAMP pathway as shown in B16 melanoma cells (Goding, 2000, 
Rubinfeld et al., 1997, Van Dyke and Merlino, 2012, Busca et al., 2000, Dumaz, 2012).  
Ceol et al., (2011) studied genes involved in melanoma in the zebrafish model. They used 
a transgenic line Tg(mitfa:BRAFV600E) which over expresses the oncogene BRAF in 
melanocytes, in a p53(lf) mutant background, to investigate genes involved in activating 
tumor formation (Ceol et al., 2011). In the transgenic Tg(mitfa:BRAFV600E); p53(lf) 
mutant, the melanocyte and tumor formation were suppressed by another mutation, the 
mitfa(lf). Consequently, Tg(mitfa:BRAFV600E); p53(lf); mitfa(lf) fish did not show 
melanised pigmentation. After identifying candidates for tumor formation from studies of 
human tumor samples, Ceol et al., (2011) cloned the candidate sequences into a transposon 
vector and injected it at one cell stage in transgenic Tg(mitfa:BRAFV600E); p53(lf); 
mitfa(lf) fish. Melanocyte production and melanoma could be rescued in adult fish injected 
with mRNA coding for the enzyme SETDB1. Consequently, using this strategy, Ceol et 
al., (2011) showed that enzyme SETDB1, which methylates the histone H3 on lysine 9 
(H3K9), could accelerate melanoma tumor formation in fish. These results could be used 
to investigate this enzyme and target it for drug design in human. 
 Zebrafish is an acceptable model for the study of melanoma as shown in Ignatius 
and Langenau, (2009), Patton and Zon, (2005), Feitsma and Cuppen, (2008), Mione and 
Trede, (2010) and Ceol et al., (2011). Combining the possibilities offered by new 
technologies to the available analysis of melanocyte cells in zebrafish brings the right 
conditions for establishing new efficient methods to test new therapeutic drugs or assays. 
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6.9 Future experiments 
 
In addition to the other experiments suggested in Chapter 3-5, future possibilities could 
also be found with transgenic lines, such as mitfa-GFP, sox10-GFP, ltk-GFP or TOP;dGFP, 
which will help to fully test the new hypotheses and improve the understanding of the 
underlying melanocyte genetics. The regulation of mitfa and sox10 in melanocytes as well 
as the discovery of new factors involved in their regulatory process through cell 
development remains a central node. The existence of a chromatoblast should be further 
tested and in this aim, single cell transcriptome analysis could be performed.  
6.10 Conclusion 
 
In conclusion, these experiments have allowed us to answer some important questions and 
to propose new research directions in the context of melanocyte development. The 
fundamental aspect of melanocyte developmental research is particularly relevant for 
developing the understanding of the mechanisms involved in several congenital and 
aggressive human diseases. The development of applied research for developing drugs 
tested in cell culture, in mouse, or in zebrafish, is then closely related and based upon the 
fundamental study of genetic regulatory networks such as the one presented here.
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 Evidence for the unsuitability of using a Mc1r morpholino (5’-
AGTGATGGCGCGAAGAGTCGTTCAT-3’) to test the role of the Mc1r 
pathway in melanocyte differentiation in zebrafish. 
Mc1r has been involved in pigmentation phenotypes in several species. In human, the 
pheomelanin:eumelanin ratio influences the skin’s reaction to the sunlight resulting in the 
tanning reaction, as well as, changes in hair colour (Naysmith et al., 2004). Activation or 
inhibition of Mc1r causes elevated or reduced levels of eumelanin and pheomelanin, 
respectively. In consequence, when the receptor is activated, a darker phenotype can be 
observed, and in contrast, inhibition of the receptor triggers a lighter phenotype (Garcia-
Borron et al., 2005, Benned-Jensen et al., 2011). In mice, the cAMP levels regulate the 
activity of the melanogenic enzyme TYR in cells and therefore its controls the ratio 
eumelanin/pheomelanin in cells. In fish, Gross et al., (2009) showed that Mc1r knockdown 
caused the reduction of melanisation in 48 hpf zebrafish. In horses, the chestnut coat colour 
has been shown to be associated with a single strand conformation polymorphism 
corresponding to a single missense mutation in the mc1r allele (Marklund et al., 1996, 
Naysmith et al., 2004, Metz et al., 2006, Takahashi and Kawauchi, 2006). The Function of 
α-Msh in fish has most frequently been attributed to inducing rapid dispersal of melanin 
granules from clustering around the nucleus to dispersal throughout the cell body and 
dendritic extensions of the melanocytes (Metz et al., 2006). Therefore, mc1r has also been 
shown to be involved in melanocyte differentiation as well as in regulation of the 
melanocyte shape and dendricity by regulating the production of catalase (Maresca et al., 
2010).  
 In contrast, in the blind Mexican cave fish Astyanax mexicanus, the brown 
phenotype was associated with reduced melanocyte pigmentation. This phenotype has been 
shown to be due to a 2-base-pair deletion in the extreme 5’ end of the coding sequence, 
corresponding to the N-terminal domain of Mc1r (Gross et al., 2009). In the study, Gross 
et al., (2009) used the zebrafish model to recapitulate the brown phenotype observed in 
Astyanax mexicanus. Morpholino injections were used to knockdown the activity of Mc1r 
at one cell stage and the phenotype in melanocyte was observed in embryos at later stage. 
However, the post-translational knockdown of Mc1r by the morpholino was not assessed 
in cells so the functionality of the protein could not be estimated. Gross et al., (2009) 
described a quantitative decrease of the melanin content in melanocyte and a decrease of 
eye pigmentation in embryos injected with the morpholino which were compared to 
control embryos. Because of its capacity to modulate the skin (and melanocyte) 
colouration in many species, but also because of its capacity to activate and regulate Mitf 
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expression, it is important to fully understand the role of mc1r in zebrafish, in melanocyte 
development 
 To confirm the results obtained by Gross et al., (2009), and before further testing of 
the effects of Mc1r knockdown in mitfa expression in zebrafish, the experiments consisting 
of injecting Mc1r morpholino at 0.2 µM, were repeated by us. However, in contrast with 
the results related in Gross et al., (2009), the staging of embryos was taken into account. 
Melanisation content changes rapidly and dynamically in embryos at early stages, therefore 
it is essential to compare embryos of the same stage to correctly analyse melanisation and 
pigment cell phenotypes. As there was no staged control in the Gross et al., (2009) 
experiment, the first objective here, was to assess the pigmentation decrease phenotype by 
comparing the morpholino injected fish to a staged control embryo. If Mc1r was a crucial 
factor for melanin content modulation, or activation, blocking its activity should result in a 
marked decrease of cell pigmentation at 48 hpf, for example. The MO-Mc1r injected 
embryos showed developmental retardation compared to embryos injected with 0.2 µM 
non-sense construct at 48 hpf (data not shown). Head inclination, heart development and 
CNS development allowed to stage the injected embryos at 36 hpf (Kimmel et al., 1995). 
Therefore, melanocyte pigmentation phenotype in morpholino injected embryos was not 
compared to 48 hpf embryos injected with the control non-sense construct, but instead, it 
was compared to the staged 36 hpf fish. Unexpectedly, comparing MO-Mc1r injected 
embryos to staged control embryos did not show any difference in melanocyte blackness, 
development or number. These results showed that the decrease of pigmentation observed 
in Gross et al., (2009) was not clearly assessed. Furthermore, no test for activity of the 
morpholino was carried out, and consequently, it remains unclear if Mc1r could be 
important for melanocyte differentiation and pigmentation in fish.  
  Other mechanisms in cells could compensate for Mc1r knockdown by increasing 
the cAMP or MEK signalling for example. Indeed, the stress induced p38 pathway has also 
been involved with activation of the cAMP and the MEK pathways in melanocytes and it 
could be interesting to experimentally block or induce both MC1R and p38 pathways in 
embryos (Bellei et al., 2010). This could be done by inducing Mc1r and p38 messengers 
ectopically in embryo, with or without, sox10 and testing mitfa or tyrosinase expression. 
From this, an ectopic boost of expression when injecting both p38 and Mc1r. 
  Interestingly, mc1r has also been identified as a potential Mitfa target in microarray 
screens (Hoek et al., 2008, Aoki and Moro, 2002). Further, comparing levels or mc1r in 
melanocyte in mitfa mutant to WT could show this interaction, suggesting the possibility of 
a regulatory loop activating mitfa expression. Other factors might be important for mitfa 
regulation and improving understanding of these factors will become a priority.  
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 Single cell qPCR results 
 
Three single cell samples (see Chapter 2, Material & Method for details of the method) 
could be analysed by RT-qPCR. Results are shown in Table A, and (Figure 7.01). Two of 
the cells show 322 and 275 copies of dct and the third shows 3087 copies of dct. These 
data on their own are not informative, and only give a sense of how many copies of the 
gene are detected at this exact time point. However, it would be interesting to collect more 
of these data for the four genes of interest (and more) at the five time points in order to 
provide numeric data for our mathematical modelling. More experimental optimisation 
would be required to improve the efficiency and the control of this experiment. More 
controls are required in order to test, by another method (e.g. single cell RT-nested PCR), 
the proportion of single cells expected to be positive for each gene. It would then be 
interesting to optimise the single cell RT-qPCR technique to match these results and 
inform us on expression levels for these genes in cells through specification and 
differentiation.   
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(B)   
                    
 
Figure 7.01:  Single cell analysis of RT-qPCR looking at dct expression at 48 hpf. 
Result of gene expression (dct) quantification in single melanocytes issued from 48 hpf 
zebrafish embryos. (A) Graph of Fluorescence signal (F1) as a function of the cycle 
number showing the dct amplification curve for each of the ten single cell samples in 
duplicate. The red line indicates the background levels. Three cells show the characteristic 
exponential linear increase of signal (cell 2, samples 3-4, cell 7, sample 13-14, cell 
10,samples 19-20) the rest of samples do not . Graph showing the exponential linear 
increase of fluorescence signal (B) above the background (red line) for samples 3,4 (cell 
2), 13,14 (cell 7), 19, 20 (cell 10) and  the standard control (21,22). Cells 2, 7 and 10 show 
a clear exponential linear increase of signal 
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TABLE A: dct copy number in single cells at 48 hpf determined by qRT-PCR 
                                  
                                  Cell:            2                   7                 10              
dct copy number:                        489                380           3364 








Figure 7.02: Graph related to TABLE A showing the dct copy number in single 
melanocytes at 48 hpf determined by qRT-PCR  
dct copy number average in cell 2, 7 and 10 (± standard deviation). 
 
 
 
 
 
